
<html lang="en"     class="pb-page"  data-request-id="531d51f1-2273-406c-a3c1-c5b407cb4ae8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.8b01854;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2019.62.issue-5;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Boron-Pleuromutilins as Anti-Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis" /></meta><meta name="dc.Creator" content="Robert T.  Jacobs" /></meta><meta name="dc.Creator" content="Christopher S.  Lunde" /></meta><meta name="dc.Creator" content="Yvonne R.  Freund" /></meta><meta name="dc.Creator" content="Vincent  Hernandez" /></meta><meta name="dc.Creator" content="Xianfeng  Li" /></meta><meta name="dc.Creator" content="Yi  Xia" /></meta><meta name="dc.Creator" content="David S.  Carter" /></meta><meta name="dc.Creator" content="Pamela W.  Berry" /></meta><meta name="dc.Creator" content="Jason  Halladay" /></meta><meta name="dc.Creator" content="Fernando  Rock" /></meta><meta name="dc.Creator" content="Rianna  Stefanakis" /></meta><meta name="dc.Creator" content="Eric  Easom" /></meta><meta name="dc.Creator" content="Jacob J.  Plattner" /></meta><meta name="dc.Creator" content="Louise  Ford" /></meta><meta name="dc.Creator" content="Kelly L.  Johnston" /></meta><meta name="dc.Creator" content="Darren A. N.  Cook" /></meta><meta name="dc.Creator" content="Rachel  Clare" /></meta><meta name="dc.Creator" content="Andrew  Cassidy" /></meta><meta name="dc.Creator" content="Laura  Myhill" /></meta><meta name="dc.Creator" content="Hayley  Tyrer" /></meta><meta name="dc.Creator" content="Joanne  Gamble" /></meta><meta name="dc.Creator" content="Ana F.  Guimaraes" /></meta><meta name="dc.Creator" content="Andrew  Steven" /></meta><meta name="dc.Creator" content="Franziska  Lenz" /></meta><meta name="dc.Creator" content="Alexandra  Ehrens" /></meta><meta name="dc.Creator" content="Stefan J.  Frohberger" /></meta><meta name="dc.Creator" content="Marianne  Koschel" /></meta><meta name="dc.Creator" content="Achim  Hoerauf" /></meta><meta name="dc.Creator" content="Marc P.  Hübner" /></meta><meta name="dc.Creator" content="Case W.  McNamara" /></meta><meta name="dc.Creator" content="Malina A.  Bakowski" /></meta><meta name="dc.Creator" content="Joseph D.  Turner" /></meta><meta name="dc.Creator" content="Mark J.  Taylor" /></meta><meta name="dc.Creator" content="Stephen A.  Ward" /></meta><meta name="dc.Description" content="A series of pleuromutilins modified by introduction of a boron-containing heterocycle on C(14) of the polycyclic core are described. These analogs were found to be potent anti-Wolbachia antibiotics..." /></meta><meta name="Description" content="A series of pleuromutilins modified by introduction of a boron-containing heterocycle on C(14) of the polycyclic core are described. These analogs were found to be potent anti-Wolbachia antibiotics..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 7, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01854" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01854" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01854" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01854" /></link>
        
    
    

<title>Boron-Pleuromutilins as Anti-Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01854" /></meta><meta property="og:title" content="Boron-Pleuromutilins as Anti-Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0010.jpeg" /></meta><meta property="og:description" content="A series of pleuromutilins modified by introduction of a boron-containing heterocycle on C(14) of the polycyclic core are described. These analogs were found to be potent anti-Wolbachia antibiotics and, as such, may be useful in the treatment of filarial infections caused by Onchocerca volvulus, resulting in Onchocerciasis or river blindness, or Wuchereria bancrofti and Brugia malayi and related parasitic nematodes resulting in lymphatic filariasis. These two important neglected tropical diseases disproportionately impact patients in the developing world. The lead preclinical candidate compound containing 7-fluoro-6-oxybenzoxaborole (15, AN11251) was shown to have good in vitro anti-Wolbachia activity and physicochemical and pharmacokinetic properties providing high exposure in plasma. The lead was effective in reducing the Wolbachia load in filarial worms following oral administration to mice." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01854"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01854">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01854&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01854&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01854&amp;href=/doi/10.1021/acs.jmedchem.8b01854" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2521-2540</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01826" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01862" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Boron-Pleuromutilins as Anti-<i>Wolbachia</i> Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Robert T. Jacobs</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Robert T. Jacobs</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Anacor Pharmaceuticals, 1020 East Meadow Circle, Palo Alto, California 94303, United States</div></div><span class="conrtib-corresp"><strong>*</strong>E-mail: <a href="/cdn-cgi/l/email-protection#1d6f69777c7e727f6e2a2c28255d7a707c7471337e7270"><span class="__cf_email__" data-cfemail="97e5e3fdf6f4f8f5e4a0a6a2afd7f0faf6fefbb9f4f8fa">[email protected]</span></a> (R.T.J.).</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Robert+T.++Jacobs">Robert T. Jacobs</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9669-2862" title="Orcid link">http://orcid.org/0000-0001-9669-2862</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christopher S. Lunde</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christopher S. Lunde</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Anacor Pharmaceuticals, 1020 East Meadow Circle, Palo Alto, California 94303, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+S.++Lunde">Christopher S. Lunde</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yvonne R. Freund</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yvonne R. Freund</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Anacor Pharmaceuticals, 1020 East Meadow Circle, Palo Alto, California 94303, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yvonne+R.++Freund">Yvonne R. Freund</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Vincent Hernandez</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Vincent Hernandez</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Anacor Pharmaceuticals, 1020 East Meadow Circle, Palo Alto, California 94303, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Vincent++Hernandez">Vincent Hernandez</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xianfeng Li</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xianfeng Li</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Anacor Pharmaceuticals, 1020 East Meadow Circle, Palo Alto, California 94303, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xianfeng++Li">Xianfeng Li</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yi Xia</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yi Xia</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Anacor Pharmaceuticals, 1020 East Meadow Circle, Palo Alto, California 94303, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yi++Xia">Yi Xia</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David S. Carter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David S. Carter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Anacor Pharmaceuticals, 1020 East Meadow Circle, Palo Alto, California 94303, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+S.++Carter">David S. Carter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pamela W. Berry</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pamela W. Berry</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Anacor Pharmaceuticals, 1020 East Meadow Circle, Palo Alto, California 94303, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pamela+W.++Berry">Pamela W. Berry</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jason Halladay</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jason Halladay</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Anacor Pharmaceuticals, 1020 East Meadow Circle, Palo Alto, California 94303, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jason++Halladay">Jason Halladay</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Fernando Rock</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Fernando Rock</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Anacor Pharmaceuticals, 1020 East Meadow Circle, Palo Alto, California 94303, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Fernando++Rock">Fernando Rock</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rianna Stefanakis</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rianna Stefanakis</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Anacor Pharmaceuticals, 1020 East Meadow Circle, Palo Alto, California 94303, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rianna++Stefanakis">Rianna Stefanakis</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eric Easom</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eric Easom</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Anacor Pharmaceuticals, 1020 East Meadow Circle, Palo Alto, California 94303, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Easom">Eric Easom</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jacob J. Plattner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jacob J. Plattner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Anacor Pharmaceuticals, 1020 East Meadow Circle, Palo Alto, California 94303, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jacob+J.++Plattner">Jacob J. Plattner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Louise Ford</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Louise Ford</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Louise++Ford">Louise Ford</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kelly L. Johnston</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kelly L. Johnston</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kelly+L.++Johnston">Kelly L. Johnston</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Darren A. N. Cook</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Darren A. N. Cook</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Darren+A.+N.++Cook">Darren A. N. Cook</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rachel Clare</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rachel Clare</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rachel++Clare">Rachel Clare</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrew Cassidy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew Cassidy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Cassidy">Andrew Cassidy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Laura Myhill</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Laura Myhill</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Laura++Myhill">Laura Myhill</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hayley Tyrer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hayley Tyrer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hayley++Tyrer">Hayley Tyrer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joanne Gamble</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joanne Gamble</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joanne++Gamble">Joanne Gamble</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ana F. Guimaraes</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ana F. Guimaraes</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ana+F.++Guimaraes">Ana F. Guimaraes</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andrew Steven</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andrew Steven</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andrew++Steven">Andrew Steven</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Franziska Lenz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Franziska Lenz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund Freud Str. 25, 53127 Bonn, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Franziska++Lenz">Franziska Lenz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Alexandra Ehrens</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Alexandra Ehrens</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund Freud Str. 25, 53127 Bonn, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Alexandra++Ehrens">Alexandra Ehrens</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefan J. Frohberger</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefan J. Frohberger</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund Freud Str. 25, 53127 Bonn, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefan+J.++Frohberger">Stefan J. Frohberger</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marianne Koschel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marianne Koschel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund Freud Str. 25, 53127 Bonn, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marianne++Koschel">Marianne Koschel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Achim Hoerauf</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Achim Hoerauf</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund Freud Str. 25, 53127 Bonn, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Achim++Hoerauf">Achim Hoerauf</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marc P. Hübner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marc P. Hübner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund Freud Str. 25, 53127 Bonn, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marc+P.++H%C3%BCbner">Marc P. Hübner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Case W. McNamara</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Case W. McNamara</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Calibr, 11119 North Torrey Pines Road, Suite 100, La Jolla, California 92037, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Case+W.++McNamara">Case W. McNamara</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Malina A. Bakowski</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Malina A. Bakowski</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Calibr, 11119 North Torrey Pines Road, Suite 100, La Jolla, California 92037, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Malina+A.++Bakowski">Malina A. Bakowski</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joseph D. Turner</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joseph D. Turner</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+D.++Turner">Joseph D. Turner</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mark J. Taylor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mark J. Taylor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mark+J.++Taylor">Mark J. Taylor</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Stephen A. Ward</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen A. Ward</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Centre for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+A.++Ward">Stephen A. Ward</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01854&amp;href=/doi/10.1021%2Facs.jmedchem.8b01854" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2521–2540</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 7, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 November 2018</li><li><span class="item_label"><b>Published</b> online</span>7 February 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 March 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01854" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01854</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01854"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3546</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">18</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01854" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Boron-Pleuromutilins as Anti-Wolbachia Agents with Potential for Treatment of Onchocerciasis and Lymphatic Filariasis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Robert&quot;,&quot;last_name&quot;:&quot;T. Jacobs&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;S. Lunde&quot;},{&quot;first_name&quot;:&quot;Yvonne&quot;,&quot;last_name&quot;:&quot;R. Freund&quot;},{&quot;first_name&quot;:&quot;Vincent&quot;,&quot;last_name&quot;:&quot;Hernandez&quot;},{&quot;first_name&quot;:&quot;Xianfeng&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Yi&quot;,&quot;last_name&quot;:&quot;Xia&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;S. Carter&quot;},{&quot;first_name&quot;:&quot;Pamela&quot;,&quot;last_name&quot;:&quot;W. Berry&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;Halladay&quot;},{&quot;first_name&quot;:&quot;Fernando&quot;,&quot;last_name&quot;:&quot;Rock&quot;},{&quot;first_name&quot;:&quot;Rianna&quot;,&quot;last_name&quot;:&quot;Stefanakis&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Easom&quot;},{&quot;first_name&quot;:&quot;Jacob&quot;,&quot;last_name&quot;:&quot;J. Plattner&quot;},{&quot;first_name&quot;:&quot;Louise&quot;,&quot;last_name&quot;:&quot;Ford&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;L. Johnston&quot;},{&quot;first_name&quot;:&quot;Darren&quot;,&quot;last_name&quot;:&quot;A. N. Cook&quot;},{&quot;first_name&quot;:&quot;Rachel&quot;,&quot;last_name&quot;:&quot;Clare&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Cassidy&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;Myhill&quot;},{&quot;first_name&quot;:&quot;Hayley&quot;,&quot;last_name&quot;:&quot;Tyrer&quot;},{&quot;first_name&quot;:&quot;Joanne&quot;,&quot;last_name&quot;:&quot;Gamble&quot;},{&quot;first_name&quot;:&quot;Ana&quot;,&quot;last_name&quot;:&quot;F. Guimaraes&quot;},{&quot;first_name&quot;:&quot;Andrew&quot;,&quot;last_name&quot;:&quot;Steven&quot;},{&quot;first_name&quot;:&quot;Franziska&quot;,&quot;last_name&quot;:&quot;Lenz&quot;},{&quot;first_name&quot;:&quot;Alexandra&quot;,&quot;last_name&quot;:&quot;Ehrens&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;J. Frohberger&quot;},{&quot;first_name&quot;:&quot;Marianne&quot;,&quot;last_name&quot;:&quot;Koschel&quot;},{&quot;first_name&quot;:&quot;Achim&quot;,&quot;last_name&quot;:&quot;Hoerauf&quot;},{&quot;first_name&quot;:&quot;Marc&quot;,&quot;last_name&quot;:&quot;P. Hübner&quot;},{&quot;first_name&quot;:&quot;Case&quot;,&quot;last_name&quot;:&quot;W. McNamara&quot;},{&quot;first_name&quot;:&quot;Malina&quot;,&quot;last_name&quot;:&quot;A. Bakowski&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;D. Turner&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;J. Taylor&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;A. Ward&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;07&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;2521-2540&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01854&quot;},&quot;abstract&quot;:&quot;A series of pleuromutilins modified by introduction of a boron-containing heterocycle on C(14) of the polycyclic core are described. These analogs were found to be potent anti-Wolbachia antibiotics and, as such, may be useful in the treatment of filarial infections caused by Onchocerca volvulus, resulting in Onchocerciasis or river blindness, or Wuchereria bancrofti and Brugia malayi and related parasitic nematodes resulting in lymphatic filariasis. These two important neglected tropical diseases disproportionately impact patients in the developing world. The lead preclinical candidate compound containing 7-fluoro-6-oxybenzoxaborole (15, AN11251) was shown to have good in vitro anti-Wolbachia activity and physicochemical and pharmacokinetic properties providing high exposure in plasma. The lead was effective in reducing the Wolbachia load in filarial worms following oral administration to mice.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01854&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01854" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01854&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01854" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01854&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01854" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01854&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01854&amp;href=/doi/10.1021/acs.jmedchem.8b01854" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01854" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01854" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (992 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01854%26sid%3Dliteratum%253Aachs%26pmid%3D30730745%26genre%3Darticle%26aulast%3DJacobs%26date%3D2019%26atitle%3DBoron-Pleuromutilins%2Bas%2BAnti-Wolbachia%2BAgents%2Bwith%2BPotential%2Bfor%2BTreatment%2Bof%2BOnchocerciasis%2Band%2BLymphatic%2BFilariasis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D5%26spage%3D2521%26epage%3D2540%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=291719" title="Redox reactions">Redox reactions</a>,</li><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/jmcmar.2019.62.issue-5/20190314/jmcmar.2019.62.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01854&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A series of pleuromutilins modified by introduction of a boron-containing heterocycle on C(14) of the polycyclic core are described. These analogs were found to be potent anti-<i>Wolbachia</i> antibiotics and, as such, may be useful in the treatment of filarial infections caused by <i>Onchocerca volvulus</i>, resulting in Onchocerciasis or river blindness, or <i>Wuchereria bancrofti</i> and <i>Brugia malayi</i> and related parasitic nematodes resulting in lymphatic filariasis. These two important neglected tropical diseases disproportionately impact patients in the developing world. The lead preclinical candidate compound containing 7-fluoro-6-oxybenzoxaborole (<b>15</b>, AN11251) was shown to have good in vitro anti-<i>Wolbachia</i> activity and physicochemical and pharmacokinetic properties providing high exposure in plasma. The lead was effective in reducing the <i>Wolbachia</i> load in filarial worms following oral administration to mice.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81666" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81666" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Parasitic nematodes of the family Filarioidea including <i>Onchocerca volvulus</i>, <i>Wuchereria bancrofti</i>, and <i>Brugia malayi</i> are responsible for significant disease burden in developing countries around the world.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Specifically, <i>O. volvulus</i> is the parasite responsible for River Blindness, and <i>W. bancrofti</i>, <i>B. malayi,</i> and <i>Brugia timori</i> cause lymphatic filariasis (elephantiasis).<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Lymphatic filariasis is one of the leading causes of global disability and accounts for at least 2.8 million disability-adjusted life years. Treatment/control and elimination programs for these infections have been in place for many years, but fall short of full effectiveness due to the demanding treatment paradigm required to break disease transmission.<a onclick="showRef(event, 'ref3 ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5">(3−5)</a> More specifically, the long life span of adult worms (up to 15 years) requires annual to bi-annual mass drug administration of therapeutics such as ivermectin which only kills the juvenile microfilariae released by adult worms and sterilizes adult worms but is not macrofilaricidal.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Very recently, the results of a triple-drug treatment (ivermectin, albendazole, and diethylcarbamazine) clinical trial demonstrated that this combination may require less frequent administration (perhaps once every 3 years), but only a marginal improvement of macrofilaricidal effects over a dual-drug therapy was noted.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Consequently, new approaches to kill the adult worms (macrofilaricides) are required in order for elimination time-frames of both diseases to be radically reduced. A short course of treatment (7 days or fewer) would likely be required for ease of implementation in the field.</div><div class="NLM_p">A unique feature of these parasitic worms is the presence of obligate symbiotic bacteria of the <i>Wolbachia</i> genus.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> It has been known for some time that classical antibacterial agents such as doxycycline can kill the bacteria present in the worms, which results in a reduced life span of the adult worm itself.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8−10)</a> Unfortunately, doxycycline presents challenges as a drug for mass administration, including the requirement for long treatment periods (4–6 weeks) and contraindications in pregnancy and in children.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> An anti-<i>Wolbachia</i> approach to the treatment of filarial infections has a number of patient benefits especially as the co-endemic eyeworm <i>Loa loa</i> does not harbor the endosymbiont and is therefore unaffected by treatment. It has been observed that concurrent killing of <i>L. loa</i> microfilariae by directly acting drugs in patients with >30 ;000 microfilariae per mL can have serious side effects including neurologic effects, coma, and death.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In addition, recent work has suggested that depleting <i>Wolbachia</i> in worms can also diminish the number of microfilariae that are able to develop in the insect vector, thus providing transmission blocking activity.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The underlying parasitology suggests that the discovery and development of new anti-<i>Wolbachia</i> drugs remains an attractive option for improving our ability to reduce the global burden of river blindness and elephantiasis and accelerate disease elimination goals.</div><div class="NLM_p">As part of our ongoing effort to capitalize on the unique properties of benzoxaboroles in modifying pharmacologic, physicochemical, and pharmacokinetic properties of existing drug scaffolds, we prepared analogs of the antibiotic class known as pleuromutilins.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> This class of ribosomal protein synthesis inhibitors predominantly targets Gram-positive bacteria and had been extensively explored since the 1950s, but had not previously been shown to have activity against <i>Wolbachia</i>. The pleuromutilins have been shown to inhibit protein synthesis through binding to the peptidyl-transfer center of the ribosome, with a crystal structure of tiamulin (<b>4</b>) with the 50S subunit of <i>Deinococcus radiodurans,</i> providing the most direct evidence of this mechanism of action.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Recently, Nabriva Therapeutics has been developing lefamulin (<b>2</b>), which is currently in clinical trials for community-acquired bacterial pneumonia, demonstrating the potential of this class of antibiotic.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Furthermore, the starting material for our explorations, pleuromutilin (<b>1</b>), is readily available and inexpensive with synthetic modification, particularly of the hydroxyacetate at C(14), being synthetically straightforward. In addition to boronated analogs of the pleuromutilin core, we also obtained or prepared several clinically relevant non-boron analogs as summarized in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21">(18−21)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Pleuromutilin and clinically relevant derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01854&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77525" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77525" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The boronpleuromutilins modified at the C(14) position of the pleuromutilin core were easily prepared via an S<sub>N</sub>2 displacement reaction of the pleuromutilin tosylate or iodide (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). These intermediates were synthesized from the commercially available pleuromutilin. For compounds wherein the vinyl group at C(12) was modified, ozonolysis of the pleuromutilin tosylate with a reductive workup provided the C(12) aldehyde (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Displacement of the C(14) tosylate with 7-fluoro-6-hydroxybenzoxaborole afforded the boronpleuromutilin, which in turn was condensed with hydroxyl amines to provide the oximes, or with amines and sodium cyanoborohydride to provide the amines. Hydrogenation of the C(12) vinyl group of the boronpleuormutilin afforded the corresponding C(12) ethyl analog.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Route to C(14)-Modified Boronpleuromutilins</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01854&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Route to C(12)-Modified Boronpleuromutilins</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01854&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The boronpleuromutilins with a C(14)-carbamate linker were prepared in two steps from 4-<i>epi</i>-pleuromutilin (<b>72</b>)<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> in a manner analogous to that described in the literature (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> For example, following conversion of <b>72</b> to the carbamoyl chloride <b>73</b>, treatment with 6-aminobenzoxaborole <b>78</b> followed by a zinc chloride-mediated 1,5-hydride shift gave the C(14)-carbamate <b>74</b>. Compounds <b>75–77</b> were also prepared in a similar manner.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Route to C(14) Boronpleuromutilin Carbamates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01854&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The boron-containing heterocycles were prepared by a variety of synthetic sequences that we have described in previous publications.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> As an example, 7-fluoro-6-hydroxybenzoxaborole was prepared by the route shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>. Protection of 3,4-difluorophenol (<b>79</b>) as the methoxymethyl ether was followed by ortho-metallation and trapping of the intermediate aryllithium with ethyl formate to provide the benzaldehyde derivative <b>81</b>. Nucleophilic displacement of the para fluorine with benzyl alcohol under basic conditions provided <b>82</b>. Deprotection of the methoxymethyl ether followed by conversion to triflate <b>84</b> permitted introduction of the boron via palladium-mediated borylation. Reduction of the aldehyde <b>85</b> with sodium borohydride followed by treatment with aqueous hydrochloric acid resulted in formation of the benzoxaborole <b>86</b>. Finally, hydrogenolysis of the benzyl ether gave the desired 7-fluoro-6-hydroxybenzoxaborole intermediate <b>87</b>.</div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 7-Fluoro-6-hydroxybenzoxaborole</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01854&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We screened the pleuromutilin drug candidates in two primary in vitro assays that differed in the strain of <i>Wolbachia</i> used, the insect cell line used to host the bacteria, and in the method of detection.<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> We used data from both assays to help ensure robust selection of compounds for progression to subsequent in vitro ADME and in vivo pharmacokinetics (PK) experiments. While the absolute potency of individual compounds varied between the two assays in some cases, the structure–-activity relationship (SAR) trends observed in these assays were generally similar. Initial screening revealed that several of the clinically relevant pleuromutilins, for example, retapamulin (<b>3</b>) and valnemulin (<b>5</b>), showed good activity in in vitro assays; significantly less activity was observed for lefamulin (<b>2</b>), tiamulin (<b>4</b>), or for the unadorned pleuromutilin core (<b>1</b>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). More interestingly, attachment of a benzoxaborole ring with either an oxygen (<b>8</b>), nitrogen (<b>25</b>), or sulfur (<b>33</b>) linker at the 6-position to the C(14) sidechain provided compounds (hereafter referred to as boronpleuromutilins) of similar in vitro potency to valnemulin and retapamulin. Introduction of a methylene spacer between the pleuromutilin core and the benzoxaborole ring as in <b>35</b> significantly reduced potency. Attachment of the benzoxaborole ring via the 5- position also provided compounds (<b>37–39</b>) with significantly reduced in vitro activity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Pleuromutilin Derivatives with Benzoxaboroles Linked via C(14)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0006.gif" alt="" id="GRAPHIC-d7e781-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ID</th><th class="colsep0 rowsep0" align="center">link atom</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">R</th><th class="colsep0 rowsep0" align="center"><i>Wolbachia</i> infected C6/36 cells (wAlb) EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>Wolbachia</i> infected LDW1 cells (wMel) EC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b> (pleuromutilin)</td><td class="colsep0 rowsep0" align="left">NA<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">OH</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">6868</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b> (lefamulin)</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">205</td><td class="colsep0 rowsep0" align="left">220</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b> (retapamulin)</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b> (tiamulin)</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">317</td><td class="colsep0 rowsep0" align="left">606</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b> (valnemulin)</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NA</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">6.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">6.3</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-Me (<i>R</i>,<i>S</i>)</td><td class="colsep0 rowsep0" align="left">215</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-Me</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">5-Me</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left">2.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">7-Me</td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-F</td><td class="colsep0 rowsep0" align="left">158</td><td class="colsep0 rowsep0" align="left">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="left">8.4</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">7-F</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">7-Cl</td><td class="colsep0 rowsep0" align="left">32</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">7-OMe</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">5,7-F<sub>2</sub></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3-CH<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">104</td><td class="colsep0 rowsep0" align="left">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">4-CH<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">64</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">7-Cl, 3-CH<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">197</td><td class="colsep0 rowsep0" align="left">49</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">7-F, 3-CH<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">317</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">7-Cl, 4-CH<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">3,3-Me<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">148</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">5.0</td><td class="colsep0 rowsep0" align="left">4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3-CH<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">229</td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">4-CH<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">409</td><td class="colsep0 rowsep0" align="left">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">5-CH<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">302</td><td class="colsep0 rowsep0" align="left">1182</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">7-CH<sub>2</sub>NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">257</td><td class="colsep0 rowsep0" align="left">173</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">3,3-Me<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">198</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">NH</td><td class="colsep0 rowsep0" align="left">7-F</td><td class="colsep0 rowsep0" align="left">106</td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">123</td><td class="colsep0 rowsep0" align="left">17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">S</td><td class="colsep0 rowsep0" align="left">7-F</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>NH–</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">243</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">–CH<sub>2</sub>NH–</td><td class="colsep0 rowsep0" align="left">3,3-Me<sub>2</sub></td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">1418</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>10 000</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>38</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="left">298</td><td class="colsep0 rowsep0" align="left">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">7-F</td><td class="colsep0 rowsep0" align="left">149</td><td class="colsep0 rowsep0" align="left">NT</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">NA = not applicable.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">NT = not tested.</p></div></div></div><div class="NLM_p">We next turned our attention to substitution of the benzoxaborole core, where we found that introduction of a fluoro substituent at the 4- (<b>13</b>), 5- (<b>14</b>) or 7- (<b>15</b>) positions was generally tolerated with the C(7) analog <b>15</b> exhibiting very potent activity. Other small substituents at C(7) such as methyl (<b>12</b>), chloro (<b>16</b>), or methoxy (<b>17</b>) were also tolerated, but did not improve activity beyond the fluoro analog. As the pleuromutilins are intrinsically very lipophilic, we also examined introduction of an aminomethyl substituent onto the benzoxaborole core (<b>19–23</b>, <b>26–29</b>), but these analogs were generally less active than the corresponding neutral compounds. Finally, we found that addition of two methyl groups at C(3) of the benzoxaborole (<b>24</b>, <b>30</b>), a strategy that had improved pharmacokinetic properties in other series,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> significantly reduced potency.</div><div class="NLM_p">Initial results with other boron-containing heterocycles linked via C(14) of the pleuromutilin core were encouraging, as a number of these analogs were very potent in the in vitro <i>Wolbachia</i> assay (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). In particular, the <i>N</i>-methanesulfonyl (<b>40</b>), <i>N</i>-acetyl (<b>42</b>), and <i>N</i>-methylcarbamoyl (<b>45</b>) derivatives of the diazaborine scaffold exhibited low nanomolar to picomolar potency. Unlike the benzoxaboroles, however, inclusion of a fluorine atom adjacent to the B–OH did not improve potency; in fact, these derivatives (<b>47–51</b>) were significantly less potent. The benzoxaborine <b>53</b>, wherein the five-membered ring was expanded by one carbon to a six membered ring, was completely inactive.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Pleuromutilins with Other Boron Heterocycles Linked via C(14)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0007.gif" alt="" id="GRAPHIC-d7e1540-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ID</th><th class="colsep0 rowsep0" align="center">P</th><th class="colsep0 rowsep0" align="center">Q–R</th><th class="colsep0 rowsep0" align="center">R<sub>8</sub></th><th class="colsep0 rowsep0" align="center"><i>Wolbachia</i> infected C6/36 cells (<i>w</i>Alb) EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>Wolbachia</i> infected LDW1 cells (<i>w</i>Mel) EC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>SO<sub>2</sub>N</td><td class="colsep0 rowsep0" align="left">N═CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">9</td><td class="colsep0 rowsep0" align="left">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>N</td><td class="colsep0 rowsep0" align="left">N═CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">14.8</td><td class="colsep0 rowsep0" align="left">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>C(═O)N</td><td class="colsep0 rowsep0" align="left">N═CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>43</b></td><td class="colsep0 rowsep0" align="left">Boc-N</td><td class="colsep0 rowsep0" align="left">N═CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">HN</td><td class="colsep0 rowsep0" align="left">N═CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">3.5</td><td class="colsep0 rowsep0" align="left">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>OC(═O)N</td><td class="colsep0 rowsep0" align="left">N═CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">N═CH</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">14.2</td><td class="colsep0 rowsep0" align="left">5.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>47</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>SO<sub>2</sub>N</td><td class="colsep0 rowsep0" align="left">N═CH</td><td class="colsep0 rowsep0" align="left">8-F</td><td class="colsep0 rowsep0" align="left">240</td><td class="colsep0 rowsep0" align="left">6.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>48</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>N</td><td class="colsep0 rowsep0" align="left">N═CH</td><td class="colsep0 rowsep0" align="left">8-F</td><td class="colsep0 rowsep0" align="left">172</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>49</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>C(═O)N</td><td class="colsep0 rowsep0" align="left">N═CH</td><td class="colsep0 rowsep0" align="left">8-F</td><td class="colsep0 rowsep0" align="left">107</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>50</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>OC(═O)N</td><td class="colsep0 rowsep0" align="left">N═CH</td><td class="colsep0 rowsep0" align="left">8-F</td><td class="colsep0 rowsep0" align="left">164</td><td class="colsep0 rowsep0" align="left">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">N═CH</td><td class="colsep0 rowsep0" align="left">8-F</td><td class="colsep0 rowsep0" align="left">329</td><td class="colsep0 rowsep0" align="left">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>C(═O)N</td><td class="colsep0 rowsep0" align="left">N═CH</td><td class="colsep0 rowsep0" align="left">8-CH<sub>3</sub></td><td class="colsep0 rowsep0" align="left">26.1</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">O</td><td class="colsep0 rowsep0" align="left">CH<sub>2</sub>CH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">NT</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">NT = not tested.</p></div></div></div><div class="NLM_p">We also explored modification of the C(12) vinyl substituent (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Work in the classical pleuromutilin literature had shown that this double bond could be reduced to provide an ethyl group (<b>54</b>), converted to the epoxide (<b>55</b>) or oxidized to an aldehyde (<b>58</b>) that could be functionalized in a variety of ways.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> In particular, we sought to introduce small amines at C(12) to modify physicochemical and pharmacokinetic properties. Given the interesting properties of <b>15</b> (vide supra), this work was performed with the 7-fluoro-6-oxobenzoxaborole linked via to C(14) of the pleuromutilin core.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Boronpleuromutilins Modified at C(12)</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0008.gif" alt="" id="GRAPHIC-d7e1882-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ID</th><th class="colsep0 rowsep0" align="center">Rb</th><th class="colsep0 rowsep0" align="center"><i>Wolbachia</i> infected C6/36 cells (wAlb) EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>Wolbachia</i> infected LDW1 cells (wMel) EC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>54</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>CH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">38</td><td class="colsep0 rowsep0" align="left">2.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">epoxide</td><td class="colsep0 rowsep0" align="left">148</td><td class="colsep0 rowsep0" align="left">13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>58</b></td><td class="colsep0 rowsep0" align="left">OHC–</td><td class="colsep0 rowsep0" align="left">278</td><td class="colsep0 rowsep0" align="left">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">HOCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">242</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60</b></td><td class="colsep0 rowsep0" align="left">HON═CH–</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">71</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>ON═CH–</td><td class="colsep0 rowsep0" align="left">197</td><td class="colsep0 rowsep0" align="left">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62</b></td><td class="colsep0 rowsep0" align="left">iso-C<sub>3</sub>H<sub>7</sub>ON═CH–</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="left">101</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>63</b></td><td class="colsep0 rowsep0" align="left">H<sub>2</sub>NCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">6892</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>64</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>NHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">1718</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>65</b></td><td class="colsep0 rowsep0" align="left">C<sub>2</sub>H<sub>5</sub>NHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">474</td><td class="colsep0 rowsep0" align="left">1399</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>66</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub>3</sub>H<sub>7</sub>NHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">357</td><td class="colsep0 rowsep0" align="left">478</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>67</b></td><td class="colsep0 rowsep0" align="left"><i>n</i>-C<sub>4</sub>H<sub>9</sub>NHCH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">372</td><td class="colsep0 rowsep0" align="left">243</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">cyclo-C<sub>3</sub>H<sub>5</sub>NHCH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">115</td><td class="colsep0 rowsep0" align="left">44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">(CH<sub>3</sub>)<sub>2</sub>NCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">328</td><td class="colsep0 rowsep0" align="left">439</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>70</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>ONHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">133</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>71</b></td><td class="colsep0 rowsep0" align="left">CH<sub>3</sub>C(═O)NHCH<sub>2</sub>–</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">29</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">NT = not tested.</p></div></div></div><div class="NLM_p">Disappointingly, only the ethyl (<b>54</b>) derivative exhibited potency close to the C(12) vinyl analog <b>15</b>; oximes (<b>60–62</b>) and amines (<b>63–70</b>) were significantly less potent. Some potency was regained by acylation of the amine (<b>71</b>), but this was not perceived as being of sufficient advantage to pursue further.</div><div class="NLM_p">As a final area of exploration, we prepared several boronpleuromutilins where the C(14)-hydroxyacetate linker was replaced by a shorter carbamate (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). This strategy had previously been explored in the pleuromutilins as a means to improve oral bioavailability.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The carbamates prepared (<b>74–77</b>) exhibited moderate-to-good in vitro potency.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Boronpleuromutilin Carbamates</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0009.gif" alt="" id="GRAPHIC-d7e2219-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ID</th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Ra</th><th class="colsep0 rowsep0" align="center"><i>Wolbachia</i> infected C6/36 cells (wAlb) EC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>Wolbachia</i> infected LDW1 cells (<i>w</i>Mel) EC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>74</b></td><td class="colsep0 rowsep0" align="left">bond</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">101</td><td class="colsep0 rowsep0" align="left">7.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="left">bond</td><td class="colsep0 rowsep0" align="left">5-F</td><td class="colsep0 rowsep0" align="left">>1000</td><td class="colsep0 rowsep0" align="left">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>76</b></td><td class="colsep0 rowsep0" align="left">CH2</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">3.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left">CH2</td><td class="colsep0 rowsep0" align="left">7-F</td><td class="colsep0 rowsep0" align="left">113</td><td class="colsep0 rowsep0" align="left">4.9</td></tr></tbody></table></div></div><div class="NLM_p">Concurrent with our evaluation of the in vitro potency of the boronpleuromutilins, we also selected a number of active analogs for characterization in both in vitro absorption, distribution, metabolism, excretion (ADME) and in vivo PK experiments. It has been suggested that one of the main limitations of the pleuromutilins is high metabolic instability leading to poor PK.<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> In fact, the majority of the clinically relevant pleuromutilins are of limited oral bioavailability, which has hampered their utility for human applications. A notable exception is the recently described lefamulin (<b>2</b>), which is currently in phase 3 clinical trials as an oral treatment for a variety of bacterial infections.<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(31,32)</a> In order to calibrate our expectations for the boronpleuromutilins, we screened several of the clinically relevant analogs in our in vitro ADME assays as well (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). As anticipated, tiamulin and retapamulin were found to be rapidly metabolized by mouse liver S9 fraction, whereas lefamulin was slowly metabolized. These classical pleuromutilins exhibited a range of binding to mouse plasma proteins, with free fraction (<i>f</i><sub>unbound</sub>) from 0.05–0.26. Slightly surprisingly, we found that lefamulin was not particularly permeable in our MDR1-MDCK assay, though the high stringency of this assay may underestimate the permeability of this compound through the gut. We had chosen the MDR1-MDCK assay to assess permeability over the related Caco2 assay due to throughput and the opportunity to more directly assess the impact of P-glycoprotein-mediated efflux in this cell line. In addition, it has also been reported that the MDR1-MDCK is an acceptable assay for evaluation of the permeability of compounds through the intestinal mucosa of humans.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vitro ADME Properties of Boronpleuromutilins</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ID</th><th class="colsep0 rowsep0" align="center">mouse S9 Cl<sub>int</sub> (μL/min/mg)</th><th class="colsep0 rowsep0" align="center">mouse protein binding (<i>f</i><sub>unbound</sub> @ 2 μM)</th><th class="colsep0 rowsep0" align="center">MDR1-MDCK <i>P</i><sub>app</sub><a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">0.218</td><td class="colsep0 rowsep0" align="left">0.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">41</td><td class="colsep0 rowsep0" align="left">0.154</td><td class="colsep0 rowsep0" align="left">6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">131</td><td class="colsep0 rowsep0" align="left">0.26<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">22.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.05<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">1.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">145</td><td class="colsep0 rowsep0" align="left">0.003</td><td class="colsep0 rowsep0" align="left">15.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">168</td><td class="colsep0 rowsep0" align="left">0.002</td><td class="colsep0 rowsep0" align="left">NT<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">139</td><td class="colsep0 rowsep0" align="left">0.005</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">77</td><td class="colsep0 rowsep0" align="left"><0.001</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">136</td><td class="colsep0 rowsep0" align="left">0.012</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">117</td><td class="colsep0 rowsep0" align="left">0.003</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">0.034</td><td class="colsep0 rowsep0" align="left">14.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">0.008</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.116</td><td class="colsep0 rowsep0" align="left">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">0.110</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.119</td><td class="colsep0 rowsep0" align="left">0.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.048</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">102</td><td class="colsep0 rowsep0" align="left">0.008</td><td class="colsep0 rowsep0" align="left">36.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">0.306</td><td class="colsep0 rowsep0" align="left">0.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.005</td><td class="colsep0 rowsep0" align="left">22.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">142</td><td class="colsep0 rowsep0" align="left">0.008</td><td class="colsep0 rowsep0" align="left">9.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">226</td><td class="colsep0 rowsep0" align="left">0.058</td><td class="colsep0 rowsep0" align="left">6.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.007</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>42</b></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.005</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>44</b></td><td class="colsep0 rowsep0" align="left">80</td><td class="colsep0 rowsep0" align="left">0.008</td><td class="colsep0 rowsep0" align="left">2.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">0.037</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>46</b></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left"><0.001</td><td class="colsep0 rowsep0" align="left">8.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">217</td><td class="colsep0 rowsep0" align="left">0.006</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>53</b></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left"><0.001</td><td class="colsep0 rowsep0" align="left">NT</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>55</b></td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">NT</td><td class="colsep0 rowsep0" align="left">8.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>59</b></td><td class="colsep0 rowsep0" align="left">53</td><td class="colsep0 rowsep0" align="left">0.033</td><td class="colsep0 rowsep0" align="left">3.7</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Permeability measured in a Madin Darby canine kidney cell monolayer transfected with the multidrug resistance 1 (mdr1) gene encoding P-glycoprotein MDR1.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Protein binding measured at 1 μM.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">NT = not tested.</p></div></div></div><div class="NLM_p">The neutral boronpleuromutilins evaluated (<b>8–12</b>, <b>14</b>, <b>25</b>, <b>33</b>) were generally metabolized quickly by mouse S9 (Cl<sub>int</sub> > 50 μL/min/mg), were highly protein bound (<i>f</i><sub>unbound</sub> < 0.03), and were predicted to have good permeability based on the MDR1-MDCK assay (<i>P</i><sub>app</sub> > 5 × 10<sup>–6</sup> cm/s). In contrast, boronpleuromutilins bearing an aminomethyl substituent (<b>19–21</b>, <b>23</b>, <b>26</b>) were less rapidly metabolized (Cl<sub>int</sub> < 10 μL/min/mg), much less protein bound (<i>f</i><sub>unbound</sub> > 0.1), but were predicted to be of low permeability (<i>P</i><sub>app</sub> < 1 × 10<sup>–6</sup> cm/s). Later compounds incorporating boron-containing heterocycles other than the benzoxaborole (<b>40–42</b>, <b>44–46</b>, <b>52</b>, <b>53</b>) or modification of C(12) (<b>55</b>, <b>59</b>) did not significantly change the overall in vitro ADME profile. One compound that stood out as having an attractive balance of properties was the 7-fluorobenzoxaborole derivative <b>15</b>, which exhibited modest clearance (Cl<sub>int</sub> = 33 μL/min/mg) and protein binding (<i>f</i><sub>unbound</sub> = 0.03), and good permeability (<i>P</i><sub>app</sub> = 14.1 × 10<sup>–6</sup> cm/s).</div><div class="NLM_p">Based on these in vitro profiles and due to resource constraints, we selected representative compounds from the various classes (e.g., neutral, aminomethyl), different linkers (e.g., O, N) and boron heterocycles (e.g., benzoxaboroles, diazaborines) for progression to in vivo PK experiments as summarized in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>. When the in vivo PK in mice of these representative compounds were measured, we observed that the PK parameters between them were variable following both IV and oral administration, consistent with the in vitro properties described above. Several observations were made from these studies. First, and as expected, clearance following intravenous dosing was generally quite high, with only compound <b>15</b> exhibiting low-to-modest clearance. Second, incorporation of an aminomethyl group on the benzoxaborole core (<b>19</b>) significantly reduced oral bioavailability, as did replacement of the benzoxaborole with a diazaborine (<b>45</b>, <b>52</b>). Finally, oral exposure and bioavailability was generally good for the 7-fluorobenzoxaborole derivatives tested (<b>15</b>, <b>32</b>, and <b>77</b>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. In Vivo Pharmacokinetic Properties of Lead Boronpleuromutilins in BALB/c Mice</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">IV at 5 mg/kg, vehicle 55/25/20 PEG/PG/H<sub>2</sub>O</th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">PO at 10 mg/kg, vehicle 55/25/20 PEG/PG/H<sub>2</sub>O</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cmpd</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μg/mL)</td><td class="colsep0 rowsep0" align="left">CL (mL/hr/kg)</td><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (mL/kg)</td><td class="colsep0 rowsep0" align="char" char=".">AUC<sub>0–last</sub> (h μg/mL)</td><td class="colsep0 rowsep0" align="char" char="."><i>C</i><sub>max</sub> (μg/mL)</td><td class="colsep0 rowsep0" align="char" char=".">AUC<sub>0–last</sub> (h μg/mL)</td><td class="colsep0 rowsep0" align="left">% F</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">4.13</td><td class="colsep0 rowsep0" align="left">2296</td><td class="colsep0 rowsep0" align="left">2716</td><td class="colsep0 rowsep0" align="char" char=".">2.18</td><td class="colsep0 rowsep0" align="char" char=".">0.673</td><td class="colsep0 rowsep0" align="char" char=".">1.54</td><td class="colsep0 rowsep0" align="left">35</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">3.21</td><td class="colsep0 rowsep0" align="left">505</td><td class="colsep0 rowsep0" align="left">4186</td><td class="colsep0 rowsep0" align="char" char=".">8.85</td><td class="colsep0 rowsep0" align="char" char=".">1.60</td><td class="colsep0 rowsep0" align="char" char=".">12.1</td><td class="colsep0 rowsep0" align="left">61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">2.48</td><td class="colsep0 rowsep0" align="left">2120</td><td class="colsep0 rowsep0" align="left">10 435</td><td class="colsep0 rowsep0" align="char" char=".">2.26</td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="left"><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>32</b></td><td class="colsep0 rowsep0" align="left">5.91</td><td class="colsep0 rowsep0" align="left">1080</td><td class="colsep0 rowsep0" align="left">2231</td><td class="colsep0 rowsep0" align="char" char=".">4.60</td><td class="colsep0 rowsep0" align="char" char=".">1.66</td><td class="colsep0 rowsep0" align="char" char=".">11.0</td><td class="colsep0 rowsep0" align="left">∼100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>45</b></td><td class="colsep0 rowsep0" align="left">7.40</td><td class="colsep0 rowsep0" align="left">1642</td><td class="colsep0 rowsep0" align="left">854</td><td class="colsep0 rowsep0" align="char" char=".">3.03</td><td class="colsep0 rowsep0" align="char" char=".">0.262</td><td class="colsep0 rowsep0" align="char" char=".">0.425</td><td class="colsep0 rowsep0" align="left">7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>52</b></td><td class="colsep0 rowsep0" align="left">3.22</td><td class="colsep0 rowsep0" align="left">3273</td><td class="colsep0 rowsep0" align="left">4658</td><td class="colsep0 rowsep0" align="char" char=".">1.52</td><td class="colsep0 rowsep0" align="char" char=".">0.227</td><td class="colsep0 rowsep0" align="char" char=".">0.166</td><td class="colsep0 rowsep0" align="left">6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>77</b></td><td class="colsep0 rowsep0" align="left">3.91</td><td class="colsep0 rowsep0" align="left">1338</td><td class="colsep0 rowsep0" align="left">2561</td><td class="colsep0 rowsep0" align="char" char=".">3.71</td><td class="colsep0 rowsep0" align="char" char=".">1.09</td><td class="colsep0 rowsep0" align="char" char=".">8.51</td><td class="colsep0 rowsep0" align="left">∼100</td></tr></tbody></table></div></div><div class="NLM_p">Given the relatively low clearance and high exposure exhibited by <b>15</b>, coupled with its good biological potency, additional PK experiments were performed with this compound. These confirmed the attractive PK profile following oral administration to mice of <b>15</b>, as systemic exposures at doses from 10 to 50 mg/kg were good, with <i>C</i><sub>max</sub> values increasing dose-dependently, while AUC values remained relatively constant, suggesting dissolution-limited absorption of the compound from the gut (<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. In Vivo Pharmacokinetic Properties of 7-Fluorobenzoxaborole Analog <b>15</b> in BALB/c Mice</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center"><b>15</b> IV</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="2" align="center">5 mg/kg (mean, <i>n</i> = 3)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle</td><td class="colsep0 rowsep0" align="left">55/25/20 PEG/PG/H<sub>2</sub>O</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μg/mL) @ 5 min</td><td class="colsep0 rowsep0" align="left">3.21 ± 1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CL (mL/h/kg)</td><td class="colsep0 rowsep0" align="left">505</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i><sub>ss</sub> (mL/kg)</td><td class="colsep0 rowsep0" align="left">4186</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>last</sub> (h μg/mL)</td><td class="colsep0 rowsep0" align="left">8.85</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–inf</sub> (h μg/mL)</td><td class="colsep0 rowsep0" align="left">9.91</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">terminal <i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">9.10</td></tr></tbody></table><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" colspan="5" align="center"><b>15</b> PO</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">10 mg/kg solution (mean, <i>n</i> = 3)</th><th class="colsep0 rowsep0" align="center">10 mg/kg suspension (mean, <i>n</i> = 3)</th><th class="colsep0 rowsep0" align="center">25 mg/kg suspension (mean, <i>n</i> = 3)</th><th class="colsep0 rowsep0" align="center">50 mg/kg suspension (mean, <i>n</i> = 3)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">vehicle</td><td class="colsep0 rowsep0" align="left">55/25/20 PEG/PG/H<sub>2</sub>O</td><td class="colsep0 rowsep0" align="left">1% CMC, 0.1% Tween 80 in H<sub>2</sub>O</td><td class="colsep0 rowsep0" align="left">1% CMC, 0.1% Tween 80 in H<sub>2</sub>O</td><td class="colsep0 rowsep0" align="left">1% CMC, 0.1% Tween 80 in H<sub>2</sub>O</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μg/mL)</td><td class="colsep0 rowsep0" align="left">1.60</td><td class="colsep0 rowsep0" align="left">2.81</td><td class="colsep0 rowsep0" align="left">4.25</td><td class="colsep0 rowsep0" align="left">6.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i><sub>max</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.083</td><td class="colsep0 rowsep0" align="left">0.50</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.50</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>last</sub> (h μg/mL)</td><td class="colsep0 rowsep0" align="left">12.1</td><td class="colsep0 rowsep0" align="left">20.7</td><td class="colsep0 rowsep0" align="left">23.7</td><td class="colsep0 rowsep0" align="left">23.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>0–inf</sub>(h μg/mL)</td><td class="colsep0 rowsep0" align="left">14.0</td><td class="colsep0 rowsep0" align="left">22.8</td><td class="colsep0 rowsep0" align="left">24.2</td><td class="colsep0 rowsep0" align="left">NC<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">terminal <i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">8.41</td><td class="colsep0 rowsep0" align="left">7.51</td><td class="colsep0 rowsep0" align="left">4.60</td><td class="colsep0 rowsep0" align="left">NC</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bioavailability (%)</td><td class="colsep0 rowsep0" align="left">61.1</td><td class="colsep0 rowsep0" align="left">NC</td><td class="colsep0 rowsep0" align="left">NC</td><td class="colsep0 rowsep0" align="left">NC</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">NC = not calculated.</p></div></div></div><div class="NLM_p">Based on this combination of in vitro potency and in vivo PK data, we next examined the ability of <b>15</b> to deplete the <i>Wolbachia</i> symbiont from filarial worms in vivo. In all in vivo efficacy assays, depletion of <i>Wolbachia</i> was determined through comparison to the <i>Wolbachia</i> load found in worms present in animals that were treated with only the dosing vehicle as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>. For our initial in vivo screen, groups of three CB.17 SCID mice were inoculated with 50 L3-stage <i>B. malayi</i> larvae via the peritoneal cavity and treated from point of infection with <b>15</b> for 7 or 14 days with oral doses of 25 mg/kg, BID. At point of necropsy, on day 14, fourth stage (L4) <i>B. malayi</i> larvae were isolated from the peritoneal cavity. Larvae were pooled per group and intraworm <i>Wolbachia</i> titers were quantified from groups of 10 larvae using qPCR. Included in the same experiment were a vehicle control group and two groups of doxycycline-treated animals as positive controls. We were encouraged to find that <b>15</b> reduced the <i>Wolbachia</i> load in the <i>B. malayi</i> larvae by 75.4 and 98.8% in the 7- and 14-day treatment groups, respectively. In this experiment, doxycycline reduced <i>Wolbachia</i> load by 76.3 and 96.7% following 7- and 14-day treatment at 50 mg/kg, QD, respectively (<a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>).</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Summary of Efficacy of <b>15</b> and Doxycycline in Reduction of <i>Wolbachia</i> in a Larval <i>B. malayi</i> SCID Mouse Model</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">dosing duration</td><td class="colsep0 rowsep0" align="left">7 days</td><td class="colsep0 rowsep0" align="left">14 days</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">doxycycline, 50 mg/kg QD</td><td class="colsep0 rowsep0" align="left">76.3%</td><td class="colsep0 rowsep0" align="left">96.7%</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b>, 25 mg/kg, BID</td><td class="colsep0 rowsep0" align="left">75.4%</td><td class="colsep0 rowsep0" align="left">98.8%</td></tr></tbody></table></div></div><div class="NLM_p">Values represent percent (%) median reduction of <i>Wolbachia</i> versus the vehicle control, as measured by qPCR of <i>Wolbachia</i> surface protein single copy gene (wsp) per <i>B. malayi</i> L4 larva (<i>n</i> = 10 per group) obtained from necropsies undertaken 2 weeks after first dose.</div><div class="NLM_p">Encouraged by the profile of <b>15</b>, and in preparation for more extensive in vivo characterization of this molecule, we conducted a number of preliminary in vitro and in vivo studies to assess the safety of this molecule. In a non-GLP Ames assay (Bioreliance, Rockville, MD), <b>15</b> was determined to be nonmutagenic. Furthermore, <b>15</b> was found to be negative in its potential to induce micronuclei in human peripheral blood lymphocytes (Bioreliance, Rockville, MD). In a panel of over 50 mammalian receptors, enzymes and ion channels (Eurofins Cerep, France), <b>15</b> was found to be without any significant effect at 10 μM, and it was also shown to have no significant (<10%) effect on the hERG potassium channel expressed in HEK cells at a concentration of 30 μM (ChanTest, Cleveland, OH). Finally in a preliminary safety study (Anacor, Palo Alto, CA), no adverse effects were observed in BALB/c mice treated with <b>15</b> at doses up to 200 mg/kg/day for 7 days.</div><div class="NLM_p">We next progressed <b>15</b> to chronic in vivo infection models of adult filarial parasitism (the target life cycle stage for an anti-<i>Wolbachia</i> indication); one using <i>B. malayi</i> and one using <i>Litomosoides sigmodontis</i>. We initially chose to use the <i>B. malayi</i> SCID mouse model<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> as this worm species is a causative agent of LF in humans.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> In this <i>B. malayi</i> assay, 100 L3-stage larvae were inoculated via the peritoneal route and adult infections were allowed to develop. At 6-weeks post-infection, the mice were treated with <b>15</b> (25 mg/kg, BID) for 7, 14, or 28 days. At the end of the experiment (12-week post-infection), worms were recovered from the mice and <i>Wolbachia</i> load was determined by qPCR. In this experiment, vehicle and minocycline (25 mg/kg, BID × 28 days) groups were included as negative and positive controls, respectively. Minocycline was chosen as the positive control for this study based on concurrent results in an <i>L. sigmondontis</i> model (vide infra), which suggested that this tetracycline antibiotic exhibited superior efficacy to doxycycline.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Slightly disappointingly, efficacy of <b>15</b> was not nearly as good in the adult model, with a 45.5% reduction of <i>Wolbachia</i> load observed for the 28 day treatment group. By comparison, minocycline provided 98.2% reduction in this experiment (<a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a></a>). We hypothesize that the failure of <b>15</b> to show efficacy at the dose chosen in the <i>B. malayi</i> adult worm model is likely due to the increased washout period between treatment start and necropsy in comparison to the <i>B. malayi</i> L3 larval model, leading to a rebound of the <i>Wolbachia</i> with a suboptimal treatment regimen of <b>15</b>.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Summary of Efficacy of <b>15</b> and Minocycline Against <i>Wolbachia</i> in the Adult <i>B. malayi</i> SCID Mouse Model</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center" char=".">dosing duration</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">28 days</th><th class="colsep0 rowsep0" align="center" char=".">14 days</th><th class="colsep0 rowsep0" align="center" char=".">7 days</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="center"><b>15</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">25 mg/kg, BID</td><td class="colsep0 rowsep0" align="char" char=".">45.5</td><td class="colsep0 rowsep0" align="char" char=".">16.6</td><td class="colsep0 rowsep0" align="char" char=".">13.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="4" align="center"><b>Minocycline</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">25 mg/kg, BID</td><td class="colsep0 rowsep0" align="char" char=".">98.2</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td></tr></tbody></table></div></div><div class="NLM_p">Values represent percent (%) median reduction of <i>Wolbachia</i> versus the vehicle control, as measured by qPCR of <i>Wolbachia</i> surface protein single copy gene (wsp) per adult female <i>B. malayi</i> (<i>n</i> = 10 per group) obtained from necropsies undertaken 6 weeks after first dose.</div><div class="NLM_p">In a second efficacy model,<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> we used mice infected with the rodent filarial nematode <i>L. sigmodontis</i>, another helminth species known to host <i>Wolbachia</i>, and treated these animals with <b>15</b> at a dose of 50 mg/kg, BID for 14 or 28 days. The <i>L. sigmodontis</i> model was chosen as an additional, confirmatory filarial model as it uses immunocompetent wild-type mice as host and initial studies demonstrated the efficacy of tetracycline against <i>Wolbachia</i>-containing filariae first in this model.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In addition, the infection could be maintained in mice using a natural infection protocol.<a onclick="showRef(event, 'ref35 ref38 ref39 ref40'); return false;" href="javascript:void(0);" class="ref ref35 ref38 ref39 ref40">(35,38−40)</a> Upon completion of dosing, animals were maintained for a total of 64–77 days (to maintain a consistent total time following the final dose), at which time worms were recovered from the peritoneum and the thoracic cavity. <i>Wolbachia</i> load was determined by qPCR. Doxycycline was included as a positive control in this experiment. We were encouraged to find that <b>15</b> was able to reduce <i>Wolbachia</i> burden in <i>L. sigmodontis</i> by >99% at this dose and duration (<a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">Table <a class="ref showTableEvent internalNav" data-ID="tbl10" href="#tbl10">10</a></a>). The stronger reduction of the <i>Wolbachia</i> load in the <i>L. sigmodontis</i> mouse model in comparison to the adult <i>B. malayi</i> mouse model is probably mostly due to the increased dose used for treatment with <b>15</b>, although <i>L. sigmodontis</i> were previously reported to have an increased susceptibility for anti-<i>Wolbachia</i> drugs compared to <i>B. malayi</i> filariae.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a></div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Efficacy of <b>15</b> and Doxycycline against <i>Wolbachia</i> in the Adult <i>L. sigmodontis</i> Mouse Model</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">dosing duration</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">28 days</th><th class="colsep0 rowsep0" align="center" char=".">14 days</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center"><b>15</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">50 mg/kg, BID</td><td class="colsep0 rowsep0" align="char" char=".">99.2</td><td class="colsep0 rowsep0" align="char" char=".">99.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="3" align="center"><b>Doxycycline</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">40 mg/kg, BID</td><td class="colsep0 rowsep0" align="char" char=".">99.9</td><td class="colsep0 rowsep0" align="char" char=".">99.9</td></tr></tbody></table></div></div><div class="NLM_p last">Values represent percent (%) reduction of <i>Wolbachia</i> versus the untreated control, as measured by qPCR FtsZ/actin per mouse, and were obtained from necropsies performed 1 month after first dose.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20037" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20037" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Previous work from our laboratories has demonstrated that boron-containing heterocycles can be useful in the treatment of various diseases, including infectious diseases of the developing world such as malaria,<a onclick="showRef(event, 'ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref42 ref43">(42,43)</a> human African trypanosomiasis,<a onclick="showRef(event, 'ref27 ref44'); return false;" href="javascript:void(0);" class="ref ref27 ref44">(27,44)</a> and tuberculosis.<a onclick="showRef(event, 'ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref45 ref46">(45,46)</a> We have extended our work to look at modification of known classes of antibacterial agents as an approach to treat river blindness via the bacterial symbiont (<i>Wolbachia</i>) present in the worms that cause this disease. Clear clinical “proof of concept” for an anti-<i>Wolbachia</i> approach has been demonstrated with the tetracycline antibiotic doxycycline.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The utility of doxycycline is limited, however, by the requirement that patients must be treated for 4–6 weeks in order to achieve significant reduction of <i>Wolbachia</i> in the <i>O. volvulus</i> parasite.<a onclick="showRef(event, 'ref8 ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref8 ref9 ref10">(8−10)</a> More recently, it has been demonstrated that combination of doxycycline (200 mg/day for 3 weeks) with albendazole (800 mg/day for 3 days) may provide a shorter treatment course.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> While moving closer to the desired short course (7 day or fewer) treatment paradigm, this combination therapy is still not ideal and does not address tetracycline contraindicated groups (children of age ≤8 and pregnant women).</div><div class="NLM_p">Our work started by evaluating representatives of various classes of antibiotics including several clinically relevant pleuromutilins. This initial screening revealed that some activity was present in this class of compounds, and we prepared several analogs containing our benzoxaborole core. The synthesis of these boronpleuromutilins was facilitated by the ready availability of the tosylate derivative of the hydroxyacetate ester at C(14) of the pleuromutilin core. Simple nucleophilic displacement reactions of this to afford C(14)-functionalized boronpleuromutilins with nitrogen, oxygen, or sulfur linker atoms proceeded in good yield. Early SARs revealed that direct attachment of the benzoxaborole ring to the pleuromutilin core provided compounds with good in vitro potency. In contrast, inclusion of a linker group such as present in the clinically relevant pleuromutilins between the core and benzoxaborole ring were of poor activity. Based on our previous work in the benzoxaboroles, we focused our attention on compounds linked through the 6-position, as these were both synthetically accessible and generally had been observed to have good ADME properties. Inclusion of a variety of substituents such as halogen, small alkyl, or aminoalkyl at positions 3, 4, 5, and 7 of the 6-O linked benzoxaboroles gave compounds of similar in vitro activity and allowed us to explore the effect of these substituents on ADME and PK. We were particularly pleased to find that the 7-fluoro analog (<b>15</b>) exhibited a good balance of potency and physicochemical and ADME properties. In particular, we were encouraged by the modest metabolic stability in mouse microsomes (Cl<sub>int</sub> = 33 μL/min/mg) and good permeability through an MDR1-MDCK monolayer (<i>P</i><sub>app</sub> = 14.1 × 10<sup>–6</sup> cm/s). We were slightly concerned about the high protein binding of <b>15</b> (<i>f</i><sub>unbound</sub> = 0.03), though this was predicted based on the calculated high lipophilicity (log <i>D</i> 4.23) of this compound. While other compounds, particularly those with an aminomethyl substituent on the benzoxaborole core (e.g. <b>20</b>) exhibited better metabolic stability (Cl<sub>int</sub> = 6 μL/min/mg), they were compromised by very low permeability (<i>P</i><sub>app</sub> < 0.1 × 10<sup>–6</sup> cm/s).</div><div class="NLM_p">When <b>15</b> was dosed to mice by the intravenous route (5 mg/kg), we were encouraged by the relatively low clearance (Cl<sub>int</sub> = 505 mL/hr/kg), good exposure (AUC<sub>0–24h</sub> = 8.85 h/μg/mL). Following oral administration (10 mg/kg), <b>15</b> exhibited good exposure (AUC<sub>0–24h</sub> = 14.0 h/μg/mL) and bioavailability (<i>F</i> = 61%). Additional PK studies at higher oral doses demonstrated that exposure increased with dose, though not dose proportionally, to very high levels (AUC<sub>0–24h</sub> = 58.7 h/μg/mL at 400 mg/kg). In addition to the parent compound, we also tracked the major (and active) metabolite of <b>15</b> (<b>15a</b>, IC<sub>50</sub> = 193 nM) where hydroxylation at C(2) of the pleuromutilin core had occurred, as this represented about 10–15% of the parent dose at most time points. Metabolism of pleuromutilins at this position of the core is well precedented.<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48,49)</a></div><div class="NLM_p">Based on these observations, <b>15</b> was selected for evaluation in several in vivo models that had been established for evaluation of anti-<i>Wolbachia</i> compounds in mice. In the first study, we found that <b>15</b>, when dosed orally at 25 mg/kg, BID, to SCID mice infected with larval stage <i>B. malayi</i>, efficacy (defined as >99% reduction in <i>Wolbachia</i> load in worms) was achieved following 14 days of dosing; 7 days dosing did not achieve full efficacy. In a second <i>B. malayi</i> model employing worms that had been allowed to mature to the adult stage, we were disappointed to find that <b>15</b> did not demonstrate measureable efficacy when dosed at 25 mg/kg, BID for 28 days. More encouraging data were obtained in the <i>L. sigmodontis</i> BALB/c mouse model, where <b>15</b> was found to show excellent efficacy (>99% <i>Wolbachia</i> depletion) when dosed at 50 mg/kg, BID for 14 or 28 days. Additional in vivo studies to address this hypothesis are ongoing and will be reported in due course.</div><div class="NLM_p last">In conclusion, exploration of a series of pleuromutilin derivatives incorporating a novel boron-containing heterocycle linked to C(14) of pleuromutilin core as anti-<i>Wolbachia</i> agents has resulted in the identification of <b>15</b> as a potential preclinical candidate. SAR developed in this program has demonstrated that optimal activity was obtained by direct linkage of the benzoxaborole to the pleuromutilin core via C(6) of the benzoxaborole, and that small substituents on the benzoxaborole ring system had an impact on potency and pharmacokinetic properties. Good-to-excellent exposure following oral administration of <b>15</b> to mice was achieved, and this translated into high levels of <i>Wolbachia</i> depletion in several in vivo models. We were encouraged by the efficacy of <b>15</b> in these models, prompting more extensive evaluation of this compound, both alone and in combination with other known anti-<i>Wolbachia</i> drugs. The outcome of these studies will be reported in due course.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i19">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_58113" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_58113" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General</h3><div class="NLM_p last">All chemicals were purchased from commercial suppliers and used as received. <sup>1</sup>H NMR spectra were recorded on a Bruker AVANCE 400 spectrometer. Chemical shifts are expressed in δ ppm referenced to an internal tetramethylsilane (δ = 0 ppm) standard. Abbreviations used in describing peak signals are br = broad, s = singlet, d = doublet, dd = doublet of doublets, t = triplet, q = quartet, m = multiplet. All final compounds were purified to have purity higher than 95% by reverse phase high-performance liquid chromatography (HPLC), supercritical fluid chromatography, normal phase flash chromatography, or crystallization. Preparative HPLC was accomplished using a Luna C18 250 × 30 mm, 10 μm column. The purity was assessed by reverse phase HPLC with a gradient of 5–95% acetonitrile in water (with or without acid modifier) and monitored by a diode array ultraviolet detector at 220 and 254 nm. Low-resolution mass spectra were recorded on a liquid chromatography–mass spectrometer in electrospray positive (ESI+) or negative (ESI−) modes.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-(Tosyloxy)acetate (<b>6</b>)</h3><div class="NLM_p last"><i>p</i>-Toluenesulfonyl chloride (19.1 g, 0.1 mol) in 1,2-dichloroethane (100 mL) was slowly added to a mixture of (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-hydroxyacetate (35.4 g, 0.1 mol), triethylamine (12.0 g, 0.1 mol), and pyridine (1 mL) in 1,2-dichloroethane (100 mL). The mixture was stirred at 10–15 °C for 20 h, washed with water (3 × 100 mL), and then concentrated to dryness. Purification was achieved by recrystallization from dichloromethane/petroleum ether (1:100) to afford (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-(tosyloxy)acetate <b>6</b> as a white solid (45.0 g, yield 90.0%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.80 (d, <i>J</i> = 8.0 Hz, 1H), 7.47 (d, <i>J</i> = 8.0 Hz, 1H), 6.05 (dd, <i>J</i> = 17.8, 11.2 Hz, 1H), 5.53 (d, <i>J</i> = 8.4 Hz, 1H), 5.09–4.96 (m, 2H), 4.81–4.59 (m, 2H), 3.40 (d, <i>J</i> = 5.6 Hz, 1H), 2.41 (s, 2H), 2.39 (br s, 1H), 2.24–1.95 (m, 5H), 1.75–1.41 (m, 4H), 1.30 (s, 4H), 1.27–1.18 (m, 4H), 1.03 (s, 3H), 0.99–0.92 (m, 2H), 0.81 (d, <i>J</i> = 7.2 Hz, 3H), 0.50 (d, <i>J</i> = 7.2 Hz, 3H).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Preparation of (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-Iodoacetate (<b>7</b>)</h3><div class="NLM_p last">To a solution of <b>6</b> (51.5 g, 96.7 mmol, 1.0 equiv) in acetonitrile (600.0 mL) was added sodium iodide (87.0 g, 580.1 mmol, 6.0 equiv). The mixture was stirred at 90 °C for 16 h at which time HPLC indicated the reaction was completed. The reaction mixture was concentrated under reduced pressure to remove acetonitrile. The residue was diluted with H<sub>2</sub>O (500 mL) and extracted with dichloromethane (3 × 500 mL). The combined organic layers were concentrated under reduced pressure to give a residue. The residue was washed with petroleum ether (200 mL). (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-iodoacetate <b>7</b> (40.0 g, 81.9 mmol, 84.7% yield) was obtained as a yellow solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 6.11 (dd, <i>J</i> = 11.2, 17.9 Hz, 1H), 5.52 (d, <i>J</i> = 7.9 Hz, 1H), 5.13–5.01 (m, 2H), 4.55 (d, <i>J</i> = 5.7 Hz, 1H), 3.82–3.75 (m, 1H), 3.73–3.66 (m, 1H), 3.43 (t, <i>J</i> = 5.3 Hz, 1H), 2.45–2.39 (m, 1H), 2.25–2.00 (m, 4H), 1.72–1.57 (m, 2H), 1.53–1.21 (m, 9H), 1.11–0.97 (m, 4H), 0.83 (d, <i>J</i> = 6.6 Hz, 3H), 0.64 (d, <i>J</i> = 7.1 Hz, 3H).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> Method A. Use of Pleuromutilin Tosylate <b>6</b>. Preparation of (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((1-Hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>8</b>)</h3><div class="NLM_p last">A solution of <b>6</b> (1.8 g, 3.3 mmol), benzo[<i>c</i>][1,2] oxaborole-1,6(3<i>H</i>)-diol (0.5 g, 3.3 mmol), and K<sub>2</sub>CO<sub>3</sub> (0.7 g, 5.0 mmol) in 20 mL of DMF was heated to 50 °C overnight, at which time LC/MS indicated the reaction was completed. Water was added and the mixture was adjusted to pH < 4 with 2 N HCl. The solid was filtered and the crude product was purified by prep HPLC to give (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl2-((1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy) acetate <b>8</b> (1.0 g, yield 57.0%). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.30 (d, <i>J</i> = 8.4 Hz, 1H), 7.19 (d, <i>J</i> = 2.0 Hz, 1H), 7.04 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H) 6.10 (dd, <i>J</i> = 17.6, 11.2 Hz, 1H), 5.59 (d, <i>J</i> = 8.4 Hz, 1H), 5.11–4.97 (m, 2H), 4.91 (s, 2H), 4.76–4.63 (m, 2H), 3.41 (d, <i>J</i> = 5.6 Hz, 1H), 2.40 (br s, 1H), 2.26–1.99 (m, 4H), 1.72–1.43 (m, 4H), 1.38 (d, <i>J</i> = 13.2 Hz, 1H), 1.34 (s, 3H), 1.29–1.15 (m, 4H), 1.03 (s, 3H), 1.01 (br s, 1H), 0.81 (d, J = 6.8 Hz, 3H), 0.63 (d, <i>J</i> = 6.8 Hz, 3H).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((1-Hydroxy-3-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>9</b>)</h3><div class="NLM_p last">Prepared from <b>6</b> by Method A. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.00 (s, 1H), 7.28 (d, <i>J</i> = 9.2 Hz, 1H), 7.15 (d, <i>J</i> = 2.4 Hz, 1H), 7.02 (d, <i>J</i> = 8.0 Hz, 1H), 6.09 (dd, <i>J</i> = 17.6, 11.4 Hz, 1H), 5.59 (d, <i>J</i> = 8.0 Hz, 1H), 5.15–4.98 (m, 3H), 4.72–4.62 (m, 2H), 4.51 (d, <i>J</i> = 6.0 Hz, 1H), 3.40 (m, 1H), 2.40 (s, 1H), 2.26–1.98 (m, 4H), 1.67–1.26 (m, 14H), 1.07–1.01 (m, 3H), 0.81 (d, <i>J</i> = 6.8 Hz, 3H), 0.63 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): mass calcd for C<sub>30</sub>H<sub>41</sub>BO<sub>7</sub>, 524.3; <i>m</i>/<i>z</i>: found, 523.2 [M – 1]<sup>−</sup>. HPLC: 93.3% (220 nm), 100% (254 nm).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((1-Hydroxy-4-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>10</b>)</h3><div class="NLM_p last">Prepared from <b>6</b> by Method A. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.02 (d, <i>J</i> = 1.76 Hz, 1H), 6.83 (d, <i>J</i> = 1.8 Hz, 1H), 6.10 (dd, <i>J</i> = 17.6, 11.2 Hz, 1H), 5.60 (d, <i>J</i> = 8.4 Hz, 1H), 5.12–4.96 (m, 2H), 4.87 (s, 2H), 4.75–4.60 (m, 2H), 2.41 (br s, 1H), 2.17 (s, 3H), 2.00–2.13 (m, 5H), 1.72–1.55 (m, 2H), 1.54–1.39 (m, 2H), 1.35 (s, 3H), 1.32–1.20 (m, 3H), 1.04 (m, 4H), 0.82 (d, <i>J</i> = 6.4 Hz, 3H), 0.64 (d, <i>J</i> = 7.2 Hz, 3H). MS: 523 (M – 1)<sup>−</sup>.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((1-Hydroxy-5-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>11</b>)</h3><div class="NLM_p last">Prepared from <b>6</b> by Method A. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.93 (br s, 1H), 7.19 (s, 1H), 7.09 (s, 1H), 6.08 (dd, <i>J</i> = 17.6, 11.2 Hz, 1H), 5.59 (d, <i>J</i> = 8.0 Hz, 1H), 5.12–4.95 (m, 2H), 4.87 (s, 2H), 4.71 (s, 2H), 3.40 (d, <i>J</i> = 4.8 Hz, 1H), 2.40 (s, 1H), 2.25 (s, 3H), 2.20–1.96 (m, 3H), 1.74–1.55 (m, 2H), 1.50–1.45 (m, 1H), 1.37 (s, 3H), 1.45–1.17 (m, 6H), 1.10–0.94 (m, 4H), 0.82 (d, <i>J</i> = 6.4 Hz, 3H), 0.62 (d, <i>J</i> = 6.4 Hz, 3H). MS: 523 (M – 1)<sup>−</sup>.</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((1-Hydroxy-7-methyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>12</b>)</h3><div class="NLM_p last">Prepared from <b>6</b> by Method A. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.09 (d, <i>J</i> = 8.0 Hz, 1H), 6.95 (d, <i>J</i> = 8.0 Hz, 1H), 6.11 (dd, <i>J</i> = 17.6, 11.2 Hz, 1H), 5.61 (d, <i>J</i> = 8.0 Hz, 1H), 5.09–4.98 (m, 2H), 4.87 (s, 2H), 4.72 (d, <i>J</i> = 2.0 Hz, 2H), 3.41 (d, <i>J</i> = 5.6 Hz, 1H), 2.36 (s, 1H), 2.33 (s, 3H), 2.20–2.10 (m, 1H), 2.10–1.95 (m, 4H), 1.72–1.55 (m, 2H), 1.54–1.36 (m, 2H), 1.34 (s, 3H), 1.31–1.15 (m, 3H), 1.03 (s, 4H), 0.82 (d, <i>J</i> = 6.8 Hz, 3H), 0.63 (d, <i>J</i> = 6.8 Hz, 3H). MS: 523 (M – 1)<sup>−</sup>.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((4-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>13</b>)</h3><div class="NLM_p last">Prepared from <b>6</b> by Method A. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.29–9.24 (br s,1H), 7.08 (s, 1H), 6.93 (d, <i>J</i> = 11.2 Hz, 1H), 6.15–6.05 (m, 1H), 5.60–5.56 (d, <i>J</i> = 8.8 Hz, 1H), 5.05–4.99 (m, 4H), 4.77–4.75 (d, <i>J</i> = 8.0 Hz, 2H), 2.41 (s, 1H), 2.41–2.04 (m, 4H), 1.63–1.41 (m, 4H), 1.33–1.28 (m, 7H), 1.04–0.85 (m, 4H), 0.81 (d, <i>J</i> = 6.4 Hz, 3H), 0.63 (d, <i>J</i> = 6.4 Hz, 3H). MS (ESI): mass calcd for C<sub>29</sub>H<sub>38</sub>BFO<sub>7</sub>, 528.27; <i>m</i>/<i>z</i>: found, 527.2 [M – 1]<sup>−</sup>. HPLC: 96.0% (220 nm), 69.6% (254 nm).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((5-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>14</b>)</h3><div class="NLM_p last">Prepared from <b>6</b> by Method A. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.10 (s, 1H), 7.35–7.26 (m, 2H), 6.08 (dd, <i>J</i> = 18.0, 11.2 Hz, 1H), 5.58 (d, <i>J</i> = 7.6 Hz, 1H), 5.09–4.96 (m, 2H), 4.90 (s, 2H), 4.85–4.74 (m, 2H), 4.52 (d, <i>J</i> = 6.0 Hz, 1H), 3.43–3.38 (m, 1H), 2.41 (s, 1H), 2.25–1.96 (m, 6H), 1.73–1.20 (m, 9H), 1.03 (s, 3H), 0.81 (d, <i>J</i> = 6.8 Hz, 3H), 0.61 (d, <i>J</i> = 6.8 Hz, 3H). MS: 527 (M – 1)<sup>−</sup>.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Method B. Use of Pleuromutilin Tosylate <b>7</b>. Preparation of (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>15</b>)</h3><div class="NLM_p last">To a solution of 7-fluorobenzo[<i>c</i>][1,2]oxaborole-1,6(3<i>H</i>)-diol <b>80</b> (5.0 g, 29.77 mmol, 1.0 equiv) and <b>7</b> (18.9 g, 38.71 mmol, 1.3 equiv) in DMSO (60.00 mL) was added Na<sub>2</sub>CO<sub>3</sub> (9.5 g, 89.32 mmol, 3.0 equiv). The mixture was stirred at 35 °C for 14 h under a nitrogen atmosphere, after which time HPLC indicated that starting material was consumed completely. The reaction mixture was quenched by addition H<sub>2</sub>O (200 mL) at 0 °C and then was adjusted to pH = 7 and then filtered to give a crude product. Four batches were combined together, and the crude product was purified by prep HPLC, then removed the acetonitrile, resulting aqueous phase was extracted by dichloromethane (3 × 1500 mL). The combined organic layers were concentrated under reduced pressure to give the product as a light yellow solid. This product was dissolved in dichloromethane, and then MTBE and petroleum ether was added until the product precipitated. The suspension was filtered and the filtrate was concentrated under reduced pressure to give additional product as a white solid. (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate <b>15</b> (15.0 g, 28.2 mmol, 24% yield, 99.0% purity) was obtained as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.26 (br s, 1H), 7.25–7.17 (m, 1H), 7.09 (d, <i>J</i> = 7.9 Hz, 1H), 6.11 (dd, <i>J</i> = 11.2, 17.9 Hz, 1H), 5.60 (d, <i>J</i> = 7.9 Hz, 1H), 5.10–4.98 (m, 2H), 4.92 (s, 2H), 4.86–4.74 (m, 2H), 4.52 (br s, 1H), 3.41 (br s, 1H), 2.41 (br s, 1H), 2.25–2.01 (m, 4H), 1.70–1.57 (m, 2H), 1.48–1.20 (m, 8H), 1.15–0.91 (m, 4H), 0.82 (d, <i>J</i> = 6.6 Hz, 3H), 0.62 (d, <i>J</i> = 7.1 Hz, 3H). MS (ESI): mass calcd for C<sub>29</sub>H<sub>38</sub>BFO<sub>7</sub>, 528.27; <i>m</i>/<i>z</i>: found, 527.3 [M – H]<sup>−</sup>. HPLC: 99.0% (220 nm), 100.0% (254 nm).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Chloro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>16</b>)</h3><div class="NLM_p last">Prepared from <b>6</b> by Method A. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.06 (s, 1H), 7.18 (d, <i>J</i> = 8 Hz, 1H), 7.07 (d, <i>J</i> = 8.4 Hz, 1H), 6.04 (dd, <i>J</i> = 17.6, 11.2 Hz, 1H), 5.53 (d, <i>J</i> = 7.2 Hz, 1H), 5.02 (m, 2H), 4.84 (s, 2H), 4.79 (s, 2H), 4.49 (d, <i>J</i> = 6.4 Hz, 1H), 3.35 (m, 1H), 2.35 (s, 1H), 2.11–1.96 (m, 4H), 1.61–1.17 (m, 10H), 0.98–0.93 (m, 4H), 0.74 (d, <i>J</i> = 6.8 Hz, 3H), 0.58 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): mass calcd For C<sub>29</sub>H<sub>38</sub>BO<sub>7</sub>Cl 544.87; <i>m</i>/<i>z</i>: found, 543.2 [M – H]<sup>−</sup>. HPLC: 100% (220 nm), 100% (254 nm).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((1-Hydroxy-7-methoxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>17</b>)</h3><div class="NLM_p last">Prepared from <b>6</b> by Method A. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.20–8.94 (m, 1H), 7.03 (d, <i>J</i> = 8.4 Hz, 1H), 6.91 (d, <i>J</i> = 8.4 Hz, 1H), 6.12 (dd, <i>J</i> = 11.5, 17.6 Hz, 1H), 5.61 (d, <i>J</i> = 8.4 Hz, 1H), 5.10–5.00 (m, 2H), 4.89 (s, 2H), 4.74–4.60 (m, 2H), 3.93 (s, 3H), 3.42 (d, <i>J</i> = 6.2 Hz, 1H), 2.41 (br s, 1H), 2.24–1.99 (m, 4H), 1.71–1.20 (m, 11H), 1.12–0.94 (m, 4H), 0.82 (d, <i>J</i> = 7.1 Hz, 3H), 0.63 (d, <i>J</i> = 6.6 Hz, 3H). MS (ESI): mass calcd for C<sub>30</sub>H<sub>41</sub>BO<sub>8</sub>, 540.3; <i>m</i>/<i>z</i>: found, 539.3 [M – 1]<sup>−</sup>. HPLC: 100% (220 nm), 100% (254 nm).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((5,7-Difluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>18</b>)</h3><div class="NLM_p last">Prepared from <b>6</b> by Method A. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.16 (d, <i>J</i> = 10.1 Hz, 1H), 6.05 (dd, <i>J</i> = 11.5, 17.6 Hz, 1H), 5.57 (d, <i>J</i> = 7.9 Hz, 1H), 4.97 (d, <i>J</i> = 6.6 Hz, 1H), 4.93 (s, 1H), 4.89 (s, 2H), 4.71 (d, <i>J</i> = 19.0 Hz, 2H), 3.36 (d, <i>J</i> = 6.2 Hz, 1H), 2.34 (br s, 1H), 2.20–2.09 (m, 1H), 2.08–1.94 (m, 3H), 1.67–1.51 (m, 3H), 1.41 (d, <i>J</i> = 17.2 Hz, 1H), 1.36–1.14 (m, 6H), 1.03–0.90 (m, 4H), 0.78 (d, <i>J</i> = 7.1 Hz, 3H), 0.53 (d, <i>J</i> = 6.6 Hz, 3H). MS (ESI): mass calcd For C<sub>29</sub>H<sub>37</sub>BF<sub>2</sub>NO<sub>7</sub>, 546.3; <i>m</i>/<i>z</i>: found, 545.2 [M – H]<sup>−</sup>. HPLC: 97.3% (220 nm), 94.0% (254 nm).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((3-(Aminomethyl)-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate Hydrochloride (<b>19</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.47 (br s, 1H), 8.13 (br s, 3H), 7.44 (d, <i>J</i> = 8.4 Hz, 1H), 7.28 (d, <i>J</i> = 2.2 Hz, 1H), 7.09 (td, <i>J</i> = 2.4, 8.5 Hz, 1H), 6.10 (dd, <i>J</i> = 11.2, 17.9 Hz, 1H), 5.60 (d, <i>J</i> = 8.4 Hz, 1H), 5.28 (dd, <i>J</i> = 2.6, 9.3 Hz, 1H), 5.12–4.96 (m, 2H), 4.80–4.64 (m, 2H), 4.62–4.48 (m, 1H), 3.42 (d, <i>J</i> = 5.7 Hz, 2H), 2.78–2.63 (m, 1H), 2.42 (br s, 1H), 2.26–2.00 (m, 4H), 1.73–1.18 (m, 7H), 1.05 (s, 2H), 0.89–0.78 (m, 5H), 0.63 (d, <i>J</i> = 7.2 Hz, 3H). MS (ESI): mass calcd for C<sub>30</sub>H<sub>42</sub>BNO<sub>7</sub>, 539.31; <i>m</i>/<i>z</i>: found, 540.1 [M + H]<sup>+</sup>. HPLC: 99.2% (220 nm), 100.0% (254 nm).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((4-(Aminomethyl)-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate Hydrochloride (<b>20</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.19 (s, 1H), 8.30 (br s, 3H), 7.26–7.17 (m, 2H), 6.11 (dd, <i>J</i> = 11.2, 17.9 Hz, 1H), 5.62 (d, <i>J</i> = 8.8 Hz, 1H), 5.15–4.95 (m, 4H), 4.79–4.65 (m, 2H), 4.55 (br s,1H), 3.93 (d, <i>J</i> = 5.3 Hz, 2H), 3.43 (br s, 2H), 2.44 (d, <i>J</i> = 7.9 Hz, 1H), 2.26–2.01 (m, 4H), 1.73–1.19 (m, 10H), 1.12–0.94 (m, 4H), 0.82 (d, <i>J</i> = 7.1 Hz, 3H), 0.65 (d, <i>J</i> = 7.1 Hz, 3H). MS (ESI): mass calcd for C<sub>30</sub>H<sub>43</sub>BClNO<sub>7</sub>, 575.3; <i>m</i>/<i>z</i>: found, 540.4 [M + H]<sup>+</sup>. HPLC: 96.1% (220 nm), 91.0% (weak absorption at 254 nm).</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((3-(Aminomethyl)-7-chloro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate Hydrochloride (<b>21</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.31 (s, 1H), 8.13 (s, 3H), 7.40 (d, <i>J</i> = 8.4 Hz, 1H), 7.18 (t, <i>J</i> = 8.4 Hz, 1H), 6.15–6.08 (m, 1H), 5.60 (d, <i>J</i> = 7.2 Hz, 1H), 5.29 (d, <i>J</i> = 8.0 Hz, 1H), 5.14–4.57 (m, 5H), 3.47–3.38 (m, 3H), 2.87 (b, 1H), 2.42 (s, 1H), 2.23–2.02 (m, 4H), 1.67–1.05 (m, 14H), 0.82 (d, <i>J</i> = 6.8 Hz, 3H), 0.63 (d, <i>J</i> = 6.8 Hz, 3H). HPLC purity: 100% (220 nm); MS (ESI): mass calcd for C<sub>30</sub>H<sub>41</sub>BClNO<sub>7</sub>, 573.27; <i>m</i>/<i>z</i>: found, 574.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((3-(Aminomethyl)-7-fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate Hydrochloride (<b>22</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.51 (br s, 1H), 8.14 (br s, 3H), 7.27–7.22 (m, 2H), 6.11 (dd, <i>J</i> = 10.8, 18.0 Hz, 1H), 5.60 (d, <i>J</i> = 7.6 Hz, 1H), 5.30 (d, <i>J</i> = 8.8 Hz, 1H), 5.06 (d, <i>J</i> = 18.0 Hz, 1H), 5.03 (d, <i>J</i> = 10.8 Hz, 1H), 4.86–4.82 (m, 2H), 2.84–2.82 (m, 2H), 2.41 (s, 1H), 2.18–2.05 (m, 4H), 1.64–1.20 (m, 9H), 1.09–0.94 (m, 4H), 0.83–0.79 (d, <i>J</i> = 6.8 Hz, 3H), 0.63 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): mass calcd for C<sub>30</sub>H<sub>42</sub>BClFNO<sub>7</sub>, 593.3; <i>m</i>/<i>z</i>: found, 558.0(M + H)<sup>+</sup>. HPLC: 99.0% (220 nm), 96.3% (254 nm).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((4-(Aminomethyl)-7-chloro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>23</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.04 (s, 1H), 7.17 (s, 1H), 6.16–6.13 (m, 1H), 5.61 (d, <i>J</i> = 8.0 Hz, 1H), 5.11–5.01 (m, 2H), 4.97 (s, 2H), 4.822 (d, <i>J</i> = 4.0 Hz, 2H), 4.54 (d, <i>J</i> = 6.0 Hz, 1H), 4.46–4.44 (m, 2H), 3.62 (s, 2H), 2.43 (s, 1H), 2.23–2.04 (m, 4H), 1.68–0.97 (m, 14H), 0.81 (d, <i>J</i> = 7.2 Hz, 3H), 0.66 (d, <i>J</i> = 6.8 Hz, 3H). HPLC purity: 100% (214 nm); MS (ESI): mass calcd For C<sub>30</sub>H<sub>41</sub>BClNO<sub>7</sub>, 573.27; <i>m</i>/<i>z</i>: found, 573.8 [M + H]<sup>+</sup>.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((1-Hydroxy-3,3-dimethyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>24</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.92 (s, 1H), 7.29 (d, <i>J</i> = 8.4 Hz, 1H), 7.11 (d, <i>J</i> = 2.4 Hz, 1H), 7.00 (dd, <i>J</i> = 8.4, 2.4 Hz, 1H), 6.09 (dd, <i>J</i> = 17.6, 11.2 Hz, 1H), 5.59 (d, <i>J</i> = 8.4 Hz, 1H), 5.08–4.95 (m, 2H), 4.75–4.61 (m, 2H), 4.51 (d, <i>J</i> = 6.0 Hz, 1H), 3.45–3.38 (m, 1H), 2.40 (s, 1H), 2.25–1.98 (m, 5H), 1.73–1.55 (m, 3H), 1.52–1.15 (m, 12H), 1.08–0.98 (m, 4H), 0.81 (d, <i>J</i> = 7.0 Hz, 3H), 0.62 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): mass calcd for C<sub>31</sub>H<sub>43</sub>BO7<sub>3</sub>, 538.3; <i>m</i>/<i>z</i>: found, 537.2 [M – 1]<sup>−</sup>. HPLC: 99.3% (220 nm), 100% (254 nm).</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl (1-Hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)glycinate (<b>25</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.09 (d, <i>J</i> = 8.4 Hz, 1H), 6.83 (br s, 1H), 6.72 (d, <i>J</i> = 8.4 Hz, 1H), 6.12–5.96 (m, 1H), 5.53 (d, <i>J</i> = 8.0 Hz, 1H), 5.07–4.90 (m, 2H), 4.87–4.77 (m, 1H), 3.78 (d, <i>J</i> = 5.2 Hz, 2H), 3.37 (d, <i>J</i> = 5.2 Hz, 1H), 2.33 (br s, 1H), 2.22–2.12 (m, 1H), 2.10–1.91 (m, 3H), 1.70–1.52 (m, 3H), 1.43 (br s, 2H), 1.37–1.15 (m, 8H), 1.06–0.89 (m, 5H), 0.79 (d, <i>J</i> = 6.4 Hz, 3H), 0.61 (d, <i>J</i> = 6.4 Hz, 3H). MS (ESI): mass calcd for C<sub>29</sub>H<sub>41</sub>BClNO<sub>6</sub>, 545.27; <i>m</i>/<i>z</i>: found, 508.3 [M – H]<sup>−</sup>. HPLC: 100.0% (220 nm), 100.0% (254 nm).</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl (3-(Aminomethyl)-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)glycinate (<b>26</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> and 6-amino-1-hydroxy-3-nitromethyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborole by Method B and reduction of the nitromethyl intermediate by hydrogenation. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.12 (br s, 2H), 7.20 (d, <i>J</i> = 7.9 Hz, 1H), 6.91 (br s, 1H), 6.73 (dd, <i>J</i> = 1.6, 8.4 Hz, 1H), 6.08 (dd, <i>J</i> = 11.2, 17.6 Hz, 1H), 5.55 (d, <i>J</i> = 8.0 Hz, 1H), 5.19 (d, <i>J</i> = 7.6 Hz, 1H), 5.04 (d, <i>J</i> = 19.2 Hz, 1H), 4.95 (d, <i>J</i> = 11.2 Hz, 1H), 3.80 (d, <i>J</i> = 13.2 Hz, 2H), 3.41 (d, <i>J</i> = 5.6 Hz, 2H), 2.39 (br s, 1H), 2.22–2.14 (m, 1H), 2.12–1.98 (m, 3H), 1.69–1.57 (m, 2H), 1.54–1.39 (m, 2H), 1.38–1.32 (m, 5H), 1.31–1.18 (m, 3H), 1.08–0.94 (m, 4H), 0.81 (d, <i>J</i> = 6.4 Hz, 3H), 0.64 (d, <i>J</i> = 6.4 Hz, 3H). MS (ESI): mass calcd For C<sub>30</sub>H<sub>44</sub>BClN<sub>2</sub>O<sub>6</sub>, 574.9; <i>m</i>/<i>z</i>: found, 539.5 [M + H]<sup>+</sup>. HPLC: 98.9% (220 nm), 100.0% (254 nm).</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl (4-(Aminomethyl)-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)glycinate (<b>27</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> and 6-amino-4-(t-butyloxycarbonyl)aminomethyl-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborole by Method B and deprotection of the (<i>t</i>-butyloxycarbonyl)aminomethyl intermediate with trifluoracetic acid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.84 (s, 1H), 6.71 (m, 2H), 6.09 (m, 1H), 5.92 (m, 1H), 5.54 (m, 1H), 4.89–5.07 (m, 4H), 4.52 (d, 1H), 3.78 (m, 2H), 3.58 (s, 4H), 3.41 (m, 1H), 2.41 (m, 1H), 2.02–2.09 (m, 5H), 1.34–1.67 (m, 7H), 1.24–1.28 (m, 4H), 1.01 (s, 4H). HPLC purity: 98.4% (214 nm), 100% (254 nm); MS (ESI): mass calcd for C<sub>30</sub>H<sub>43</sub>BN<sub>2</sub>O<sub>6</sub>, 538.32; <i>m</i>/<i>z</i>: found, 539.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl (5-(Aminomethyl)-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)glycinate (<b>28</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> and 6-amino-5-(<i>t</i>-butyloxycarbonyl)aminomethyl-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborole by Method B and deprotection of the (<i>t</i>-butyloxycarbonyl)aminomethyl intermediate with trifluoracetic acid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.98 (s, 1H), 7.22 (s, 1H), 6.82 (s, 1H), 6.00–6.08 (dd, 1H), 5.56 (s, 1H), 5.53–5.57 (d, 1H), 4.88–5.02 (m, 3H), 4.43–4.54 (m, 1H), 3.85–4.04 (m, 2H), 3.04 (s, 1H), 2.07–2.50 (m, 7H), 1.31–1.66 (m, 13H), 1.05–1.24 (m, 4H), 0.50–0.60 (m, 3H), 0.22–0.37 (m, 3H). HPLC purity: 100% (214 nm), 100% (254 nm); MS (ESI): mass calcd for C<sub>30</sub>H<sub>43</sub>BN<sub>2</sub>O<sub>6</sub>, 538.32; <i>m</i>/<i>z</i>: found, 539.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl (7-(Aminomethyl)-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)glycinate (<b>29</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> and 6-amino-7-(<i>t</i>-butyloxycarbonyl)aminomethyl-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborole by Method B and deprotection of the (<i>t</i>-butyloxycarbonyl)aminomethyl intermediate with trifluoracetic acid. <sup>1</sup>H NMR (500 MHz, added one drop of con. HCl, DMSO-<i>d</i><sub>6</sub>): δ 8.2 (s, 3H), 7.19 (d, <i>J</i> = 8.0 Hz, 1H), 6.70 (d, <i>J</i> = 8.5 Hz, 1H), 6.08 (m, 1H), 5.55 (d, <i>J</i> = 8.5 Hz, 2H), 4.89 (s, 4H), 4.21 (m, 2H), 3.91 (m, 2H), 3.41 (m, 1H), 2.41 (s, 1H), 2.00–2.22 (m, 4H), 1.58–1.66 (m, 2H), 1.48 (m, 1H), 1.24–1.39 (m, 7H), 0.97–1.03 (m, 4H), 0.80 (d, <i>J</i> = 7.5 Hz, 3H), 0.64 (d, <i>J</i> = 7.0 Hz, 3H). HPLC purity: 100% (214 nm), 100% (254 nm); MS (ESI): mass calcd for C<sub>30</sub>H<sub>43</sub>BN<sub>2</sub>O<sub>6</sub>, 538.32; <i>m</i>/<i>z</i>: found, 539.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl (1-Hydroxy-3,3-dimethyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)glycinate (<b>30</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.72 (s, 1H), 7.06 (d, <i>J</i> = 8.4 Hz, 1H), 6.75–6.65 (m, 2H), 6.11–6.03 (m, 2H), 5.55 (d, <i>J</i> = 8.4 Hz, 1H), 5.04–4.93 (m, 2H), 4.50 (d, <i>J</i> = 6 Hz, 1H), 3.83–3.75 (m, 2H), 3.40 (t, <i>J</i> = 7.8 Hz, 1H), 2.39 (s, 1H), 1.48–1.21 (m, 21H), 0.80 (d, <i>J</i> = 6.8 Hz, 3H), 0.63 (d, <i>J</i> = 8.8 Hz, 3H). MS (ESI): mass calcd For C<sub>31</sub>H<sub>44</sub>BNO<sub>6</sub>, 537.33; <i>m</i>/<i>z</i>: found, 538.4 [M + H]<sup>+</sup>. HPLC: 98.8% (220 nm), 99.5% (254 nm).</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl (5-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)glycinate (<b>31</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.88 (s, 1H), 7.11–7.09 (d, <i>J</i> = 8.0 Hz, 1H), 6.88–6.86 (d, <i>J</i> = 8.0 Hz, 1H), 6.09–6.04 (m, 1H), 5.75 (s, 1H), 5.54–5.42 (d, <i>J</i> = 8.0 Hz, 1H), 5.05–5.01 (m, 1H), 4.95–4.93 (m, 1H), 4.83 (s, 2H), 3.86–3.83 (m, 2H), 2.37–2.17 (m, 1H), 2.14–2.08 (m, 2H), 2.06–2.01 (m, 3H),1.66–1.62 (m, 3H),1.59–1.32 (m, 5H), 1.24–1.21 (m, 4H), 1.00 (s, 3H), 0.81–0.79 (d, <i>J</i> = 8.0 Hz, 3H), 0.62–0.61 (d, <i>J</i> = 4.0 Hz, 3H).</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl (7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)glycinate (<b>32</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.10 (s, 1H), 6.94 (d, <i>J</i> = 7.9 Hz, 1H), 6.73 (t, <i>J</i> = 8.2 Hz, 1H), 6.09 (dd, <i>J</i> = 11.0, 17.6 Hz, 1H), 5.63 (br s, 1H), 5.55 (d, <i>J</i> = 7.9 Hz, 1H), 5.08–4.96 (m, 2H), 4.86 (s, 2H), 4.49 (d, <i>J</i> = 6.2 Hz, 1H), 3.91–3.81 (m, 2H), 3.38 (s, 1H), 2.38 (br s, 1H), 2.23–2.12 (m, 1H), 2.11–1.97 (m, 3H), 1.69–1.56 (m, 2H), 1.52–1.42 (m, 2H), 1.32 (s, 3H), 1.29–1.16 (m, 3H), 1.05–0.96 (m, 3H), 0.80 (d, <i>J</i> = 7.1 Hz, 3H), 0.63 (d, <i>J</i> = 6.6 Hz, 3H). MS (ESI): mass calcd For C<sub>29</sub>H<sub>39</sub>BFNO<sub>6</sub>, 527.4; <i>m</i>/<i>z</i>: found, 526.3 [M – H]<sup>−</sup>. HPLC: 96.7% (220 nm), 100.00% (254 nm).</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((1-Hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)thio)acetate (<b>33</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.18 (s, 1H), 7.72 (s, 1H), 7.49 (dd, <i>J</i> = 1.2, 8.0 Hz, 1H), 7.35 (d, <i>J</i> = 8.0 Hz, 1H), 6.03–5.94 (m, 1H), 5.47 (d, <i>J</i> = 8.8 Hz, 1H), 4.94 (s, 2H), 4.90 (d, <i>J</i> = 4.4 Hz, 1H), 4.47 (d, <i>J</i> = 6.0 Hz, 1H), 3.79 (q, <i>J</i> = 16.0 Hz, 2H), 3.37 (s, 1H), 2.37–2.31 (m, 1H), 2.22–1.87 (m, 4H), 1.68–1.55 (m, 2H), 1.50–1.14 (m, 7H), 1.08–0.93 (m, 6H), 0.79 (d, <i>J</i> = 6.4 Hz, 3H), 0.55 (d, <i>J</i> = 6.4 Hz, 3H). MS (ESI): mass calcd for C<sub>29</sub>H<sub>39</sub>BO<sub>6</sub>S 526.26; <i>m</i>/<i>z</i>: found, 549.3 [M + Na]<sup>+</sup>. HPLC: 96.5% (220 nm), 96.8% (254 nm).</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)thio)acetate (<b>34</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.34 (s, 1H), 7.61 (t, <i>J</i> = 7.2 Hz, 1H), 7.22 (d, <i>J</i> = 8.0 Hz, 1H), 6.04–5.94 (m, 1H), 5.46 (d, <i>J</i> = 8.0 Hz, 1H), 5.00–4.88 (m, 4H), 4.50 (d, <i>J</i> = 6.0 Hz, 1H), 3.88–3.71 (m, 2H), 3.41–3.36 (m, 2H), 2.38–2.35 (m, 1H), 2.24–1.87 (m, 4H), 1.69–1.55 (m, 2H), 1.50–1.40 (m, 1H), 1.29 (s, 5H), 1.06–0.93 (m, 5H), 0.80 (d, <i>J</i> = 6.8 Hz, 3H), 0.55 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): mass calcd for C<sub>29</sub>H<sub>38</sub>BFO<sub>6</sub>S 544.25; <i>m</i>/<i>z</i>: found, 543.2 [M – H]<sup>−</sup>. HPLC: 100% (220 nm), 100% (254 nm).</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl ((1-Hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)methyl)glycinate (<b>35</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (400 M Hz, DMSO-<i>d</i><sub>6</sub>): δ 0.60 (d, <i>J</i> = 7.2 Hz, 3H), 0.78 (d, <i>J</i> = 6.8 Hz, 3H), 0.97 (br s, 1H), 1.02 (d, 3H), 1.24 (d, 3H), 1.25 (s, 1H), 1.4, (m, 3H), 1.61–1.9 (m, 3H), 2.02 (m, 2H), 2.07 (m, 2H), 2.4 (s, 2H), 3.8 (m, 2H), 4.1 (m, 2H), 4.4 (br, s, 1H), 5.0–5.1 (m, 4H), 5.59 (d, <i>J</i> = 8.4 Hz, 1H), 6.06 (dd, <i>J</i> = 17.8, 11.2 Hz, 1H), 7.5 (m, 2H), 7.75 (s, 1H), 9.3 (br, s, 1H), 9.5 (br, s, 1H). MS (ESI): mass calcd For C<sub>30</sub>H<sub>42</sub>BNO<sub>6</sub>, 523.31; <i>m</i>/<i>z</i>: found, 524.3 [M + H]<sup>+</sup>. HPLC: 99.0% (220 nm).</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl ((1-Hydroxy-3,3-dimethyl-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)methyl)glycinate (<b>36</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.96 (s, 1H), 7.57 (s, 1H), 7.38–7.32 (m, 2H), 6.24–6.17 (m, 1H), 5.62 (d, <i>J</i> = 8.0 Hz, 1H), 5.12–5.06 (m, 2H), 4.53 (d, <i>J</i> = 6.0 Hz, 1H), 3.71–3.68 (m, 2H), 3.43–3.17 (m, 3H), 2.42 (s, 2H), 2.16–2.08 (m, 4H), 1.70–1.03 (m, 21H), 0.83 (d, <i>J</i> = 6.8 Hz, 3H), 0.62 (d, <i>J</i> = 6.8 Hz, 3H). HPLC purity: 100% (214 nm), 100% (254 nm); MS (ESI): mass calcd for C<sub>32</sub>H<sub>46</sub>BNO<sub>6</sub>, 551.34; <i>m</i>/<i>z</i>: found, 552.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((1-Hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-5-yl)oxy)acetate (<b>37</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.05 (s, 1H), 7.54 (d, <i>J</i> = 7.2 Hz, 1H), 6.82 (m, 2H), 6.03 (dd, <i>J</i> = 17.6, 11.2 Hz, 1H), 5.54 (d, <i>J</i> = 8.4 Hz, 1H), 5.00 (m, 2H), 4.81 (s, 2H), 4.70 (m, 2H), 4.51 (d, <i>J</i> = 6 Hz, 1H), 3.36 (m, 1H), 2.35 (s, 1H), 2.11–1.97 (m, 4H), 1.68–1.17 (m, 10H), 0.92 (m, 4H),0.74 (d, <i>J</i> = 7.2 Hz, 3H), 0.56 (d, <i>J</i> = 7.2 Hz, 3H). HPLC: 100% (220 nm), 100% (254 nm).</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((6-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-5-yl)oxy)acetate (<b>38</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.28 (s, 1H), 7.39 (d, <i>J</i> = 10.4 Hz, 1H), 7.02 (d, <i>J</i> = 7.2 Hz, 1H), 6.03 (dd, <i>J</i> = 18.0, 11.2 Hz, 1H), 5.53 (d, <i>J</i> = 8.0 Hz, 1H), 4.96 (m, 2H), 4.81 (d, 2H), 4.78 (s, 2H), 4.50 (d, <i>J</i> = 6 Hz, 1H), 3.36 (m, 1H), 2.35 (s, 1H), 2.08–1.96 (m, 4H), 1.60–1.19 (m, 10H), 0.98–0.93 (m, 4H),0.74 (d, <i>J</i> = 6.8 Hz, 3H), 0.56 (d, <i>J</i> = 7.2 Hz, 3H). MS (ESI): mass calcd For C<sub>29</sub>H<sub>38</sub>BO<sub>7</sub>F 528.42; <i>m</i>/<i>z</i>: found, 527.2 [M – H]<sup>−</sup>. HPLC: 100% (220 nm), 100% (254 nm).</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-5-yl)oxy)acetate (<b>39</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.20 (s, 1H), 6.73 (s, 1H), 6.60 (d, <i>J</i> = 10 Hz, 1H), 6.03 (dd, <i>J</i> = 18.0, 11.2 Hz, 1H), 5.54 (d, <i>J</i> = 8.4 Hz, 1H), 4.97 (m, 2H), 4.84 (s, 2H), 4.75 (m, 2H), 4.51 (d, <i>J</i> = 6 Hz, 1H), 3.36 (m, 1H), 2.35 (s, 1H), 2.13–1.96 (m, 4H), 1.61–1.17 (m, 10H), 0.98–0.91 (m, 4H),0.75 (d, <i>J</i> = 7.2 Hz, 3H), 0.57 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): mass calcd For C<sub>29</sub>H<sub>38</sub>BO<sub>7</sub>F 528.42; <i>m</i>/<i>z</i>: found, 586.0 [M+59-H]<sup>-</sup>. HPLC: 100% (220 nm), 100% (254 nm).</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((1-Hydroxy-2-(methylsulfonyl)-1,2-dihydrobenzo[<i>d</i>][1,2,3]diazaborinin-7-yl)oxy)acetate (<b>40</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.18 (s, 1H), 8.80–8.78 (m, 1H), 8.66 (s, 1H), 7.41–7.39 (m, 1H), 6.12–6.08 (m, 1H), 5.12–5.08 (m, 1H), 5.01–4.98 (m, 2H), 4.88–4.86 (m, 2H),3.37 (s, 5H), 2.40 (s, 1H), 2.09–2.03 (m, 4H), 1.70–1.45 (m, 3H), 1.33–1.25 (m, 8H), 1.05–0.95 (m, 4H), 0.82–0.80 (m, 3H), 0.65–0.64 (m, 3H).</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,12-trimethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((1-Hydroxy-2-methyl-1,2-dihydrobenzo[<i>d</i>][1,2,3]diazaborinin-7-yl)oxy)acetate (<b>41</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.31 (s, 1H), 7.90 (s, 1H), 7.76 (br s, 1H), 7.68 (d, <i>J</i> = 8.8 Hz, 1H), 7.28 (d, <i>J</i> = 7.3 Hz, 1H), 6.10 (dd, <i>J</i> = 10.8, 17.2 Hz, 1H), 5.60 (d, <i>J</i> = 7.8 Hz, 1H), 5.14–4.93 (m, 2H), 4.88–4.71 (m, 2H), 4.54 (d, <i>J</i> = 5.8 Hz, 1H), 3.47 (s, 2H), 3.41 (br s, 1H), 3.07 (s, 3H), 2.41 (br s, 1H), 2.26–1.95 (m, 4H), 1.73–0.92 (m, 10H), 0.90–0.76 (m, 3H), 0.63 (d, <i>J</i> = 6.0 Hz, 3H). MS (ESI): mass calcd for C<sub>30</sub>H<sub>41</sub>BN<sub>2</sub>O<sub>6</sub>, 536.3; <i>m</i>/<i>z</i>: found, 535.3 (M – H)<sup>−</sup>. HPLC: 90.7% in 220 nm; 93.3% in 254 nm.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((2-Acetyl-1-hydroxy-1,2-dihydrobenzo[<i>d</i>][1,2,3]diazaborinin-7-yl)oxy)acetate (<b>42</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6,</sub> 400 MHz): δ 8.02 (s, 1H), 7.53 (d, <i>J</i> = 8.4 Hz, 1H), 7.07–6.94 (m, 2H), 6.16–6.03 (m, 1H), 5.56 (t, <i>J</i> = 8.0 Hz, 1H), 5.11–4.96 (m, 2H), 4.77 (t, <i>J</i> = 10.0 Hz, 2H), 4.53 (d, <i>J</i> = 5.8 Hz, 1H), 3.39 (d, <i>J</i> = 5.2 Hz, 1H), 2.36 (d, <i>J</i> = 1.4 Hz, 3H), 2.23–1.94 (m, 4H), 1.63 (br s, 2H), 1.49–1.09 (m, 7H), 1.00 (d, <i>J</i> = 17.8 Hz, 4H), 0.80 (d, <i>J</i> = 3.6 Hz, 3H), 0.61 (dd, <i>J</i> = 7.0, 12.0 Hz, 3H). MS (ESI): mass calcd for C<sub>31</sub>H<sub>41</sub>BN<sub>2</sub>O<sub>7</sub>, 564.3; <i>m</i>/<i>z</i>: found, 581.3 (M + H<sub>2</sub>O – H)<sup>-</sup>. HPLC: 94.9% in 220 nm; 100% in 254 nm.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>tert</i>-Butyl 1-Hydroxy-7-(2-(((3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl)oxy)-2-oxoethoxy)benzo[<i>d</i>][1,2,3]diazaborinine-2(1<i>H</i>)-carboxylate (<b>43</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.57 (s, 1H), 8.10 (s, 1H), 7.75 (d, <i>J</i> = 8.2 Hz, 1H), 7.47 (br s, 1H), 7.38 (d, <i>J</i> = 9.2 Hz, 1H), 6.09 (dd, <i>J</i> = 11.0, 17.8 Hz, 1H), 5.60 (d, <i>J</i> = 8.6 Hz, 1H), 5.11–4.96 (m, 2H), 4.89 (d, <i>J</i> = 6.0 Hz, 1H), 4.53 (d, <i>J</i> = 6.0 Hz, 1H), 2.41 (s, 1H), 2.26–1.96 (m, 4H), 1.65–1.58 (m, 11H), 1.53–1.21 (m, 8H), 1.13–0.97 (m, 5H), 0.81 (d, <i>J</i> = 6.8 Hz, 3H), 0.66 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): mass calcd for C<sub>34</sub>H<sub>47</sub>BN<sub>2</sub>O<sub>8</sub>, 622.3; <i>m</i>/<i>z</i>: found, 639.4 (M + H<sub>2</sub>O – H)<sup>−</sup>. HPLC: 96.4% in 220 nm; 96.5% in 254 nm.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((1-Hydroxy-1,2-dihydrobenzo[<i>d</i>][1,2,3]diazaborinin-7-yl)oxy)acetate (<b>44</b>)</h3><div class="NLM_p last">Prepared from <b>43</b> by deprotection with HCl/ethyl acetate in dichloromethane. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.90 (s, 1H), 7.96 (s, 1H), 7.75–7.64 (m, 2H), 7.31 (d, <i>J</i> = 8.8 Hz, 1H), 6.09 (dd, <i>J</i> = 11.2, 17.8 Hz, 1H), 5.60 (d, <i>J</i> = 8.2 Hz, 1H), 5.13–4.95 (m, 2H), 4.89–4.74 (m, 2H), 3.41 (d, <i>J</i> = 5.6 Hz, 1H), 2.41 (s, 1H), 2.25–1.97 (m, 4H), 1.71–1.18 (m, 10H), 1.07–0.93 (m, 4H), 0.81 (d, <i>J</i> = 6.8 Hz, 3H), 0.64 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): mass calcd for C<sub>29</sub>H<sub>39</sub>BN<sub>2</sub>O<sub>6</sub>, 522.3; <i>m</i>/<i>z</i>: found, 521.3 (M – H)<sup>−</sup>. HPLC: 99.7% in 220 nm; 100% in 254 nm.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Methyl 1-Hydroxy-7-(2-(((3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl)oxy)-2-oxoethoxy)benzo[<i>d</i>][1,2,3]diazaborinine-2(1<i>H</i>)-carboxylate (<b>45</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.12 (s, 1H), 7.78 (d, <i>J</i> = 8.4 Hz, 1H), 7.48 (s, 1H), 7.39 (dd, <i>J</i> = 2.4, 8.4 Hz, 1H), 6.09 (dd, <i>J</i> = 11.2, 17.6 Hz, 1H), 5.60 (d, <i>J</i> = 7.8 Hz, 1H), 5.13–4.97 (m, 2H), 4.96–4.84 (m, 2H), 3.91 (s, 3H), 3.41 (d, <i>J</i> = 5.8 Hz, 1H), 2.41 (s, 1H), 2.25–1.99 (m, 4H), 1.74–1.20 (m, 10H), 1.10–0.94 (m, 4H), 0.81 (d, <i>J</i> = 6.8 Hz, 3H), 0.67 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): mass calcd for C<sub>31</sub>H<sub>41</sub>BN<sub>2</sub>O<sub>8</sub>, 580.3; <i>m</i>/<i>z</i>: found, 597.4 (M + H<sub>2</sub>O – H)<sup>−</sup>. HPLC: 97.2% in 220 nm; 96.1% in 254 nm.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((1-Hydroxy-1<i>H</i>-benzo[<i>d</i>][1,2,6]oxazaborinin-7-yl)oxy)acetate (<b>46</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.29 (s, 1H), 8.54 (s, 1H), 7.71 (d, <i>J</i> = 8.2 Hz, 1H), 7.49 (s, 1H), 7.37 (d, <i>J</i> = 6.0 Hz, 1H), 6.13–6.04 (m, 1H), 5.60 (d, <i>J</i> = 7.8 Hz, 1H), 5.11–4.96 (m, 2H), 4.87 (d, <i>J</i> = 7.2 Hz, 1H), 4.53 (d, <i>J</i> = 6.2 Hz, 1H), 3.41 (m, 1H), 2.41 (s, 1H), 2.05 (m, 4H), 1.71–1.44 (m, 4H), 1.40–1.20 (m, 7H), 1.04 (s, 4H), 0.81 (d, <i>J</i> = 6.8 Hz, 3H), 0.65 (d, <i>J</i> = 7.0 Hz, 3H). MS (ESI): mass calcd for C<sub>29</sub>H<sub>38</sub>BNO<sub>7</sub>, 523.3; <i>m</i>/<i>z</i>: found, 522.3 (M – H)<sup>−</sup>. HPLC: 97.5% in 220 nm; 94.3% in 254 nm.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((8-Fluoro-1-hydroxy-2-(methylsulfonyl)-1,2-dihydrobenzo[<i>d</i>][1,2,3]diazaborinin-7-yl)oxy)acetate (<b>47</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.90 (s, 1H), 7.50–7.28 (m, 2H), 6.13 (m, 1H), 5.61 (s, 1H), 5.19–4.84 (m, 3H), 4.54 (s, 1H), 3.24 (s, 3H), 2.41 (s, 1H), 2.07 (m, 4H), 1.73–1.19 (m, 11H), 1.06 (m, 4H), 0.82 (d, <i>J</i> = 6.8 Hz, 3H), 0.65 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): mass calcd for C<sub>30</sub>H<sub>40</sub>BFN<sub>2</sub>O<sub>8</sub>S 618.3; <i>m</i>/<i>z</i>: found, 619.2 (M + H)<sup>+</sup>. HPLC: 95.2% in 220 nm; 98.0% in 254 nm.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((8-Fluoro-1-hydroxy-2-methyl-1,2-dihydrobenzo[<i>d</i>][1,2,3]diazaborinin-7-yl)oxy)acetate (<b>48</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.93 (d, <i>J</i> = 2.4 Hz, 1H), 7.54–7.44 (m, 2H), 6.10 (dd, <i>J</i> = 11.2, 17.6 Hz, 1H), 5.60 (d, <i>J</i> = 8.4 Hz, 1H), 5.10–4.98 (m, 2H), 4.94 (d, <i>J</i> = 3.6 Hz, 1H), 3.49 (s, 3H), 3.40 (d, <i>J</i> = 6.4 Hz, 1H), 2.40 (br s, 1H), 2.24–1.97 (m, 5H), 1.72–1.19 (m, 10H), 1.04 (s, 4H), 0.81 (d, <i>J</i> = 7.2 Hz, 3H), 0.63 (d, <i>J</i> = 7.2 Hz, 3H). MS (ESI): mass calcd for C<sub>30</sub>H<sub>40</sub>BFN<sub>2</sub>O<sub>6</sub>, 554.5; <i>m</i>/<i>z</i>: found, 555.3 [M + H]<sup>+</sup>. HPLC: 100.00% (220 nm), 100.00% (254 nm).</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((2-Acetyl-8-fluoro-1-hydroxy-1,2-dihydrobenzo[<i>d</i>][1,2,3]diazaborinin-7-yl)oxy)acetate (<b>49</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.05 (s, 1H), 7.40 (d, <i>J</i> = 8.4 Hz, 1H), 7.17–7.12 (m, 1H), 6.15–6.07 (m, 1H), 5.61 (d, <i>J</i> = 7.6 Hz, 1H), 5.13–5.00 (d, <i>J</i> = 3.6 Hz, 2H), 4.97–4.83 (m, 2H), 4.56–4.50 (m, 1H), 2.44–2.38 (m, 2H), 2.23–2.00 (m, 7H), 1.70–1.19 (m, 11H), 1.05 (d, <i>J</i> = 3.2 Hz, 3H), 0.82 (d, <i>J</i> = 6.8 Hz, 3H), 0.65 (dd, <i>J</i> = 6.8, 17.6 Hz, 2H). MS (ESI): mass calcd for C<sub>31</sub>H<sub>40</sub>BFN<sub>2</sub>O<sub>7</sub>, 582.5; <i>m</i>/<i>z</i>: found, 583.3(M + H)<sup>+</sup>. HPLC: 90.0% (220 nm), 90.4% (254 nm).</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Methyl 8-Fluoro-1-hydroxy-7-(2-(((3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl)oxy)-2-oxoethoxy)benzo[<i>d</i>][1,2,3]diazaborinine-2(1<i>H</i>)-carboxylate (<b>50</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 8.53 (br s, 1H), 7.86 (br s, 1H), 7.48–7.29 (m, 2H), 6.11 (dd, <i>J</i> = 10.8, 17.6 Hz, 1H), 5.60 (d, <i>J</i> = 8.0 Hz, 1H), 5.13–4.99 (m, 2H), 4.98–4.86 (m, 2H), 4.54 (d, <i>J</i> = 6.4 Hz, 1H), 3.84 (s, 2H), 3.44–3.39 (m, 1H), 2.41 (br s, 1H), 2.29–2.00 (m, 3H), 1.73–1.19 (m, 10H), 1.11–0.94 (m, 4H), 0.81 (d, <i>J</i> = 6.4 Hz, 3H), 0.70–0.60 (m, 3H). MS (ESI): mass calcd for C<sub>31</sub>H<sub>40</sub>BFN<sub>2</sub>O<sub>8</sub>, 598.5; <i>m</i>/<i>z</i>: found, 599.3(M + H)<sup>+</sup>. HPLC: 89.1% (220 nm), 100.0% (254 nm).</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((8-Fluoro-1-hydroxy-1<i>H</i>-benzo[<i>d</i>][1,2,6]oxazaborinin-7-yl)oxy)acetate (<b>51</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.44–9.27 (m, 1H), 8.55 (br s, 1H), 7.54 (br s, 2H), 6.10 (dd, <i>J</i> = 11.2, 17.6 Hz, 1H), 5.59 (d, <i>J</i> = 8.8 Hz, 1H), 5.23–4.90 (m, 4H), 4.54 (br s, 1H), 2.40 (br s, 1H), 2.24–1.97 (m, 4H), 1.72–1.19 (m, 10H), 1.10–0.94 (m, 3H), 0.81 (d, <i>J</i> = 6.4 Hz, 3H), 0.64 (d, <i>J</i> = 7.2 Hz, 3H). MS (ESI): mass calcd for C<sub>29</sub>H<sub>37</sub>BFNO<sub>7</sub>, 541.4; <i>m</i>/<i>z</i>: found, 558.3(M + H<sub>2</sub>O – H)<sup>−</sup>. HPLC: 94.9% (220 nm), 95.8% (254 nm).</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> Methyl 1-Hydroxy-7-(2-(((3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl)oxy)-2-oxoethoxy)-8-methylbenzo[<i>d</i>][1,2,3]diazaborinine-2(1<i>H</i>)-carboxylate (<b>52</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.15 (br s, 1H), 8.02 (br s, 1H), 7.59 (br s, 1H), 7.33 (br s, 1H), 6.11 (dd, <i>J</i> = 17.6, 11.2 Hz, 1H), 5.61 (d, <i>J</i> = 8.4 Hz, 1H), 5.09–4.98 (m, 2H), 4.90 (s, 1H), 4.52 (d, <i>J</i> = 2.4 Hz, 2H), 3.90 (s, 3H), 3.41 (d, <i>J</i> = 5.6 Hz, 1H), 2.33 (s, 3H), 2.20–2.05 (m, 4H), 1.72–1.55 (m, 2H), 1.54–1.36 (m, 2H), 1.34 (s, 3H), 1.31–1.15 (m, 3H), 1.03 (m, 4H), 0.82 (d, <i>J</i> = 6.8 Hz, 3H), 0.65 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): mass calcd for C<sub>32</sub>H<sub>43</sub>BN<sub>2</sub>O<sub>8</sub>, 594.5; <i>m</i>/<i>z</i>: found, 595.4 [M + H]<sup>+</sup>. HPLC: 93.0% (220 nm), 88.6% (254 nm).</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((1-Hydroxy-3,4-dihydro-1<i>H</i>-benzo[<i>c</i>][1,2]oxaborinin-7-yl)oxy)acetate (<b>53</b>)</h3><div class="NLM_p last">Prepared from <b>7</b> by Method B. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6,</sub> 400 MHz): δ 7.14 (s, 1H), 7.07 (d, <i>J</i> = 8.4 Hz, 1H), 6.90 (d, <i>J</i> = 8.4 Hz, 1H), 6.06 (dd, <i>J</i> = 11.2, 17.6 Hz, 1H), 5.56 (d, <i>J</i> = 8.0 Hz, 1H), 5.05–4.95 (m, 3H), 4.82–4.65 (m, 2H), 3.99 (t, <i>J</i> = 5.6 Hz, 2H), 3.42–3.37 (m, 1H), 2.74 (t, <i>J</i> = 5.6 Hz, 2H), 2.38–2.32 (m, 1H), 2.23–1.98 (m, 4H), 1.72–1.19 (m, 10H), 1.08–0.94 (m, 4H), 0.77 (d, <i>J</i> = 6.4 Hz, 3H), 0.60 (d, <i>J</i> = 6.4 Hz, 3H). MS (ESI): mass calcd for C<sub>30</sub>H<sub>41</sub>BO<sub>7</sub>, 524.29; <i>m</i>/<i>z</i>: found, 523.2 [M – H]<sup>−</sup>. HPLC: 99.9% (220 nm), 99.9% (254 nm).</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>R</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-Ethyl-8-hydroxy-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>54</b>)</h3><div class="NLM_p">A suspension of <b>6</b> (500.0 mg, 938.6 μmol, 1.0 equiv) and Pd/C (300.0 mg, 938.6 μmol, 1.0 equiv) in THF (30.0 mL) was stirred at 25 °C for 12 h under 40 psi hydrogen atmosphere. The mixture was filtered and the filtrate was concentrated to give (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>R</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-ethyl-8-hydroxy-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-(tosyloxy)acetate (500.0 mg, 902.8 μmol, 96.2% yield, 96.5% purity) as a white foam. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.83 (d, <i>J</i> = 8.4 Hz, 2H), 7.36 (d, <i>J</i> = 8.4 Hz, 2H), 5.66 (d, <i>J</i> = 7.9 Hz, 1H), 4.51 (s, 2H), 3.45–3.37 (m, 1H), 2.46 (s, 3H), 2.41–2.14 (m, 4H), 2.09 (br s, 1H), 1.85–1.05 (m, 15H), 0.99–0.91 (m, 6H), 0.72 (t, <i>J</i> = 7.5 Hz, 3H), 0.61 (d, <i>J</i> = 7.1 Hz, 2H).</div><div class="NLM_p last">A solution of (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>R</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-ethyl-8-hydroxy-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-(tosyloxy)acetate (300.0 mg, 561.1 μmol, 1.0 equiv), <b>80</b> (94.22 mg, 561.06 μmol, 1.00 equiv), and Na<sub>2</sub>CO<sub>3</sub> (178.4 mg, 1.7 mmol, 3.0 equiv) in DMSO (15.0 mL) was heated to 30–40 °C for 12 h. Water (20 mL) was added to the mixture, white solid was precipitated. The mixture was filtered to give a crude product, which was purified by prep HPLC to give (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>R</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-ethyl-8-hydroxy-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate <b>54</b> (95.00 mg, 179.10 μmol, 31.92% yield, 100% purity) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.26 (s, 1H), 7.24–7.21 (m, 1H), 7.12–7.06 (m, 1H), 5.58 (d, <i>J</i> = 8.4 Hz, 1H), 4.92–4.83 (m, 2H), 4.84–4.80 (m, 2H), 4.40 (d, <i>J</i> = 5.6 Hz, 1H), 3.34–3.32 (m, 1H), 2.37–2.18 (m, 1H), 2.24–2.00 (m, 3H), 1.80–0.93 (m, 20H), 0.88–0.77 (m, 3H), 0.66–0.56 (m, 3H). MS (ESI): mass calcd for C<sub>29</sub>H<sub>40</sub>BFO<sub>7</sub>, 530.3; <i>m</i>/<i>z</i>: found, 529.3 [M – H]<sup>−</sup>. HPLC: 100% in 220 nm; 100% in 254 nm.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>R</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-7-((<i>R</i>)-oxiran-2-yl)-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>55</b>)</h3><div class="NLM_p">A mixture of <b>6</b> (20.0 g, 37.5 mmol, 1.0 equiv) and <i>m</i>-chloroperoxybenzoic acid (8.9 g, 41.3 mmol, 1.1 equiv) in dichloromethane (200.0 mL) was degassed and purged with N<sub>2</sub> for three times, and then the mixture was stirred at 25 °C for 12 h under an N<sub>2</sub> atmosphere. The mixture was poured into ice–water (w/w = 1/1) (100 mL). The combined organic phase was washed with aq NaHCO<sub>3</sub> (20 mL) and brine (100 mL), dried, filtered, and concentrated in vacuum. The residue was purified by silica gel chromatography (petroleum ether/ethyl acetate = 1/1) to give (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>R</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-4,7,9,12-tetramethyl-7-((<i>R</i>)-oxiran-2-yl)-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-(tosyloxy)acetate (11.0 g, 20.0 mmol, 53.4% yield) as a white solid.</div><div class="NLM_p">A mixture of (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>R</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-4,7,9,12-tetramethyl-7-((<i>R</i>)-oxiran-2-yl)-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-(tosyloxy)acetate (2.0 g, 3.6 mmol, 1.0 equiv), 7-fluoro-1-hydroxy-3<i>H</i>-2,1-benzoxaborol-6-ol (612.9 mg, 3.6 mmol, 1.0 equiv), and Na<sub>2</sub>CO<sub>3</sub> (1.2 g, 10.9 mmol, 3.0 equiv) in DMSO (30.0 mL) was degassed and purged with N<sub>2</sub> for three times, and then the mixture was stirred at 30 °C for 12 h under an N<sub>2</sub> atmosphere. The mixture was poured into ice–water (w/w = 1/1) (50 mL) and precipitating solid. The solid was collected to afford (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>R</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-4,7,9,12-tetramethyl-7-((<i>R</i>)-oxiran-2-yl)-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>] [1,2]oxaborol-6-yl)oxy)acetate <b>55</b> (1.7 g) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6,</sub> 400 MHz): δ 9.27 (s, 1H), 7.25–7.19 (m, 1H), 7.13 (d, <i>J</i> = 8.4 Hz, 1H), 5.6 (d, <i>J</i> = 8.4 Hz, 1H), 4.97–4.90 (m, 2H), 4.89–4.75 (m, 2H), 4.35 (d, <i>J</i> = 6.4 Hz, 1H), 3.48 (t, <i>J</i> = 6.4 Hz, 1H), 3.13–3.10 (m, 1H), 2.43–2.37 (m, 1H), 2.30–1.99 (m, 5H), 1.76–1.57 (m, 3H), 1.55–1.23 (m, 6H), 1.18–0.97 (m, 3H), 0.93–0.75 (m, 6H), 0.64 (d, <i>J</i> = 7.2 Hz, 3H) MS (ESI): mass calcd for C<sub>29</sub>H<sub>38</sub>BFO<sub>8</sub>, 544.26; <i>m</i>/<i>z</i>: found, 543.3 [M – H]<sup>−</sup>. HPLC: 96.6% (220 nm), 100.0% (254 nm).</div><div class="NLM_p last">The following compounds are derived from (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>R</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-formyl-8-hydroxy-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-(tosyloxy)acetate <b>57</b>, which was prepared by reaction of (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>R</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-formyl-8-hydroxy-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-hydroxyacetate<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (<b>56</b>) and <i>p</i>-toluenesulfonyl chloride in pyridine.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>R</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-formyl-8-hydroxy-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>58</b>)</h3><div class="NLM_p last">A solution of <b>57</b> (300.0 mg, 561.1 μmol, 1.0 equiv), <b>80</b> (94.2 mg, 561.1 μmol, 1.0 equiv), and Na<sub>2</sub>CO<sub>3</sub> (178.41 mg, 1.68 mmol, 3.00 equiv) in DMSO (10.0 mL) was heated to 30–40 °C for 12 h. Water (20 mL) was added to the mixture, white solid was precipitated and filtered to give a crude product. The crude product was purified by prep HPLC to give (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>R</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-formyl-8-hydroxy-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate <b>58</b> (81.0 mg, 152.7 μmol, 27.2% yield, 10% purity) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.67 (s, 1H), 9.27 (s, 1H), 7.24 (t, <i>J</i> = 7.9 Hz, 1H), 7.11 (d, <i>J</i> = 8.4 Hz, 1H), 5.42 (d, <i>J</i> = 8.4 Hz, 1H), 4.92 (s, 2H), 4.86–4.75 (m, 3H), 3.57 (t, <i>J</i> = 6.6 Hz, 1H), 2.43–2.03 (m, 4H), 1.76–1.21 (m, 10H), 1.09 (s, 3H), 0.95 (d, <i>J</i> = 7.1 Hz, 3H), 0.89–0.80 (m, 2H), 0.62 (d, <i>J</i> = 7.1 Hz, 3H). MS (ESI): mass calcd for C<sub>28</sub>H<sub>36</sub>BFO<sub>8</sub>, 530.3; <i>m</i>/<i>z</i>: found, 529.3 [M – H]<sup>−</sup>. HPLC: 100% in 220 nm; 100% in 254 nm.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-7-(Hydroxymethyl)-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>59</b>)</h3><div class="NLM_p">A solution of <b>57</b> (300.0 mg, 561.1 μmol, 1.0 equiv) and NaBH(OAc)<sub>3</sub> (237.8 mg, 1.1 mmol, 2.0 equiv) in dichloromethane (15.0 mL) was stirred at 20 °C for 2 h. Water (20 mL) was added to the mixture, the aqueous layer was treated with dichloromethane (10 mL × 3), the combined organic phase was treated with brine, dried and concentrated in vacuo to give crude (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-7-(hydroxymethyl)-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-(tosyloxy)acetate (300.0 mg, crude) as a colorless oil.</div><div class="NLM_p last">(3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-7-(hydroxymethyl)-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-(tosyloxy)acetate (300.0 mg, 559.0 μmol, 1.0 equiv), <b>80</b> (93.9 mg, 559.0 μmol, 1.0 equiv), and Na<sub>2</sub>CO<sub>3</sub> (177.7 mg, 1.7 mmol, 3.0 equiv) in DMSO (5.0 mL) were heated to 30–40 °C for 12 h. Water (20 mL) was added to the mixture; white solid was precipitated and filtered to give a crude product. The crude product was purified by prep HPLC to give (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-7-(hydroxymethyl)-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate <b>59</b> (47.0 mg, 88.3 μmol, 15.8% yield) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.26 (s, 1H), 7.22–7.20 (m, 1H), 7.10–7.00 (m, 1H), 5.55–5.53 (m, 1H), 5.17–5.15 (m, 1H), 4.92 (s, 1H), 4.83–4.72 (m, 3H), 4.56–4.48 (m, 2H), 3.90 (d, <i>J</i> = 11.0 Hz, 1H), 3.41 (d, <i>J</i> = 6.2 Hz, 1H), 3.32 (d, <i>J</i> = 11.0 Hz, 1H), 2.32–2.30 (m, 2H), 2.26–1.98 (m, 3H), 1.88–1.21 (m, 10H), 1.02 (s, 3H), 0.83 (d, <i>J</i> = 7.1 Hz, 3H), 0.61 (d, <i>J</i> = 6.6 Hz, 3H). MS (ESI): mass calcd for C<sub>28</sub>H<sub>38</sub>BFO<sub>8</sub>, 532.3; <i>m</i>/<i>z</i>: found, 531.3 [M – H]<sup>−</sup>. HPLC: 100% in 220 nm; 100% in 254 nm.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-7-((hydroxyimino)methyl)-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>60</b>)</h3><div class="NLM_p last">A solution of <b>58</b> (400.0 mg, 754.2 μmol, 1.0 equiv) and hydroxylamine hydrochloride (62.9 mg, 905.0 μmol, 1.2 equiv) in H<sub>2</sub>O (5.0 mL) and ethanol (10.0 mL) were stirred at 15 °C for 12 h. HPLC and LCMS showed the desired product as major component and starting material consumed. Water (30 mL) was added to the mixture, white solid precipitated, the mixture was filtered to give a crude product. The crude product was purified by prep HPLC. The solvent was concentrated to about 15 mL and then lyophilized to give (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-7-((hydroxyimino)methyl)-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate <b>60</b> (99.0 mg, 174.3 μmol, 23.1% yield, 96.0% purity) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 10.41 (br s, 1H), 9.25 (br s, 1H), 7.51 (s, 1H), 7.23 (t, <i>J</i> = 7.9 Hz, 1H), 7.10 (d, <i>J</i> = 7.9 Hz, 1H), 5.55 (d, <i>J</i> = 7.9 Hz, 1H), 4.92 (s, 2H), 4.78 (s, 2H), 3.46 (d, <i>J</i> = 6.6 Hz, 1H), 2.41 (br s, 1H), 2.25–2.01 (m, 3H), 1.75–0.94 (m, 16H), 0.85 (d, <i>J</i> = 7.1 Hz, 3H), 0.62 (d, <i>J</i> = 6.6 Hz, 3H). MS (ESI): mass calcd for C<sub>28</sub>H<sub>37</sub>BFNO<sub>8</sub>, 545.26; <i>m</i>/<i>z</i>: found, 546.3 [M + H]<sup>+</sup>. HPLC: 96.2% in 220 nm; 100% in 254 nm.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-7-((methoxyimino)methyl)-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>61</b>)</h3><div class="NLM_p last">This compound was prepared in a manner similar to that described for <b>60</b>, using O-methyl hydroxylamine in place of hydroxylamine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6<i>,</i></sub> 400 MHz): δ 9.25 (br s, 1H), 7.50 (s, 1H), 7.25 (t, <i>J</i> = 8.0 Hz, 1H), 7.10 (d, <i>J</i> = 8.4 Hz, 1H), 5.60 (d, <i>J</i> = 8.0 Hz, 1H), 4.92 (s, 2H), 4.78 (s, 2H), 3.62 (s, 3H), 3.48 (d, <i>J</i> = 5.6 Hz, 1H), 2.41 (br s, 1H), 2.24–1.97 (m, 4H), 1.72–1.40 (m, 5H), 1.35–1.19 (m, 5H), 1.15–0.96 (m, 5H), 0.85 (d, <i>J</i> = 6.4 Hz, 3H), 0.63 (d, <i>J</i> = 5.6 Hz, 3H) MS (ESI): mass calcd for C<sub>29</sub>H<sub>39</sub>BFNO<sub>8</sub>, 559.28; <i>m</i>/<i>z</i>: found, 560.3 [M + H]<sup>+</sup>. HPLC: 97.5% (220 nm), 100.0% (254 nm).</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-7-((isopropoxyimino)methyl)-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>62</b>)</h3><div class="NLM_p last">This compound was prepared in a manner similar to that described for <b>60</b>, using <i>O</i>-isopropyl hydroxylamine in place of hydroxylamine. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6,</sub> 400 MHz): δ 9.26 (br s, 1H), 7.47 (s, 1H), 7.23 (t, <i>J</i> = 8.0 Hz, 1H), 7.10 (d, <i>J</i> = 8.0 Hz, 1H), 5.57 (d, <i>J</i> = 8.0 Hz, 1H), 4.92 (s, 1H), 4.76 (s, 1H), 4.16 (dt, <i>J</i> = 5.6, 12.1 Hz, 1H), 3.48 (d, <i>J</i> = 5.2 Hz, 2H), 2.41 (br s, 1H), 2.09 (d, <i>J</i> = 15.6 Hz, 4H), 1.73–1.21 (m, 12H), 1.19–0.97 (m, 10H), 0.86 (d, <i>J</i> = 6.4 Hz, 3H), 0.63 (d, <i>J</i> = 6.4 Hz, 3H). MS (ESI): mass calcd for C<sub>31</sub>H<sub>43</sub>BFNO<sub>8</sub>, 587.48; <i>m</i>/<i>z</i>: found, 586.3 [M – H]<sup>−</sup>. HPLC: 98.8% (220 nm), 85.1% (254 nm).</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-(Aminomethyl)-8-hydroxy-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>63</b>)</h3><div class="NLM_p last">To a solution of <b>60</b> (570.0 mg, 1.0 mmol, 1.0 equiv) in methanol (10.0 mL) was added Raney–nickel (0.5 g) under an N<sub>2</sub> atmosphere. The suspension was degassed and purged with H<sub>2</sub> for three times. The mixture was stirred under H<sub>2</sub> (50 psi) at 25 °C for 2 h. The reaction mixture was filtered and the filter was concentrated to give a residue, which was purified by prep HPLC to give (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-(aminomethyl)-8-hydroxy-4,7,9,12-tetramethyl -3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-fluoro-1-hydroxy-1,3-dihydro benzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate <b>63</b> (300.0 mg, 464.8 μmol, 44.2% yield, TFA) as a light yellow solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6,</sub> 400 MHz): δ 9.27 (br s, 1H), 7.55 (br s, 2H), 7.25 (t, <i>J</i> = 7.6 Hz, 1H), 7.15–7.06 (m, 1H), 5.49–5.28 (m, 2H), 4.91 (br s, 1H), 4.78 (br s, 1H), 3.51 (br s, 1H), 3.18 (br s, 1H), 2.92 (br s, 1H), 2.42 (d, <i>J</i> = 8.4 Hz, 2H), 2.25–1.90 (m, 4H), 1.69–1.21 (m, 10H), 1.04 (br s, 3H), 0.84 (d, <i>J</i> = 5.6 Hz, 2H), 0.64 (d, <i>J</i> = 6.4 Hz, 3H) MS (ESI): mass calcd for C<sub>30</sub>H<sub>40</sub>BF<sub>4</sub>NO<sub>9</sub>, 531.28; <i>m</i>/<i>z</i>: found, 532.3 [M + H]<sup>+</sup>. HPLC: 97.1% (220 nm), 93.6% (254 nm).</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-7-((methylamino)methyl)-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>64</b>)</h3><div class="NLM_p">Sodium cyanoborohydride (142.2 mg, 2.3 mmol, 4.0 equiv) was added to a solution of <b>58</b> (300.0 mg, 565.6 μmol, 1.0 equiv) and methylamine (4.0 equiv) in methanol (10.0 mL) and acetic acid (1.0 mL). The mixture was stirred at 15 °C for 12 h. Water (30 mL) was added to the mixture, and the mixture was treated with dichloromethane (3 × 30 mL). The combined organic phase was concentrated to give a crude product. The crude product was purified by prep HPLC. The solvent was concentrated to about 15–20 mL of solution left and then was lyophilized to give (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-4,7,9,12-tetramethyl-7-((methylamino)methyl)-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate <b>64</b> (52.0 mg, 95.3 μmol, 16.8% yield) as a white TFA salt solid. <sup>1</sup>H NMR DMSO-<i>d</i><sub>6</sub>, (400 MHz): δ 9.30 (br s, 1H), 8.01 (br s, 2H), 7.31 (t, <i>J</i> = 8.0 Hz, 1H), 7.13 (d, <i>J</i> = 7.8 Hz, 1H), 5.36 (d, <i>J</i> = 8.0 Hz, 1H), 4.93 (s, 2H), 4.87–4.71 (m, 2H), 3.47 (d, <i>J</i> = 5.3 Hz, 1H), 3.27 (d, <i>J</i> = 8.8 Hz, 1H), 3.12 (d, <i>J</i> = 10.5 Hz, 1H), 2.62–2.57 (m, 3H), 2.26–1.93 (m, 6H), 1.71–1.21 (m, 10H), 1.14–0.94 (m, 4H), 0.84 (d, <i>J</i> = 6.3 Hz, 3H), 0.64 (d, <i>J</i> = 7.0 Hz, 3H). MS (ESI): mass calcd for C<sub>31</sub>H<sub>42</sub>BF<sub>4</sub>NO<sub>9</sub>, 545.3; <i>m</i>/<i>z</i>: found, 546.3 [M + H]<sup>+</sup>. HPLC: 96.4% in 220 nm; 100% in 254 nm.</div><div class="NLM_p last">The following compounds were prepared in a manner similar to that described for <b>64</b> from <b>58</b> and the appropriate amine.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-((Ethylamino)methyl)-8-hydroxy-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>65</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.28 (br s, 1H), 7.88 (br s, 1H), 7.73 (br s, 1H), 7.31 (t, <i>J</i> = 8.2 Hz, 1H), 7.12 (d, <i>J</i> = 8.4 Hz, 1H), 5.42 (br s, 1H), 5.36 (d, <i>J</i> = 8.4 Hz, 1H), 4.93 (s, 2H), 4.86–4.74 (m, 2H), 3.49 (d, <i>J</i> = 5.7 Hz, 1H), 3.33–3.22 (m, 1H), 3.14–2.94 (m, 3H), 2.42 (br s, 1H), 2.25–1.94 (m, 4H), 1.72–0.94 (m, 18H), 0.84 (d, <i>J</i> = 7.1 Hz, 2H), 0.64 (d, <i>J</i> = 7.1 Hz, 3H). MS (ESI): mass calcd for C<sub>32</sub>H<sub>44</sub>BF<sub>4</sub>NO<sub>9</sub>, 559.3; <i>m</i>/<i>z</i>: found, 560.3 [M + H]<sup>+</sup>. HPLC: 98.2% in 220 nm; 100% in 254 nm.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-((propylamino)methyl)decahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>66</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.29 (br s, 1H), 7.96 (br s, 2H), 7.77 (br s, 1H), 7.31 (t, <i>J</i> = 7.9 Hz, 1H), 7.11 (d, <i>J</i> = 7.9 Hz, 1H), 5.48 (br s, 1H), 5.35 (d, <i>J</i> = 7.9 Hz, 1H), 4.93 (s, 2H), 4.87–4.75 (m, 2H), 3.49 (d, <i>J</i> = 5.7 Hz, 1H), 3.29 (t, <i>J</i> = 10.1 Hz, 1H), 3.17–3.04 (m, 1H), 2.97–2.82 (m, 2H), 2.41 (br s, 1H), 2.24–1.91 (m, 4H), 1.75–0.95 (m, 17H), 0.90–0.79 (m, 4H), 0.65 (d, <i>J</i> = 7.1 Hz, 3H). MS (ESI): mass calcd for C<sub>33</sub>H<sub>46</sub>BF<sub>4</sub>NO<sub>9</sub>, 573.3; <i>m</i>/<i>z</i>: found, 574.3 [M + H]<sup>+</sup>. HPLC: 98.9% in 220 nm; 100% in 254 nm.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-((Butylamino)methyl)-8-hydroxy-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>67</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.28 (br s, 1H), 7.97 (br s, 1H), 7.76 (br s, 1H), 7.31 (t, <i>J</i> = 8.2 Hz, 1H), 7.11 (d, <i>J</i> = 7.9 Hz, 1H), 5.35 (d, <i>J</i> = 8.4 Hz, 1H), 4.92 (s, 2H), 4.86–4.75 (m, 2H), 3.49 (d, <i>J</i> = 6.2 Hz, 1H), 3.28 (t, <i>J</i> = 9.9 Hz, 1H), 3.18–3.06 (m, 1H), 2.93 (br s, 2H), 2.42 (br s, 1H), 2.25–1.91 (m, 5H), 1.73–1.20 (m, 15H), 1.17–0.96 (m, 4H), 0.90–0.79 (m, 5H), 0.65 (d, <i>J</i> = 6.6 Hz, 3H). MS (ESI): mass calcd for C<sub>34</sub>H<sub>48</sub>BF<sub>4</sub>NO<sub>9</sub>, 587.3; <i>m</i>/<i>z</i>: found, 588.5 [M + H]<sup>+</sup>. HPLC: 98.6% in 220 nm; 91.6% in 254 nm.</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-((Cyclopropylamino)methyl)-8-hydroxy-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>68</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.29 (br s, 1H), 8.29 (br s, 1H), 7.99 (br s, 1H), 7.32 (t, <i>J</i> = 8.2 Hz, 1H), 7.12 (d, <i>J</i> = 7.9 Hz, 1H), 5.42 (d, <i>J</i> = 8.4 Hz, 2H), 4.93 (s, 2H), 4.87–4.75 (m, 2H), 3.48 (d, <i>J</i> = 6.2 Hz, 1H), 3.39–3.22 (m, 2H), 2.73 (br s, 1H), 2.42 (br s, 1H), 2.25–1.91 (m, 5H), 1.74–1.22 (m, 10H), 1.13–0.92 (m, 6H), 0.89–0.68 (m, 6H), 0.65 (d, <i>J</i> = 7.1 Hz, 3H). MS (ESI): mass calcd for C<sub>33</sub>H<sub>44</sub>BF<sub>4</sub>NO<sub>9</sub>, 571.3; <i>m</i>/<i>z</i>: found, 572.3 [M + H]<sup>+</sup>. HPLC: 97.7% in 220 nm; 100% in 254 nm.</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-((Dimethylamino)methyl)-8-hydroxy-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>69</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.29 (br s, 1H), 8.81 (br s, 1H), 7.27 (t, <i>J</i> = 7.7 Hz, 1H), 7.12 (d, <i>J</i> = 8.4 Hz, 1H), 5.94 (br s, 1H), 5.35 (d, <i>J</i> = 7.9 Hz, 1H), 4.93 (s, 2H), 4.83 (br s, 2H), 3.72–3.40 (m, 4H), 3.10 (d, <i>J</i> = 13.2 Hz, 1H), 2.86–2.84 (m, 4H), 2.41 (br s, 1H), 2.27–1.99 (m, 4H), 1.77–1.18 (m, 12H), 1.12–0.96 (m, 2H), 0.88 (d, J = 6.2 Hz, 3H), 0.65 (d, <i>J</i> = 5.7 Hz, 3H). MS (ESI): mass calcd for C<sub>32</sub>H<sub>44</sub>BF<sub>4</sub>NO<sub>9</sub>, 559.3; <i>m</i>/<i>z</i>: found, 560.3 [M + H]<sup>+</sup>. HPLC: 96.8% in 220 nm; 100% in 254 nm.</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-(Acetamidomethyl)-8-hydroxy-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>70</b>)</h3><div class="NLM_p last">A mixture of <b>63</b> (300.0 mg, 564.5 μmol, 1.0 equiv), acetic anhydride (63.4 mg, 620.9 μmol, 1.1 equiv), acetic acid (67.8 mg, 1.1 mmol, 2.0 equiv) in dichloromethane (20.0 mL) was degassed and purged with N<sub>2</sub> for three times, and then the mixture was stirred at 60 °C for 12 h under an N<sub>2</sub> atmosphere. LC/MS showed <b>63</b> was consumed completely and one main peak with desired MS was detected. The solvent was removed. The residue was purified by prep HPLC to give (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>, 8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-7-(acetamidomethyl)-8-hydroxy-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate <b>70</b> (97.0 mg, 169.1 μmol, 29.9% yield) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6,</sub> 400MHz): δ 7.28 (t, <i>J</i> = 8.4 Hz, 1H), 7.09 (d, <i>J</i> = 8.4 Hz, 1H), 7.00–6.94 (m, 1H), 5.51 (d, <i>J</i> = 8.4 Hz, 1H), 4.90 (s, 2H), 4.85–4.74 (m, 2H), 3.60 (dd, <i>J</i> = 6.4, 13.8 Hz, 1H), 3.43 (d, <i>J</i> = 5.6 Hz, 1H), 3.00 (dd, <i>J</i> = 4.4, 13.8 Hz, 1H), 2.36 (br s, 1H), 2.31 (br s, 1H), 2.23–1.99 (m, 3H), 1.94–1.82 (m, 1H), 1.81–1.73 (m, 2H), 1.69–1.55 (m, 2H), 1.48 (br s, 1H), 1.40–1.20 (m, 6H), 1.05–0.87 (m, 4H), 0.83 (d, <i>J</i> = 6.4 Hz, 2H), 0.62 (d, <i>J</i> = 6.4 Hz, 3H) MS (ESI): mass calcd for C<sub>30</sub>H<sub>41</sub>BFNO<sub>8</sub>, 573.29; <i>m</i>/<i>z</i>: found, 574.3 [M + H]<sup>+</sup>. HPLC: 100.0% (220 nm), 100.0% (254 nm).</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> 2-Tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate (<b>71</b>)</h3><div class="NLM_p last">To a solution of <b>70</b> (1.0 g, 1.8 mmol, 1.0 equiv) in ethanol (15.0 mL) was added pyridin-1-ium-1-ylboranuide (1.7 g, 17.9 mmol, 10.0 equiv). Subsequently, methanol/HCl (4 M, 8.0 mL, 17.9 equiv) was added under an N<sub>2</sub> atmosphere at 0 °C. The mixture was stirred at 25 °C for 12 h. The mixture was adjusted to pH ≈ 6 with saturated NaHCO<sub>3</sub> and extracted with ethyl acetate (20 mL × 2). After concentrated in vacuo, the residue was purified by prep HPLC to afford (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-hydroxy-7-((methoxyamino)methyl)-4,7,9,12-tetramethyl-3-oxodecahydro-4,9a-propanocyclopenta[8]annulen-5-yl 2-((7-fluoro-1-hydroxy-1,3-dihydro-benzo[<i>c</i>][1,2]oxaborol-6-yl)oxy)acetate <b>71</b> (432.0 mg, 769.4 μmol, 43.0% yield) as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6,</sub> 400 MHz): δ 7.28 (t, <i>J</i> = 8.0 Hz, 1H), 7.12 (d, <i>J</i> = 8.0 Hz, 1H), 5.45–5.36 (m, 1H), 4.93 (s, 2H), 4.81 (d, <i>J</i> = 2.4 Hz, 2H), 4.31 (d, <i>J</i> = 5.6 Hz, 1H), 3.77–3.71 (m, 4H), 3.50–3.44 (m, 1H), 3.26 (t, <i>J</i> = 13.2 Hz, 1H), 2.40 (br s, 1H), 2.23–1.93 (m, 4H), 1.77–1.23 (m, 10H), 1.19–0.97 (m, 4H), 0.87 (d, <i>J</i> = 6.4 Hz, 3H), 0.65 (dd, <i>J</i> = 3.2, 6.8 Hz, 3H). MS (ESI): mass calcd for C<sub>31</sub>H<sub>42</sub>BF<sub>4</sub>NO<sub>10</sub>, 561.29; <i>m</i>/<i>z</i>: found, 562.4 [M + H]<sup>+</sup>. HPLC: 95.4% (220 nm), 95.1% (254 nm).</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-4,7,9,12-Tetramethyl-3,8-dioxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl (1-Hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)carbamate (<b>74</b>)</h3><div class="NLM_p">Trichloromethylchloroformate (215.0 mL, 1.5 mmol) and triethylamine (495.0 mL, 3.6 mmol) were added to an ice cooled solution of (3<i>R</i>,3a<i>R</i>,4<i>R</i>,5<i>R</i>,7S,9<i>R</i>,9a<i>R</i>,12<i>R</i>)-5-hydroxy-3-methoxy-4,7,9,12-tetramethyl-7-vinyloctahydro-4,9a-propanocyclopenta[8]annulen-8(9<i>H</i>)-one <b>72</b> (1.0 g, 3.0 mmol) in THF (10 mL). The mixture was stirred at room temperature for 2 h and then treated with further quantities of trichloromethylchloroformate (215.0 mL, 1.5 mmol) and triethylamine (495.0 mL, 3.6 mmol). After a further 2 h, the mixture was diluted with ethyl acetate and washed with brine. The organic phase was dried and concentrated to give (3<i>R</i>,3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,9<i>R</i>,9a<i>R</i>,12<i>R</i>)-3-methoxy-4,7,9,12-tetramethyl-8-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl carbonochloridate <b>73</b> without further purification (1.2 g, 100.0%).</div><div class="NLM_p">To a solution of 6-aminobenzo[<i>c</i>][1,2]oxaborol-1(3<i>H</i>)-ol (200.0 mg, 1.4 mmol) in dichloromethane (15 mL) was added triethylamine (137.0 mg, 1.4 mmol) and <b>73</b> (1.2 g, 3.0 mmol). The reaction mixture was stirred at room temperature overnight, at which time TLC showed the starting materials were consumed completely. The mixture was extracted with ethyl acetate, washed with brine, dried, and concentrated in vacuo give the crude intermediate, to which was added a solution of zinc chloride in concentrated HCl. The mixture was stirred at room temperature for 0.5 h. Then, the mixture was added water and extracted with ethyl acetate. The crude product was purified by prep HPLC to give (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>, 9a<i>S</i>,12<i>R</i>)-8-hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl (1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)carbamate <b>74</b> (61.0 mg). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.38 (s, 1H), 7.89 (s, 1H), 7.43 (d, <i>J</i> = 7.6 Hz, 1H), 7.27 (d, <i>J</i> = 8.0 Hz, 1H), 6.26 (m, 1H), 5.58 (s, 1H), 5.13 (m, 2H), 4.89 (s, 2H), 2.38 (m, 1H), 2.05 (m, 4H), 1.06–1.50 (m, 13H), 1.07 (m, 4H), 0.82 (d, 3H), 0.69 (d, 3H).</div><div class="NLM_p last">The following compounds were prepared from <b>73</b> in a similar manner:</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl (5-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)carbamate (<b>75</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.25 (s, 2H), 7.99 (s, 1H), 7.32 (d, <i>J</i> = 10.4 Hz, 1H), 6.74 (dd, <i>J</i> = 10.8, 17.6 Hz, 1H), 5.64 (d, <i>J</i> = 9.6 Hz, 1H), 5.29 (d, <i>J</i> = 10.8 Hz, 1H), 4.98 (m, 3H), 3.40 (s, 1H), 3.12 (s, 3H), 2.88 (m, 1H), 2.34 (m, 1H), 2.04 (s, 3H), 1.90 (m, 1H), 1.72 (m, 1H), 1.67 (d, 2H), 1.43 (m, 2H), 1.25–1.07 (m, 9H), 0.87–0.75 (m, 5H). MS (ESI): mass calcd for C<sub>29</sub>H<sub>39</sub>BNO<sub>6</sub>, 527.2; <i>m</i>/<i>z</i>: found, 526.2 [M – H]<sup>−</sup>. HPLC: 99.6% (220 nm), 100% (254 nm).</div></div><div id="sec4_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl ((1-Hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)methyl)carbamate (<b>76</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.70 (t, <i>J</i> = 5.8 Hz, 1H), 7.61 (s, 1H), 7.38–7.33 (m, 2H), 6.74 (dd, <i>J</i> = 10.8, 17.6 Hz, 1H), 5.53 (d, <i>J</i> = 9.6 Hz, 1H), 5.24 (d, <i>J</i> = 10.4 Hz, 1H), 4.96–4.90 (m, 3H), 4.32–4.16 (m, 2H), 3.13–3.10 (m, 3H), 2.85 (d, <i>J</i> = 6.4 Hz, 1H), 2.36–2.33 (m, 1H), 2.07–1.61 (m, 5H), 1.41–1.38 (m, 2H), 1.18–1.01 (m, 11H), 0.90 (d, <i>J</i> = 6.4 Hz, 3H), 0.78 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): mass calcd for C<sub>30</sub>H<sub>42</sub>BNO<sub>6</sub>, 523.3; <i>m</i>/<i>z</i>: found, 522.2 [M – H]<sup>−</sup>. HPLC: 99.0% (220 nm), 100% (254 nm).</div></div><div id="sec4_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-4,7,9,12-tetramethyl-3-oxo-7-vinyldecahydro-4,9a-propanocyclopenta[8]annulen-5-yl ((7-Fluoro-1-hydroxy-1,3-dihydrobenzo[<i>c</i>][1,2]oxaborol-6-yl)methyl)carbamate (<b>77</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.23 (s, 1H), 7.50 (t, <i>J</i> = 6.0 Hz, 1H), 7.38 (t, <i>J</i> = 7.2 Hz, 1H), 7.14 (d, <i>J</i> = 8.0 Hz, 1H), 6.20 (dd, <i>J</i> = 11.2, 18.0 Hz, 1H), 5.41 (d, <i>J</i> = 8.8 Hz, 1H), 5.09–4.86 (m, 4H), 4.25–4.10 (m, 2H), 3.38 (d, J = 5.6 Hz, 1H), 2.29 (s, 1H), 2.22–1.95 (m, 4H), 1.69–1.14 (m, 10H), 1.06–0.88 (m, 4H), 0.78 (d, <i>J</i> = 6.6 Hz, 3H), 0.62 (d, <i>J</i> = 5.2 Hz, 3H). MS (ESI): mass calcd for C<sub>29</sub>H<sub>39</sub>BFNO<sub>6</sub>, 527.29; <i>m</i>/<i>z</i>: found, 526.3 [M – H]<sup>−</sup>. HPLC: 100% (220 nm), 100% (254 nm).</div></div><div id="sec4_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> (3a<i>R</i>,4<i>R</i>,5<i>R</i>,7<i>S</i>,8<i>S</i>,9<i>R</i>,9a<i>S</i>,12<i>R</i>)-8-Hydroxy-7-((methoxyamino)methyl)-4,7,9,11,2-difluoro-3-(methoxymethoxy)benzene <b>80</b></h3><div class="NLM_p last">To a solution of 2,3-difluorophenol (300.0 g, 2.3 mol, 1.0 equiv) in dichloromethane (1.5 L) was added methoxymethyl chloride (278.9 g, 3.5 mol, 1.5 equiv) and DIEA (597.1 g, 4.6 mol, 2.0 equiv). The mixture was stirred at 0 °C for 2 h. TLC indicated that starting material was consumed. The reaction mixture was quenched by addition of H<sub>2</sub>O (1500 mL) at 0 °C and then was adjusted to pH = 6. The combined organic layers were washed with saturation NH<sub>4</sub>Cl (3 × 500 mL), dried, filtered, and concentrated under reduced pressure to give a residue. 1,2-Difluoro-3-(methoxymethoxy)benzene (400.0 g, 2.3 mol, 99.4% yield) was obtained as yellow oil, which was used into the next step without further purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 7.03–6.93 (m, 1H), 6.89–6.78 (m, 1H), 5.28–5.20 (m, 2H), 3.58–3.50 (m, 3H).</div></div><div id="sec4_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> 3,4-Difluoro-2-(methoxymethoxy)benzaldehyde <b>81</b></h3><div class="NLM_p last">To a solution of <b>80</b> (100.0 g, 574.3 mmol, 1.0 equiv) in THF (1.5 L) was added <i>n</i>-butyllithium (2.5 M, 298.6 mL, 1.3 equiv). The mixture was stirred at −78 °C for 7 h. Then, ethyl formate (85.1 g, 1150 mmol, 2.0 equiv) was added and the mixture was stirred for another 1 h. TLC indicated that starting material was consumed completely. The reaction mixture was quenched by addition of H<sub>2</sub>O (1000 mL) at 0 °C and then was extracted with ethyl acetate (3 × 800 mL). The combined organic layers were washed with brine 1000 mL, dried, filtered, and concentrated under reduced pressure to give a residue. The 3,4-difluoro-2-(methoxymethoxy)benzaldehyde <b>81</b> (492.0 g, crude) as a yellow oil was used into the next step without further purification. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 10.40–10.29 (m, 1H), 7.73–7.57 (m, 1H), 7.11–6.98 (m, 1H), 5.33 (s, 2H), 3.63–3.58 (m, 3H).</div></div><div id="sec4_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> 4-(Benzyloxy)-3-fluoro-2-(methoxymethoxy)benzaldehyde <b>82</b></h3><div class="NLM_p last">To a solution of <b>81</b> (256.0 g, 1.27 mol, 1.0 equiv) in DMF (1.5 L) was added Cs<sub>2</sub>CO<sub>3</sub> (618.9 g, 1.90 mol, 1.5 equiv) and benzyl alcohol (136.9 g, 1.3 mol, 1.0 equiv). The mixture was stirred at 70 °C for 10 h. TLC indicated that starting material was consumed completely. The reaction mixture was quenched by addition of H<sub>2</sub>O (1000 mL) at 0 °C, then diluted with ethyl acetate (1200 mL), and extracted with ethyl acetate (1200 mL × 2). The combined organic layers were washed with H<sub>2</sub>O (2 × 1000 mL), dried, filtered, and concentrated under reduced pressure to give a residue. 4-(Benzyloxy)-3-fluoro-2-(methoxymethoxy)benzaldehyde <b>82</b> (400.0 g, crude) was obtained as a yellow oil, which was used into the next step without further purification.</div></div><div id="sec4_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> 4-(Benzyloxy)-3-fluoro-2-hydroxybenzaldehyde <b>83</b></h3><div class="NLM_p last">To a solution of <b>82</b> (760.0 g, 2.6 mol, 1.0 equiv) in CH<sub>3</sub>OH (600.0 mL) was added aq HCl (2 M, 200.0 mL). The mixture was stirred at 40 °C for 4 h. TLC indicated that starting material was consumed completely. The reaction was quenched by addition of H<sub>2</sub>O (300 mL) and the mixture was concentrated under reduced pressure to remove methanol. The residue was diluted with dichloromethane 500 mL and extracted with dichloromethane 1000 mL (2 × 500 mL). The combined organic layers were washed with brine (3 × 500 mL), dried, filtered, and concentrated under reduced pressure to give a residue. The residue was purified by column chromatography (SiO<sub>2</sub>, petroleum ether/ethyl acetate = 20:1 to 5:1). 4-(Benzyloxy)-3-fluoro-2-hydroxybenzaldehyde <b>83</b> (225.0 g, 913.8 mmol, 34.9% yield) was obtained as a black-brown solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 10.97 (s, 1H), 10.06 (s, 1H), 7.34–7.52 (m, 6H), 6.90–6.98 (m, 1H), 5.28 (s, 2H).</div></div><div id="sec4_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> 3-(Benzyloxy)-2-fluoro-6-formylphenyl Trifluoromethanesulfonate <b>84</b></h3><div class="NLM_p last">To a solution of <b>83</b> (117.0 g, 475.2 mmol, 1.0 equiv), pyridine (75.2 g, 950.3 mmol, 2.0 equiv) and 4-dimethylaminopyridine (5.8 g, 47.5 mmol, 0.1 equiv) in dichloromethane (1.5 L) was added Tf<sub>2</sub>O (201.1 g, 712.8 mmol, 1.5 equiv) dropwise. The mixture was stirred at 0 °C for 2 h. HPLC indicated that starting material was consumed completely. The reaction mixture was quenched by addition of H<sub>2</sub>O (1000 mL) and then extracted with dichloromethane (2 × 1000 mL). The combined organic layers were washed with brine (500 mL), dried, filtered, and concentrated under reduced pressure to give a residue. The residue was purified by column chromatography (SiO<sub>2</sub>, petroleum ether/ethyl acetate = 20:1 to 2:1). 3-(Benzyloxy)-2-fluoro-6-formylphenyl trifluoromethanesulfonate <b>84</b> (150.0 g, 396.5 mmol, 83.5% yield) was obtained as a yellow oil. <sup>1</sup>H NMR (CDCl<sub>3</sub>, 400 MHz): δ 10.08 (s, 1H), 7.71 (d, <i>J</i> = 7.8 Hz, 1H), 7.49–7.36 (m, 5H), 7.19–7.13 (m, 1H), 5.28 (s, 2H).</div></div><div id="sec4_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> 4-(Benzyloxy)-3-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde <b>85</b></h3><div class="NLM_p last">To a solution of <b>84</b> (52.0 g, 137.5 mmol, 1.00 equiv), potassium acetate (40.5 g, 412.4 mmol, 3.0 equiv), and dipinacol diborane (104.7 g, 412.4 mmol, 3.0 equiv) in dioxane (1.0 L) was added Pd(dppf)Cl<sub>2</sub> (2.0 g, 2.75 mmol, 0.02 equiv). The mixture was stirred at 70 °C for 16 h. HPLC indicated that starting material was consumed completely. The reaction mixture was filtered and concentrated under reduced pressure to give a residue. The residue was purified by column chromatography (SiO<sub>2</sub>, petroleum ether/ethyl acetate = 50:1 to 5:1). 4-(Benzyloxy)-3-fluoro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzaldehyde <b>85</b> (37.0 g, 103.9 mmol, 75.6% yield) was obtained as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.81 (d, <i>J</i> = 3.0 Hz, 1H), 7.81 (d, <i>J</i> = 8.3 Hz, 1H), 7.54–7.33 (m, 7H), 5.31 (s, 2H), 1.39–1.28 (m, 12H).</div></div><div id="sec4_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> 6-(Benzyloxy)-7-fluorobenzo[<i>c</i>][1,2]oxaborol-1(3<i>H</i>)-ol <b>86</b></h3><div class="NLM_p last">To a solution of <b>85</b> (20.0 g, 56.2 mmol, 1.00 equiv) in THF (50.0 mL) was added NaBH<sub>4</sub> (3.2 g, 84.2 mmol, 1.5 equiv). The mixture was stirred at 0 °C for 1 h. TLC indicated that starting material was consumed completely. The reaction mixture was quenched by addition H<sub>2</sub>O (100 mL) at 0 °C, then adjusted pH = 5, removed the THF, then filtered, and concentrated under reduced pressure to give a residue. 6-(Benzyloxy)-7-fluorobenzo[<i>c</i>][1,2]oxaborol-1(3<i>H</i>)-ol <b>86</b> (43.0 g, 166.6 mmol, 98.9% yield) was obtained as a white solid. 1H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 7.31–7.48 (m, 5H), 7.17 (t, <i>J</i> = 7.78 Hz, 1H), 7.01 (d, <i>J</i> = 8.03 Hz, 1H), 5.18 (s, 2H), 5.04 (s, 2H), 4.89 (s, 1H).</div></div><div id="sec4_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> 7-Fluorobenzo[<i>c</i>][1,2]oxaborole-1,6(3<i>H</i>)-diol <b>87</b></h3><div class="NLM_p last">To a solution of <b>86</b> (15.0 g, 58.1 mmol, 1.0 equiv) in ethyl acetate (400.0 mL) was added Pd/C (2.0 g). The mixture was stirred at 25 °C for 2 h under an H<sub>2</sub> atmosphere (50 psi). TLC indicated that starting material was consumed completely. The reaction mixture was filtered and concentrated under reduced pressure to give a residue. 7-Fluorobenzo[<i>c</i>][1,2]oxaborole-1,6(3<i>H</i>)-diol <b>87</b> (7.0 g, 41.7 mmol, 71.7% yield) was obtained as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.59 (s, 1H), 9.14 (s, 1H), 7.05–7.12 (m, 1H), 6.97–7.03 (m, 1H), 4.88 (s, 2H). MS (ESI): mass calcd for C<sub>7</sub>H<sub>6</sub>BFO<sub>3</sub>, 168.04; <i>m</i>/<i>z</i>: found, 167.1 [M – H]<sup>−</sup>. HPLC: 92.5% (220 nm), 94.4% (254 nm).</div></div><div id="sec4_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Anti-wAlb High-Content in Vitro Assay</h3><div class="NLM_p">C6/36 cells (ECACC #89051705, derived from <i>Aedes albopictus</i> larvae) were infected with <i>Wolbachia pipientis</i> derived from the supernatant of cultured <i>A. albopictus</i> Aa23 cells to create a stably <i>Wolbachia</i>-infected cell line C6/36 (wAlbB). This cell line was subpassaged 6–8 days prior to plating out at a density of 2000 viable cells per well in a 384-well CellCarrier plate suspended in Liebovitz media supplemented with 20% fetal bovine serum, 2% tryptose phosphate broth, and 1% non-essential amino acids. Compounds were dissolved and diluted in DMSO, and compound solution was added to each well to provide a final DMSO concentration <1% and a total volume of 100 μL per well.</div><div class="NLM_p">Following 7 days of sterile incubation at 26 °C, staining media-containing SYTO 11 DNA dye was added to each well. After 15 min, all media was removed from each well and fresh media (no stain) was added. Imaging of each well was accomplished using a PerkinElmer Operetta high-content imaging system. Five fields per well were imaged using a confocal 60× objective with the fluorescein filter (excitation filter: 460–490 nm; emission filter: 500–550 nm). Images were analyzed using the PerkinElmer Harmony software to score each intact cell on the basis of texture complexity of the cytoplasm. Full details of the image analysis have been published.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p last">Compound sample wells were analyzed and normalized (along with the positive controls) against the vehicle (untreated) control to give a percentage reduction of <i>Wolbachia</i>-infected cells. Using the cell number analysis, compounds with a host cell number amounting to less than 50% of the vehicle control were classified as toxic and retested at a reduced compound concentration. Dose–response curves were generated with percentage reduction of <i>Wolbachia</i>-infected cells versus compound concentration, using 5–10 compound serial dilutions. Data were analyzed and compound EC<sub>50’</sub>s determined using a 4-parameter logistic nonlinear regression model. EC<sub>50</sub> is defined as the compound concentration producing a 50% reduction of <i>Wolbachia</i> in the C6/36 cell line.</div></div><div id="sec4_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Anti-wMel <i>Wolbachia</i> High-Content in Vitro Assay</h3><div class="NLM_p last">The assay was developed based on previous work<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and carried out as previously described.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> Briefly, <i>D. melanogaster</i> LDW1 cells naturally infected with wMel strain of <i>Wolbachia</i> were maintained in Shields and Sang M3 (SSM3) Insect Medium (Sigma, S3652) supplemented with 10% heat-inactivated fetal bovine serum (FBS) (qualified, One Shot Format, Gibco, 26140-111) at 25 °C, in flasks with unvented caps. Greiner 1536-well assay plates (Part. no. 789091) were coated with 1 mg/mL solution of Concanavalin-A lectin (MP Biomedicals, 02195283) to facilitate cell adhesion. Compounds were acoustically transferred into plates using the Echo 555 Liquid Handler (Labcyte Inc.). Cells were seeded at 4000 cells/well in SSM3 medium supplemented with 2% FBS using the MultiFlo FX Multi-Mode Dispenser (Biotek). After incubating at 25 °C for 6 days, the cells were fixed with 4% paraformaldehyde (PFA) for at least 10 min and washed with phosphate buffered saline, pH 7, 0.1% Tween 20. Fluorescence in situ hybridization (FISH) was used to stain <i>Wolbachia</i> and 3 μM DAPI was used to stain DNA. The “bottle valve” dispenser with an angled-head (Kalypsys Inc, San Diego, CA) was used for fixation and staining. Stained cells were imaged using the CX5 Insight Cellomics high-content imaging instrument with a 10× objective (Thermo). Each well was analyzed using Compartmental Analysis in HCS Studio (Thermo) for cell number and <i>Wolbachia</i> content. Analysis outputs included (1) the total object number per well and (2) the total fluorescence intensity of all spots within each cell (averaged per well). Data were analyzed in Genedata Screener, Version 13.0.1-Standard by normalizing to DMSO (neutral) and inhibitor control-treated wells (12.5 μM doxycycline and 125 nM rifampicin). To determine the EC<sub>50</sub>’s, dose response curves (11′ point, 1:3 dilution) were fitted using the four parameter Hill equation. Each compound was tested in triplicate.</div></div><div id="sec4_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Ethics Statement on Animal Studies</h3><div class="NLM_p last">All in vivo experiments involving <i>B. malayi</i> were conducted at the Liverpool School of Tropical Medicine (LSTM), were approved by the ethical committees of the University of Liverpool and LSTM, and were conducted according to Home Office (UK) requirements. All animal experiments with <i>L. sigmodontis</i> were conducted at the Institute for Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital of Bonn, in accordance to the European Union animal welfare guidelines. All protocols were approved by the local authorities (Landesamt für Natur, Umwelt und Verbraucherschutz, Cologne, Germany (AZ 84-02.04.2015.A507; 84-02.04.2012.A140). In vivo pharmacokinetic studies in mice were conducted either at Anacor Pharmaceuticals or Shanghai ChemPartner under appropriate review by Institutional Animal Care and Use Committees (IACUC) at each site.</div></div><div id="sec4_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> <i>B. malayi</i> SCID Mouse Infection Models</h3><div class="NLM_p last">A <i>B. malayi</i> SCID mouse infection model for anti-<i>Wolbachia</i> drug screening was used as previously described<a onclick="showRef(event, 'ref34 ref51 ref52 ref53'); return false;" href="javascript:void(0);" class="ref ref34 ref51 ref52 ref53">(34,51−53)</a> In brief, <i>B. malayi</i> L3 larvae were generated by membrane blood feeding Liverpool strain filarial susceptible <i>Aedes aegypti</i> mosquitoes with microfilariae isolated from patently infected <i>Meriones unguiculatus</i> gerbils. CB.17 SCID mice were purchased from Charles River UK. Groups of 3 or 5 SCID mice were infected with either 50 or 100 L3, ip, for larval or adult <i>B. malayi</i> efficacy testing, respectively. Drugs were dosed from point of infection for larval testing or after an incubation period of 6 weeks for adult-stage testing with variable length washout. Test drugs were administered orally at indicated doses and as detailed below. Doxycycline or minocycline positive controls were administered in water at indicated doses. At 2-weeks (larval testing) or 12-weeks post-infection (adult testing) motile <i>B. malayi</i> L4 or female parasites were isolated by peritoneal lavage, enumerated by microscopy and individually snap frozen. Total genomic DNA was isolated per worm, and QPCR quantifications of single copy <i>B. malayi</i><i>Wolbachia</i> were undertaken per group of 10 worms per treatment/control, as previously described.<a onclick="showRef(event, 'ref34 ref54'); return false;" href="javascript:void(0);" class="ref ref34 ref54">(34,54)</a> Efficacy of <i>Wolbachia</i> depletion is reported as median <i>Wolbachia</i> load per drug group expressed as a percentage of median vehicle control levels from animals treated only with vehicle.</div></div><div id="sec4_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> <i>L. sigmodontis</i> in Vivo Mouse Model</h3><div class="NLM_p last">Female BALB/c wild type mice were obtained from Janvier (Saint-Berthevin, France) and were housed at the animal facility of the IMMIP in individually ventilated cages on a 12 h light/dark cycle with food and water ad libidum. Mice were infected at 6–8 weeks of age via exposure to the natural mite vector <i>Ornithonyssus bacoti</i> containing infectious <i>L. sigmodontis</i> L3 larvae.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> To compare the infection, the same batch of mite-containing bedding was used to infect all animals of one experiment. Then, 35 days post infection, time point adult worms have developed within the thoracic cavity, and mice were treated per oral gavage with the test compounds at concentrations indicated in the result section. As a vehicle, 1% CMC + 0.1% Tween80 was used. Negative controls were treated with vehicle only, and as a positive control, mice were treated orally with doxycycline (Sigma) in 10% DMSO/1× PBS. Necropsies were performed at 64–77 days post-infection using an overdose of isoflurane (Baxter, Germany) and adult worms were isolated from the thoracic cavity and peritoneum and enumerated. Realtime PCR was performed from remaining female adult worms to quantify <i>Wolbachia</i> FtsZ and <i>L. sigmodontis</i> actin values by qRT-PCR as previously described.<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></div></div><div id="sec4_83" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> General PK Study Protocol</h3><div class="NLM_p">Animals were allowed to acclimate a minimum of 72 h prior to selection for study. On the morning of dosing, animals were weighed and grouped randomly. Animals received the test material by tail-vein injection (IV), or oral gavage (PO). After dosing, all clinical signs and observations were recorded, and if adverse effects were noted, the exact time that the animals returned to normal was also recorded. At prescribed timepoints, animals were anesthetized by isoflurane inhalation and blood samples were collected via retro-orbital bleed or cardiac puncture. After the blood sample collection, animals were euthanized by CO<sub>2</sub> inhalation followed by cervical dislocation.</div><div class="NLM_p last">Blood samples were collected into microtainer tubes (K<sub>2</sub>EDTA) on ice and processed to provide plasma by centrifugation for 6 min at approximately 2000<i>g</i> or 6000 rpm. Processed samples were transferred to analysis tubes that were placed on dry ice. Samples were analyzed by LC/MS/MS.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i103"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01854" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16884" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16884" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01854" class="ext-link">10.1021/acs.jmedchem.8b01854</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings (SMILES) and biochemical and in vitro ADME data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01854/suppl_file/jm8b01854_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01854/suppl_file/jm8b01854_si_001.csv">jm8b01854_si_001.csv (9.55 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b01854" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43805" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43805" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robert T. Jacobs</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, 1020
East Meadow Circle, Palo Alto, California 94303, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9669-2862" title="Orcid link">http://orcid.org/0000-0001-9669-2862</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#84f6f0eee5e7ebe6f7b3b5b1bcc4e3e9e5ede8aae7ebe9"><span class="__cf_email__" data-cfemail="592b2d33383a363b2a6e686c61193e34383035773a3634">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher S. Lunde</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, 1020
East Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yvonne R. Freund</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, 1020
East Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincent Hernandez</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, 1020
East Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xianfeng Li</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, 1020
East Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi Xia</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, 1020
East Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David S. Carter</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, 1020
East Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pamela W. Berry</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, 1020
East Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason Halladay</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, 1020
East Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fernando Rock</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, 1020
East Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rianna Stefanakis</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, 1020
East Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Easom</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, 1020
East Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacob J. Plattner</span> - <span class="hlFld-Affiliation affiliation">Anacor
Pharmaceuticals, 1020
East Meadow Circle, Palo Alto, California 94303, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louise Ford</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly L. Johnston</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darren A. N. Cook</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rachel Clare</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Cassidy</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura Myhill</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hayley Tyrer</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joanne Gamble</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ana F. Guimaraes</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andrew Steven</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Franziska Lenz</span> - <span class="hlFld-Affiliation affiliation">Institute
for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund Freud Str. 25, 53127 Bonn, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexandra Ehrens</span> - <span class="hlFld-Affiliation affiliation">Institute
for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund Freud Str. 25, 53127 Bonn, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan J. Frohberger</span> - <span class="hlFld-Affiliation affiliation">Institute
for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund Freud Str. 25, 53127 Bonn, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marianne Koschel</span> - <span class="hlFld-Affiliation affiliation">Institute
for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund Freud Str. 25, 53127 Bonn, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Achim Hoerauf</span> - <span class="hlFld-Affiliation affiliation">Institute
for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund Freud Str. 25, 53127 Bonn, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc P. Hübner</span> - <span class="hlFld-Affiliation affiliation">Institute
for Medical Microbiology, Immunology and Parasitology, University Hospital Bonn, Sigmund Freud Str. 25, 53127 Bonn, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Case W. McNamara</span> - <span class="hlFld-Affiliation affiliation">Calibr, 11119 North
Torrey Pines Road, Suite 100, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Malina A. Bakowski</span> - <span class="hlFld-Affiliation affiliation">Calibr, 11119 North
Torrey Pines Road, Suite 100, La Jolla, California 92037, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph D. Turner</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark J. Taylor</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen A. Ward</span> - <span class="hlFld-Affiliation affiliation">Centre
for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine, Pembroke Place, Liverpool L3 5QA, U.K.</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>R.T.J., C.J.L., D.S.C., and Y.R.F. wrote the manuscript and contributed equally to the design and execution of the project. R.T.J., V.H., X.L., Y.X., D.S.C., and J.J.P. designed and coordinated synthesis of the compounds. R.T.J., Y.R.F., E.E., J.J.P., R.S., A.H., M.J.T., and S.A.W. provided scientific leadership and management of the project. P.W.B. and J.J. designed, coordinated, and interpreted in vitro and in vivo pharmacokinetics studies. L.F., K.L.J., D.A.N.C., R.C., A.C., L.M., H.T., J.G., A.F.G., A.S., F.L., A.E., S.J.F., M.K., and M.A.B. conducted in vitro and in vivo biological assays, which were designed and coordinated by Y.R.F., F.R., L.F., A.H., M.P.H., C.W.M., J.D.T., M.J.T., and S.A.W. The manuscript was edited by Y.R.F., P.W.B., A.H., M.P.H., J.D.T., M.J.T., and S.A.W.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i105">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73050" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73050" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors would like to thank the Bill & Melinda Gates Foundation for funding of this program through awards to Anacor (Contract number 23629), to the Liverpool School of Tropical Medicine (grant number OPP1054324), to the University of Bonn (grant number OPP1134310), and to Calibr (grant number OPP1107194). We thank Richard Elliott and Ken Duncan of the BMGF foundation for their support and guidance and Michael Xu and his team at WuXi AppTec for their contributions to the medicinal chemistry. We acknowledge the technical contributions of Bettina Dubben and Martina Fendler of University Hospital Bonn.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">NTDs</td><td class="NLM_def"><p class="first last">neglected tropical diseases</p></td></tr><tr><td class="NLM_term">DALYs</td><td class="NLM_def"><p class="first last">disability-adjusted life years</p></td></tr><tr><td class="NLM_term">MDA</td><td class="NLM_def"><p class="first last">mass drug administration</p></td></tr><tr><td class="NLM_term">PTC</td><td class="NLM_def"><p class="first last">peptidyl-transfer center</p></td></tr><tr><td class="NLM_term">MDR1-MDCK</td><td class="NLM_def"><p class="first last">multidrug resistance-1 transfected Madin Darby canine kidney cell line</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>unbound</sub></td><td class="NLM_def"><p class="first last">fraction unbound to plasma protein</p></td></tr><tr><td class="NLM_term">mouse S9</td><td class="NLM_def"><p class="first last">supernatant from 9000 g × 20 min fractionation of mouse liver preparation</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximal plasma concentration</p></td></tr><tr><td class="NLM_term">SCID</td><td class="NLM_def"><p class="first last">severe combined immune deficiency</p></td></tr><tr><td class="NLM_term">L3-stage</td><td class="NLM_def"><p class="first last">third stage larvae</p></td></tr><tr><td class="NLM_term">qPCR</td><td class="NLM_def"><p class="first last">quantitative polymerase chain reaction</p></td></tr><tr><td class="NLM_term">BID</td><td class="NLM_def"><p class="first last">twice daily</p></td></tr><tr><td class="NLM_term">QD</td><td class="NLM_def"><p class="first last">once daily</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability</p></td></tr><tr><td class="NLM_term">Cl<sub>int</sub></td><td class="NLM_def"><p class="first last">intrinsic clearance</p></td></tr><tr><td class="NLM_term">wsp</td><td class="NLM_def"><p class="first last"><i>Wolbachia</i> surface protein</p></td></tr><tr><td class="NLM_term">FtsZ</td><td class="NLM_def"><p class="first last">prokaryotic homolog of mammalian tubulin</p></td></tr><tr><td class="NLM_term">BALB/c</td><td class="NLM_def"><p class="first last">Bagg albino strain mice</p></td></tr><tr><td class="NLM_term">br</td><td class="NLM_def"><p class="first last">broad</p></td></tr><tr><td class="NLM_term">s</td><td class="NLM_def"><p class="first last">singlet</p></td></tr><tr><td class="NLM_term">d</td><td class="NLM_def"><p class="first last">doublet</p></td></tr><tr><td class="NLM_term">dd</td><td class="NLM_def"><p class="first last">doublet of doublets</p></td></tr><tr><td class="NLM_term">t</td><td class="NLM_def"><p class="first last">triplet</p></td></tr><tr><td class="NLM_term">q</td><td class="NLM_def"><p class="first last">quartet</p></td></tr><tr><td class="NLM_term">m</td><td class="NLM_def"><p class="first last">multiplet</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i107">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18788" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18788" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 54 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simonsen, P. E. F.</span>; <span class="NLM_string-name">Fischer, P. U.</span>; <span class="NLM_string-name">Hoerauf, A.</span>; <span class="NLM_string-name">Weil, G.
J.</span></span> <span> </span><span class="NLM_article-title">The Filariases</span>. In  <i>Manson’s Tropical Diseases</i>, <span class="NLM_edition">23</span>rd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrar, J. H.</span>, <span class="NLM_string-name">Junghanss, T.</span>, <span class="NLM_string-name">Kang, G.</span>, <span class="NLM_string-name">Lalloo, D.</span>, <span class="NLM_string-name">White, N. J.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier Saunders</span>: <span class="NLM_publisher-loc">Amsterdam</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">765</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2FB978-0-7020-5101-2.00055-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=737-765&author=P.+E.+F.+Simonsen&author=P.+U.+Fischer&author=A.+Hoerauf&author=G.%0AJ.+Weilauthor=J.+H.+Farrar&author=T.+Junghanss&author=G.+Kang&author=D.+Lalloo&author=N.+J.+White&title=Manson%E2%80%99s+Tropical+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FB978-0-7020-5101-2.00055-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-7020-5101-2.00055-8%26sid%3Dliteratum%253Aachs%26aulast%3DSimonsen%26aufirst%3DP.%2BE.%2BF.%26atitle%3DThe%2520Filariases%26btitle%3DManson%25E2%2580%2599s%2520Tropical%2520Diseases%26aulast%3DFarrar%26aufirst%3DJ.%2BH.%26pub%3DElsevier%2520Saunders%26date%3D2014%26spage%3D737%26epage%3D765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bockarie, M.</span></span> <span> </span><span class="NLM_article-title">Lymphatic filariasis and onchocerciasis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>376</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1185</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(10)60586-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fs0140-6736%2810%2960586-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=20739055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A280%3ADC%252BC3cfmsFOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2010&pages=1175-1185&author=M.+J.+Taylorauthor=A.+Hoeraufauthor=M.+Bockarie&title=Lymphatic+filariasis+and+onchocerciasis&doi=10.1016%2Fs0140-6736%2810%2960586-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Lymphatic filariasis and onchocerciasis</span></div><div class="casAuthors">Taylor Mark J; Hoerauf Achim; Bockarie Moses</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">9747</span>),
    <span class="NLM_cas:pages">1175-85</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lymphatic filariasis and onchocerciasis are parasitic helminth diseases that constitute a serious public health issue in tropical regions.  The filarial nematodes that cause these diseases are transmitted by blood-feeding insects and produce chronic and long-term infection through suppression of host immunity.  Disease pathogenesis is linked to host inflammation invoked by the death of the parasite, causing hydrocoele, lymphoedema, and elephantiasis in lymphatic filariasis, and skin disease and blindness in onchocerciasis.  Most filarial species that infect people co-exist in mutualistic symbiosis with Wolbachia bacteria, which are essential for growth, development, and survival of their nematode hosts.  These endosymbionts contribute to inflammatory disease pathogenesis and are a target for doxycycline therapy, which delivers macrofilaricidal activity, improves pathological outcomes, and is effective as monotherapy.  Drugs to treat filariasis include diethylcarbamazine, ivermectin, and albendazole, which are used mostly in combination to reduce microfilariae in blood (lymphatic filariasis) and skin (onchocerciasis).  Global programmes for control and elimination have been developed to provide sustained delivery of drugs to affected communities to interrupt transmission of disease and ultimately eliminate this burden on public health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmTWInjypR6b9KldV63DuefW6udTcc2eaU6HZyMu0zILntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfmsFOltA%253D%253D&md5=44dd7936d02ca073197617d540f295ed</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2810%2960586-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252810%252960586-7%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DBockarie%26aufirst%3DM.%26atitle%3DLymphatic%2520filariasis%2520and%2520onchocerciasis%26jtitle%3DLancet%26date%3D2010%26volume%3D376%26spage%3D1175%26epage%3D1185%26doi%3D10.1016%2Fs0140-6736%2810%2960586-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottesen, E. A.</span></span> <span> </span><span class="NLM_article-title">Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e3319</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0003319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1371%2Fjournal.pntd.0003319" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=e3319&author=K.+D.+Ramaiahauthor=E.+A.+Ottesen&title=Progress+and+impact+of+13+years+of+the+global+programme+to+eliminate+lymphatic+filariasis+on+reducing+the+burden+of+filarial+disease&doi=10.1371%2Fjournal.pntd.0003319"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0003319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0003319%26sid%3Dliteratum%253Aachs%26aulast%3DRamaiah%26aufirst%3DK.%2BD.%26aulast%3DOttesen%26aufirst%3DE.%2BA.%26atitle%3DProgress%2520and%2520impact%2520of%252013%2520years%2520of%2520the%2520global%2520programme%2520to%2520eliminate%2520lymphatic%2520filariasis%2520on%2520reducing%2520the%2520burden%2520of%2520filarial%2520disease%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2014%26volume%3D8%26spage%3De3319%26doi%3D10.1371%2Fjournal.pntd.0003319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katiyar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, L. K.</span></span> <span> </span><span class="NLM_article-title">Filariasis: Current status, treatment and recent advances in drug development</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2174</span>– <span class="NLM_lpage">2185</span>, <span class="refDoi"> DOI: 10.2174/092986711795656234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.2174%2F092986711795656234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=21521163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFegs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=2174-2185&author=D.+Katiyarauthor=L.+K.+Singh&title=Filariasis%3A+Current+status%2C+treatment+and+recent+advances+in+drug+development&doi=10.2174%2F092986711795656234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Filariasis: current status, treatment and recent advances in drug development</span></div><div class="casAuthors">Katiyar, D.; Singh, L. K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2174-2185</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Lymphatic filariasis, onchocerciasis and loiasis caused by human filarial nematodes are diseases of tropical and subtropical countries causing considerable morbidity.  The available control strategies have significant limitations such that current drugs are ineffective against macrofilariae (adult worms), require repeated and prolonged treatment over years and are threatened by emergence of drug resistance.  Due to this concern, these diseases are the focus of renewed scientific interest and much has been done in filariasis research in the past decade.  This review summarizes the current status of filariasis, different control strategies, recent advances in antifilarial chemotherapy including currently used drugs, their pros and cons, their mechanism of action, and recently discovered targets and prototypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogceQjWSj2YrVg90H21EOLACvtfcHk0ljmZVl0Ok74MA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFegs7c%253D&md5=f745cd6c9ed0bb6eff8b2a2d36be5adc</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F092986711795656234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795656234%26sid%3Dliteratum%253Aachs%26aulast%3DKatiyar%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DL.%2BK.%26atitle%3DFilariasis%253A%2520Current%2520status%252C%2520treatment%2520and%2520recent%2520advances%2520in%2520drug%2520development%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D2174%26epage%3D2185%26doi%3D10.2174%2F092986711795656234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geary, T.</span></span> <span> </span><span class="NLM_article-title">Ivermectin 20 years on: maturation of a wonder drug</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">530</span>– <span class="NLM_lpage">532</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2005.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fj.pt.2005.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=16126457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeiu7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2005&pages=530-532&author=T.+Geary&title=Ivermectin+20+years+on%3A+maturation+of+a+wonder+drug&doi=10.1016%2Fj.pt.2005.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Ivermectin 20 years on: maturation of a wonder drug</span></div><div class="casAuthors">Geary, Timothy G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">530-532</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Ivermectin has been on the veterinary market for almost a quarter of a century and has been approved for human use for 18 years.  Its use has revolutionized the treatment of nematode and arthropod parasites in animals and has provided hope for the control or even eradication of filariases in humans.  Although much remains to be learned about how the drug works and how resistance to it will develop, it has earned the title of 'wonder drug'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojSYF8c9NaXrVg90H21EOLACvtfcHk0lh9oRkJFtch5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeiu7vE&md5=1cdddc83be460a7f18b5c6ede8783c4b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2005.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2005.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DGeary%26aufirst%3DT.%26atitle%3DIvermectin%252020%2520years%2520on%253A%2520maturation%2520of%2520a%2520wonder%2520drug%26jtitle%3DTrends%2520Parasitol.%26date%3D2005%26volume%3D21%26spage%3D530%26epage%3D532%26doi%3D10.1016%2Fj.pt.2005.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suamani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanuku, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satofan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goss, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siba, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weil, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazura, J. W.</span></span> <span> </span><span class="NLM_article-title">A trial of a triple-drug treatment for lymphatic filariasis</span>. <i>New Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">1801</span>– <span class="NLM_lpage">1810</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1706854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1056%2Fnejmoa1706854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=30403937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Gktb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2018&pages=1801-1810&author=C.+L.+Kingauthor=J.+Suamaniauthor=N.+Sanukuauthor=Y.-C.+Chengauthor=S.+Satofanauthor=B.+Mancusoauthor=C.+W.+Gossauthor=L.+J.+Robinsonauthor=P.+M.+Sibaauthor=G.+J.+Weilauthor=J.+W.+Kazura&title=A+trial+of+a+triple-drug+treatment+for+lymphatic+filariasis&doi=10.1056%2Fnejmoa1706854"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A trial of a triple-drug treatment for lymphatic filariasis</span></div><div class="casAuthors">King, Christopher L.; Suamani, James; Sanuku, Nelly; Cheng, Yao-Chieh; Satofan, Samson; Mancuso, Brooke; Goss, Charles W.; Robinson, Leanne J.; Siba, Peter M.; Weil, Gary J.; Kazura, James W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1801-1810</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND The World Health Organization has targeted lymphatic filariasis for global elimination by 2020 with a strategy of mass drug administration.  This trial tested whether a single dose of a three-drug regimen of ivermectin plus diethylcarbamazine plus albendazole results in a greater sustained clearance of microfilariae than a single dose of a two-drug regimen of diethylcarbamazine plus albendazole and is noninferior to the two-drug regimen administered once a year for 3 years.  METHODS In a randomized, controlled trial involving adults from Papua New Guinea with Wuchereria bancrofti microfilaremia, we assigned 182 participants to receive a single dose of the three-drug regimen (60 participants), a single dose of the two-drug regimen (61 participants), or the two-drug regimen once a year for 3 years (61 participants).  Clearance of microfilariae from the blood was measured at 12, 24, and 36 mo after trial initiation.  RESULTS The three-drug regimen cleared microfilaremia in 55 of 57 participants (96%) at 12 mo, in 52 of 54 participants (96%) at 24 mo, and in 55 of 57 participants (96%) at 36 mo.  A single dose of the two-drug regimen cleared microfilaremia in 18 of 56 participants (32%) at 12 mo, in 31 of 55 participants (56%) at 24 mo, and in 43 of 52 participants (83%) at 36 mo (P = 0.02 for the three-drug regimen vs. a single dose of the two-drug regimen at 36 mo).  The two-drug regimen administered once a year for 3 years cleared microfilaremia in 20 of 59 participants (34%) at 12 mo, in 42 of 56 participants (75%) at 24 mo, and in 51 of 52 participants (98%) at 36 mo (P = 0.004 for noninferiority of the three-drug regimen vs. the two-drug regimen administered once a year for 3 years at 36 mo).  Moderate adverse events were more common in the group that received the three-drug regimen than in the combined two-drug-regimen groups (27% vs. 5%, P<0.001).  There were no serious adverse events.  CONCLUSIONS The three-drug regimen induced clearance of microfilariae from the blood for 3 years in almost all participants who received the treatment and was superior to the two-drug regimen administered once and noninferior to the two-drug regimen administered once a year for 3 years. (Funded by the Bill and Melinda Gates Foundation; ClinicalTrials.gov no., NCT01975441.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY6AcjxP4Fp7Vg90H21EOLACvtfcHk0lh9oRkJFtch5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Gktb3I&md5=214d933b84da2a47562e3358531f0fec</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1706854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1706854%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DC.%2BL.%26aulast%3DSuamani%26aufirst%3DJ.%26aulast%3DSanuku%26aufirst%3DN.%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DSatofan%26aufirst%3DS.%26aulast%3DMancuso%26aufirst%3DB.%26aulast%3DGoss%26aufirst%3DC.%2BW.%26aulast%3DRobinson%26aufirst%3DL.%2BJ.%26aulast%3DSiba%26aufirst%3DP.%2BM.%26aulast%3DWeil%26aufirst%3DG.%2BJ.%26aulast%3DKazura%26aufirst%3DJ.%2BW.%26atitle%3DA%2520trial%2520of%2520a%2520triple-drug%2520treatment%2520for%2520lymphatic%2520filariasis%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2018%26volume%3D379%26spage%3D1801%26epage%3D1810%26doi%3D10.1056%2Fnejmoa1706854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slatko, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, J. M.</span></span> <span> </span><span class="NLM_article-title">The Wolbachia endosymbiont as an anti-filarial nematode target</span>. <i>Symbiosis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1007/s13199-010-0067-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1007%2Fs13199-010-0067-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=20730111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A280%3ADC%252BC2sbos1OrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=55-65&author=B.+E.+Slatkoauthor=M.+J.+Taylorauthor=J.+M.+Foster&title=The+Wolbachia+endosymbiont+as+an+anti-filarial+nematode+target&doi=10.1007%2Fs13199-010-0067-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Wolbachia endosymbiont as an anti-filarial nematode target</span></div><div class="casAuthors">Slatko Barton E; Taylor Mark J; Foster Jeremy M</div><div class="citationInfo"><span class="NLM_cas:title">Symbiosis (Philadelphia, Pa.)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-65</span>
        ISSN:<span class="NLM_cas:issn">0334-5114</span>.
    </div><div class="casAbstract">Human disease caused by parasitic filarial nematodes is a major cause of global morbidity.  The parasites are transmitted by arthropod intermediate hosts and are responsible for lymphatic filariasis (elephantiasis) or onchocerciasis (river blindness).  Within these filarial parasites are intracellular alpha-proteobacteria, Wolbachia, that were first observed almost 30 years ago.  The obligate endosymbiont has been recognized as a target for anti-filarial nematode chemotherapy as evidenced by the loss of worm fertility and viability upon antibiotic treatment in an extensive series of human trials.  While current treatments with doxycycline and rifampicin are not practical for widespread use due to the length of required treatments and contraindications, anti-Wolbachia targeting nevertheless appears a promising alternative for filariasis control in situations where current programmatic strategies fail or are unable to be delivered and it provides a superior efficacy for individual therapy.  The mechanisms that underlie the symbiotic relationship between Wolbachia and its nematode hosts remain elusive.  Comparative genomics, bioinfomatic and experimental analyses have identified a number of potential interactions, which may be drug targets.  One candidate is de novo heme biosynthesis, due to its absence in the genome sequence of the host nematode, Brugia malayi, but presence in Wolbachia and its potential roles in worm biology.  We describe this and several additional candidate targets, as well as our approaches for understanding the nature of the host-symbiont relationship.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIXJeADOTvyHthwrmtH4OBfW6udTcc2eaGIU3Myyz2trntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbos1OrsQ%253D%253D&md5=0e8be5a2bb0819139ea34b8693282248</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs13199-010-0067-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13199-010-0067-1%26sid%3Dliteratum%253Aachs%26aulast%3DSlatko%26aufirst%3DB.%2BE.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DFoster%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520Wolbachia%2520endosymbiont%2520as%2520an%2520anti-filarial%2520nematode%2520target%26jtitle%3DSymbiosis%26date%3D2010%26volume%3D51%26spage%3D55%26epage%3D65%26doi%3D10.1007%2Fs13199-010-0067-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volkmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Büttner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfo-Debrekyei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adjei, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Büttner, D. W.</span></span> <span> </span><span class="NLM_article-title">Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms</span>. <i>Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1016/s1286-4579(03)00026-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fs1286-4579%2803%2900026-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=12706439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFGitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=261-273&author=A.+Hoeraufauthor=S.+Mandauthor=L.+Volkmannauthor=M.+B%C3%BCttnerauthor=Y.+Marfo-Debrekyeiauthor=M.+Taylorauthor=O.+Adjeiauthor=D.+W.+B%C3%BCttner&title=Doxycycline+in+the+treatment+of+human+onchocerciasis%3A+Kinetics+of+Wolbachia+endobacteria+reduction+and+of+inhibition+of+embryogenesis+in+female+Onchocerca+worms&doi=10.1016%2Fs1286-4579%2803%2900026-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Doxycycline in the treatment of human onchocerciasis: kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms</span></div><div class="casAuthors">Hoerauf, Achim; Mand, Sabine; Volkmann, Lars; Buttner, Marcelle; Marfo-Debrekyei, Yeboah; Taylor, Mark; Adjei, Ohene; Buttner, Dietrich W.</div><div class="citationInfo"><span class="NLM_cas:title">Microbes and Infection</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">261-273</span>CODEN:
                <span class="NLM_cas:coden">MCINFS</span>;
        ISSN:<span class="NLM_cas:issn">1286-4579</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">Recently, experts have warned that mass treatment with ivermectin alone may not interrupt the transmission of Onchocerca.  Hence, addnl. drugs are needed, such as antibiotics acting on symbiotic endobacteria of the filariae, the causative agents of onchocerciasis.  Based on animal expts., human onchocerciasis was treated with doxycycline, and preliminary observations published in 2001 in The Lancet showed sterility in female worms by depletion and marked redn. in symbiotic Wolbachia endobacteria from the filariae.  Here, a detailed kinetic anal. of the features of the worms, following administration or not of doxycycline to the patients is reported.  Sixty-three onchocerciasis patients in Ghana were treated with 100 mg doxycycline daily for 6 wk and 2 or 6 mo later with ivermectin.  Onchocercomas were extirpated 2, 6, 11 and 18 mo after the onset of treatment and the filariae were examd. by immunohistol. and PCR.  The anal. showed: (i) progressive depletion of Wolbachia from adult worms and microfilariae by doxycycline over a period of 6 mo; (ii) inhibition of embryogenesis by doxycycline after 6 mo with respect to all embryo stages followed by decline in microfilariae after 11 mo; (iii) redn. in spermatozoa in the female genital tract by doxycycline, whereas spermiogenesis was only partly reduced after 11 and 18 mo; (iv) no relevant macro- or microfilaricidal activity; (v) depletion/marked redn. in endobacteria and inhibition of embryogenesis were sustained until 18 mo after doxycycline and 12 mo after co-administration of ivermectin; (vi) no severe adverse side effects were seen.  Due to its long-lasting inhibition of embryogenesis, doxycycline presents an addnl. strategy for the treatment of onchocerciasis and control of Onchocerca microfilariae transmission.  Extension of the existing registration will not require much time or high cost.  Treatment of individual patients can be considered immediately.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX76OYzrrgGLVg90H21EOLACvtfcHk0lhPzfAgcYs5GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFGitb0%253D&md5=72a1546db5deb6cf6a5ebba1945c24f2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fs1286-4579%2803%2900026-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1286-4579%252803%252900026-1%26sid%3Dliteratum%253Aachs%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DMand%26aufirst%3DS.%26aulast%3DVolkmann%26aufirst%3DL.%26aulast%3DB%25C3%25BCttner%26aufirst%3DM.%26aulast%3DMarfo-Debrekyei%26aufirst%3DY.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DAdjei%26aufirst%3DO.%26aulast%3DB%25C3%25BCttner%26aufirst%3DD.%2BW.%26atitle%3DDoxycycline%2520in%2520the%2520treatment%2520of%2520human%2520onchocerciasis%253A%2520Kinetics%2520of%2520Wolbachia%2520endobacteria%2520reduction%2520and%2520of%2520inhibition%2520of%2520embryogenesis%2520in%2520female%2520Onchocerca%2520worms%26jtitle%3DMicrobes%2520Infect.%26date%3D2003%26volume%3D5%26spage%3D261%26epage%3D273%26doi%3D10.1016%2Fs1286-4579%2803%2900026-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruppa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfo-Debrekyei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debrah, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfarr, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adjei, O.</span></span> <span> </span><span class="NLM_article-title">Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production</span>. <i>Med. Microbiol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>192</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1007/s00430-002-0174-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1007%2Fs00430-002-0174-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=12684759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVOiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2003&pages=211-216&author=A.+Hoeraufauthor=S.+Mandauthor=K.+Fischerauthor=T.+Kruppaauthor=Y.+Marfo-Debrekyeiauthor=A.+Y.+Debrahauthor=K.+M.+Pfarrauthor=O.+Adjei&title=Doxycycline+as+a+novel+strategy+against+bancroftian+filariasis-depletion+of+Wolbachia+endosymbionts+from+Wuchereria+bancrofti+and+stop+of+microfilaria+production&doi=10.1007%2Fs00430-002-0174-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production</span></div><div class="casAuthors">Hoerauf, Achim; Mand, Sabine; Fischer, Kerstin; Kruppa, Thomas; Marfo-Debrekyei, Yeboah; Debrah, Alexander Yaw; Pfarr, Kenneth M.; Adjei, Ohene; Buettner, Dietrich W.</div><div class="citationInfo"><span class="NLM_cas:title">Medical Microbiology and Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">211-216</span>CODEN:
                <span class="NLM_cas:coden">MMIYAO</span>;
        ISSN:<span class="NLM_cas:issn">0300-8584</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Chemotherapy of onchocerciasis by doxycycline, which targets symbiotic Wolbachia endobacteria, has been shown to result in a long-term sterility of adult female worms and corresponding absence of microfilariae.  It represents an addnl. chemotherapeutic approach.  The aim of this study was to det. whether a similar regimen would also show efficacy against Wuchereria bancrofti.  Ghanaian individuals (n = 93) with lymphatic filariasis and a min. microfilaremia of 40 microfilariae/mL were included in a treatment study consisting of four arms: (1) doxycycline 200 mg/day for 6 wk; (2) doxycycline as in (1), followed by a single dose of ivermectin after 4 mo; (3) ivermectin only; or (4) no treatment during observation period of 1 yr (ivermectin at the end of the study).  Doxycycline treatment resulted in a 96% loss of Wolbachia, as detd. by real time PCR from microfilariae.  After 12 mo, doxycycline had led to a 99% redn. of microfilaremia when given alone, and to a complete amicrofilaremia together with ivermectin.  In contrast, after ivermectin treatment alone a significant presence of microfilariae remained (9% compared to pretreatment), as known from other studies.  This study shows that doxycycline is also effective in depleting Wolbachia from W. bancrofti.  It is likely that the mechanism of doxycycline is similar to that in other filarial species, i.e., a predominant blockade of embryogenesis, leading to a decline of microfilariae according to their half-life.  This could render doxycycline treatment an addnl. tool for the treatment of microfilaria-assocd. diseases in bancroftian filariasis, such as tropical pulmonary eosinophilia and microfiluria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgWs6R6DU07Vg90H21EOLACvtfcHk0lhPzfAgcYs5GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVOiurc%253D&md5=26491a1dc911595fadcc5d608c1732ac</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00430-002-0174-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00430-002-0174-6%26sid%3Dliteratum%253Aachs%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DMand%26aufirst%3DS.%26aulast%3DFischer%26aufirst%3DK.%26aulast%3DKruppa%26aufirst%3DT.%26aulast%3DMarfo-Debrekyei%26aufirst%3DY.%26aulast%3DDebrah%26aufirst%3DA.%2BY.%26aulast%3DPfarr%26aufirst%3DK.%2BM.%26aulast%3DAdjei%26aufirst%3DO.%26atitle%3DDoxycycline%2520as%2520a%2520novel%2520strategy%2520against%2520bancroftian%2520filariasis-depletion%2520of%2520Wolbachia%2520endosymbionts%2520from%2520Wuchereria%2520bancrofti%2520and%2520stop%2520of%2520microfilaria%2520production%26jtitle%3DMed.%2520Microbiol.%2520Immunol.%26date%3D2003%26volume%3D192%26spage%3D211%26epage%3D216%26doi%3D10.1007%2Fs00430-002-0174-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adjei, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleischer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Büttner, D. W.</span></span> <span> </span><span class="NLM_article-title">Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">1415</span>– <span class="NLM_lpage">1416</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(00)04581-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fs0140-6736%2800%2904581-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=11356444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A280%3ADC%252BD3M3mtlGmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2001&pages=1415-1416&author=A.+Hoeraufauthor=S.+Mandauthor=O.+Adjeiauthor=B.+Fleischerauthor=D.+W.+B%C3%BCttner&title=Depletion+of+Wolbachia+endobacteria+in+Onchocerca+volvulus+by+doxycycline+and+microfilaridermia+after+ivermectin+treatment&doi=10.1016%2Fs0140-6736%2800%2904581-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment</span></div><div class="casAuthors">Hoerauf A; Mand S; Adjei O; Fleischer B; Buttner D W</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">9266</span>),
    <span class="NLM_cas:pages">1415-6</span>
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    </div><div class="casAbstract">Ivermectin is the drug used for mass chemotherapy of onchocerciasis within the WHO African Programme for Onchocerciasis Control.  This approach aims to eliminate the disease as a public health problem but using one dose per year may not completely interrupt transmission since it does not suppress microfilaridermia thoroughly enough.  Here we show that additional treatment with doxycycline, previously shown to sterilise adult female worms for a few months by depletion of symbiotic wolbachia endobacteria, significantly enhances ivermectin-induced suppression of microfilaridermia, rendering anti-wolbachia treatment a promising basis for blocking transmission by a drug-based approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_4Vhuc5mpj5dYoSR9eyvsfW6udTcc2eZdhQDE-phB17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3mtlGmsQ%253D%253D&md5=80d853b62b101ffcb3144d12dfc0e227</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2800%2904581-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252800%252904581-5%26sid%3Dliteratum%253Aachs%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DMand%26aufirst%3DS.%26aulast%3DAdjei%26aufirst%3DO.%26aulast%3DFleischer%26aufirst%3DB.%26aulast%3DB%25C3%25BCttner%26aufirst%3DD.%2BW.%26atitle%3DDepletion%2520of%2520Wolbachia%2520endobacteria%2520in%2520Onchocerca%2520volvulus%2520by%2520doxycycline%2520and%2520microfilaridermia%2520after%2520ivermectin%2520treatment%26jtitle%3DLancet%26date%3D2001%26volume%3D357%26spage%3D1415%26epage%3D1416%26doi%3D10.1016%2Fs0140-6736%2800%2904581-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goetze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiernickel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsner, P.</span></span> <span> </span><span class="NLM_article-title">Phototoxicity of doxycycline: a systematic review on clinical manifestations, frequency, cofactors, and prevention</span>. <i>Skin Pharmacol. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1159/000458761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1159%2F000458761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=28291967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVOju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2017&pages=76-80&author=S.+Goetzeauthor=C.+Hiernickelauthor=P.+Elsner&title=Phototoxicity+of+doxycycline%3A+a+systematic+review+on+clinical+manifestations%2C+frequency%2C+cofactors%2C+and+prevention&doi=10.1159%2F000458761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Phototoxicity of Doxycycline: A Systematic Review on Clinical Manifestations, Frequency, Cofactors, and Prevention</span></div><div class="casAuthors">Goetze, Steven; Hiernickel, Christian; Elsner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Skin Pharmacology and Physiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">76-80</span>CODEN:
                <span class="NLM_cas:coden">SPPKE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-5527</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: One of the most important dermatol. side effects of doxycycline is photosensitivity.  As doxycycline is important for malaria prophylaxis and malaria is mainly spread in countries with high sun radiation, special attention should be paid to this adverse effect.  While there are many publications on the phototoxicity of tetracyclines in general, only a few exist focusing on doxycycline.  The objective of this systematic review was to summarize all available reports on clin. manifestations, influencing factors like UV dose or dose of medication, and the possibilities of prevention by sun protection.  Methods: This review is based on a systematic search in PubMed for articles in English and German and a manual search between 1990 and 2015.  Results: The no. of publications is low.  Clin. symptoms vary from light sunburn-like sensation (burning, erythema) to large-area photodermatitis.  Also, onycholysis is possible.  The triggering UV spectrum seems to consist mainly of UVA1 (340-400 nm), so UV-protective products should be used that cover this range.  Travelers to tropical countries taking doxycycline for malaria prophylaxis need thorough medical counseling to avoid possibly severe phototoxic reactions.  Conclusion: Evidence base must be improved for giving advice on appropriate prevention measures to travelers taking doxycycline and having a risk of significant sun exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsu5U1oK1WZLVg90H21EOLACvtfcHk0lhpBnInpZdpCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVOju74%253D&md5=bd16f4b8013da5b5754226f396ac5737</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1159%2F000458761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000458761%26sid%3Dliteratum%253Aachs%26aulast%3DGoetze%26aufirst%3DS.%26aulast%3DHiernickel%26aufirst%3DC.%26aulast%3DElsner%26aufirst%3DP.%26atitle%3DPhototoxicity%2520of%2520doxycycline%253A%2520a%2520systematic%2520review%2520on%2520clinical%2520manifestations%252C%2520frequency%252C%2520cofactors%252C%2520and%2520prevention%26jtitle%3DSkin%2520Pharmacol.%2520Physiol.%26date%3D2017%26volume%3D30%26spage%3D76%26epage%3D80%26doi%3D10.1159%2F000458761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardon-Wendel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demanga-Ngangue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamgno, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chippaux, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boussinesq, M.</span></span> <span> </span><span class="NLM_article-title">Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(96)11094-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fs0140-6736%2896%2911094-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=9217715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFygsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1997&pages=18-22&author=J.+Gardonauthor=N.+Gardon-Wendelauthor=N.+Demanga-Ngangueauthor=J.+Kamgnoauthor=J.-P.+Chippauxauthor=M.+Boussinesq&title=Serious+reactions+after+mass+treatment+of+onchocerciasis+with+ivermectin+in+an+area+endemic+for+Loa+loa+infection&doi=10.1016%2Fs0140-6736%2896%2911094-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection</span></div><div class="casAuthors">Gardon, Jacques; Gardon-Wendel, Nathalie; Demanga-Ngangue; Kamgno, Joseph; Chippaux, Jean-Philippe; Boussinesq, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">9070</span>),
    <span class="NLM_cas:pages">18-22</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet</span>)
        </div><div class="casAbstract">In 1995, the World Bank launched an African Program for Onchocerciasis Control to eliminate Onchocerca volvulus disease from 19 African countries by means of community-based ivermectin treatment (CBIT).  Several cases of encephalopathy have been reported after ivermectin in people heavily infected with microfilaria of Loa loa (loiasis).  We assessed the incidence of serious events in an area where onchocerciasis and loiasis are both endemic.  Ivermectin (at 150 μg/kg) was given to 17877 people living in the Lekie area of Cameroon.  50 μL samples of capillary blood were taken during the daytime before treatment from all adults (aged ≥15 yr), and the nos. of L loa and Mansonella perstans microfilaria in them were counted.  Patients were monitored for 7 days after treatment.  Adverse reactions were classified as mild, marked, or serious.  Serious reactions were defined as those assocd. with a functional impairment that required at least a week of full-time assistance to undertake normal activities.  We calcd. the relative risk of developing marked or serious reactions for increasing L loa microfilarial loads.  Risk factors for serious reactions were identified and assessed with a logistic regression model.  20 Patients (0.11%) developed serious reactions without neurol. signs but assocd. with a functional impairment lasting more than a week.  Two other patients were in coma for 2-3 days, assocd. with L loa microfilaria in cerebrospinal fluid.  Occurrence of serious reactions was related to the intensity of pretreatment L loa microfilaremia.  The relative risk of developing marked or serious reactions was significantly higher when the L loa load exceeded 8000 microfilaria/mL; for serious reactions, the risk is very high (odds ratio >1000) for loads above 50 000 microfilaria/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiBNGlpdyehrVg90H21EOLACvtfcHk0lhpBnInpZdpCA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFygsLc%253D&md5=59a4ad8f92ea9b9f295f0885e52caaf3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2896%2911094-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252896%252911094-1%26sid%3Dliteratum%253Aachs%26aulast%3DGardon%26aufirst%3DJ.%26aulast%3DGardon-Wendel%26aufirst%3DN.%26aulast%3DDemanga-Ngangue%26aufirst%3DN.%26aulast%3DKamgno%26aufirst%3DJ.%26aulast%3DChippaux%26aufirst%3DJ.-P.%26aulast%3DBoussinesq%26aufirst%3DM.%26atitle%3DSerious%2520reactions%2520after%2520mass%2520treatment%2520of%2520onchocerciasis%2520with%2520ivermectin%2520in%2520an%2520area%2520endemic%2520for%2520Loa%2520loa%2520infection%26jtitle%3DLancet%26date%3D1997%26volume%3D350%26spage%3D18%26epage%3D22%26doi%3D10.1016%2Fs0140-6736%2896%2911094-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tendongfor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klarmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfarr, K.</span></span> <span> </span><span class="NLM_article-title">Retarded Onchocerca volvulus L1 to L3 larval development in the Simulium damnosum vector after anti-wolbachial treatment of the human host</span>. <i>Parasites Vectors</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">12</span>, <span class="refDoi"> DOI: 10.1186/1756-3305-5-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1186%2F1756-3305-5-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=22236497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtVOksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=12&author=A.+Albersauthor=M.+Esumauthor=N.+Tendongforauthor=P.+Enyongauthor=U.+Klarmannauthor=S.+Wanjiauthor=A.+Hoeraufauthor=K.+Pfarr&title=Retarded+Onchocerca+volvulus+L1+to+L3+larval+development+in+the+Simulium+damnosum+vector+after+anti-wolbachial+treatment+of+the+human+host&doi=10.1186%2F1756-3305-5-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Retarded Onchocerca volvulus L1 to L3 larval development in the Simulium damnosum vector after anti-wolbachial treatment of the human host</span></div><div class="casAuthors">Albers, Anna; Esum, Mathias Eyong; Tendongfor, Nicholas; Enyong, Peter; Klarmann, Ute; Wanji, Samuel; Hoerauf, Achim; Pfarr, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Parasites & Vectors</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12</span>CODEN:
                <span class="NLM_cas:coden">PVAEAK</span>;
        ISSN:<span class="NLM_cas:issn">1756-3305</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The human parasite Onchocerca volvulus harbours Wolbachia endosymbionts essential for worm embryogenesis, larval development and adult survival.  In this study, the development of Wolbachia-depleted microfilariae (first stage larvae) to infective third stage larvae (L3) in the insect vector Simulium damnosum was analyzed.  Methods: Infected volunteers in Cameroon were randomly and blindly allocated into doxycycline (200 mg/day for 6 wk) or placebo treatment groups.  After treatment, blackflies were allowed to take a blood meal on the volunteers, captured and dissected for larval counting and DNA extn. for quant. real-time PCR anal.  Results: PCR results showed a clear redn. in Wolbachia DNA after doxycycline treatment in microfilariae from human skin biopsies with >50% redn. at one month post-treatment, eventually reaching a redn. of >80%.  Larval stages recovered from the insect vector had similar levels of redn. of endosymbiotic bacteria.  Larval recoveries were analyzed longitudinally after treatment to follow the kinetics of larval development.  Beginning at three months post-treatment, significantly fewer L3 were seen in the blackflies that had fed on doxycycline treated volunteers.  Concomitant with this, the proportion of second stage larvae (L2) was significantly increased in this group.  Conclusions: Doxycycline treatment and the resulting decline of Wolbachia endobacteria from the microfilaria resulted in retarded development of larvae in the insect vector.  Thus, anti-wolbachial treatment could have an additive effect for interrupting transmission by reducing the no. of L3 that can be transmitted by blackflies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqoeSq_H3p2bVg90H21EOLACvtfcHk0liKAOWKiJvHMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtVOksr0%253D&md5=2f0334d4af00957da6b6aeb64c9296bf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2F1756-3305-5-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-3305-5-12%26sid%3Dliteratum%253Aachs%26aulast%3DAlbers%26aufirst%3DA.%26aulast%3DEsum%26aufirst%3DM.%26aulast%3DTendongfor%26aufirst%3DN.%26aulast%3DEnyong%26aufirst%3DP.%26aulast%3DKlarmann%26aufirst%3DU.%26aulast%3DWanji%26aufirst%3DS.%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DPfarr%26aufirst%3DK.%26atitle%3DRetarded%2520Onchocerca%2520volvulus%2520L1%2520to%2520L3%2520larval%2520development%2520in%2520the%2520Simulium%2520damnosum%2520vector%2520after%2520anti-wolbachial%2520treatment%2520of%2520the%2520human%2520host%26jtitle%3DParasites%2520Vectors%26date%3D2012%26volume%3D5%26spage%3D12%26doi%3D10.1186%2F1756-3305-5-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, W. J.</span></span> <span> </span><span class="NLM_article-title">Antibiotic substances from basidiomycetes: IX. Drosophila subtarata. (batsch ex fr.) quel</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1952</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1073/pnas.38.7.555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1073%2Fpnas.38.7.555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=16589145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADyaG3sXivFSqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1952&pages=555-560&author=F.+Kavanaghauthor=A.+Herveyauthor=W.+J.+Robbins&title=Antibiotic+substances+from+basidiomycetes%3A+IX.+Drosophila+subtarata.+%28batsch+ex+fr.%29+quel&doi=10.1073%2Fpnas.38.7.555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic substances from basidiomycetes. IX. Drosophila subatrata</span></div><div class="casAuthors">Kavanagh, Frederick; Hervey, Annette; Robbins, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">555-60</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">cf. C.A. 46, 5662d; following abstr.  Drosophila subatrata produced an activity of 1000 diln. units/ml. for Staphylococcus aureus when grown in shake culture for two weeks on corn steep medium.  Active substances were isolated thus: culture liquid was acidified to pH 3.4, extd. with 0.1 vol. CHCl3 which was then extd. with 0.5 M NaHCO3 to give an aq. ext. (I) contg. 37% of the solids and 20% of the S. aureus activity.  The CHCl3 extn. was evapd. to 1/10 vol. and extd. with an equal vol. of 0.5 M NaHCO3 to give a soln. (II) contg. 25% of the S. aureus activity and 3% of the solids.  The remaining CHCl3 ext. was further extd. with 0.5 M carbonate buffer pH 10 which removed a small amt. of an active substance, drosophilin A (III), isolated by acidifying the buffer soln., extg. with Et2O, and evapg. to yield yellow crystals of III, yield 100 mg. from 31 l. of culture medium.  III dissolved in C6H6, decolorized with C, filtered, and the C6H6 evapd. yielded crystals, which after recrystn. from hexane or dil. aq. alc. m. 118°.  III was also sol. in Me2CO, EtOH, CHCl3, Et2O, and slightly sol. in H2O, showed no basic properties was weakly acidic, gave a color reaction with alc. FeCl3, had absorption peak at 301 mμ, did not ppt. with AgNO3, reduced alk. MnO4-, reacted with alk. AgNO3 with formation of AgCl, did not react with 2, 4-(NO2)2C6H3NHNH2, did not give reactions for α,β-unsatd. ketones, contained 11.70% OCH3, had a mol. wt. 249, and infrared analysis indicated H attached to unsatd. C, a OH group and a CH3 or CH2 group.  The above CHCl3 concentrate after extn. with pH 10 buffer was extd. with 0.5 M Na2CO3 and then by N KOH, the CHCl3 evapd., the solids remaining dissolved in C6H6, and C6H6 evapd. to yield crystals of drosophilin B (IV) which were identical with pleuromutilin.  The II ext. was acidified, the acids taken up in Et2O, the Et2O soln. shaken repeatedly with 0.25 vol. 0.1 N AgNO3, and the yellow ppt. removed each time and kept under H2O.  The combined Ag ppts. were washed with Et2O and H2O, more Et2O added, the Ag compd. decompd. with HCl and the acids were taken up in Et2O.  The substances in Et2O were subjected to counter-current distribution between CHCl3 and 0.5 M phosphate buffer at pH 6.9; most of the solids and antibacterial activity were in the CHCl3 which was distributed again in a 4 funnel system using pH 7.5 buffer.  The purest substance, 4 mg. of drosophilin C (V), was found in the third funnel.  I was acidified, extd. with CHCl3, the CHCl3 shaken with 0.5 vol. pH 6 buffer, and the CHCl3 extd. repeatedly with AgNO3 with removal of the pptd. Ag compd. before using fresh AgNO3.  Counter-current distributions with pH 7 buffer of the CHCl3 soln. yielded drosophilin D (VI), sol. in org. solvents, and pptd. from aq. alc. by AgNO3 as was V.  VI titrated in 20% EtOH as a monobasic acid with pK 4.2 and equiv. wt. 405 and showed ultraviolet spectra characteristic of polyacetylene substances.  The activities of the 4 compds. were measured against 7 organisms and 60 bacteriophages.  The substances were active mainly against gram-pos. bacteria; III was active against staphylophage 8, IV against streptophage 6 and 7; V and VI were inactive against phage.  III and IV were not inactivated by incubation with blood; V was 7/8 inactivated and VI lost 0.5 its activity.  IV was not toxic to mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrexTWmThQB87Vg90H21EOLACvtfcHk0liKAOWKiJvHMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXivFSqtA%253D%253D&md5=9824a5c8bb8d0c1fdb840a43025d7699</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.38.7.555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.38.7.555%26sid%3Dliteratum%253Aachs%26aulast%3DKavanagh%26aufirst%3DF.%26aulast%3DHervey%26aufirst%3DA.%26aulast%3DRobbins%26aufirst%3DW.%2BJ.%26atitle%3DAntibiotic%2520substances%2520from%2520basidiomycetes%253A%2520IX.%2520Drosophila%2520subtarata.%2520%2528batsch%2520ex%2520fr.%2529%2520quel%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1952%26volume%3D38%26spage%3D555%26epage%3D560%26doi%3D10.1073%2Fpnas.38.7.555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, W. J.</span></span> <span> </span><span class="NLM_article-title">Antibiotic substances from basidiomycetes: viii. pleurotus multilus (fr.) sacc. and pleurotus passeckerianus pilat</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">570</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1073/pnas.37.9.570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1073%2Fpnas.37.9.570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=16589015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADyaG38XjtlSntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1951&pages=570-574&author=F.+Kavanaghauthor=A.+Herveyauthor=W.+J.+Robbins&title=Antibiotic+substances+from+basidiomycetes%3A+viii.+pleurotus+multilus+%28fr.%29+sacc.+and+pleurotus+passeckerianus+pilat&doi=10.1073%2Fpnas.37.9.570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic substances from Basidiomyces. VIII. Pleurotus mutilus and Pleurotus passeckerianus</span></div><div class="casAuthors">Kavanagh, Frederick; Hervey, Annette; Robbins, Wm. J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1951</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">570-4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">cf. C.A. 44, 8423c.  Pleuromutilin (I), an antibacterial substance formed by both P. mutilis and P. passeckerianus was recovered from the fermentation beer by extn. with CHCl3 at pH 5.3, the CHCl3 evapd. at low temp., and the remaining brown gum dissolved in ether which on evapn. yielded white crystals of I.  I was sol. in alc., acetone, CHCl3, and ether; slightly sol. in H2O; and insol. in hexane.  I contains 69.75% C and 9.03% H, has a mol. wt. of 310, m. 166-9° (cor.) without decompn., and [α]D20 ≤ 0.05° (0.2% in 50% EtOH).  The absorption spectrum showed a weak band at 290 mμ (ε = 21.7) and end absorption below 230 mμ.  I was a stable, neutral compd. and sublimed at about 140°.  Crystals were obtained from the fifth funnel of an 8-funnel counter-current distribution of crude gum between 50% H2O-MeOH and a 3:2 mixt. of Et2O-hexane.  I was active mainly against gram-pos. bacteria, showed partial activity against streptococci phage, and was inactive against several fungi species when tested at 0.5 mg./ml.  The activity of I was not reduced after 4 hrs. in broth contg. 5% blood.  I was bacteriostatic for Staphylococcus aureus at 0.25-2 γ/ml. broth and bactericidal at 4 γ/ml.  The LD50 of I for mice (intraperitoneally) was greater than 60 mg./kg.  A single subcutaneous dose of I at 50 mg./kg. protected 63% of the mice, infected with Streptococcus hemolyticus, for 7 days.  I had no effect on growth of sarcoma 180 or Plasmodium gallinaceum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqRlKsz11Vq7Vg90H21EOLACvtfcHk0liKAOWKiJvHMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XjtlSntQ%253D%253D&md5=6e77a9a767c3732146a93cc28e2be781</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.37.9.570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.37.9.570%26sid%3Dliteratum%253Aachs%26aulast%3DKavanagh%26aufirst%3DF.%26aulast%3DHervey%26aufirst%3DA.%26aulast%3DRobbins%26aufirst%3DW.%2BJ.%26atitle%3DAntibiotic%2520substances%2520from%2520basidiomycetes%253A%2520viii.%2520pleurotus%2520multilus%2520%2528fr.%2529%2520sacc.%2520and%2520pleurotus%2520passeckerianus%2520pilat%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1951%26volume%3D37%26spage%3D570%26epage%3D574%26doi%3D10.1073%2Fpnas.37.9.570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlünzen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyetan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fucini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of peptide bond formation by pleuromutilins: the structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1287</span>– <span class="NLM_lpage">1294</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2004.04346.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1111%2Fj.1365-2958.2004.04346.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=15554968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOlsr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=1287-1294&author=F.+Schl%C3%BCnzenauthor=E.+Pyetanauthor=P.+Fuciniauthor=A.+Yonathauthor=J.+M.+Harms&title=Inhibition+of+peptide+bond+formation+by+pleuromutilins%3A+the+structure+of+the+50S+ribosomal+subunit+from+Deinococcus+radiodurans+in+complex+with+tiamulin&doi=10.1111%2Fj.1365-2958.2004.04346.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of peptide bond formation by pleuromutilins: The structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin</span></div><div class="casAuthors">Schluenzen, Frank; Pyetan, Erez; Fucini, Paola; Yonath, Ada; Harms, Joerg M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1287-1294</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Tiamulin, a prominent member of the pleuromutilin class of antibiotics, is a potent inhibitor of protein synthesis in bacteria.  Up to now the effect of pleuromutilins on the ribosome has not been detd. on a mol. level.  The 3.5 Å structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin provides for the first time a detailed picture of its interactions with the 23S rRNA, thus explaining the mol. mechanism of the antimicrobial activity of the pleuromutilin class of antibiotics.  Our results show that tiamulin is located within the peptidyl transferase center (PTC) of the 50S ribosomal subunit with its tricyclic mutilin core positioned in a tight pocket at the A-tRNA binding site.  Also, the extension, which protrudes from its mutilin core, partially overlaps with the P-tRNA binding site.  Thereby, tiamulin directly inhibits peptide bond formation.  Comparison of the tiamulin binding site with other PTC targeting drugs, like chloramphenicol, clindamycin and streptogramins, may facilitate the design of modified or hybridized drugs that extend the applicability of this class of antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2D1Idh-v-kLVg90H21EOLACvtfcHk0lg95iXhqu0w6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOlsr3I&md5=9c1cff85ea16f04813897b2778077237</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2004.04346.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2004.04346.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchl%25C3%25BCnzen%26aufirst%3DF.%26aulast%3DPyetan%26aufirst%3DE.%26aulast%3DFucini%26aufirst%3DP.%26aulast%3DYonath%26aufirst%3DA.%26aulast%3DHarms%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520peptide%2520bond%2520formation%2520by%2520pleuromutilins%253A%2520the%2520structure%2520of%2520the%252050S%2520ribosomal%2520subunit%2520from%2520Deinococcus%2520radiodurans%2520in%2520complex%2520with%2520tiamulin%26jtitle%3DMol.%2520Microbiol.%26date%3D2004%26volume%3D54%26spage%3D1287%26epage%3D1294%26doi%3D10.1111%2Fj.1365-2958.2004.04346.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veve, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J. L.</span></span> <span> </span><span class="NLM_article-title">Lefamulin: review of a promising novel pleuromutilin antibiotic</span>. <i>Pharmacotherapy</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">946</span>, <span class="refDoi"> DOI: 10.1002/phar.2166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1002%2Fphar.2166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=30019769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs12is7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=935-946&author=M.+P.+Veveauthor=J.+L.+Wagner&title=Lefamulin%3A+review+of+a+promising+novel+pleuromutilin+antibiotic&doi=10.1002%2Fphar.2166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Lefamulin: Review of a Promising Novel Pleuromutilin Antibiotic</span></div><div class="casAuthors">Veve, Michael P.; Wagner, Jamie L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">935-946</span>CODEN:
                <span class="NLM_cas:coden">PHPYDQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-9114</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The emergence and spread of antimicrobial resistance have led to a global public health emergency requiring development of new antimicrobial classes.  Lefamulin (formally BC-3781) is a novel pleuromutilin antibiotic currently undergoing Food and Drug Administration review for community-acquired bacterial pneumonia (CABP) as i.v. (IV) and oral (PO) formulations.  Although pleuromutilin antibiotics were first developed in the 1950s, lefamulin is the first to be used for systemic treatment of bacterial infections in humans.  Lefamulin exhibits a unique mechanism of action through inhibition of protein synthesis by binding to the peptidyl transferase center of the 50S bacterial ribosome, thus preventing the binding of tRNA for peptide transfer.  Lefamulin displays activity against gram-pos. and atypical organisms assocd. with CABP (i.e., Streptococcus pneumoniae,Haemophilus influenzae, Mycoplasma pneumoniae,Legionella pneumophila, and Chlamydophila pneumoniae), with an expanded gram-pos. spectrum including Staphylococcus aureus (i.e., methicillin-resistant, vancomycin-intermediate, and heterogeneous strains) and vancomycin-resistant Enterococcus faecium.  Lefamulin was also shown to retain activity against multidrug-resistant Neisseria gonorrhoeae and Mycoplasma genitalium.  Lefamulin exhibits time-dependent killing, and the pharmacodynamic target best assocd. with antibacterial activity is fAUC0-24/MIC (min. inhibitory concn. [MIC]).  Preclin. and phase II trials indicate that lefamulin concs. in lung tissue are well tolerated at an IV dose of 150 mg twice/day over 1 h or a PO dose of 600 mg twice/day, and preliminary phase III data suggest similar efficacy when compared with moxifloxacin with or without linezolid in CABP.  Documented resistance and cross-resistance with other gram-pos. antibacterials remains low.  Addnl. published in vitro, in vivo, and preclin. trial data suggest further exploration of lefamulin in various infectious disease states (e.g., acute bacterial skin and skin structure infections, and sexually transmitted infections).  This review discusses the pertinent bacterial spectrum of activity, preclin. and ongoing clin. data, and potential roles in therapy for lefamulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrai5MjdMSCqLVg90H21EOLACvtfcHk0lg95iXhqu0w6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs12is7zE&md5=1d12eb7df78105bde865e23af4e9c636</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fphar.2166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fphar.2166%26sid%3Dliteratum%253Aachs%26aulast%3DVeve%26aufirst%3DM.%2BP.%26aulast%3DWagner%26aufirst%3DJ.%2BL.%26atitle%3DLefamulin%253A%2520review%2520of%2520a%2520promising%2520novel%2520pleuromutilin%2520antibiotic%26jtitle%3DPharmacotherapy%26date%3D2018%26volume%3D38%26spage%3D935%26epage%3D946%26doi%3D10.1002%2Fphar.2166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dornhelm, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogenauer, G.</span></span> <span> </span><span class="NLM_article-title">The effects of tiamulin, a semisynthetic pleuromutilin derivative, on bacterial polypeptide chain initiation</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1978.tb12699.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1111%2Fj.1432-1033.1978.tb12699.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=365525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADyaE1MXms1Grtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1978&pages=465-473&author=P.+Dornhelmauthor=G.+Hogenauer&title=The+effects+of+tiamulin%2C+a+semisynthetic+pleuromutilin+derivative%2C+on+bacterial+polypeptide+chain+initiation&doi=10.1111%2Fj.1432-1033.1978.tb12699.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of tiamulin, a semisynthetic pleuromutilin derivative, on bacterial polypeptide chain initiation</span></div><div class="casAuthors">Dornhelm, Peter; Hoegenauer, Gregor</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">465-73</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Tiamulin (I)  [55297-95-5], a water-sol. and highly effective semisynthetic deriv. of pleuromutilin led to the formation of physiolog. inactive polypeptide chain initiation complexes which readily decompd. and did not enter the phase of peptide chain elongation.  Once elongation began it continued even in the presence of I as was shown by measuring the formation of N-acetylphenylalanine-poly(phenylalanine).  The formation of abortive initiation complexes was obsd. regardless of whether AcPhe-tRNA of fMet-tRNA was used as an initiator or whether artificial messengers or a natural messenger, like R17 bacteriophage RNA, was used.  When this drug was acting on whole cells, it led to the disappearance of polysomes.  The only structures which could be detected were of the monosome size.  Therefore, polysomes seem to elongate the polypeptide chains in whole cells in the presence of this antibiotic, but since effective reinitiation is blocked, the polysome pool of the cell soon becomes depleted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_mj68-cgi2rVg90H21EOLACvtfcHk0lg95iXhqu0w6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXms1Grtw%253D%253D&md5=82b5285c1ffcb795194b8155ee6de2ae</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1978.tb12699.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1978.tb12699.x%26sid%3Dliteratum%253Aachs%26aulast%3DDornhelm%26aufirst%3DP.%26aulast%3DHogenauer%26aufirst%3DG.%26atitle%3DThe%2520effects%2520of%2520tiamulin%252C%2520a%2520semisynthetic%2520pleuromutilin%2520derivative%252C%2520on%2520bacterial%2520polypeptide%2520chain%2520initiation%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1978%26volume%3D91%26spage%3D465%26epage%3D473%26doi%3D10.1111%2Fj.1432-1033.1978.tb12699.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritsche, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sader, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, J. E.</span></span> <span> </span><span class="NLM_article-title">Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2583</span>– <span class="NLM_lpage">2586</span>, <span class="refDoi"> DOI: 10.1128/aac.01432-05</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1128%2Faac.01432-05" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=16801451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVWrtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=2583-2586&author=R.+N.+Jonesauthor=T.+R.+Fritscheauthor=H.+S.+Saderauthor=J.+E.+Ross&title=Activity+of+retapamulin+%28SB-275833%29%2C+a+novel+pleuromutilin%2C+against+selected+resistant+gram-positive+cocci&doi=10.1128%2Faac.01432-05"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant Gram-positive cocci</span></div><div class="casAuthors">Jones, Ronald N.; Fritsche, Thomas R.; Sader, Helio S.; Ross, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2583-2586</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Retapamulin (SB-275833), the first pleuromutilin to be developed for human topical use, was tested against a selected population of staphylococci and β-hemolytic streptococci.  The MIC90 results for retapamulin were 0.12 μg/mL for Staphylococcus aureus and ≤0.03 μg/mL for Streptococcus pyogenes; no cross-resistance was obsd. for organism subsets resistant to oxacillin, erythromycin, or mupirocin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1DMTvarj5ALVg90H21EOLACvtfcHk0lg95iXhqu0w6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVWrtL0%253D&md5=48b91d3b2458757e9d898a573d6d4faa</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2Faac.01432-05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.01432-05%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BN.%26aulast%3DFritsche%26aufirst%3DT.%2BR.%26aulast%3DSader%26aufirst%3DH.%2BS.%26aulast%3DRoss%26aufirst%3DJ.%2BE.%26atitle%3DActivity%2520of%2520retapamulin%2520%2528SB-275833%2529%252C%2520a%2520novel%2520pleuromutilin%252C%2520against%2520selected%2520resistant%2520gram-positive%2520cocci%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D2583%26epage%3D2586%26doi%3D10.1128%2Faac.01432-05" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sader, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paukner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivezic-Schoenfeld, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biedenbach, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. N.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1170</span>– <span class="NLM_lpage">1175</span>, <span class="refDoi"> DOI: 10.1093/jac/dks001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1093%2Fjac%2Fdks001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=22287234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1GnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=1170-1175&author=H.+S.+Saderauthor=S.+Pauknerauthor=Z.+Ivezic-Schoenfeldauthor=D.+J.+Biedenbachauthor=F.+J.+Schmitzauthor=R.+N.+Jones&title=Antimicrobial+activity+of+the+novel+pleuromutilin+antibiotic+BC-3781+against+organisms+responsible+for+community-acquired+respiratory+tract+infections+%28CARTIs%29&doi=10.1093%2Fjac%2Fdks001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)</span></div><div class="casAuthors">Sader, Helio S.; Paukner, Susanne; Ivezic-Schoenfeld, Zrinka; Biedenbach, Douglas J.; Schmitz, Franz J.; Jones, Ronald N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1170-1175</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">BC-3781 is an investigational semi-synthetic pleuromutilin antibiotic, which recently finished a clin. Phase 2 trial in acute bacterial skin and skin structure infections.  BC-3781 binds to the 50S ribosomal subunit and cross-resistance with other antimicrobial classes is uncommon.  The authors evaluated the activity of BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs).  BC-3781 and comparator agents were susceptibility tested against Streptococcus pneumoniae (157 isolates; 33% penicillin resistant), Haemophilus influenzae (102; 50% β-lactamase producers), Moraxella catarrhalis (50) and Legionella pneumophila (30) by broth microdilution and the agar diln. method.  Mycoplasma pneumoniae (50 strains) was tested by broth microdilution, while Chlamydophila pneumoniae (50 strains) MIC values were detd. using HEp-2 cells.  Against S. pneumoniae (MIC50/90 0.12/0.25 mg/L) BC-3781 was 16- and 8-fold more active than azithromycin (MIC50/90 2/>16 mg/L) and levofloxacin (MIC50/90 1/1 mg/L), resp., and its activity was not adversely affected by resistance to penicillin.  S. pneumoniae showed high resistance rates to azithromycin (50.3%) and clindamycin (31.2%), all being inhibited by BC-3781 at concns. ≤0.5 mg/L.  H. influenzae and M. catarrhalis exhibited low BC-3781 MIC values independent of β-lactamase prodn.  BC-3781 activity against L. pneumophila (MIC50/90 0.06/0.5 mg/L) was similar to that of erythromycin, but lower than that of azithromycin.  BC-3781 also showed potent activity against M. pneumoniae and C. pneumoniae, with MIC50/90 of 0.006/0.006 and 0.02/0.04 mg/L, resp.  Thus, BC-3781 was very active against organisms commonly assocd. with CARTIs and its activity was not neg. influenced by resistance to other antimicrobials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXyavd7lK10bVg90H21EOLACvtfcHk0ljuFgcX9h8Uug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1GnsLs%253D&md5=1e3c11b2a906ed7f46ff354381e6b135</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks001%26sid%3Dliteratum%253Aachs%26aulast%3DSader%26aufirst%3DH.%2BS.%26aulast%3DPaukner%26aufirst%3DS.%26aulast%3DIvezic-Schoenfeld%26aufirst%3DZ.%26aulast%3DBiedenbach%26aufirst%3DD.%2BJ.%26aulast%3DSchmitz%26aufirst%3DF.%2BJ.%26aulast%3DJones%26aufirst%3DR.%2BN.%26atitle%3DAntimicrobial%2520activity%2520of%2520the%2520novel%2520pleuromutilin%2520antibiotic%2520BC-3781%2520against%2520organisms%2520responsible%2520for%2520community-acquired%2520respiratory%2520tract%2520infections%2520%2528CARTIs%2529%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D1170%26epage%3D1175%26doi%3D10.1093%2Fjac%2Fdks001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalziel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burch, D. G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripley, P. H.</span></span> <span> </span><span class="NLM_article-title">Comparative in vitro activity of valnemulin against porcine bacterial pathogens</span>. <i>Vet. Rec.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">128</span>, <span class="refDoi"> DOI: 10.1136/vr.144.5.128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1136%2Fvr.144.5.128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10070704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A280%3ADyaK1M7mvF2isg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=1999&pages=128&author=I.+A.+Aitkenauthor=J.+H.+Morganauthor=R.+Dalzielauthor=D.+G.+S.+Burchauthor=P.+H.+Ripley&title=Comparative+in+vitro+activity+of+valnemulin+against+porcine+bacterial+pathogens&doi=10.1136%2Fvr.144.5.128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative in vitro activity of valnemulin against porcine bacterial pathogens</span></div><div class="casAuthors">Aitken I A; Morgan J H; Dalziel R; Burch D G; Ripley P H</div><div class="citationInfo"><span class="NLM_cas:title">The Veterinary record</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">128</span>
        ISSN:<span class="NLM_cas:issn">0042-4900</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXoNoODdxxBuR_TJajKxJDfW6udTcc2eb0rwiYGQ-pMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7mvF2isg%253D%253D&md5=1a1b725cb2584f3abec176be211fab41</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1136%2Fvr.144.5.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fvr.144.5.128%26sid%3Dliteratum%253Aachs%26aulast%3DAitken%26aufirst%3DI.%2BA.%26aulast%3DMorgan%26aufirst%3DJ.%2BH.%26aulast%3DDalziel%26aufirst%3DR.%26aulast%3DBurch%26aufirst%3DD.%2BG.%2BS.%26aulast%3DRipley%26aufirst%3DP.%2BH.%26atitle%3DComparative%2520in%2520vitro%2520activity%2520of%2520valnemulin%2520against%2520porcine%2520bacterial%2520pathogens%26jtitle%3DVet.%2520Rec.%26date%3D1999%26volume%3D144%26spage%3D128%26doi%3D10.1136%2Fvr.144.5.128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, H.</span></span> <span> </span><span class="NLM_article-title">Synthese ab-trans-anellierter derivate des tricyclischen diterpens pleuromutilin durch intramolekulare 1,5-hydrid-verschiebung</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1807</span>– <span class="NLM_lpage">1811</span>, <span class="refDoi"> DOI: 10.1016/0040-4020(80)80078-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2F0040-4020%2880%2980078-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADyaL3MXmsFyrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1980&pages=1807-1811&author=H.+Bernerauthor=G.+Schulzauthor=H.+Schneider&title=Synthese+ab-trans-anellierter+derivate+des+tricyclischen+diterpens+pleuromutilin+durch+intramolekulare+1%2C5-hydrid-verschiebung&doi=10.1016%2F0040-4020%2880%2980078-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of an AB-trans-annulated derivative of the tricyclic diterpene pleuromutilin through an intramolecular 1,5-hydride shift</span></div><div class="casAuthors">Berner, H.; Schulz, G.; Schneider, H.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1807-11</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">Reaction of the diterpene pleuromutilin I with HC(OMe)3 (MeOH, 25°, 48 h) gave the 11-keto-3-methylester II with AB-trans-configuration (almost quant.).  The reaction occurred through a 1,5-hydride shift between C-3 and C-11.  The reverse reaction occurred on treatment of II with Lewis acid (ZnCl2, dioxane, 25°, 4 h).  Mechanistic aspects and structural assignments are discussed, based on chem. and spectral (1H and 13C NMR) study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYELtJ0RC_JbVg90H21EOLACvtfcHk0ljuFgcX9h8Uug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXmsFyrtw%253D%253D&md5=563f99fecaac59a80a2c1eae76c8ad5d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0040-4020%2880%2980078-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4020%252880%252980078-0%26sid%3Dliteratum%253Aachs%26aulast%3DBerner%26aufirst%3DH.%26aulast%3DSchulz%26aufirst%3DG.%26aulast%3DSchneider%26aufirst%3DH.%26atitle%3DSynthese%2520ab-trans-anellierter%2520derivate%2520des%2520tricyclischen%2520diterpens%2520pleuromutilin%2520durch%2520intramolekulare%25201%252C5-hydrid-verschiebung%26jtitle%3DTetrahedron%26date%3D1980%26volume%3D36%26spage%3D1807%26epage%3D1811%26doi%3D10.1016%2F0040-4020%2880%2980078-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colthurst, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinks, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shea, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takle, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodnutt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleuromutilins</span></span> <span> </span><span class="NLM_article-title">Pleuromutilins. Part 1 The identification of novel mutilin 14-carbamates</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1221</span>– <span class="NLM_lpage">1231</span>, <span class="refDoi"> DOI: 10.1016/s0968-0896(00)00338-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fs0968-0896%2800%2900338-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=1221-1231&author=G.+Brooksauthor=W.+Burgessauthor=D.+Colthurstauthor=J.+D.+Hinksauthor=E.+Huntauthor=M.+J.+Pearsonauthor=B.+Sheaauthor=A.+K.+Takleauthor=J.+M.+Wilsonauthor=G.+Woodnuttauthor=+Pleuromutilins&title=Pleuromutilins.+Part+1+The+identification+of+novel+mutilin+14-carbamates&doi=10.1016%2Fs0968-0896%2800%2900338-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fs0968-0896%2800%2900338-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0968-0896%252800%252900338-2%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DG.%26aulast%3DBurgess%26aufirst%3DW.%26aulast%3DColthurst%26aufirst%3DD.%26aulast%3DHinks%26aufirst%3DJ.%2BD.%26aulast%3DHunt%26aufirst%3DE.%26aulast%3DPearson%26aufirst%3DM.%2BJ.%26aulast%3DShea%26aufirst%3DB.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DWilson%26aufirst%3DJ.%2BM.%26aulast%3DWoodnutt%26aufirst%3DG.%26aulast%3DPleuromutilins%26atitle%3DPleuromutilins.%2520Part%25201%2520The%2520identification%2520of%2520novel%2520mutilin%252014-carbamates%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26spage%3D1221%26epage%3D1231%26doi%3D10.1016%2Fs0968-0896%2800%2900338-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. L.</span>; <span class="NLM_string-name">Jacobs, R. T.</span>; <span class="NLM_string-name">Hernandez, V.</span>; <span class="NLM_string-name">Xia, Y.</span>; <span class="NLM_string-name">Plattner, J. J.</span>; <span class="NLM_string-name">Cao, K. J.</span></span> <span> </span><span class="NLM_article-title">Boron Containing Small Molecules</span>. WO <span class="NLM_patent">2006089067 A2</span>, Feb 27, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=X.+L.+Li&author=R.+T.+Jacobs&author=V.+Hernandez&author=Y.+Xia&author=J.+J.+Plattner&author=K.+J.+Cao&title=Boron+Containing+Small+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%2BL.%26atitle%3DBoron%2520Containing%2520Small%2520Molecules%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clare, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span> <span> </span><span class="NLM_article-title">Development and Validation of a High-Throughput Anti-WolbachiaWhole-Cell Screen</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1177/1087057114551518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1177%2F1087057114551518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=25278497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlCqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=64-69&author=R.+H.+Clareauthor=D.+A.+N.+Cookauthor=K.+L.+Johnstonauthor=L.+Fordauthor=S.+A.+Wardauthor=M.+J.+Taylor&title=Development+and+Validation+of+a+High-Throughput+Anti-WolbachiaWhole-Cell+Screen&doi=10.1177%2F1087057114551518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a high-throughput anti-Wolbachia whole-cell screen: a route to macrofilaricidal drugs against onchocerciasis and lymphatic filariasis</span></div><div class="casAuthors">Clare, Rachel H.; Cook, Darren A. N.; Johnston, Kelly L.; Ford, Louise; Ward, Stephen A.; Taylor, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-69, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">There is an urgent need to develop new, safe, and affordable macrofilaricidal drugs for onchocerciasis and lymphatic filariasis treatment and control.  The Anti-Wolbachia Consortium (A·WOL) aims to provide a novel treatment with macrofilaricidal activity by targeting the essential bacterial symbiont Wolbachia.  The consortium is currently screening a diverse range of compds. to find new chem. space to drive this drug discovery initiative and address this unmet demand.  To increase the throughput and capacity of the A·WOL cell-based screen, we have developed a 384-well format assay using a high-content imaging system (Operetta) in conjunction with optimized Wolbachia growth dynamics in the C6/36 Aedes albopictus mosquito cell line.  This assay uses texture anal. of cells stained with SYTO 11 as a direct measure of bacterial load.  This validated assay has dramatically increased the capacity and throughput of the A·WOL compd. library screening program 25-fold, enriching the no. of new anti-Wolbachia hits identified for further development as potential macrofilaricides for onchocerciasis and lymphatic filariasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSxBmXB7eU-7Vg90H21EOLACvtfcHk0lhIKSNp5vzR1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlCqsw%253D%253D&md5=d1ede349473598c6e4bd9e9e531fe73e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1177%2F1087057114551518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057114551518%26sid%3Dliteratum%253Aachs%26aulast%3DClare%26aufirst%3DR.%2BH.%26aulast%3DCook%26aufirst%3DD.%2BA.%2BN.%26aulast%3DJohnston%26aufirst%3DK.%2BL.%26aulast%3DFord%26aufirst%3DL.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26atitle%3DDevelopment%2520and%2520Validation%2520of%2520a%2520High-Throughput%2520Anti-WolbachiaWhole-Cell%2520Screen%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2015%26volume%3D20%26spage%3D64%26epage%3D69%26doi%3D10.1177%2F1087057114551518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serbus, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruybal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debec, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, W.</span></span> <span> </span><span class="NLM_article-title">A cell-based screen reveals that the albendazole metabolite, albendazole sulfone, targets Wolbachia</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e1002922</span>, <span class="refDoi"> DOI: 10.1371/journal.ppat.1002922</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1371%2Fjournal.ppat.1002922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=23028321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaktrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=e1002922&author=L.+R.+Serbusauthor=F.+Landmannauthor=W.+M.+Brayauthor=P.+M.+Whiteauthor=J.+Ruybalauthor=R.+S.+Lokeyauthor=A.+Debecauthor=W.+Sullivan&title=A+cell-based+screen+reveals+that+the+albendazole+metabolite%2C+albendazole+sulfone%2C+targets+Wolbachia&doi=10.1371%2Fjournal.ppat.1002922"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A cell-based screen reveals that the albendazole metabolite, albendazole sulfone, targets Wolbachia</span></div><div class="casAuthors">Serbus, Laura R.; Landmann, Frederic; Bray, Walter M.; White, Pamela M.; Ruybal, Jordan; Lokey, R. Scott; Debec, Alain; Sullivan, William</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1002922</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Wolbachia endosymbionts carried by filarial nematodes give rise to the neglected diseases African river blindness and lymphatic filariasis afflicting millions worldwide.  Here, the authors identify new Wolbachia-disrupting compds. by conducting high-throughput cell-based chem. screens using a Wolbachia-infected, fluorescently labeled Drosophila cell line.  This screen yielded several Wolbachia-disrupting compds. including three that resembled albendazole, a widely used anthelmintic drug that targets nematode microtubules.  Follow-up studies demonstrate that a common albendazole metabolite, albendazole sulfone, reduces intracellular Wolbachia titer both in Drosophila melanogaster and Brugia malayi, the nematode responsible for lymphatic filariasis.  Significantly, albendazole sulfone does not disrupt Drosophila microtubule organization, suggesting that this compd. reduces titer through direct targeting of Wolbachia.  Accordingly, both DNA staining and FtsZ immunofluorescence demonstrates that albendazole sulfone treatment induces Wolbachia elongation, a phenotype indicative of binary fission defects.  This suggests that the efficacy of albendazole in treating filarial nematode-based diseases is attributable to dual targeting of nematode microtubules and their Wolbachia endosymbionts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzCFI0jrY1z7Vg90H21EOLACvtfcHk0lhIKSNp5vzR1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaktrjK&md5=a6f0050e35f00284158b4289f6a24d03</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002922%26sid%3Dliteratum%253Aachs%26aulast%3DSerbus%26aufirst%3DL.%2BR.%26aulast%3DLandmann%26aufirst%3DF.%26aulast%3DBray%26aufirst%3DW.%2BM.%26aulast%3DWhite%26aufirst%3DP.%2BM.%26aulast%3DRuybal%26aufirst%3DJ.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26aulast%3DDebec%26aufirst%3DA.%26aulast%3DSullivan%26aufirst%3DW.%26atitle%3DA%2520cell-based%2520screen%2520reveals%2520that%2520the%2520albendazole%2520metabolite%252C%2520albendazole%2520sulfone%252C%2520targets%2520Wolbachia%26jtitle%3DPLoS%2520Pathog.%26date%3D2012%26volume%3D8%26spage%3De1002922%26doi%3D10.1371%2Fjournal.ppat.1002922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wring, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sligar, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowling, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercer, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rewerts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaukel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacchi, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scandale, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, R.</span></span> <span> </span><span class="NLM_article-title">SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1151</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0001151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1371%2Fjournal.pntd.0001151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=21738803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlOgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=e1151&author=R.+T.+Jacobsauthor=B.+Nareauthor=S.+A.+Wringauthor=M.+D.+Orrauthor=D.+Chenauthor=J.+M.+Sligarauthor=M.+X.+Jenksauthor=R.+A.+Noeauthor=T.+S.+Bowlingauthor=L.+T.+Mercerauthor=C.+Rewertsauthor=E.+Gaukelauthor=J.+Owensauthor=R.+Parhamauthor=R.+Randolphauthor=B.+Beaudetauthor=C.+J.+Bacchiauthor=N.+Yarlettauthor=J.+J.+Plattnerauthor=Y.+Freundauthor=C.+Dingauthor=T.+Akamaauthor=Y.-K.+Zhangauthor=R.+Brunauthor=M.+Kaiserauthor=I.+Scandaleauthor=R.+Don&title=SCYX-7158%2C+an+orally-active+benzoxaborole+for+the+treatment+of+stage+2+human+African+trypanosomiasis&doi=10.1371%2Fjournal.pntd.0001151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 Human African trypanosomiasis</span></div><div class="casAuthors">Jacobs, Robert T.; Nare, Bakela; Wring, Stephen A.; Orr, Matthew D.; Chen, Daitao; Sligar, Jessica M.; Jenks, Matthew X.; Noe, Robert A.; Bowling, Tana S.; Mercer, Luke T.; Rewerts, Cindy; Gaukel, Eric; Owens, Jennifer; Parham, Robin; Randolph, Ryan; Beaudet, Beth; Bacchi, Cyrus J.; Yarlett, Nigel; Plattner, Jacob J.; Freund, Yvonne; Ding, Charles; Akama, Tsutomu; Zhang, Y.-K.; Brun, Reto; Kaiser, Marcel; Scandale, Ivan; Don, Robert</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1151</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Human African trypanosomiasis (HAT) is an important public health problem in sub-Saharan Africa, affecting hundreds of thousands of individuals.  An urgent need exists for the discovery and development of new, safe, and effective drugs to treat HAT, as existing therapies suffer from poor safety profiles, difficult treatment regimens, limited effectiveness, and a high cost of goods.  We have discovered and optimized a novel class of small-mol. boron-contg. compds., benzoxaboroles, to identify SCYX-7158 as an effective, safe and orally active treatment for HAT.  Methodol./Principal Findings: A drug discovery project employing integrated biol. screening, medicinal chem. and pharmacokinetic characterization identified SCYX-7158 as an optimized analog, as it is active in vitro against relevant strains of Trypanosoma brucei, including T. b. rhodesiense and T. b. gambiense, is efficacious in both stage 1 and stage 2 murine HAT models and has physicochem. and in vitro absorption, distribution, metab., elimination and toxicol. (ADMET) properties consistent with the compd. being orally available, metabolically stable and CNS permeable.  In a murine stage 2 study, SCYX-7158 is effective orally at doses as low as 12.5 mg/kg (QD × 7 days).  In vivo pharmacokinetic characterization of SCYX-7158 demonstrates that the compd. is highly bioavailable in rodents and non-human primates, has low i.v. plasma clearance and has a 24-h elimination half-life and a vol. of distribution that indicate good tissue distribution.  Most importantly, in rodents brain exposure of SCYX-7158 is high, with Cmax>10 μg/mL and AUC0-24 hr>100 μg*h/mL following a 25 mg/kg oral dose.  Furthermore, SCYX-7158 readily distributes into cerebrospinal fluid to achieve therapeutically relevant concns. in this compartment.  Conclusions/Significance: The biol. and pharmacokinetic properties of SCYX-7158 suggest that this compd. will be efficacious and safe to treat stage 2 HAT.  SCYX-7158 has been selected to enter preclin. studies, with expected progression to phase 1 clin. trials in 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdyaAga5lprVg90H21EOLACvtfcHk0lg660Evj5leeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlOgsLY%253D&md5=a54f2d57149e6714c7f6acf5f5280a7d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0001151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0001151%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DOrr%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DSligar%26aufirst%3DJ.%2BM.%26aulast%3DJenks%26aufirst%3DM.%2BX.%26aulast%3DNoe%26aufirst%3DR.%2BA.%26aulast%3DBowling%26aufirst%3DT.%2BS.%26aulast%3DMercer%26aufirst%3DL.%2BT.%26aulast%3DRewerts%26aufirst%3DC.%26aulast%3DGaukel%26aufirst%3DE.%26aulast%3DOwens%26aufirst%3DJ.%26aulast%3DParham%26aufirst%3DR.%26aulast%3DRandolph%26aufirst%3DR.%26aulast%3DBeaudet%26aufirst%3DB.%26aulast%3DBacchi%26aufirst%3DC.%2BJ.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DScandale%26aufirst%3DI.%26aulast%3DDon%26aufirst%3DR.%26atitle%3DSCYX-7158%252C%2520an%2520orally-active%2520benzoxaborole%2520for%2520the%2520treatment%2520of%2520stage%25202%2520human%2520African%2520trypanosomiasis%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2011%26volume%3D5%26spage%3De1151%26doi%3D10.1371%2Fjournal.pntd.0001151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berner, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span> <span> </span><span class="NLM_article-title">Chemie der pleuromutiline-II</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">915</span>– <span class="NLM_lpage">919</span>, <span class="refDoi"> DOI: 10.1016/s0040-4020(01)97660-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fs0040-4020%2801%2997660-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADyaL3MXltFCrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1981&pages=915-919&author=H.+G.+Bernerauthor=H.+Schulz&title=Chemie+der+pleuromutiline-II&doi=10.1016%2Fs0040-4020%2801%2997660-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry of pleuromutilins.  II.  Synthesis of 12-devinylpleuromutilins</span></div><div class="casAuthors">Berner, H.; Schulz, G.; Schneider, H.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">915-19</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">The title compd. I was prepd. from the AB-trans annulated pleuromutilin deriv. II (R = CH:CH2) (III) by sequential ozonolysis, decarbonylation, and rearrangement reactions.  The key intermediate in the prepn. of II (R = H) (IV) was assigned the α-configuration on the basis of chem. correlation and spectroscopic anal.  Several related species, including 12-devinyltiamulin, were also prepd. from III and IV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsgSl-Snn5_LVg90H21EOLACvtfcHk0lg660Evj5leeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXltFCrtbc%253D&md5=571e9a76e10b95bc77bc6cb6739ee3c8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fs0040-4020%2801%2997660-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0040-4020%252801%252997660-4%26sid%3Dliteratum%253Aachs%26aulast%3DBerner%26aufirst%3DH.%2BG.%26aulast%3DSchulz%26aufirst%3DH.%26atitle%3DChemie%2520der%2520pleuromutiline-II%26jtitle%3DTetrahedron%26date%3D1981%26volume%3D37%26spage%3D915%26epage%3D919%26doi%3D10.1016%2Fs0040-4020%2801%2997660-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novak, R.</span></span> <span> </span><span class="NLM_article-title">Are pleuromutilin antibiotics finally fit for human use?</span>. <i>Ann. N.Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1241</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.2011.06219.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1111%2Fj.1749-6632.2011.06219.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=22191527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFGmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1241&publication_year=2011&pages=71-81&author=R.+Novak&title=Are+pleuromutilin+antibiotics+finally+fit+for+human+use%3F&doi=10.1111%2Fj.1749-6632.2011.06219.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Are pleuromutilin antibiotics finally fit for human use?</span></div><div class="casAuthors">Novak, Rodger</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1241</span>
        (<span class="NLM_cas:issue">Antimicrobial Therapeutics Reviews</span>),
    <span class="NLM_cas:pages">71-81</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  In 1951, the first ref. to the antibacterial substance pleuromutilin was made in a paper published in the Proceedings of the National Academy of Sciences.  Researchers had identified several species of the mold genus Pleurotus that inhibited the growth of Staphylococcus aureus.  The elucidation of the structure in 1962 led to the initiation of a development program at Sandoz, which was followed by the approval of tiamulin in 1979 for use in veterinary medicine.  Although in 2007 retapamulin became the first pleuromutilin approved for topical use in humans, it was not until 2011, exactly 60 years after the first mention of the class, that a pleuromutilin antibiotic, BC-3781, could be tested successfully in a clin. phase II trial for systemic use in patients.  This review will discuss key aspects of this antibacterial class and provide some insight into the question of why it took half a century to develop a systemic pleuromutilin for human use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-f4Y5rdMUT7Vg90H21EOLACvtfcHk0lg660Evj5leeA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFGmtbs%253D&md5=7fbae3ecd8b88799cc25f857a58cceaf</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2011.06219.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2011.06219.x%26sid%3Dliteratum%253Aachs%26aulast%3DNovak%26aufirst%3DR.%26atitle%3DAre%2520pleuromutilin%2520antibiotics%2520finally%2520fit%2520for%2520human%2520use%253F%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2011%26volume%3D1241%26spage%3D71%26epage%3D81%26doi%3D10.1111%2Fj.1749-6632.2011.06219.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shlaes, D. M.</span></span> <span> </span><span class="NLM_article-title">The pleuromutilin antibiotics: a new class for human use</span>. <i>Curr. Opin. Investig. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=182-191&author=R.+Novakauthor=D.+M.+Shlaes&title=The+pleuromutilin+antibiotics%3A+a+new+class+for+human+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNovak%26aufirst%3DR.%26aulast%3DShlaes%26aufirst%3DD.%2BM.%26atitle%3DThe%2520pleuromutilin%2520antibiotics%253A%2520a%2520new%2520class%2520for%2520human%2520use%26jtitle%3DCurr.%2520Opin.%2520Investig.%2520Drugs%26date%3D2010%26volume%3D11%26spage%3D182%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prince, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivezic-Schoenfeld, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tack, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obermayr, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, G. H.</span></span> <span> </span><span class="NLM_article-title">Phase II clinical study of BC-3781, a pleuromutilin antibiotic, in treatment of patients with acute bacterial skin and skin structure infections</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2087</span>– <span class="NLM_lpage">2094</span>, <span class="refDoi"> DOI: 10.1128/aac.02106-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1128%2Faac.02106-12" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=2087-2094&author=W.+T.+Princeauthor=Z.+Ivezic-Schoenfeldauthor=C.+Lellauthor=K.+J.+Tackauthor=R.+Novakauthor=F.+Obermayrauthor=G.+H.+Talbot&title=Phase+II+clinical+study+of+BC-3781%2C+a+pleuromutilin+antibiotic%2C+in+treatment+of+patients+with+acute+bacterial+skin+and+skin+structure+infections&doi=10.1128%2Faac.02106-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2Faac.02106-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.02106-12%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DW.%2BT.%26aulast%3DIvezic-Schoenfeld%26aufirst%3DZ.%26aulast%3DLell%26aufirst%3DC.%26aulast%3DTack%26aufirst%3DK.%2BJ.%26aulast%3DNovak%26aufirst%3DR.%26aulast%3DObermayr%26aufirst%3DF.%26aulast%3DTalbot%26aufirst%3DG.%2BH.%26atitle%3DPhase%2520II%2520clinical%2520study%2520of%2520BC-3781%252C%2520a%2520pleuromutilin%2520antibiotic%252C%2520in%2520treatment%2520of%2520patients%2520with%2520acute%2520bacterial%2520skin%2520and%2520skin%2520structure%2520infections%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D2087%26epage%3D2094%26doi%3D10.1128%2Faac.02106-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeitlinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwameis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzneller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wicha, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickmann, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, W.</span></span> <span> </span><span class="NLM_article-title">Simultaneous assessment of the pharmacokinetics of a pleuromutilin, lefamulin, in plasma, soft tissues and pulmonary epithelial lining fluid</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1022</span>– <span class="NLM_lpage">1026</span>, <span class="refDoi"> DOI: 10.1093/jac/dkv442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1093%2Fjac%2Fdkv442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=26747098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFyltrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2016&pages=1022-1026&author=M.+Zeitlingerauthor=R.+Schwameisauthor=A.+Burianauthor=B.+Burianauthor=P.+Matznellerauthor=M.+M%C3%BCllerauthor=W.+W.+Wichaauthor=D.+B.+Strickmannauthor=W.+Prince&title=Simultaneous+assessment+of+the+pharmacokinetics+of+a+pleuromutilin%2C+lefamulin%2C+in+plasma%2C+soft+tissues+and+pulmonary+epithelial+lining+fluid&doi=10.1093%2Fjac%2Fdkv442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous assessment of the pharmacokinetics of a pleuromutilin, lefamulin, in plasma, soft tissues and pulmonary epithelial lining fluid</span></div><div class="casAuthors">Zeitlinger, M.; Schwameis, R.; Burian, A.; Burian, B.; Matzneller, P.; Mueller, M.; Wicha, W. W.; Strickmann, D. B.; Prince, W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1022-1026</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Lefamulin is a pleuromutilin antibiotic under evaluation for the treatment of bacterial infections, including respiratory tract infections.  Currently, there are no high-quality pharmacokinetic data on drug tissue concns. of lefamulin available.  Methods: A single dose of i.v. lefamulin (150 mg) was given to 12 healthy men.  The registered EudraCT no. for this study was 2010-021938-54.  Lefamulin concns. were simultaneously measured in plasma, skeletal muscle tissue, s.c. adipose tissue and epithelial lining fluid (ELF) over 24 h, and corresponding pharmacokinetic parameters were calcd.  Microdialysis was used to measure unbound lefamulin concns. in skeletal muscle tissue and s.c. adipose tissue, which were similar to unbound lefamulin concns. in plasma.  Bronchoalveolar lavage was performed 1, 2, 4 and 8 h post-dose to det. lefamulin concns. in ELF.  Results: Unbound lefamulin levels showed a 5.7-fold higher exposure in ELF compared with that in plasma, demonstrating good penetration to the target site.  Conclusions: Lefamulin may be an addn. to the therapeutic armamentarium for the treatment of infections.  Simultaneous measurements of unbound drug concn. can guide target attainment for future therapeutic trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsVcGJen007rVg90H21EOLACvtfcHk0ljW80qj_i2I2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFyltrzO&md5=f0cc6808f773dd46ddc9d21f0a6a34bb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkv442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkv442%26sid%3Dliteratum%253Aachs%26aulast%3DZeitlinger%26aufirst%3DM.%26aulast%3DSchwameis%26aufirst%3DR.%26aulast%3DBurian%26aufirst%3DA.%26aulast%3DBurian%26aufirst%3DB.%26aulast%3DMatzneller%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DWicha%26aufirst%3DW.%2BW.%26aulast%3DStrickmann%26aufirst%3DD.%2BB.%26aulast%3DPrince%26aufirst%3DW.%26atitle%3DSimultaneous%2520assessment%2520of%2520the%2520pharmacokinetics%2520of%2520a%2520pleuromutilin%252C%2520lefamulin%252C%2520in%2520plasma%252C%2520soft%2520tissues%2520and%2520pulmonary%2520epithelial%2520lining%2520fluid%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2016%26volume%3D71%26spage%3D1022%26epage%3D1026%26doi%3D10.1093%2Fjac%2Fdkv442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borchardt, R. T.</span></span> <span> </span><span class="NLM_article-title">Lingua::EN::Titlecase</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">772</span>, <span class="refDoi"> DOI: 10.1023/a:1016140429238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1023%2Fa%3A1016140429238" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2002&pages=765-772&author=F.+Tangauthor=K.+Horieauthor=R.+T.+Borchardt&title=Lingua%3A%3AEN%3A%3ATitlecase&doi=10.1023%2Fa%3A1016140429238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1023%2Fa%3A1016140429238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252Fa%253A1016140429238%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DF.%26aulast%3DHorie%26aufirst%3DK.%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26atitle%3DLingua%253A%253AEN%253A%253ATitlecase%26jtitle%3DPharm.%2520Res.%26date%3D2002%26volume%3D19%26spage%3D765%26epage%3D772%26doi%3D10.1023%2Fa%3A1016140429238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halliday, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimaraes, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrer, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metuge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaud, K.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwenti, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsbrook, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steven, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J. D.</span></span> <span> </span><span class="NLM_article-title">A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis</span>. <i>Parasites Vectors</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">472</span>, <span class="refDoi"> DOI: 10.1186/preaccept-4686600213964315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1186%2Fpreaccept-4686600213964315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=25338621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=472&author=A.+Hallidayauthor=A.+F.+Guimaraesauthor=H.+E.+Tyrerauthor=H.+Metugeauthor=C.+Patrickauthor=K.-O.+Arnaudauthor=T.+Kwentiauthor=G.+Forsbrookauthor=A.+Stevenauthor=D.+Cookauthor=P.+Enyongauthor=S.+Wanjiauthor=M.+J.+Taylorauthor=J.+D.+Turner&title=A+murine+macrofilaricide+pre-clinical+screening+model+for+onchocerciasis+and+lymphatic+filariasis&doi=10.1186%2Fpreaccept-4686600213964315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis</span></div><div class="casAuthors">Halliday, Alice; Guimaraes, Ana F.; Tyrer, Hayley E.; Metuge, Haelly Mejane; Patrick, Chounna Ndongmo Winston; Arnaud, Kengne-Ouafo Jonas; Kwenti, Tayong Dizzle Bita; Forsbrook, George; Steven, Andrew; Cook, Darren; Enyong, Peter; Wanji, Samuel; Taylor, Mark J.; Turner, Joseph D.</div><div class="citationInfo"><span class="NLM_cas:title">Parasites & Vectors</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">472/1-472/31, 31 pp.</span>CODEN:
                <span class="NLM_cas:coden">PVAEAK</span>;
        ISSN:<span class="NLM_cas:issn">1756-3305</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: New drugs effective against adult filariae macrofilaricides would accelerate the elimination of lymphatic filariasis and onchocerciasis.  Anti-Onchocerca drug development is hampered by the lack of a facile model.  We postulated that SCID mice could be developed as a fmacrofilaricide screening model.  Methods: The filaricides: albendazole ABZ, diethylcarbamazine DEC, flubendazole FBZ, ivermectin IVM and the anti-Wolbachia macrofilaricide, minocycline MIN were tested in Brugia malayi Bm-parasitized BALB/c SCID mice vs vehicle control VC.  Responses were compared to BALB/c wild type WT.  Onchocerca ochengi male worms or onchocercomata were surgically implanted into BALB/c SCID, CB.17 SCID, BALB/c WT mice or Meriones gerbils.  Survival was evaluated at 7-15 days.  BALB/c SCID were tested to evaluate the responsiveness of pre-clin. macrofilaricides FBZ and rifapentine RIFAP against male Onchocerca.  Results: WT and SCID responded with >95% efficacy following ABZ or DEC treatments against Bm larvae P < 0.0001.  IVM was partially filaricidal against Bm larvae in WT and SCID WT; 39.8%, P = 0.0356 and SCID; 56.7%, P = 0.026.  SCID responded similarly to WT following IVM treatment of microfilaremias WT; 79%, P = 0.0194.  SCID; 76%, P = 0.0473.  FBZ induced a total macrofilaricidal response against adult Bm in WT and SCID WT; P = 0.0067, SCID; P = 0.0071.  MIN induced a >90% redn. in Bm Wolbachia burdens P < 0.0001 and a blockade of microfilarial release P = 0.0215 in SCID.  Male Onchocerca survival was significantly higher in SCID vs WT mice, but not gerbils, after +15 days 60% vs 22% vs 39% P = 0.0475.  Onchocercoma implants had engrafted into host tissues, with evidence of neovascularisation, after +7 days and yielded viable macro/microfilariae ex vivo.  FBZ induced a macrofilaricidal effect in Onchocerca male implanted SCID at +5 wk FBZ; 1.67% vs VC; 43.81%, P = 0.0089.  Wolbachia loads within male Onchocerca were reduced by 99% in implanted SCID receiving RIFAP for +2 wk.  Conclusions: We have developed a 'pan-filarial' small animal research model that is sufficiently robust, with adequate capacity and throughput, to screen existing and future pre-clin. candidate macrofilaricides.  Pilot data suggests a murine onchocercoma xenograft model is achievable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3XSy0WTfXYbVg90H21EOLACvtfcHk0ljW80qj_i2I2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGmsr4%253D&md5=002f530a288c6d90cd60f22597634c1e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1186%2Fpreaccept-4686600213964315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fpreaccept-4686600213964315%26sid%3Dliteratum%253Aachs%26aulast%3DHalliday%26aufirst%3DA.%26aulast%3DGuimaraes%26aufirst%3DA.%2BF.%26aulast%3DTyrer%26aufirst%3DH.%2BE.%26aulast%3DMetuge%26aufirst%3DH.%26aulast%3DPatrick%26aufirst%3DC.%26aulast%3DArnaud%26aufirst%3DK.-O.%26aulast%3DKwenti%26aufirst%3DT.%26aulast%3DForsbrook%26aufirst%3DG.%26aulast%3DSteven%26aufirst%3DA.%26aulast%3DCook%26aufirst%3DD.%26aulast%3DEnyong%26aufirst%3DP.%26aulast%3DWanji%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DTurner%26aufirst%3DJ.%2BD.%26atitle%3DA%2520murine%2520macrofilaricide%2520pre-clinical%2520screening%2520model%2520for%2520onchocerciasis%2520and%2520lymphatic%2520filariasis%26jtitle%3DParasites%2520Vectors%26date%3D2014%26volume%3D7%26spage%3D472%26doi%3D10.1186%2Fpreaccept-4686600213964315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Specht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfarr, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arriens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klarmann-Schulz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koschel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span> <span> </span><span class="NLM_article-title">Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse model</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0006116</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0006116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1371%2Fjournal.pntd.0006116" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=e0006116&author=S.+Spechtauthor=K.+M.+Pfarrauthor=S.+Arriensauthor=M.+P.+H%C3%BCbnerauthor=U.+Klarmann-Schulzauthor=M.+Koschelauthor=S.+Sternbergauthor=C.+Martinauthor=L.+Fordauthor=M.+J.+Taylorauthor=A.+Hoerauf&title=Combinations+of+registered+drugs+reduce+treatment+times+required+to+deplete+Wolbachia+in+the+Litomosoides+sigmodontis+mouse+model&doi=10.1371%2Fjournal.pntd.0006116"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0006116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0006116%26sid%3Dliteratum%253Aachs%26aulast%3DSpecht%26aufirst%3DS.%26aulast%3DPfarr%26aufirst%3DK.%2BM.%26aulast%3DArriens%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DM.%2BP.%26aulast%3DKlarmann-Schulz%26aufirst%3DU.%26aulast%3DKoschel%26aufirst%3DM.%26aulast%3DSternberg%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DC.%26aulast%3DFord%26aufirst%3DL.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DHoerauf%26aufirst%3DA.%26atitle%3DCombinations%2520of%2520registered%2520drugs%2520reduce%2520treatment%2520times%2520required%2520to%2520deplete%2520Wolbachia%2520in%2520the%2520Litomosoides%2520sigmodontis%2520mouse%2520model%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2018%26volume%3D12%26spage%3De0006116%26doi%3D10.1371%2Fjournal.pntd.0006116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volkmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span> <span> </span><span class="NLM_article-title">Antibiotic therapy in murine filariasis (Litomosoides sigmodontis): comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability</span>. <i>Trop. Med. Int. Health</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1046/j.1365-3156.2003.01040.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1046%2Fj.1365-3156.2003.01040.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=12753632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVagsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=392-401&author=L.+Volkmannauthor=K.+Fischerauthor=M.+Taylorauthor=A.+Hoerauf&title=Antibiotic+therapy+in+murine+filariasis+%28Litomosoides+sigmodontis%29%3A+comparative+effects+of+doxycycline+and+rifampicin+on+Wolbachia+and+filarial+viability&doi=10.1046%2Fj.1365-3156.2003.01040.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic therapy in murine filariasis (Litomosoides sigmodontis): Comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability</span></div><div class="casAuthors">Volkmann, Lars; Fischer, Kerstin; Taylor, Mark; Hoerauf, Achim</div><div class="citationInfo"><span class="NLM_cas:title">Tropical Medicine & International Health</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">392-401</span>CODEN:
                <span class="NLM_cas:coden">TMIHFL</span>;
        ISSN:<span class="NLM_cas:issn">1360-2276</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The symbiosis of filarial nematodes and rickettsial Wolbachia endobacteria has been exploited as a target for antibiotic therapy of filariasis.  Depletion of Wolbachia after tetracycline treatment results in filarial sterility because of interruption of embryogenesis and inhibits larval development and adult worm viability.  The aim of this study was to investigate if antibiotic intervention of BALB/c mice infected with the rodent filaria Litomosoides sigmodontis with rifampicin or the combination of rifampicin and doxycycline can be used to shorten the treatment period.  Both regimens, when given over a period of 14 days initiated with infection, were sufficient to deplete Wolbachia as evidenced by immunohistol. and semiquant. PCR.  Worm development and filarial load were significantly reduced in expts. followed up until 63 days p.i.  The therapy inhibited embryogenesis and led to filarial sterility.  In contrast, treatment with doxycycline alone for 21 days led only to a modest redn. of Wolbachia, filarial growth retardation, worm viability and fertility.  In conclusion, the combination of antirickettsial drugs could be used as a suitable tool to explore the min. duration of therapy required for the depletion of Wolbachia in parasitized hosts subsequent to the onset of patency in human and animal filariasis and the prevention of adverse reactions in human infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlfCS_Sos3PrVg90H21EOLACvtfcHk0lhcQC8Rb171zw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVagsbg%253D&md5=c7f510a315609608385a898e59ad8deb</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-3156.2003.01040.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-3156.2003.01040.x%26sid%3Dliteratum%253Aachs%26aulast%3DVolkmann%26aufirst%3DL.%26aulast%3DFischer%26aufirst%3DK.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DHoerauf%26aufirst%3DA.%26atitle%3DAntibiotic%2520therapy%2520in%2520murine%2520filariasis%2520%2528Litomosoides%2520sigmodontis%2529%253A%2520comparative%2520effects%2520of%2520doxycycline%2520and%2520rifampicin%2520on%2520Wolbachia%2520and%2520filarial%2520viability%26jtitle%3DTrop.%2520Med.%2520Int.%2520Health%26date%3D2003%26volume%3D8%26spage%3D392%26epage%3D401%26doi%3D10.1046%2Fj.1365-3156.2003.01040.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissen-Pähle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmetz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkle-Dührsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaxter, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Büttner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallin, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Qaoud, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucius, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleischer, B.</span></span> <span> </span><span class="NLM_article-title">Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1172/jci4768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1172%2Fjci4768" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1999&pages=11-18&author=A.+Hoeraufauthor=K.+Nissen-P%C3%A4hleauthor=C.+Schmetzauthor=K.+Henkle-D%C3%BChrsenauthor=M.+L.+Blaxterauthor=D.+W.+B%C3%BCttnerauthor=M.+Y.+Gallinauthor=K.+M.+Al-Qaoudauthor=R.+Luciusauthor=B.+Fleischer&title=Tetracycline+therapy+targets+intracellular+bacteria+in+the+filarial+nematode+Litomosoides+sigmodontis+and+results+in+filarial+infertility&doi=10.1172%2Fjci4768"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1172%2Fjci4768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci4768%26sid%3Dliteratum%253Aachs%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DNissen-P%25C3%25A4hle%26aufirst%3DK.%26aulast%3DSchmetz%26aufirst%3DC.%26aulast%3DHenkle-D%25C3%25BChrsen%26aufirst%3DK.%26aulast%3DBlaxter%26aufirst%3DM.%2BL.%26aulast%3DB%25C3%25BCttner%26aufirst%3DD.%2BW.%26aulast%3DGallin%26aufirst%3DM.%2BY.%26aulast%3DAl-Qaoud%26aufirst%3DK.%2BM.%26aulast%3DLucius%26aufirst%3DR.%26aulast%3DFleischer%26aufirst%3DB.%26atitle%3DTetracycline%2520therapy%2520targets%2520intracellular%2520bacteria%2520in%2520the%2520filarial%2520nematode%2520Litomosoides%2520sigmodontis%2520and%2520results%2520in%2520filarial%2520infertility%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1999%26volume%3D103%26spage%3D11%26epage%3D18%26doi%3D10.1172%2Fjci4768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ajendra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Specht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gondorf, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentil, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, M. P.</span></span> <span> </span><span class="NLM_article-title">ST2 deficiency does not impair type 2 immune responses during chronic filarial infection but leads to an increased microfilaremia due to an impaired splenic microfilarial clearance</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e93072</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0093072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1371%2Fjournal.pone.0093072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=24663956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWgu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e93072&author=J.+Ajendraauthor=S.+Spechtauthor=A.-L.+Neumannauthor=F.+Gondorfauthor=D.+Schmidtauthor=K.+Gentilauthor=W.+H.+Hoffmannauthor=M.+J.+Taylorauthor=A.+Hoeraufauthor=M.+P.+H%C3%BCbner&title=ST2+deficiency+does+not+impair+type+2+immune+responses+during+chronic+filarial+infection+but+leads+to+an+increased+microfilaremia+due+to+an+impaired+splenic+microfilarial+clearance&doi=10.1371%2Fjournal.pone.0093072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">ST2 deficiency does not impair type 2 immune responses during chronic filarial infection but leads to an increased microfilaremia due to an impaired splenic microfilarial clearance</span></div><div class="casAuthors">Ajendra, Jesuthas; Specht, Sabine; Neumann, Anna-Lena; Gondorf, Fabian; Schmidt, David; Gentil, Katrin; Hoffmann, Wolfgang H.; Taylor, Mark J.; Hoerauf, Achim; Huebner, Marc P.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e93072/1-e93072/13, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Interactions of the Th2 cytokine IL-33 with its receptors ST2 lead to amplified Type 2 immune responses.  As Type 2 immune responses are known to mediate protection against helminth infections we hypothesized that the lack of ST2 would lead to an increased susceptibility to filarial infections.  Methodol./Principal Finding: ST2 deficient and immunocompetent BALB/c mice were infected with the filarial nematode Litomosoides sigmodontis.  At different time points after infection mice were analyzed for worm burden and their immune responses were examd. within the thoracic cavity, the site of infection, and systemically using spleen cells and plasma.  Absence of ST2 led to significantly increased levels of peripheral blood microfilariae, the filarial progeny, whereas L. sigmodontis adult worm burden was not affected.  Development of local and systemic Type 2 immune responses were not impaired in ST2 deficient mice after the onset of microfilaremia, but L. sigmodontis infected ST2-ko mice had significantly reduced total nos. of cells within the thoracic cavity and spleen compared to infected immunocompetent controls.  Pronounced microfilaremia in ST2-ko mice did not result from an increased microfilariae release by adult female worms, but an impaired splenic clearance of microfilariae.  Conclusions/Significance: Our findings suggest that the absence of ST2 does not impair the establishment of adult L. sigmodontis worms, but is important for the splenic clearance of microfilariae from peripheral blood.  Thus, ST2 interactions may be important for therapies that intend to block the transmission of filarial disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCbPEcyfdJq7Vg90H21EOLACvtfcHk0li9ABFs_AU-aQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWgu7fP&md5=4e2b67df481b83a657a6d3b9f1489af0</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0093072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0093072%26sid%3Dliteratum%253Aachs%26aulast%3DAjendra%26aufirst%3DJ.%26aulast%3DSpecht%26aufirst%3DS.%26aulast%3DNeumann%26aufirst%3DA.-L.%26aulast%3DGondorf%26aufirst%3DF.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DGentil%26aufirst%3DK.%26aulast%3DHoffmann%26aufirst%3DW.%2BH.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DH%25C3%25BCbner%26aufirst%3DM.%2BP.%26atitle%3DST2%2520deficiency%2520does%2520not%2520impair%2520type%25202%2520immune%2520responses%2520during%2520chronic%2520filarial%2520infection%2520but%2520leads%2520to%2520an%2520increased%2520microfilaremia%2520due%2520to%2520an%2520impaired%2520splenic%2520microfilarial%2520clearance%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De93072%26doi%3D10.1371%2Fjournal.pone.0093072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitre, E.</span></span> <span> </span><span class="NLM_article-title">A comprehensive, model-based review of vaccine and repeat infection trials for filariasis</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.1128/cmr.00002-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1128%2Fcmr.00002-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=23824365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A280%3ADC%252BC3sjotVamtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=381-421&author=C.+P.+Morrisauthor=H.+Evansauthor=S.+E.+Larsenauthor=E.+Mitre&title=A+comprehensive%2C+model-based+review+of+vaccine+and+repeat+infection+trials+for+filariasis&doi=10.1128%2Fcmr.00002-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive, model-based review of vaccine and repeat infection trials for filariasis</span></div><div class="casAuthors">Morris C Paul; Evans Holly; Larsen Sasha E; Mitre Edward</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">381-421</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">SUMMARY Filarial worms cause highly morbid diseases such as elephantiasis and river blindness.  Since the 1940s, researchers have conducted vaccine trials in 27 different animal models of filariasis.  Although no vaccine trial in a permissive model of filariasis has provided sterilizing immunity, great strides have been made toward developing vaccines that could block transmission, decrease pathological sequelae, or decrease susceptibility to infection.  In this review, we have organized, to the best of our ability, all published filaria vaccine trials and reviewed them in the context of the animal models used.  Additionally, we provide information on the life cycle, disease phenotype, concomitant immunity, and natural immunity during primary and secondary infections for 24 different filaria models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNFVB97lPF5q69lAbTj9rGfW6udTcc2eYbg88EGm23s7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjotVamtQ%253D%253D&md5=d3ba508e642aec25807c2a1128de1854</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1128%2Fcmr.00002-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fcmr.00002-13%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DC.%2BP.%26aulast%3DEvans%26aufirst%3DH.%26aulast%3DLarsen%26aufirst%3DS.%2BE.%26aulast%3DMitre%26aufirst%3DE.%26atitle%3DA%2520comprehensive%252C%2520model-based%2520review%2520of%2520vaccine%2520and%2520repeat%2520infection%2520trials%2520for%2520filariasis%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2013%26volume%3D26%26spage%3D381%26epage%3D421%26doi%3D10.1128%2Fcmr.00002-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Layland, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajendra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiszniewsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubner, M. P.</span></span> <span> </span><span class="NLM_article-title">Development of patent Litomosoides sigmodontis infections in semi-susceptible C57BL/6 mice in the absence of adaptive immune responses</span>. <i>Parasites Vectors</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">396</span>, <span class="refDoi"> DOI: 10.1186/s13071-015-1011-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1186%2Fs13071-015-1011-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=26209319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FmvFKisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=396&author=L.+E.+Laylandauthor=J.+Ajendraauthor=M.+Ritterauthor=A.+Wiszniewskyauthor=A.+Hoeraufauthor=M.+P.+Hubner&title=Development+of+patent+Litomosoides+sigmodontis+infections+in+semi-susceptible+C57BL%2F6+mice+in+the+absence+of+adaptive+immune+responses&doi=10.1186%2Fs13071-015-1011-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Development of patent Litomosoides sigmodontis infections in semi-susceptible C57BL/6 mice in the absence of adaptive immune responses</span></div><div class="casAuthors">Layland Laura E; Ajendra Jesuthas; Ritter Manuel; Wiszniewsky Anna; Hoerauf Achim; Hubner Marc P</div><div class="citationInfo"><span class="NLM_cas:title">Parasites & vectors</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">396</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  One of the most advantageous research aspects of the murine model of filariasis, Litomosoides sigmodontis, is the availability of mouse strains with varying susceptibility to the nematode infection.  In C57BL/6 mice, L. sigmodontis worms are largely eliminated in this strain by day 40 post-infection and never produce their offspring, microfilariae (Mf).  This provides a unique opportunity to decipher potential immune pathways that are required by filariae to achieve a successful infection.  In this study we tracked worm development and patency, the production of microfilariae and thus the transmission life-stage, in Rag2IL-2Rγ(-/-) mice which are deficient in T, B and NK cell populations.  FINDINGS:  Although worm burden was comparable between wildtype (WT) and Rag2IL-2Rγ(-/-) mice on d30, by day 72 post-infection, parasites in Rag2IL-2Rγ(-/-) mice were still in abundance, freely motile and all mice presented high quantities of Mf both at the site of infection, the thoracic cavity (TC), and in peripheral blood.  Levels of cytokine (IL-4, IL-6, TNFα) and chemokine (MIP-2, RANTES, Eotaxin) parameters were generally low in the TC of infected Rag2IL-2Rγ(-/-)mice at both time-points.  The frequency of neutrophils however was higher in Rag2IL-2Rγ(-/-)mice whereas eosinophils and macrophage populations, including alternatively activated macrophages, were elevated in WT controls.  CONCLUSION:  Our data highlight that adaptive immune responses prevent the development of patent L. sigmodontis infections in semi-susceptible C57BL/6 mice and suggest that induction of such responses may offer a strategy to prevent transmission of human filariasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJvMC16URAclHFYivNCdPRfW6udTcc2eYbg88EGm23s7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FmvFKisA%253D%253D&md5=0e4b52446072a84c5023100cc003a5e5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1186%2Fs13071-015-1011-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13071-015-1011-2%26sid%3Dliteratum%253Aachs%26aulast%3DLayland%26aufirst%3DL.%2BE.%26aulast%3DAjendra%26aufirst%3DJ.%26aulast%3DRitter%26aufirst%3DM.%26aulast%3DWiszniewsky%26aufirst%3DA.%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DHubner%26aufirst%3DM.%2BP.%26atitle%3DDevelopment%2520of%2520patent%2520Litomosoides%2520sigmodontis%2520infections%2520in%2520semi-susceptible%2520C57BL%252F6%2520mice%2520in%2520the%2520absence%2520of%2520adaptive%2520immune%2520responses%26jtitle%3DParasites%2520Vectors%26date%3D2015%26volume%3D8%26spage%3D396%26doi%3D10.1186%2Fs13071-015-1011-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benayoud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixon, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clare, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiotani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webborn, P. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aljayyoussi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steven, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struever, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frohberger, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrens, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, A. T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serwa, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gusovsky, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemingway, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, P. M.</span></span> <span> </span><span class="NLM_article-title">AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1414</span>– <span class="NLM_lpage">1419</span>, <span class="refDoi"> DOI: 10.1073/pnas.1816585116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1073%2Fpnas.1816585116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=30617067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsF2nurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=1414-1419&author=W.+D.+Hongauthor=F.+Benayoudauthor=G.+L.+Nixonauthor=L.+Fordauthor=K.+L.+Johnstonauthor=R.+H.+Clareauthor=A.+Cassidyauthor=D.+A.+N.+Cookauthor=A.+Siuauthor=M.+Shiotaniauthor=P.+J.+H.+Webbornauthor=S.+Kavanaghauthor=G.+Aljayyoussiauthor=E.+Murphyauthor=A.+Stevenauthor=J.+Archerauthor=D.+Strueverauthor=S.+J.+Frohbergerauthor=A.+Ehrensauthor=M.+P.+H%C3%BCbnerauthor=A.+Hoeraufauthor=A.+P.+Robertsauthor=A.+T.+M.+Hubbardauthor=E.+W.+Tateauthor=R.+A.+Serwaauthor=S.+C.+Leungauthor=L.+Qieauthor=N.+G.+Berryauthor=F.+Gusovskyauthor=J.+Hemingwayauthor=J.+D.+Turnerauthor=M.+J.+Taylorauthor=S.+A.+Wardauthor=P.+M.+O%E2%80%99Neill&title=AWZ1066S%2C+a+highly+specific+anti-Wolbachia+drug+candidate+for+a+short-course+treatment+of+filariasis&doi=10.1073%2Fpnas.1816585116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis</span></div><div class="casAuthors">Hong, W. David; Benayoud, Farid; Nixon, Gemma L.; Ford, Louise; Johnston, Kelly L.; Clare, Rachel H.; Cassidy, Andrew; Cook, Darren A. N.; Siu, Amy; Shiotani, Motohiro; Webborn, Peter J. H.; Kavanagh, Stefan; Aljayyoussi, Ghaith; Murphy, Emma; Steven, Andrew; Archer, John; Struever, Dominique; Frohberger, Stefan J.; Ehrens, Alexandra; Hubner, Marc P.; Hoerauf, Achim; Roberts, Adam P.; Hubbard, Alasdair T. M.; Tate, Edward W.; Serwa, Remigiusz A.; Leung, Suet C.; Qie, Li; Berry, Neil G.; Gusovsky, Fabian; Hemingway, Janet; Turner, Joseph D.; Taylor, Mark J.; Ward, Stephen A.; O'Neill, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1414-1419</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Onchocerciasis and lymphatic filariasis are two neglected tropical diseases that together affect ∼ 157 million people and inflict severe disability.  Both diseases are caused by parasitic filarial nematodes with elimination efforts constrained by the lack of a safe drug that can kill the adult filaria (macrofilaricide).  Previous proof-of-concept human trials have demonstrated that depleting > 90% of the essential nematode endosymbiont bacterium, Wolbachia, using antibiotics, can lead to permanent sterilization of adult female parasites and a safe macrofilaricidal outcome.  AWZ1066S is a highly specific anti-Wolbachia candidate selected through a lead optimization program focused on balancing efficacy, safety and drug metab./pharmacokinetic (DMPK) features of a thienopyrimidine/quinazoline scaffold derived from phenotypic screening.  AWZ1066S shows superior efficacy to existing anti-Wolbachia therapies in validated preclin. models of infection and has DMPK characteristics that are compatible with a short therapeutic regimen of 7 days or less.  This candidate mol. is well-positioned for onward development and has the potential to make a significant impact on communities affected by filariasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCa13fiW76BbVg90H21EOLACvtfcHk0ljKu25scIG5jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsF2nurY%253D&md5=55b391a0e3ca8ad730191fb9aa47cf8f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1816585116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1816585116%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DW.%2BD.%26aulast%3DBenayoud%26aufirst%3DF.%26aulast%3DNixon%26aufirst%3DG.%2BL.%26aulast%3DFord%26aufirst%3DL.%26aulast%3DJohnston%26aufirst%3DK.%2BL.%26aulast%3DClare%26aufirst%3DR.%2BH.%26aulast%3DCassidy%26aufirst%3DA.%26aulast%3DCook%26aufirst%3DD.%2BA.%2BN.%26aulast%3DSiu%26aufirst%3DA.%26aulast%3DShiotani%26aufirst%3DM.%26aulast%3DWebborn%26aufirst%3DP.%2BJ.%2BH.%26aulast%3DKavanagh%26aufirst%3DS.%26aulast%3DAljayyoussi%26aufirst%3DG.%26aulast%3DMurphy%26aufirst%3DE.%26aulast%3DSteven%26aufirst%3DA.%26aulast%3DArcher%26aufirst%3DJ.%26aulast%3DStruever%26aufirst%3DD.%26aulast%3DFrohberger%26aufirst%3DS.%2BJ.%26aulast%3DEhrens%26aufirst%3DA.%26aulast%3DH%25C3%25BCbner%26aufirst%3DM.%2BP.%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DA.%2BP.%26aulast%3DHubbard%26aufirst%3DA.%2BT.%2BM.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DSerwa%26aufirst%3DR.%2BA.%26aulast%3DLeung%26aufirst%3DS.%2BC.%26aulast%3DQie%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DN.%2BG.%26aulast%3DGusovsky%26aufirst%3DF.%26aulast%3DHemingway%26aufirst%3DJ.%26aulast%3DTurner%26aufirst%3DJ.%2BD.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26atitle%3DAWZ1066S%252C%2520a%2520highly%2520specific%2520anti-Wolbachia%2520drug%2520candidate%2520for%2520a%2520short-course%2520treatment%2520of%2520filariasis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2019%26volume%3D116%26spage%3D1414%26epage%3D1419%26doi%3D10.1073%2Fpnas.1816585116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easom, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.</span></span> <span> </span><span class="NLM_article-title">Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1299</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fj.bmcl.2011.12.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=22243961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1299-1307&author=Y.-K.+Zhangauthor=J.+J.+Plattnerauthor=Y.+R.+Freundauthor=E.+E.+Easomauthor=Y.+Zhouauthor=L.+Yeauthor=H.+Zhouauthor=D.+Watersonauthor=F.-J.+Gamoauthor=L.+M.+Sanzauthor=M.+Geauthor=Z.+Liauthor=L.+Liauthor=H.+Wangauthor=H.+Cui&title=Benzoxaborole+antimalarial+agents.+Part+2%3A+Discovery+of+fluoro-substituted+7-%282-carboxyethyl%29-1%2C3-dihydro-1-hydroxy-2%2C1-benzoxaboroles&doi=10.1016%2Fj.bmcl.2011.12.096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span></div><div class="casAuthors">Zhang, Yong-Kang; Plattner, Jacob J.; Freund, Yvonne R.; Easom, Eric E.; Zhou, Yasheen; Ye, Long; Zhou, Huchen; Waterson, David; Gamo, Francisco-Javier; Sanz, Laura M.; Ge, Min; Li, Zhiya; Li, Lingchao; Wang, Hailong; Cui, Han</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1299-1307</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">New boron-contg. benzoxaborole compds. were designed and synthesized for a continuing structure-activity relation (SAR) study to assess the antimalarial activity changes derived from side-chain structural variation, substituent modification on the benzene ring and removal of boron from five-membered oxaborole ring.  This SAR study demonstrated that boron is required for the antimalarial activity, and discovered that three of the newly prepd. fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles have excellent potencies (IC50 0.026-0.209 μM) against Plasmodium falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqR7ILmo50S7Vg90H21EOLACvtfcHk0ljKu25scIG5jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCnsbg%253D&md5=1b1dfbd62c694f926255c6edb7016b0f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.096%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DFreund%26aufirst%3DY.%2BR.%26aulast%3DEasom%26aufirst%3DE.%2BE.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DGamo%26aufirst%3DF.-J.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGe%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCui%26aufirst%3DH.%26atitle%3DBenzoxaborole%2520antimalarial%2520agents.%2520Part%25202%253A%2520Discovery%2520of%2520fluoro-substituted%25207-%25282-carboxyethyl%2529-1%252C3-dihydro-1-hydroxy-2%252C1-benzoxaboroles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1299%26epage%3D1307%26doi%3D10.1016%2Fj.bmcl.2011.12.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easom, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retz, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.-H.</span></span> <span> </span><span class="NLM_article-title">Benzoxaborole antimalarial agents. Part 3: design and syntheses of (carboxy-13C-3,3-2H2)-labeled and (3-14C)-labeled 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1002/jlcr.2926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1002%2Fjlcr.2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFeksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=201-205&author=Y.-K.+Zhangauthor=J.+J.+Plattnerauthor=E.+E.+Easomauthor=L.+Liuauthor=D.+M.+Retzauthor=M.+Geauthor=H.-H.+Zhou&title=Benzoxaborole+antimalarial+agents.+Part+3%3A+design+and+syntheses+of+%28carboxy-13C-3%2C3-2H2%29-labeled+and+%283-14C%29-labeled+7-%282-carboxyethyl%29-1%2C3-dihydro-1-hydroxy-2%2C1-benzoxaboroles&doi=10.1002%2Fjlcr.2926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxaborole antimalarial agents. Part 3: design and syntheses of (carboxy-13C-3,3-2H2)-labeled and (3-14C)-labeled 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span></div><div class="casAuthors">Zhang, Yong-Kang; Plattner, Jacob J.; Easom, Eric E.; Liu, Liang; Retz, Daniel M.; Ge, Min; Zhou, Hui-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">201-205</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Two new isotopically labeled compds., (carboxy-13C-3,3-2H2)-7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (2) and (3-14C)-7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (3), were designed and synthesized to support the preclin. development studies of a potential new antimalarial agent, 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (1).  Copyright © 2012 John Wiley and Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4FVwqW_iAjrVg90H21EOLACvtfcHk0liZ1es9Ra_SCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFeksL0%253D&md5=65431e32fb81b0c68fd53e1e67f9325a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.2926%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DEasom%26aufirst%3DE.%2BE.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DRetz%26aufirst%3DD.%2BM.%26aulast%3DGe%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.-H.%26atitle%3DBenzoxaborole%2520antimalarial%2520agents.%2520Part%25203%253A%2520design%2520and%2520syntheses%2520of%2520%2528carboxy-13C-3%252C3-2H2%2529-labeled%2520and%2520%25283-14C%2529-labeled%25207-%25282-carboxyethyl%2529-1%252C3-dihydro-1-hydroxy-2%252C1-benzoxaboroles%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2012%26volume%3D55%26spage%3D201%26epage%3D205%26doi%3D10.1002%2Fjlcr.2926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wring, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowling, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaukel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarnagin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mejia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rattendi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rewerts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sligar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4379</span>– <span class="NLM_lpage">4388</span>, <span class="refDoi"> DOI: 10.1128/aac.00498-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1128%2Faac.00498-10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=4379-4388&author=B.+Nareauthor=S.+Wringauthor=C.+Bacchiauthor=B.+Beaudetauthor=T.+Bowlingauthor=R.+Brunauthor=D.+Chenauthor=C.+Dingauthor=Y.+Freundauthor=E.+Gaukelauthor=A.+Hussainauthor=K.+Jarnaginauthor=M.+Jenksauthor=M.+Kaiserauthor=L.+Mercerauthor=E.+Mejiaauthor=A.+Noeauthor=M.+Orrauthor=R.+Parhamauthor=J.+Plattnerauthor=R.+Randolphauthor=D.+Rattendiauthor=C.+Rewertsauthor=J.+Sligarauthor=N.+Yarlettauthor=R.+Donauthor=R.+Jacobs&title=Discovery+of+novel+orally+bioavailable+oxaborole+6-carboxamides+that+demonstrate+cure+in+a+murine+model+of+late-stage+central+nervous+system+african+trypanosomiasis&doi=10.1128%2Faac.00498-10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1128%2Faac.00498-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.00498-10%26sid%3Dliteratum%253Aachs%26aulast%3DNare%26aufirst%3DB.%26aulast%3DWring%26aufirst%3DS.%26aulast%3DBacchi%26aufirst%3DC.%26aulast%3DBeaudet%26aufirst%3DB.%26aulast%3DBowling%26aufirst%3DT.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DGaukel%26aufirst%3DE.%26aulast%3DHussain%26aufirst%3DA.%26aulast%3DJarnagin%26aufirst%3DK.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DMercer%26aufirst%3DL.%26aulast%3DMejia%26aufirst%3DE.%26aulast%3DNoe%26aufirst%3DA.%26aulast%3DOrr%26aufirst%3DM.%26aulast%3DParham%26aufirst%3DR.%26aulast%3DPlattner%26aufirst%3DJ.%26aulast%3DRandolph%26aufirst%3DR.%26aulast%3DRattendi%26aufirst%3DD.%26aulast%3DRewerts%26aufirst%3DC.%26aulast%3DSligar%26aufirst%3DJ.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DDon%26aufirst%3DR.%26aulast%3DJacobs%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520novel%2520orally%2520bioavailable%2520oxaborole%25206-carboxamides%2520that%2520demonstrate%2520cure%2520in%2520a%2520murine%2520model%2520of%2520late-stage%2520central%2520nervous%2520system%2520african%2520trypanosomiasis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D4379%26epage%3D4388%26doi%3D10.1128%2Faac.00498-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palencia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easom, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meewan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolhiser, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruppo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenaerts, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusack, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel oral protein synthesis inhibitors of mycobacterium tuberculosis that target leucyl-trna synthetase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6271</span>– <span class="NLM_lpage">6280</span>, <span class="refDoi"> DOI: 10.1128/aac.01339-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1128%2Faac.01339-16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=6271-6280&author=A.+Palenciaauthor=X.+Liauthor=W.+Buauthor=W.+Choiauthor=C.+Z.+Dingauthor=E.+E.+Easomauthor=L.+Fengauthor=V.+Hernandezauthor=P.+Houstonauthor=L.+Liuauthor=M.+Meewanauthor=M.+Mohanauthor=F.+L.+Rockauthor=H.+Sextonauthor=S.+Zhangauthor=Y.+Zhouauthor=B.+Wanauthor=Y.+Wangauthor=S.+G.+Franzblauauthor=L.+Woolhiserauthor=V.+Gruppoauthor=A.+J.+Lenaertsauthor=T.+O%E2%80%99Malleyauthor=T.+Parishauthor=C.+B.+Cooperauthor=M.+G.+Watersauthor=Z.+Maauthor=T.+R.+Ioergerauthor=J.+C.+Sacchettiniauthor=J.+Rullasauthor=I.+Angulo-Barturenauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=A.+Mendozaauthor=D.+Barrosauthor=S.+Cusackauthor=J.+J.+Plattnerauthor=M.+R.+K.+Alley&title=Discovery+of+novel+oral+protein+synthesis+inhibitors+of+mycobacterium+tuberculosis+that+target+leucyl-trna+synthetase&doi=10.1128%2Faac.01339-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1128%2Faac.01339-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.01339-16%26sid%3Dliteratum%253Aachs%26aulast%3DPalencia%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DChoi%26aufirst%3DW.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DEasom%26aufirst%3DE.%2BE.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DHouston%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMeewan%26aufirst%3DM.%26aulast%3DMohan%26aufirst%3DM.%26aulast%3DRock%26aufirst%3DF.%2BL.%26aulast%3DSexton%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWoolhiser%26aufirst%3DL.%26aulast%3DGruppo%26aufirst%3DV.%26aulast%3DLenaerts%26aufirst%3DA.%2BJ.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DT.%26aulast%3DParish%26aufirst%3DT.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DWaters%26aufirst%3DM.%2BG.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DCusack%26aufirst%3DS.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26atitle%3DDiscovery%2520of%2520novel%2520oral%2520protein%2520synthesis%2520inhibitors%2520of%2520mycobacterium%2520tuberculosis%2520that%2520target%2520leucyl-trna%2520synthetase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D6271%26epage%3D6280%26doi%3D10.1128%2Faac.01339-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, Y. S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easom, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemparte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[<i>c</i>][1,2]oxaborol-1(3H)-ol (GSK656)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8011</span>– <span class="NLM_lpage">8026</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00631</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00631" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGms7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8011-8026&author=X.+Liauthor=V.+Hernandezauthor=F.+L.+Rockauthor=W.+Choiauthor=Y.+S.+L.+Makauthor=M.+Mohanauthor=W.+Maoauthor=Y.+Zhouauthor=E.+E.+Easomauthor=J.+J.+Plattnerauthor=W.+Zouauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=I.+Giordanoauthor=A.+Mendoza-Losanaauthor=C.+Alemparteauthor=J.+Rullasauthor=I.+Angulo-Barturenauthor=S.+Crouchauthor=F.+Ortegaauthor=D.+Barrosauthor=M.+R.+K.+Alley&title=Discovery+of+a+Potent+and+Specific+M.+tuberculosis+Leucyl-tRNA+Synthetase+Inhibitor%3A+%28S%29-3-%28Aminomethyl%29-4-chloro-7-%282-hydroxyethoxy%29benzo%5Bc%5D%5B1%2C2%5Doxaborol-1%283H%29-ol+%28GSK656%29&doi=10.1021%2Facs.jmedchem.7b00631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent and specific M. tuberculosis leucyl-tRNA synthetase inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)</span></div><div class="casAuthors">Li, Xianfeng; Hernandez, Vincent; Rock, Fernando L.; Choi, Wai; Mak, Yvonne S. L.; Mohan, Manisha; Mao, Weimin; Zhou, Yasheen; Easom, Eric E.; Plattner, Jacob J.; Zou, Wuxin; Perez-Herran, Esther; Giordano, Ilaria; Mendoza-Losana, Alfonso; Alemparte, Carlos; Rullas, Joaquin; Angulo-Barturen, Inigo; Crouch, Sabrinia; Ortega, Fatima; Barros, David; Alley, M. R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8011-8026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic boronate monoesters I (X = Cl, Br; R1, R2 = alkoxy, aryloxy, 2-hydroxyethyl; R1R2 = OCH2O, OCH2CH2O) were prepd. by cyclization of substituted 2-boronobenzaldehydes with nitromethane with subsequent nitro-group redn. and examd. in vitro for their inhibition of M. tuberculosis leucyl-tRNA synthetase (Mtb LeuRS) and in vivo in a mouse model of acute TB infection.  There is an urgent need to develop new and safer antitubercular agents that possess a novel mode of action.  We synthesized and evaluated a novel series of 3-aminomethyl 4-halogen benzoxaboroles as Mycobacterium tuberculosis (Mtb) leucyl-tRNA synthetase (LeuRS) inhibitors.  A no. of Mtb LeuRS inhibitors were identified that demonstrated good antitubercular activity with high selectivity over human mitochondrial and cytoplasmic LeuRS.  Further evaluation of these Mtb LeuRS inhibitors by in vivo pharmacokinetics (PK) and murine tuberculosis (TB) efficacy models led to the discovery of GSK3036656 (abbreviated as GSK656).  This mol. shows potent inhibition of Mtb LeuRS (IC50 = 0.20 μM) and in vitro antitubercular activity (Mtb H37Rv MIC = 0.08 μM).  Addnl., it is highly selective for the Mtb LeuRS enzyme with IC50 of >300 μM and 132 μM for human mitochondrial LeuRS and human cytoplasmic LeuRS, resp.  In addn., it exhibits remarkable PK profiles and efficacy against Mtb in mouse TB infection models with superior tolerability over initial leads.  This compd. has been progressed to clin. development for the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2t6WBCJKOrVg90H21EOLACvtfcHk0lg_JYEBTCDvlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGms7jJ&md5=c5626f1a1028f79e175a07cb6c01ec44</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00631%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DRock%26aufirst%3DF.%2BL.%26aulast%3DChoi%26aufirst%3DW.%26aulast%3DMak%26aufirst%3DY.%2BS.%2BL.%26aulast%3DMohan%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DEasom%26aufirst%3DE.%2BE.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DZou%26aufirst%3DW.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DGiordano%26aufirst%3DI.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DAlemparte%26aufirst%3DC.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DCrouch%26aufirst%3DS.%26aulast%3DOrtega%26aufirst%3DF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520and%2520Specific%2520M.%2520tuberculosis%2520Leucyl-tRNA%2520Synthetase%2520Inhibitor%253A%2520%2528S%2529-3-%2528Aminomethyl%2529-4-chloro-7-%25282-hydroxyethoxy%2529benzo%255Bc%255D%255B1%252C2%255Doxaborol-1%25283H%2529-ol%2520%2528GSK656%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8011%26epage%3D8026%26doi%3D10.1021%2Facs.jmedchem.7b00631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klarmann-Schulz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Specht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debrah, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batsa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayisi-Boateng, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osei-Mensah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mubarik, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konadu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricchiuto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fimmers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arriens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubben, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span> <span> </span><span class="NLM_article-title">Comparison of doxycycline, minocycline, doxycycline plus albendazole and albendazole alone in their efficacy against onchocerciasis in a randomized, open-label, pilot trial</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0005156</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0005156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1371%2Fjournal.pntd.0005156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=28056021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1CltbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=e0005156&author=U.+Klarmann-Schulzauthor=S.+Spechtauthor=A.+Y.+Debrahauthor=L.+Batsaauthor=N.+K.+Ayisi-Boatengauthor=J.+Osei-Mensahauthor=Y.+Mubarikauthor=P.+Konaduauthor=A.+Ricchiutoauthor=R.+Fimmersauthor=S.+Arriensauthor=B.+Dubbenauthor=L.+Fordauthor=M.+Taylorauthor=A.+Hoerauf&title=Comparison+of+doxycycline%2C+minocycline%2C+doxycycline+plus+albendazole+and+albendazole+alone+in+their+efficacy+against+onchocerciasis+in+a+randomized%2C+open-label%2C+pilot+trial&doi=10.1371%2Fjournal.pntd.0005156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of doxycycline, minocycline, doxycycline plus albendazole and albendazole alone in their efficacy against onchocerciasis in a randomized, open-label, pilot trial</span></div><div class="casAuthors">Klarmann-Schulz, Ute; Specht, Sabine; Debrah, Alexander Yaw; Batsa, Linda; Ayisi-Boateng, Nana Kwame; Osei-Mensah, Jubin; Mubarik, Yusif; Konadu, Peter; Ricchiuto, Arcangelo; Fimmers, Rolf; Arriens, Sandra; Dubben, Bettina; Ford, Louise; Taylor, Mark; Hoerauf, Achim</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e0005156/1-e0005156/22</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The search for new macrofilaricidal drugs against onchocerciasis that can be administered in shorter regimens than required for doxycycline (DOX, 200mg/d given for 4-6 wk), identified minocycline (MIN) with superior efficacy to DOX.  Further redn. in the treatment regimen may be achieved with co-administration with std. anti-filarial drugs.  Therefore a randomized, open-label, pilot trial was carried out in an area in Ghana endemic for onchocerciasis, comprising 5 different regimens: the std. regimen DOX 200mg/d for 4 wk (DOX 4w, N = 33), the exptl. regimens MIN 200mg/d for 3 wk (MIN 3w; N = 30), DOX 200mg/d for 3 wk plus albendazole (ALB) 800mg/d for 3 days (DOX 3w + ALB 3d, N = 32), DOX 200mg/d for 3 wk (DOX 3w, N = 31) and ALB 800mg for 3 days (ALB 3d, N = 30).  Out of 158 randomized participants, 116 (74.4%) were present for the follow-up at 6 mo of whom 99 participants (63.5%) followed the treatment per protocol and underwent surgery.  Histol. anal. of the adult worms in the extirpated nodules revealed absence of Wolbachia in 98.8% (DOX 4w), 81.4% (DOX 3w + ALB 3d), 72.7% (MIN 3w), 64.1% (DOX 3w) and 35.2% (ALB 3d) of the female worms.  All 4 treatment regimens showed superiority to ALB 3d (p < 0.001, p < 0.001, p = 0.002, p = 0.008, resp.), which was confirmed by real-time PCR.  Addnl., DOX 4w showed superiority to all other treatment arms.  Furthermore DOX 4w and DOX 3w + ALB 3d showed a higher amt. of female worms with degenerated embryogenesis compared to ALB 3d (p = 0.028, p = 0.042, resp.).  These results confirm earlier studies that DOX 4w is sufficient for Wolbachia depletion and the desired parasitol. effects.  The data further suggest that there is an additive effect of ALB (3 days) on top of that of DOX alone, and that MIN shows a trend for stronger potency than DOX.  These latter two results are preliminary and need confirmation in a fully randomized controlled phase 2 trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlwgxbbUwQlLVg90H21EOLACvtfcHk0lg_JYEBTCDvlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1CltbjE&md5=7289403e651ec6f4be3aa5068d5fd7f9</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0005156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0005156%26sid%3Dliteratum%253Aachs%26aulast%3DKlarmann-Schulz%26aufirst%3DU.%26aulast%3DSpecht%26aufirst%3DS.%26aulast%3DDebrah%26aufirst%3DA.%2BY.%26aulast%3DBatsa%26aufirst%3DL.%26aulast%3DAyisi-Boateng%26aufirst%3DN.%2BK.%26aulast%3DOsei-Mensah%26aufirst%3DJ.%26aulast%3DMubarik%26aufirst%3DY.%26aulast%3DKonadu%26aufirst%3DP.%26aulast%3DRicchiuto%26aufirst%3DA.%26aulast%3DFimmers%26aufirst%3DR.%26aulast%3DArriens%26aufirst%3DS.%26aulast%3DDubben%26aufirst%3DB.%26aulast%3DFord%26aufirst%3DL.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DHoerauf%26aufirst%3DA.%26atitle%3DComparison%2520of%2520doxycycline%252C%2520minocycline%252C%2520doxycycline%2520plus%2520albendazole%2520and%2520albendazole%2520alone%2520in%2520their%2520efficacy%2520against%2520onchocerciasis%2520in%2520a%2520randomized%252C%2520open-label%252C%2520pilot%2520trial%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2017%26volume%3D11%26spage%3De0005156%26doi%3D10.1371%2Fjournal.pntd.0005156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo metabolite profiling of valnemulin using ultraperformance liquid chromatography-quadrupole/time-of-flight hybrid mass spectrometry</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9201</span>– <span class="NLM_lpage">9210</span>, <span class="refDoi"> DOI: 10.1021/jf5012402</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf5012402" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2014&pages=9201-9210&author=S.+Yangauthor=W.+Shiauthor=D.+Huauthor=S.+Zhangauthor=H.+Zhangauthor=Z.+Wangauthor=L.+Chengauthor=F.+Sunauthor=J.+Shenauthor=X.+Cao&title=In+vitro+and+in+vivo+metabolite+profiling+of+valnemulin+using+ultraperformance+liquid+chromatography-quadrupole%2Ftime-of-flight+hybrid+mass+spectrometry&doi=10.1021%2Fjf5012402"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjf5012402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf5012402%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DX.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520metabolite%2520profiling%2520of%2520valnemulin%2520using%2520ultraperformance%2520liquid%2520chromatography-quadrupole%252Ftime-of-flight%2520hybrid%2520mass%2520spectrometry%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2014%26volume%3D62%26spage%3D9201%26epage%3D9210%26doi%3D10.1021%2Fjf5012402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lykkeberg, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halling-Sørensen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S. H.</span></span> <span> </span><span class="NLM_article-title">Isolation and structural elucidation of tiamulin metabolites formed in liver microsomes of pigs</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2006.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fj.jpba.2006.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=16725295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD28Xosl2msLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=223-231&author=A.+K.+Lykkebergauthor=C.+Cornettauthor=B.+Halling-S%C3%B8rensenauthor=S.+H.+Hansen&title=Isolation+and+structural+elucidation+of+tiamulin+metabolites+formed+in+liver+microsomes+of+pigs&doi=10.1016%2Fj.jpba.2006.03.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structural elucidation of tiamulin metabolites formed in liver microsomes of pigs</span></div><div class="casAuthors">Lykkeberg, Anne Kruse; Cornett, Claus; Halling-Sorensen, Bent; Hansen, Steen Honore</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-231</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Although the antimicrobial tiamulin is extensively metabolized in pigs, the metab. is not well investigated.  In this work the NADPH dependent metab. of tiamulin in liver microsomes from pigs has been studied.  The tiamulin metabolites formed in the incubations were analyzed using LC-MS, and three major metabolites were isolated using solid phase extn. and preparative HPLC.  The final structure elucidations were performed by tandem mass spectrometry and 1H and 13C NMR.  The structures of the metabolites were found to be 2β-hydroxy-tiamulin, 8α-hydroxy-tiamulin and N-deethyl-tiamulin.  In addn., the LC-MS chromatograms revealed two other minor metabolites.  From their chromatog. and from MS2 anal. the structures were estd. to be 2β-hydroxy-N-deethyl-tiamulin and 8α-hydroxy-N-deethyl-tiamulin, but the structures were not confirmed by NMR.  In these studies approx. 20% of tiamulin was deethylated, 10% was hydroxylated in the 2β-position and 7% was hydroxylated in the 8α-position.  About 40% of tiamulin was metabolized during the incubation conditions used.  The protein pptn. in the incubations was performed using perchloric acid, and the preparative purifn. was performed under alk. conditions.  Therefore, the stability of the metabolites under these conditions was studied.  The metabolites were found to be stable in the acid soln., but under alk. conditions, particularly at room temp., the stability of esp. 8α-hydroxy-tiamulin was considerably reduced (40% loss after 1 wk).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2qHszJYcLlrVg90H21EOLACvtfcHk0li1ABAyrh-row"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xosl2msLk%253D&md5=891a4fd581e29fa7350ec30ab2baad20</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2006.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2006.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DLykkeberg%26aufirst%3DA.%2BK.%26aulast%3DCornett%26aufirst%3DC.%26aulast%3DHalling-S%25C3%25B8rensen%26aufirst%3DB.%26aulast%3DHansen%26aufirst%3DS.%2BH.%26atitle%3DIsolation%2520and%2520structural%2520elucidation%2520of%2520tiamulin%2520metabolites%2520formed%2520in%2520liver%2520microsomes%2520of%2520pigs%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2006%26volume%3D42%26spage%3D223%26epage%3D231%26doi%3D10.1016%2Fj.jpba.2006.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bakowski, M. A.</span>; <span class="NLM_string-name">Shiroodi, R. K.</span>; <span class="NLM_string-name">Liu, R.</span>; <span class="NLM_string-name">Olejniczak, J.</span>; <span class="NLM_string-name">Yang, B.</span>; <span class="NLM_string-name">Gagaring, K.</span>; <span class="NLM_string-name">Guo, H.</span>; <span class="NLM_string-name">White, P. M.</span>; <span class="NLM_string-name">Chappell, L.</span>; <span class="NLM_string-name">Debec, A.</span>; <span class="NLM_string-name">Landmann, F.</span>; <span class="NLM_string-name">Dubben, B.</span>; <span class="NLM_string-name">Lenz, F.</span>; <span class="NLM_string-name">Struever, D.</span>; <span class="NLM_string-name">Ehrens, A.</span>; <span class="NLM_string-name">Frohberger, S.</span>; <span class="NLM_string-name">Sjoberg, H.</span>; <span class="NLM_string-name">Pionnier, N.</span>; <span class="NLM_string-name">Murphy, E.</span>; <span class="NLM_string-name">Archer, J.</span>; <span class="NLM_string-name">Steven, A.</span>; <span class="NLM_string-name">Chunda, V. C.</span>; <span class="NLM_string-name">Fombad, F. F.</span>; <span class="NLM_string-name">Chounna, P. W.</span>; <span class="NLM_string-name">Njouendou, A. J.</span>; <span class="NLM_string-name">Metuge, H. M.</span>; <span class="NLM_string-name">Ndzeshang, B. L.</span>; <span class="NLM_string-name">Gandjui, N. V.</span>; <span class="NLM_string-name">Akumtoh, D. N.</span>; <span class="NLM_string-name">Kwenti, T. D.</span>; <span class="NLM_string-name">Woods, A. K.</span>; <span class="NLM_string-name">Joseph, S. B.</span>; <span class="NLM_string-name">Hull, M. V.</span>; <span class="NLM_string-name">Xiong, W.</span>; <span class="NLM_string-name">Kuhen, K. L.</span>; <span class="NLM_string-name">Taylor, M.</span>; <span class="NLM_string-name">Wanji, S.</span>; <span class="NLM_string-name">Turner, J. D.</span>; <span class="NLM_string-name">Hübner, M. P.</span>; <span class="NLM_string-name">Hoerauf, A.</span>; <span class="NLM_string-name">Roland, J.</span>; <span class="NLM_string-name">Tremblay, M. S.</span>; <span class="NLM_string-name">Schultz, P. G.</span>; <span class="NLM_string-name">Sullivan, W.</span>; <span class="NLM_string-name">Chu, X.</span>; <span class="NLM_string-name">Petrassi, H. M.</span>; <span class="NLM_string-name">McNamara, C. W.</span></span> <span> </span><span class="NLM_article-title">A single-dose oral therapy for the treatment of lymphatic filariasis and river blindness</span>.  <i>Sci. Transl. Med.</i>, accepted.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bakowski%2C+M.+A.%3B+Shiroodi%2C+R.+K.%3B+Liu%2C+R.%3B+Olejniczak%2C+J.%3B+Yang%2C+B.%3B+Gagaring%2C+K.%3B+Guo%2C+H.%3B+White%2C+P.+M.%3B+Chappell%2C+L.%3B+Debec%2C+A.%3B+Landmann%2C+F.%3B+Dubben%2C+B.%3B+Lenz%2C+F.%3B+Struever%2C+D.%3B+Ehrens%2C+A.%3B+Frohberger%2C+S.%3B+Sjoberg%2C+H.%3B+Pionnier%2C+N.%3B+Murphy%2C+E.%3B+Archer%2C+J.%3B+Steven%2C+A.%3B+Chunda%2C+V.+C.%3B+Fombad%2C+F.+F.%3B+Chounna%2C+P.+W.%3B+Njouendou%2C+A.+J.%3B+Metuge%2C+H.+M.%3B+Ndzeshang%2C+B.+L.%3B+Gandjui%2C+N.+V.%3B+Akumtoh%2C+D.+N.%3B+Kwenti%2C+T.+D.%3B+Woods%2C+A.+K.%3B+Joseph%2C+S.+B.%3B+Hull%2C+M.+V.%3B+Xiong%2C+W.%3B+Kuhen%2C+K.+L.%3B+Taylor%2C+M.%3B+Wanji%2C+S.%3B+Turner%2C+J.+D.%3B+H%C3%BCbner%2C+M.+P.%3B+Hoerauf%2C+A.%3B+Roland%2C+J.%3B+Tremblay%2C+M.+S.%3B+Schultz%2C+P.+G.%3B+Sullivan%2C+W.%3B+Chu%2C+X.%3B+Petrassi%2C+H.+M.%3B+McNamara%2C+C.+W.+A+single-dose+oral+therapy+for+the+treatment+of+lymphatic+filariasis+and+river+blindness.+Sci.+Transl.+Med.%2C+accepted."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBakowski%26aufirst%3DM.%2BA.%26atitle%3DA%2520single-dose%2520oral%2520therapy%2520for%2520the%2520treatment%2520of%2520lymphatic%2520filariasis%2520and%2520river%2520blindness%26jtitle%3DSci.%2520Transl.%2520Med." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayoussi, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrer, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimaraes, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myhill, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clare, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steven, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span> <span> </span><span class="NLM_article-title">Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">23458</span>, <span class="refDoi"> DOI: 10.1038/srep23458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1038%2Fsrep23458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=26996237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1Chsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=23458&author=R.+Sharmaauthor=G.+A.+Jayoussiauthor=H.+E.+Tyrerauthor=J.+Gambleauthor=L.+Haywardauthor=A.+F.+Guimaraesauthor=J.+Daviesauthor=D.+Waterhouseauthor=D.+A.+Cookauthor=L.+J.+Myhillauthor=R.+H.+Clareauthor=A.+Cassidyauthor=A.+Stevenauthor=K.+L.+Johnstonauthor=L.+Fordauthor=J.+D.+Turnerauthor=S.+A.+Wardauthor=M.+J.+Taylor&title=Minocycline+as+a+re-purposed+anti-Wolbachia+macrofilaricide%3A+superiority+compared+with+doxycycline+regimens+in+a+murine+infection+model+of+human+lymphatic+filariasis&doi=10.1038%2Fsrep23458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis</span></div><div class="casAuthors">Sharma, Raman; Jayoussi, Ghaith Al; Tyrer, Hayley E.; Gamble, Joanne; Hayward, Laura; Guimaraes, Ana F.; Davies, Jill; Waterhouse, David; Cook, Darren A. N.; Myhill, Laura J.; Clare, Rachel H.; Cassidy, Andrew; Steven, Andrew; Johnston, Kelly L.; Ford, Louise; Turner, Joseph D.; Ward, Stephen A.; Taylor, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23458</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lymphatic filariasis and onchocerciasis are parasitic helminth diseases, which cause severe morbidities such as elephantiasis, skin disease and blindness, presenting a major public health burden in endemic communities.  The anti-Wolbachia consortium (A·WOL: http://www.a-wol.com/) has identified a no. of registered antibiotics that target the endosymbiotic bacterium, Wolbachia, delivering macrofilaricidal activity.  Here we use pharmacokinetics/pharmacodynamics (PK/PD) anal. to rationally develop an anti-Wolbachia chemotherapy by linking drug exposure to pharmacol. effect.  We compare the pharmacokinetics and anti-Wolbachia efficacy in a murine Brugia malayi model of minocycline vs. doxycycline.  Doxycycline exhibits superior PK in comparison to minocycline resulting in a 3-fold greater exposure in SCID mice.  Monte-Carlo simulations confirmed that a bi-daily 25-40 mg/Kg regimen is bioequivalent to a clin. effective 100-200 mg/day dose for these tetracyclines.  Pharmacodynamic studies showed that minocycline depletes Wolbachia more effectively than doxycycline (99.51% vs. 90.35%) after 28 day 25 mg/Kg bid regimens with a more potent block in microfilarial prodn.  PK/PD anal. predicts that minocycline would be expected to be 1.7 fold more effective than doxycycline in man despite lower exposure in our infection models.  Our findings warrant onward clin. investigations to examine the clin. efficacy of minocycline treatment regimens against lymphatic filariasis and onchocerciasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5k1pdDtponbVg90H21EOLACvtfcHk0lg953xJgFtKdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1Chsbg%253D&md5=37b9ba73b50edf26c88c5e557c01d802</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fsrep23458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep23458%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DJayoussi%26aufirst%3DG.%2BA.%26aulast%3DTyrer%26aufirst%3DH.%2BE.%26aulast%3DGamble%26aufirst%3DJ.%26aulast%3DHayward%26aufirst%3DL.%26aulast%3DGuimaraes%26aufirst%3DA.%2BF.%26aulast%3DDavies%26aufirst%3DJ.%26aulast%3DWaterhouse%26aufirst%3DD.%26aulast%3DCook%26aufirst%3DD.%2BA.%26aulast%3DMyhill%26aufirst%3DL.%2BJ.%26aulast%3DClare%26aufirst%3DR.%2BH.%26aulast%3DCassidy%26aufirst%3DA.%26aulast%3DSteven%26aufirst%3DA.%26aulast%3DJohnston%26aufirst%3DK.%2BL.%26aulast%3DFord%26aufirst%3DL.%26aulast%3DTurner%26aufirst%3DJ.%2BD.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26atitle%3DMinocycline%2520as%2520a%2520re-purposed%2520anti-Wolbachia%2520macrofilaricide%253A%2520superiority%2520compared%2520with%2520doxycycline%2520regimens%2520in%2520a%2520murine%2520infection%2520model%2520of%2520human%2520lymphatic%2520filariasis%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D23458%26doi%3D10.1038%2Fsrep23458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Jayoussi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrer, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priestley, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clare, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steven, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemingway, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span> <span> </span><span class="NLM_article-title">Albendazole and antibiotics synergize to deliver short-course anti-Wolbachiacurative treatments in preclinical models of filariasis</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E9712</span>– <span class="NLM_lpage">E9721</span>, <span class="refDoi"> DOI: 10.1073/pnas.1710845114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1073%2Fpnas.1710845114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E9712-E9721&author=J.+D.+Turnerauthor=R.+Sharmaauthor=G.+Al+Jayoussiauthor=H.+E.+Tyrerauthor=J.+Gambleauthor=L.+Haywardauthor=R.+S.+Priestleyauthor=E.+A.+Murphyauthor=J.+Daviesauthor=D.+Waterhouseauthor=D.+A.+N.+Cookauthor=R.+H.+Clareauthor=A.+Cassidyauthor=A.+Stevenauthor=K.+L.+Johnstonauthor=J.+McCallauthor=L.+Fordauthor=J.+Hemingwayauthor=S.+A.+Wardauthor=M.+J.+Taylor&title=Albendazole+and+antibiotics+synergize+to+deliver+short-course+anti-Wolbachiacurative+treatments+in+preclinical+models+of+filariasis&doi=10.1073%2Fpnas.1710845114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1710845114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1710845114%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DJ.%2BD.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DAl%2BJayoussi%26aufirst%3DG.%26aulast%3DTyrer%26aufirst%3DH.%2BE.%26aulast%3DGamble%26aufirst%3DJ.%26aulast%3DHayward%26aufirst%3DL.%26aulast%3DPriestley%26aufirst%3DR.%2BS.%26aulast%3DMurphy%26aufirst%3DE.%2BA.%26aulast%3DDavies%26aufirst%3DJ.%26aulast%3DWaterhouse%26aufirst%3DD.%26aulast%3DCook%26aufirst%3DD.%2BA.%2BN.%26aulast%3DClare%26aufirst%3DR.%2BH.%26aulast%3DCassidy%26aufirst%3DA.%26aulast%3DSteven%26aufirst%3DA.%26aulast%3DJohnston%26aufirst%3DK.%2BL.%26aulast%3DMcCall%26aufirst%3DJ.%26aulast%3DFord%26aufirst%3DL.%26aulast%3DHemingway%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26atitle%3DAlbendazole%2520and%2520antibiotics%2520synergize%2520to%2520deliver%2520short-course%2520anti-Wolbachiacurative%2520treatments%2520in%2520preclinical%2520models%2520of%2520filariasis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3DE9712%26epage%3DE9721%26doi%3D10.1073%2Fpnas.1710845114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aljayyoussi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrer, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjoberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pionnier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metuge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steven, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimaraes, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clare, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myhill, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span> <span> </span><span class="NLM_article-title">Short-course, high-dose rifampicin achieves wolbachia depletion predictive of curative outcomes in preclinical models of lymphatic filariasis and onchocerciasis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">210</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-00322-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1038%2Fs41598-017-00322-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=28303006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A280%3ADC%252BC1czntFGisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=210&author=G.+Aljayyoussiauthor=H.+E.+Tyrerauthor=L.+Fordauthor=H.+Sjobergauthor=N.+Pionnierauthor=D.+Waterhouseauthor=J.+Daviesauthor=J.+Gambleauthor=H.+Metugeauthor=D.+A.+N.+Cookauthor=A.+Stevenauthor=R.+Sharmaauthor=A.+F.+Guimaraesauthor=R.+H.+Clareauthor=A.+Cassidyauthor=K.+L.+Johnstonauthor=L.+Myhillauthor=L.+Haywardauthor=S.+Wanjiauthor=J.+D.+Turnerauthor=M.+J.+Taylorauthor=S.+A.+Ward&title=Short-course%2C+high-dose+rifampicin+achieves+wolbachia+depletion+predictive+of+curative+outcomes+in+preclinical+models+of+lymphatic+filariasis+and+onchocerciasis&doi=10.1038%2Fs41598-017-00322-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis</span></div><div class="casAuthors">Aljayyoussi Ghaith; Tyrer Hayley E; Ford Louise; Sjoberg Hanna; Pionnier Nicolas; Waterhouse David; Davies Jill; Gamble Joanne; Cook Darren A N; Steven Andrew; Sharma Raman; Guimaraes Ana F; Clare Rachel H; Cassidy Andrew; Johnston Kelly L; Myhill Laura; Hayward Laura; Turner Joseph D; Taylor Mark J; Ward Stephen A; Metuge Haelly; Wanji Samuel; Metuge Haelly; Wanji Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">210</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lymphatic filariasis (LF) and onchocerciasis are priority neglected tropical diseases targeted for elimination.  The only safe drug treatment with substantial curative activity against the filarial nematodes responsible for LF (Brugia malayi, Wuchereria bancrofti) or onchocerciasis (Onchocerca volvulus) is doxycycline.  The target of doxycycline is the essential endosymbiont, Wolbachia.  Four to six weeks doxycycline therapy achieves >90% depletion of Wolbachia in worm tissues leading to blockade of embryogenesis, adult sterility and premature death 18-24 months post-treatment.  Long treatment length and contraindications in children and pregnancy are obstacles to implementing doxycycline as a public health strategy.  Here we determine, via preclinical infection models of Brugia malayi or Onchocerca ochengi that elevated exposures of orally-administered rifampicin can lead to Wolbachia depletions from filariae more rapidly than those achieved by doxycycline.  Dose escalation of rifampicin achieves >90% Wolbachia depletion in time periods of 7 days in B. malayi and 14 days in O. ochengi.  Using pharmacokinetic-pharmacodynamic modelling and mouse-human bridging analysis, we conclude that clinically relevant dose elevations of rifampicin, which have recently been determined as safe in humans, could be administered as short courses to filariasis target populations with potential to reduce anti-Wolbachia curative therapy times to between one and two weeks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEk6Y8PgO0_pHZzFRCXxVKfW6udTcc2ea1jdjjG0qBjrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czntFGisA%253D%253D&md5=f5d52bcb266b99691966a8f6ce86fc2a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-00322-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-00322-5%26sid%3Dliteratum%253Aachs%26aulast%3DAljayyoussi%26aufirst%3DG.%26aulast%3DTyrer%26aufirst%3DH.%2BE.%26aulast%3DFord%26aufirst%3DL.%26aulast%3DSjoberg%26aufirst%3DH.%26aulast%3DPionnier%26aufirst%3DN.%26aulast%3DWaterhouse%26aufirst%3DD.%26aulast%3DDavies%26aufirst%3DJ.%26aulast%3DGamble%26aufirst%3DJ.%26aulast%3DMetuge%26aufirst%3DH.%26aulast%3DCook%26aufirst%3DD.%2BA.%2BN.%26aulast%3DSteven%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DGuimaraes%26aufirst%3DA.%2BF.%26aulast%3DClare%26aufirst%3DR.%2BH.%26aulast%3DCassidy%26aufirst%3DA.%26aulast%3DJohnston%26aufirst%3DK.%2BL.%26aulast%3DMyhill%26aufirst%3DL.%26aulast%3DHayward%26aufirst%3DL.%26aulast%3DWanji%26aufirst%3DS.%26aulast%3DTurner%26aufirst%3DJ.%2BD.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DWard%26aufirst%3DS.%2BA.%26atitle%3DShort-course%252C%2520high-dose%2520rifampicin%2520achieves%2520wolbachia%2520depletion%2520predictive%2520of%2520curative%2520outcomes%2520in%2520preclinical%2520models%2520of%2520lymphatic%2520filariasis%2520and%2520onchocerciasis%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D210%26doi%3D10.1038%2Fs41598-017-00322-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGarry, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerton, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span> <span> </span><span class="NLM_article-title">Population dynamics of Wolbachia bacterial endosymbionts in Brugia malayi</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/s0166-6851(04)00028-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fs0166-6851%2804%2900028-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=15287587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFalurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2004&pages=57-67&author=H.+McGarryauthor=G.+L.+Egertonauthor=M.+J.+Taylor&title=Population+dynamics+of+Wolbachia+bacterial+endosymbionts+in+Brugia+malayi&doi=10.1016%2Fs0166-6851%2804%2900028-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Population dynamics of Wolbachia bacterial endosymbionts in Brugia malayi</span></div><div class="casAuthors">McGarry, Helen F.; Egerton, Gillian L.; Taylor, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-67</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The human filarial nematode Brugia malayi contains an endosymbiotic bacterium, Wolbachia.  We used real-time quant. polymerase chain reaction (QPCR) and microscopy to investigate the population dynamics of the bacterium-nematode assocn.  Two Wolbachia (wsp and ftsZ) and one nematode (gst) genes were amplified from all life-cycle stages of B. malayi and results expressed as gene copies per worm and as Wolbachia/nematode ratios.  Since the genes were single copy and there was one genome per Wolbachia, the gene copy nos. were equiv. to the nos. of bacteria.  These were similar in microfilariae and the mosquito-borne larval stages (L2 and L3), with the lowest ratios of Wolbachia/nematode DNA.  However, within 7 days of infection of the mammalian host, bacteria had increased 600-fold and the bacteria/worm ratio was the highest of all life-cycle stages.  The rapid multiplication continued throughout L4 development, so that the major period of bacterial population growth occurred within 4 wk of infection of the definitive host.  Microscopy confirmed that there were few bacteria in mosquito-derived L3 but many, in large groups, in L4 collected 9 and 21 days after infection.  In adult male worms up to 15 mo of age, the bacterial populations were maintained, while in females, bacteria nos. increased as the worms matured and as the ovary and embryonic larval stages became infected.  These results support the hypothesis that the bacteria are essential for larval development in the mammalian host and for the long-term survival of adult worms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEXDmoBxaKO7Vg90H21EOLACvtfcHk0lgeKoR0BPm-vw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFalurs%253D&md5=d128f8033d8067a3ccb89d421f0d3ab7</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fs0166-6851%2804%2900028-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0166-6851%252804%252900028-3%26sid%3Dliteratum%253Aachs%26aulast%3DMcGarry%26aufirst%3DH.%26aulast%3DEgerton%26aufirst%3DG.%2BL.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26atitle%3DPopulation%2520dynamics%2520of%2520Wolbachia%2520bacterial%2520endosymbionts%2520in%2520Brugia%2520malayi%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2004%26volume%3D135%26spage%3D57%26epage%3D67%26doi%3D10.1016%2Fs0166-6851%2804%2900028-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 18 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Natalie A. Hawryluk</span>. </span><span class="cited-content_cbyCitation_article-title">Macrofilaricides: An Unmet Medical Need for Filarial Diseases. </span><span class="cited-content_cbyCitation_journal-name">ACS Infectious Diseases</span><span> <strong>2020,</strong> <em>6 </em>
                                    (4)
                                     , 662-671. <a href="https://doi.org/10.1021/acsinfecdis.9b00469" title="DOI URL">https://doi.org/10.1021/acsinfecdis.9b00469</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsinfecdis.9b00469&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsinfecdis.9b00469%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Infectious%2520Diseases%26atitle%3DMacrofilaricides%25253A%252BAn%252BUnmet%252BMedical%252BNeed%252Bfor%252BFilarial%252BDiseases%26aulast%3DHawryluk%26aufirst%3DNatalie%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D30112019%26date%3D05032020%26date%3D24022020%26volume%3D6%26issue%3D4%26spage%3D662%26epage%3D671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kelly L.  Johnston</span>, <span class="hlFld-ContribAuthor ">W. David  Hong</span>, <span class="hlFld-ContribAuthor ">Joseph D.  Turner</span>, <span class="hlFld-ContribAuthor ">Paul M.  O’Neill</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Ward</span>, <span class="hlFld-ContribAuthor ">Mark J.  Taylor</span>. </span><span class="cited-content_cbyCitation_article-title">Anti-Wolbachia drugs for filariasis. </span><span class="cited-content_cbyCitation_journal-name">Trends in Parasitology</span><span> <strong>2021,</strong> <em>13 </em><a href="https://doi.org/10.1016/j.pt.2021.06.004" title="DOI URL">https://doi.org/10.1016/j.pt.2021.06.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pt.2021.06.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pt.2021.06.004%26sid%3Dliteratum%253Aachs%26jtitle%3DTrends%2520in%2520Parasitology%26atitle%3DAnti-Wolbachia%252Bdrugs%252Bfor%252Bfilariasis%26aulast%3DJohnston%26aufirst%3DKelly%2BL.%26date%3D2021%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paolo Saul  Coghi</span>, <span class="hlFld-ContribAuthor ">Yinghuai  Zhu</span>, <span class="hlFld-ContribAuthor ">Hongming  Xie</span>, <span class="hlFld-ContribAuthor ">Narayan S.  Hosmane</span>, <span class="hlFld-ContribAuthor ">Yingjun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Organoboron Compounds: Effective Antibacterial and Antiparasitic Agents. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (11)
                                     , 3309. <a href="https://doi.org/10.3390/molecules26113309" title="DOI URL">https://doi.org/10.3390/molecules26113309</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26113309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26113309%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DOrganoboron%252BCompounds%25253A%252BEffective%252BAntibacterial%252Band%252BAntiparasitic%252BAgents%26aulast%3DCoghi%26aufirst%3DPaolo%2BSaul%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D11%26spage%3D3309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ivan S.  Golovanov</span>, <span class="hlFld-ContribAuthor ">Alexey Yu.  Sukhorukov</span>. </span><span class="cited-content_cbyCitation_article-title">Merging Boron with Nitrogen–Oxygen Bonds: A Review on BON Heterocycles. </span><span class="cited-content_cbyCitation_journal-name">Topics in Current Chemistry</span><span> <strong>2021,</strong> <em>379 </em>
                                    (2)
                                     <a href="https://doi.org/10.1007/s41061-020-00317-3" title="DOI URL">https://doi.org/10.1007/s41061-020-00317-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s41061-020-00317-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs41061-020-00317-3%26sid%3Dliteratum%253Aachs%26jtitle%3DTopics%2520in%2520Current%2520Chemistry%26atitle%3DMerging%252BBoron%252Bwith%252BNitrogen%2525E2%252580%252593Oxygen%252BBonds%25253A%252BA%252BReview%252Bon%252BBON%252BHeterocycles%26aulast%3DGolovanov%26aufirst%3DIvan%2BS.%26date%3D2021%26date%3D2021%26volume%3D379%26issue%3D2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frederic  Risch</span>, <span class="hlFld-ContribAuthor ">Manuel  Ritter</span>, <span class="hlFld-ContribAuthor ">Achim  Hoerauf</span>, <span class="hlFld-ContribAuthor ">Marc P.  Hübner</span>. </span><span class="cited-content_cbyCitation_article-title">Human filariasis—contributions of the Litomosoides sigmodontis and Acanthocheilonema viteae animal model. </span><span class="cited-content_cbyCitation_journal-name">Parasitology Research</span><span> <strong>2021,</strong> <em>82 </em><a href="https://doi.org/10.1007/s00436-020-07026-2" title="DOI URL">https://doi.org/10.1007/s00436-020-07026-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00436-020-07026-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00436-020-07026-2%26sid%3Dliteratum%253Aachs%26jtitle%3DParasitology%2520Research%26atitle%3DHuman%252Bfilariasis%2525E2%252580%252594contributions%252Bof%252Bthe%252BLitomosoides%252Bsigmodontis%252Band%252BAcanthocheilonema%252Bviteae%252Banimal%252Bmodel%26aulast%3DRisch%26aufirst%3DFrederic%26date%3D2021%26date%3D2021%26volume%3D82" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Schiefer</span>, <span class="hlFld-ContribAuthor ">Marc P.  Hübner</span>, <span class="hlFld-ContribAuthor ">Anna  Krome</span>, <span class="hlFld-ContribAuthor ">Christine  Lämmer</span>, <span class="hlFld-ContribAuthor ">Alexandra  Ehrens</span>, <span class="hlFld-ContribAuthor ">Tilman  Aden</span>, <span class="hlFld-ContribAuthor ">Marianne  Koschel</span>, <span class="hlFld-ContribAuthor ">Helene  Neufeld</span>, <span class="hlFld-ContribAuthor ">Lillibeth  Chaverra-Muñoz</span>, <span class="hlFld-ContribAuthor ">Rolf  Jansen</span>, <span class="hlFld-ContribAuthor ">Stefan  Kehraus</span>, <span class="hlFld-ContribAuthor ">Gabriele M.  König</span>, <span class="hlFld-ContribAuthor ">Domen  Pogorevc</span>, <span class="hlFld-ContribAuthor ">Rolf  Müller</span>, <span class="hlFld-ContribAuthor ">Marc  Stadler</span>, <span class="hlFld-ContribAuthor ">Stephan  Hüttel</span>, <span class="hlFld-ContribAuthor ">Thomas  Hesterkamp</span>, <span class="hlFld-ContribAuthor ">Karl  Wagner</span>, <span class="hlFld-ContribAuthor ">Kenneth  Pfarr</span>, <span class="hlFld-ContribAuthor ">Achim  Hoerauf</span>, . </span><span class="cited-content_cbyCitation_article-title">Corallopyronin A for short-course anti-wolbachial, macrofilaricidal treatment of filarial infections. </span><span class="cited-content_cbyCitation_journal-name">PLOS Neglected Tropical Diseases</span><span> <strong>2020,</strong> <em>14 </em>
                                    (12)
                                     , e0008930. <a href="https://doi.org/10.1371/journal.pntd.0008930" title="DOI URL">https://doi.org/10.1371/journal.pntd.0008930</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pntd.0008930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pntd.0008930%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Neglected%2520Tropical%2520Diseases%26atitle%3DCorallopyronin%252BA%252Bfor%252Bshort-course%252Banti-wolbachial%25252C%252Bmacrofilaricidal%252Btreatment%252Bof%252Bfilarial%252Binfections%26aulast%3DSchiefer%26aufirst%3DAndrea%26date%3D2020%26date%3D2020%26volume%3D14%26issue%3D12%26spage%3De0008930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthew  Chung</span>, <span class="hlFld-ContribAuthor ">Preston J  Basting</span>, <span class="hlFld-ContribAuthor ">Rayanna S  Patkus</span>, <span class="hlFld-ContribAuthor ">Alexandra  Grote</span>, <span class="hlFld-ContribAuthor ">Ashley N  Luck</span>, <span class="hlFld-ContribAuthor ">Elodie  Ghedin</span>, <span class="hlFld-ContribAuthor ">Barton E  Slatko</span>, <span class="hlFld-ContribAuthor ">Michelle  Michalski</span>, <span class="hlFld-ContribAuthor ">Jeremy M  Foster</span>, <span class="hlFld-ContribAuthor ">Casey M  Bergman</span>, <span class="hlFld-ContribAuthor ">Julie C Dunning  Hotopp</span>. </span><span class="cited-content_cbyCitation_article-title">A Meta-Analysis of
              Wolbachia
              Transcriptomics Reveals a Stage-Specific
              Wolbachia
              Transcriptional Response Shared Across Different Hosts. </span><span class="cited-content_cbyCitation_journal-name">G3 Genes|Genomes|Genetics</span><span> <strong>2020,</strong> <em>10 </em>
                                    (9)
                                     , 3243-3260. <a href="https://doi.org/10.1534/g3.120.401534" title="DOI URL">https://doi.org/10.1534/g3.120.401534</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1534/g3.120.401534&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1534%2Fg3.120.401534%26sid%3Dliteratum%253Aachs%26jtitle%3DG3%2520Genes%257CGenomes%257CGenetics%26atitle%3DA%252BMeta-Analysis%252Bof%252BWolbachia%252BTranscriptomics%252BReveals%252Ba%252BStage-Specific%252BWolbachia%252BTranscriptional%252BResponse%252BShared%252BAcross%252BDifferent%252BHosts%26aulast%3DChung%26aufirst%3DMatthew%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D9%26spage%3D3243%26epage%3D3260" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc P.  Hübner</span>, <span class="hlFld-ContribAuthor ">Coralie  Martin</span>, <span class="hlFld-ContribAuthor ">Sabine  Specht</span>, <span class="hlFld-ContribAuthor ">Marianne  Koschel</span>, <span class="hlFld-ContribAuthor ">Bettina  Dubben</span>, <span class="hlFld-ContribAuthor ">Stefan J.  Frohberger</span>, <span class="hlFld-ContribAuthor ">Alexandra  Ehrens</span>, <span class="hlFld-ContribAuthor ">Martina  Fendler</span>, <span class="hlFld-ContribAuthor ">Dominique  Struever</span>, <span class="hlFld-ContribAuthor ">Edward  Mitre</span>, <span class="hlFld-ContribAuthor ">Nathaly  Vallarino-Lhermitte</span>, <span class="hlFld-ContribAuthor ">Suzanne  Gokool</span>, <span class="hlFld-ContribAuthor ">Sara  Lustigman</span>, <span class="hlFld-ContribAuthor ">Manfred  Schneider</span>, <span class="hlFld-ContribAuthor ">Simon  Townson</span>, <span class="hlFld-ContribAuthor ">Achim  Hoerauf</span>, <span class="hlFld-ContribAuthor ">Ivan  Scandale</span>, . </span><span class="cited-content_cbyCitation_article-title">Oxfendazole mediates macrofilaricidal efficacy against the filarial nematode Litomosoides sigmodontis in vivo and inhibits Onchocerca spec. motility in vitro. </span><span class="cited-content_cbyCitation_journal-name">PLOS Neglected Tropical Diseases</span><span> <strong>2020,</strong> <em>14 </em>
                                    (7)
                                     , e0008427. <a href="https://doi.org/10.1371/journal.pntd.0008427" title="DOI URL">https://doi.org/10.1371/journal.pntd.0008427</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pntd.0008427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pntd.0008427%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Neglected%2520Tropical%2520Diseases%26atitle%3DOxfendazole%252Bmediates%252Bmacrofilaricidal%252Befficacy%252Bagainst%252Bthe%252Bfilarial%252Bnematode%252BLitomosoides%252Bsigmodontis%252Bin%252Bvivo%252Band%252Binhibits%252BOnchocerca%252Bspec.%252Bmotility%252Bin%252Bvitro%26aulast%3DH%25C3%25BCbner%26aufirst%3DMarc%2BP.%26date%3D2020%26date%3D2020%26volume%3D14%26issue%3D7%26spage%3De0008427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanqiong  Na</span>, <span class="hlFld-ContribAuthor ">Xiaofei  Hu</span>, <span class="hlFld-ContribAuthor ">Yaning  Sun</span>, <span class="hlFld-ContribAuthor ">Sharon  Kwee</span>, <span class="hlFld-ContribAuthor ">Guangxu  Xing</span>, <span class="hlFld-ContribAuthor ">Yunrui  Xing</span>, <span class="hlFld-ContribAuthor ">Gaiping  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">A highly sensitive monoclonal antibody−based paper sensor for simultaneously detecting valnemulin and tiamulin in porcine liver. </span><span class="cited-content_cbyCitation_journal-name">Journal of Food Science</span><span> <strong>2020,</strong> <em>85 </em>
                                    (6)
                                     , 1681-1688. <a href="https://doi.org/10.1111/1750-3841.15136" title="DOI URL">https://doi.org/10.1111/1750-3841.15136</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/1750-3841.15136&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2F1750-3841.15136%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Food%2520Science%26atitle%3DA%252Bhighly%252Bsensitive%252Bmonoclonal%252Bantibody%2525E2%252588%252592based%252Bpaper%252Bsensor%252Bfor%252Bsimultaneously%252Bdetecting%252Bvalnemulin%252Band%252Btiamulin%252Bin%252Bporcine%252Bliver%26aulast%3DNa%26aufirst%3DGuanqiong%26date%3D2020%26date%3D2020%26volume%3D85%26issue%3D6%26spage%3D1681%26epage%3D1688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc P.  Hübner</span>, <span class="hlFld-ContribAuthor ">Emma  Gunderson</span>, <span class="hlFld-ContribAuthor ">Ian  Vogel</span>, <span class="hlFld-ContribAuthor ">Christina A.  Bulman</span>, <span class="hlFld-ContribAuthor ">K.C.  Lim</span>, <span class="hlFld-ContribAuthor ">Marianne  Koschel</span>, <span class="hlFld-ContribAuthor ">Alexandra  Ehrens</span>, <span class="hlFld-ContribAuthor ">Stefan J.  Frohberger</span>, <span class="hlFld-ContribAuthor ">Martina  Fendler</span>, <span class="hlFld-ContribAuthor ">Nancy  Tricoche</span>, <span class="hlFld-ContribAuthor ">Denis  Voronin</span>, <span class="hlFld-ContribAuthor ">Andrew  Steven</span>, <span class="hlFld-ContribAuthor ">Victor  Chi</span>, <span class="hlFld-ContribAuthor ">Malina A.  Bakowski</span>, <span class="hlFld-ContribAuthor ">Ashley K.  Woods</span>, <span class="hlFld-ContribAuthor ">H. Michael  Petrassi</span>, <span class="hlFld-ContribAuthor ">Case W.  McNamara</span>, <span class="hlFld-ContribAuthor ">Brenda  Beerntsen</span>, <span class="hlFld-ContribAuthor ">Laura  Chappell</span>, <span class="hlFld-ContribAuthor ">William  Sullivan</span>, <span class="hlFld-ContribAuthor ">Mark J.  Taylor</span>, <span class="hlFld-ContribAuthor ">Joseph D.  Turner</span>, <span class="hlFld-ContribAuthor ">Achim  Hoerauf</span>, <span class="hlFld-ContribAuthor ">Sara  Lustigman</span>, <span class="hlFld-ContribAuthor ">Judy A.  Sakanari</span>. </span><span class="cited-content_cbyCitation_article-title">Short-course quinazoline drug treatments are effective in the Litomosoides sigmodontis and Brugia pahangi jird models. </span><span class="cited-content_cbyCitation_journal-name">International Journal for Parasitology: Drugs and Drug Resistance</span><span> <strong>2020,</strong> <em>12 </em>, 18-27. <a href="https://doi.org/10.1016/j.ijpddr.2019.12.001" title="DOI URL">https://doi.org/10.1016/j.ijpddr.2019.12.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpddr.2019.12.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpddr.2019.12.001%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520for%2520Parasitology%253A%2520Drugs%2520and%2520Drug%2520Resistance%26atitle%3DShort-course%252Bquinazoline%252Bdrug%252Btreatments%252Bare%252Beffective%252Bin%252Bthe%252BLitomosoides%252Bsigmodontis%252Band%252BBrugia%252Bpahangi%252Bjird%252Bmodels%26aulast%3DH%25C3%25BCbner%26aufirst%3DMarc%2BP.%26date%3D2020%26volume%3D12%26spage%3D18%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph D.  Turner</span>, <span class="hlFld-ContribAuthor ">Amy E.  Marriott</span>, <span class="hlFld-ContribAuthor ">David  Hong</span>, <span class="hlFld-ContribAuthor ">Paul  O’ Neill</span>, <span class="hlFld-ContribAuthor ">Steve A.  Ward</span>, <span class="hlFld-ContribAuthor ">Mark J.  Taylor</span>. </span><span class="cited-content_cbyCitation_article-title">Novel anti-Wolbachia drugs, a new approach in the treatment and prevention of veterinary filariasis?. </span><span class="cited-content_cbyCitation_journal-name">Veterinary Parasitology</span><span> <strong>2020,</strong> <em>279 </em>, 109057. <a href="https://doi.org/10.1016/j.vetpar.2020.109057" title="DOI URL">https://doi.org/10.1016/j.vetpar.2020.109057</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.vetpar.2020.109057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.vetpar.2020.109057%26sid%3Dliteratum%253Aachs%26jtitle%3DVeterinary%2520Parasitology%26atitle%3DNovel%252Banti-Wolbachia%252Bdrugs%25252C%252Ba%252Bnew%252Bapproach%252Bin%252Bthe%252Btreatment%252Band%252Bprevention%252Bof%252Bveterinary%252Bfilariasis%25253F%26aulast%3DTurner%26aufirst%3DJoseph%2BD.%26date%3D2020%26volume%3D279%26spage%3D109057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandra  Ehrens</span>, <span class="hlFld-ContribAuthor ">Christopher S.  Lunde</span>, <span class="hlFld-ContribAuthor ">Robert T.  Jacobs</span>, <span class="hlFld-ContribAuthor ">Dominique  Struever</span>, <span class="hlFld-ContribAuthor ">Marianne  Koschel</span>, <span class="hlFld-ContribAuthor ">Stefan J.  Frohberger</span>, <span class="hlFld-ContribAuthor ">Franziska  Lenz</span>, <span class="hlFld-ContribAuthor ">Martina  Fendler</span>, <span class="hlFld-ContribAuthor ">Joseph D.  Turner</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Ward</span>, <span class="hlFld-ContribAuthor ">Mark J.  Taylor</span>, <span class="hlFld-ContribAuthor ">Yvonne R.  Freund</span>, <span class="hlFld-ContribAuthor ">Rianna  Stefanakis</span>, <span class="hlFld-ContribAuthor ">Eric  Easom</span>, <span class="hlFld-ContribAuthor ">Xianfeng  Li</span>, <span class="hlFld-ContribAuthor ">Jacob J.  Plattner</span>, <span class="hlFld-ContribAuthor ">Achim  Hoerauf</span>, <span class="hlFld-ContribAuthor ">Marc P.  Hübner</span>, . </span><span class="cited-content_cbyCitation_article-title">In vivo efficacy of the boron-pleuromutilin AN11251 against Wolbachia of the rodent filarial nematode Litomosoides sigmodontis. </span><span class="cited-content_cbyCitation_journal-name">PLOS Neglected Tropical Diseases</span><span> <strong>2020,</strong> <em>14 </em>
                                    (1)
                                     , e0007957. <a href="https://doi.org/10.1371/journal.pntd.0007957" title="DOI URL">https://doi.org/10.1371/journal.pntd.0007957</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pntd.0007957&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pntd.0007957%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Neglected%2520Tropical%2520Diseases%26atitle%3DIn%252Bvivo%252Befficacy%252Bof%252Bthe%252Bboron-pleuromutilin%252BAN11251%252Bagainst%252BWolbachia%252Bof%252Bthe%252Brodent%252Bfilarial%252Bnematode%252BLitomosoides%252Bsigmodontis%26aulast%3DEhrens%26aufirst%3DAlexandra%26date%3D2020%26date%3D2020%26volume%3D14%26issue%3D1%26spage%3De0007957" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Ren</span>, <span class="hlFld-ContribAuthor ">Wei  Shi</span>, <span class="hlFld-ContribAuthor ">Damin  Zhao</span>, <span class="hlFld-ContribAuthor ">Qinglin  Wang</span>, <span class="hlFld-ContribAuthor ">Xiayun  Chang</span>, <span class="hlFld-ContribAuthor ">Xiangyi  He</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Wang</span>, <span class="hlFld-ContribAuthor ">Yong  Gao</span>, <span class="hlFld-ContribAuthor ">Peng  Lu</span>, <span class="hlFld-ContribAuthor ">Xiquan  Zhang</span>, <span class="hlFld-ContribAuthor ">Hongjiang  Xu</span>, <span class="hlFld-ContribAuthor ">Yinsheng  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of boron-containing diphenylpyrimidines as potent BTK and JAK3 dual inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (2)
                                     , 115236. <a href="https://doi.org/10.1016/j.bmc.2019.115236" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.115236</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.115236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.115236%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252Bboron-containing%252Bdiphenylpyrimidines%252Bas%252Bpotent%252BBTK%252Band%252BJAK3%252Bdual%252Binhibitors%26aulast%3DRen%26aufirst%3DJing%26date%3D2020%26volume%3D28%26issue%3D2%26spage%3D115236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emilie  Lefoulon</span>, <span class="hlFld-ContribAuthor ">Jeremy M.  Foster</span>, <span class="hlFld-ContribAuthor ">Alex  Truchon</span>, <span class="hlFld-ContribAuthor ">C. K. S.  Carlow</span>, <span class="hlFld-ContribAuthor ">Barton E.  Slatko</span>. </span><span class="cited-content_cbyCitation_article-title">The Wolbachia Symbiont: Here, There and Everywhere. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 423-451. <a href="https://doi.org/10.1007/978-3-030-51849-3_16" title="DOI URL">https://doi.org/10.1007/978-3-030-51849-3_16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-030-51849-3_16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-030-51849-3_16%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BWolbachia%252BSymbiont%25253A%252BHere%25252C%252BThere%252Band%252BEverywhere%26aulast%3DLefoulon%26aufirst%3DEmilie%26date%3D2020%26date%3D2020%26spage%3D423%26epage%3D451%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSymbiosis%25253A%252BCellular%25252C%252BMolecular%25252C%252BMedical%252Band%252BEvolutionary%252BAspects%26aulast%3DKloc%26aufirst%3DMalgorzata%26date%3D2020%26volume%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guilherme Felipe Santos  Fernandes</span>, <span class="hlFld-ContribAuthor ">William Alexander  Denny</span>, <span class="hlFld-ContribAuthor ">Jean Leandro  Dos Santos</span>. </span><span class="cited-content_cbyCitation_article-title">Boron in drug design: Recent advances in the development of new therapeutic agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>179 </em>, 791-804. <a href="https://doi.org/10.1016/j.ejmech.2019.06.092" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.06.092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.06.092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.06.092%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBoron%252Bin%252Bdrug%252Bdesign%25253A%252BRecent%252Badvances%252Bin%252Bthe%252Bdevelopment%252Bof%252Bnew%252Btherapeutic%252Bagents%26aulast%3DFernandes%26aufirst%3DGuilherme%2BFelipe%2BSantos%26date%3D2019%26volume%3D179%26spage%3D791%26epage%3D804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malina A.  Bakowski</span>, <span class="hlFld-ContribAuthor ">Case W.  McNamara</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Antiwolbachial Drug Discovery for Treatment of Parasitic Filarial Worm Infections. </span><span class="cited-content_cbyCitation_journal-name">Tropical Medicine and Infectious Disease</span><span> <strong>2019,</strong> <em>4 </em>
                                    (3)
                                     , 108. <a href="https://doi.org/10.3390/tropicalmed4030108" title="DOI URL">https://doi.org/10.3390/tropicalmed4030108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/tropicalmed4030108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Ftropicalmed4030108%26sid%3Dliteratum%253Aachs%26jtitle%3DTropical%2520Medicine%2520and%2520Infectious%2520Disease%26atitle%3DAdvances%252Bin%252BAntiwolbachial%252BDrug%252BDiscovery%252Bfor%252BTreatment%252Bof%252BParasitic%252BFilarial%252BWorm%252BInfections%26aulast%3DBakowski%26aufirst%3DMalina%2BA.%26date%3D2019%26date%3D2019%26volume%3D4%26issue%3D3%26spage%3D108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marc P.  Hübner</span>, <span class="hlFld-ContribAuthor ">Marianne  Koschel</span>, <span class="hlFld-ContribAuthor ">Dominique  Struever</span>, <span class="hlFld-ContribAuthor ">Venelin  Nikolov</span>, <span class="hlFld-ContribAuthor ">Stefan J.  Frohberger</span>, <span class="hlFld-ContribAuthor ">Alexandra  Ehrens</span>, <span class="hlFld-ContribAuthor ">Martina  Fendler</span>, <span class="hlFld-ContribAuthor ">Iliana  Johannes</span>, <span class="hlFld-ContribAuthor ">Thomas W.  von Geldern</span>, <span class="hlFld-ContribAuthor ">Kennan  Marsh</span>, <span class="hlFld-ContribAuthor ">Joseph D.  Turner</span>, <span class="hlFld-ContribAuthor ">Mark J.  Taylor</span>, <span class="hlFld-ContribAuthor ">Stephen A.  Ward</span>, <span class="hlFld-ContribAuthor ">Kenneth  Pfarr</span>, <span class="hlFld-ContribAuthor ">Dale J.  Kempf</span>, <span class="hlFld-ContribAuthor ">Achim  Hoerauf</span>, . </span><span class="cited-content_cbyCitation_article-title">In vivo kinetics of Wolbachia depletion by ABBV-4083 in L. sigmodontis adult worms and microfilariae. </span><span class="cited-content_cbyCitation_journal-name">PLOS Neglected Tropical Diseases</span><span> <strong>2019,</strong> <em>13 </em>
                                    (8)
                                     , e0007636. <a href="https://doi.org/10.1371/journal.pntd.0007636" title="DOI URL">https://doi.org/10.1371/journal.pntd.0007636</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pntd.0007636&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pntd.0007636%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Neglected%2520Tropical%2520Diseases%26atitle%3DIn%252Bvivo%252Bkinetics%252Bof%252BWolbachia%252Bdepletion%252Bby%252BABBV-4083%252Bin%252BL.%252Bsigmodontis%252Badult%252Bworms%252Band%252Bmicrofilariae%26aulast%3DH%25C3%25BCbner%26aufirst%3DMarc%2BP.%26date%3D2019%26date%3D2019%26volume%3D13%26issue%3D8%26spage%3De0007636" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Malina A.  Bakowski</span>, <span class="hlFld-ContribAuthor ">Roohollah Kazem  Shiroodi</span>, <span class="hlFld-ContribAuthor ">Renhe  Liu</span>, <span class="hlFld-ContribAuthor ">Jason  Olejniczak</span>, <span class="hlFld-ContribAuthor ">Baiyuan  Yang</span>, <span class="hlFld-ContribAuthor ">Kerstin  Gagaring</span>, <span class="hlFld-ContribAuthor ">Hui  Guo</span>, <span class="hlFld-ContribAuthor ">Pamela M.  White</span>, <span class="hlFld-ContribAuthor ">Laura  Chappell</span>, <span class="hlFld-ContribAuthor ">Alain  Debec</span>, <span class="hlFld-ContribAuthor ">Frédéric  Landmann</span>, <span class="hlFld-ContribAuthor ">Bettina  Dubben</span>, <span class="hlFld-ContribAuthor ">Franziska  Lenz</span>, <span class="hlFld-ContribAuthor ">Dominique  Struever</span>, <span class="hlFld-ContribAuthor ">Alexandra  Ehrens</span>, <span class="hlFld-ContribAuthor ">Stefan J.  Frohberger</span>, <span class="hlFld-ContribAuthor ">Hanna  Sjoberg</span>, <span class="hlFld-ContribAuthor ">Nicolas  Pionnier</span>, <span class="hlFld-ContribAuthor ">Emma  Murphy</span>, <span class="hlFld-ContribAuthor ">John  Archer</span>, <span class="hlFld-ContribAuthor ">Andrew  Steven</span>, <span class="hlFld-ContribAuthor ">Valerine C.  Chunda</span>, <span class="hlFld-ContribAuthor ">Fanny F.  Fombad</span>, <span class="hlFld-ContribAuthor ">Patrick W.  Chounna</span>, <span class="hlFld-ContribAuthor ">Abdel J.  Njouendou</span>, <span class="hlFld-ContribAuthor ">Haelly M.  Metuge</span>, <span class="hlFld-ContribAuthor ">Bertrand L.  Ndzeshang</span>, <span class="hlFld-ContribAuthor ">Narcisse V.  Gandjui</span>, <span class="hlFld-ContribAuthor ">Desmond N.  Akumtoh</span>, <span class="hlFld-ContribAuthor ">Tayong D. B.  Kwenti</span>, <span class="hlFld-ContribAuthor ">Ashley K.  Woods</span>, <span class="hlFld-ContribAuthor ">Sean B.  Joseph</span>, <span class="hlFld-ContribAuthor ">Mitchell V.  Hull</span>, <span class="hlFld-ContribAuthor ">Wen  Xiong</span>, <span class="hlFld-ContribAuthor ">Kelli L.  Kuhen</span>, <span class="hlFld-ContribAuthor ">Mark J.  Taylor</span>, <span class="hlFld-ContribAuthor ">Samuel  Wanji</span>, <span class="hlFld-ContribAuthor ">Joseph D.  Turner</span>, <span class="hlFld-ContribAuthor ">Marc P.  Hübner</span>, <span class="hlFld-ContribAuthor ">Achim  Hoerauf</span>, <span class="hlFld-ContribAuthor ">Arnab K.  Chatterjee</span>, <span class="hlFld-ContribAuthor ">Jason  Roland</span>, <span class="hlFld-ContribAuthor ">Matt S.  Tremblay</span>, <span class="hlFld-ContribAuthor ">Peter G.  Schultz</span>, <span class="hlFld-ContribAuthor ">William  Sullivan</span>, <span class="hlFld-ContribAuthor ">Xin-Jie  Chu</span>, <span class="hlFld-ContribAuthor ">H. Michael  Petrassi</span>, <span class="hlFld-ContribAuthor ">Case W.  McNamara</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of short-course antiwolbachial quinazolines for elimination of filarial worm infections. </span><span class="cited-content_cbyCitation_journal-name">Science Translational Medicine</span><span> <strong>2019,</strong> <em>11 </em>
                                    (491)
                                     , eaav3523. <a href="https://doi.org/10.1126/scitranslmed.aav3523" title="DOI URL">https://doi.org/10.1126/scitranslmed.aav3523</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scitranslmed.aav3523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscitranslmed.aav3523%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Translational%2520Medicine%26atitle%3DDiscovery%252Bof%252Bshort-course%252Bantiwolbachial%252Bquinazolines%252Bfor%252Belimination%252Bof%252Bfilarial%252Bworm%252Binfections%26aulast%3DBakowski%26aufirst%3DMalina%2BA.%26date%3D2019%26date%3D2019%26volume%3D11%26issue%3D491%26spage%3Deaav3523" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01854&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Pleuromutilin and clinically relevant derivatives.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01854&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Route to C(14)-Modified Boronpleuromutilins</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01854&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Route to C(12)-Modified Boronpleuromutilins</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01854&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Route to C(14) Boronpleuromutilin Carbamates</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01854&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/medium/jm-2018-018544_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of 7-Fluoro-6-hydroxybenzoxaborole</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-5/acs.jmedchem.8b01854/20190308/images/large/jm-2018-018544_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01854&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i107">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_16726" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_16726" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 54 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simonsen, P. E. F.</span>; <span class="NLM_string-name">Fischer, P. U.</span>; <span class="NLM_string-name">Hoerauf, A.</span>; <span class="NLM_string-name">Weil, G.
J.</span></span> <span> </span><span class="NLM_article-title">The Filariases</span>. In  <i>Manson’s Tropical Diseases</i>, <span class="NLM_edition">23</span>rd ed.; <span class="NLM_contrib-group"><span class="NLM_string-name">Farrar, J. H.</span>, <span class="NLM_string-name">Junghanss, T.</span>, <span class="NLM_string-name">Kang, G.</span>, <span class="NLM_string-name">Lalloo, D.</span>, <span class="NLM_string-name">White, N. J.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier Saunders</span>: <span class="NLM_publisher-loc">Amsterdam</span>, <span class="NLM_year">2014</span>; pp  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">765</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2FB978-0-7020-5101-2.00055-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=737-765&author=P.+E.+F.+Simonsen&author=P.+U.+Fischer&author=A.+Hoerauf&author=G.%0AJ.+Weilauthor=J.+H.+Farrar&author=T.+Junghanss&author=G.+Kang&author=D.+Lalloo&author=N.+J.+White&title=Manson%E2%80%99s+Tropical+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2FB978-0-7020-5101-2.00055-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-7020-5101-2.00055-8%26sid%3Dliteratum%253Aachs%26aulast%3DSimonsen%26aufirst%3DP.%2BE.%2BF.%26atitle%3DThe%2520Filariases%26btitle%3DManson%25E2%2580%2599s%2520Tropical%2520Diseases%26aulast%3DFarrar%26aufirst%3DJ.%2BH.%26pub%3DElsevier%2520Saunders%26date%3D2014%26spage%3D737%26epage%3D765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bockarie, M.</span></span> <span> </span><span class="NLM_article-title">Lymphatic filariasis and onchocerciasis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>376</i></span>,  <span class="NLM_fpage">1175</span>– <span class="NLM_lpage">1185</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(10)60586-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fs0140-6736%2810%2960586-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=20739055" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A280%3ADC%252BC3cfmsFOltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=376&publication_year=2010&pages=1175-1185&author=M.+J.+Taylorauthor=A.+Hoeraufauthor=M.+Bockarie&title=Lymphatic+filariasis+and+onchocerciasis&doi=10.1016%2Fs0140-6736%2810%2960586-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Lymphatic filariasis and onchocerciasis</span></div><div class="casAuthors">Taylor Mark J; Hoerauf Achim; Bockarie Moses</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">376</span>
        (<span class="NLM_cas:issue">9747</span>),
    <span class="NLM_cas:pages">1175-85</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lymphatic filariasis and onchocerciasis are parasitic helminth diseases that constitute a serious public health issue in tropical regions.  The filarial nematodes that cause these diseases are transmitted by blood-feeding insects and produce chronic and long-term infection through suppression of host immunity.  Disease pathogenesis is linked to host inflammation invoked by the death of the parasite, causing hydrocoele, lymphoedema, and elephantiasis in lymphatic filariasis, and skin disease and blindness in onchocerciasis.  Most filarial species that infect people co-exist in mutualistic symbiosis with Wolbachia bacteria, which are essential for growth, development, and survival of their nematode hosts.  These endosymbionts contribute to inflammatory disease pathogenesis and are a target for doxycycline therapy, which delivers macrofilaricidal activity, improves pathological outcomes, and is effective as monotherapy.  Drugs to treat filariasis include diethylcarbamazine, ivermectin, and albendazole, which are used mostly in combination to reduce microfilariae in blood (lymphatic filariasis) and skin (onchocerciasis).  Global programmes for control and elimination have been developed to provide sustained delivery of drugs to affected communities to interrupt transmission of disease and ultimately eliminate this burden on public health.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSmTWInjypR6b9KldV63DuefW6udTcc2eZBICabYgH6u7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cfmsFOltA%253D%253D&md5=44dd7936d02ca073197617d540f295ed</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2810%2960586-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252810%252960586-7%26sid%3Dliteratum%253Aachs%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DBockarie%26aufirst%3DM.%26atitle%3DLymphatic%2520filariasis%2520and%2520onchocerciasis%26jtitle%3DLancet%26date%3D2010%26volume%3D376%26spage%3D1175%26epage%3D1185%26doi%3D10.1016%2Fs0140-6736%2810%2960586-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ramaiah, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottesen, E. A.</span></span> <span> </span><span class="NLM_article-title">Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e3319</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0003319</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1371%2Fjournal.pntd.0003319" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2014&pages=e3319&author=K.+D.+Ramaiahauthor=E.+A.+Ottesen&title=Progress+and+impact+of+13+years+of+the+global+programme+to+eliminate+lymphatic+filariasis+on+reducing+the+burden+of+filarial+disease&doi=10.1371%2Fjournal.pntd.0003319"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0003319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0003319%26sid%3Dliteratum%253Aachs%26aulast%3DRamaiah%26aufirst%3DK.%2BD.%26aulast%3DOttesen%26aufirst%3DE.%2BA.%26atitle%3DProgress%2520and%2520impact%2520of%252013%2520years%2520of%2520the%2520global%2520programme%2520to%2520eliminate%2520lymphatic%2520filariasis%2520on%2520reducing%2520the%2520burden%2520of%2520filarial%2520disease%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2014%26volume%3D8%26spage%3De3319%26doi%3D10.1371%2Fjournal.pntd.0003319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Katiyar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, L. K.</span></span> <span> </span><span class="NLM_article-title">Filariasis: Current status, treatment and recent advances in drug development</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2174</span>– <span class="NLM_lpage">2185</span>, <span class="refDoi"> DOI: 10.2174/092986711795656234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.2174%2F092986711795656234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=21521163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmvFegs7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=2174-2185&author=D.+Katiyarauthor=L.+K.+Singh&title=Filariasis%3A+Current+status%2C+treatment+and+recent+advances+in+drug+development&doi=10.2174%2F092986711795656234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Filariasis: current status, treatment and recent advances in drug development</span></div><div class="casAuthors">Katiyar, D.; Singh, L. K.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2174-2185</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Lymphatic filariasis, onchocerciasis and loiasis caused by human filarial nematodes are diseases of tropical and subtropical countries causing considerable morbidity.  The available control strategies have significant limitations such that current drugs are ineffective against macrofilariae (adult worms), require repeated and prolonged treatment over years and are threatened by emergence of drug resistance.  Due to this concern, these diseases are the focus of renewed scientific interest and much has been done in filariasis research in the past decade.  This review summarizes the current status of filariasis, different control strategies, recent advances in antifilarial chemotherapy including currently used drugs, their pros and cons, their mechanism of action, and recently discovered targets and prototypes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogceQjWSj2YrVg90H21EOLACvtfcHk0lh2JixTKvRIOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmvFegs7c%253D&md5=f745cd6c9ed0bb6eff8b2a2d36be5adc</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2174%2F092986711795656234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711795656234%26sid%3Dliteratum%253Aachs%26aulast%3DKatiyar%26aufirst%3DD.%26aulast%3DSingh%26aufirst%3DL.%2BK.%26atitle%3DFilariasis%253A%2520Current%2520status%252C%2520treatment%2520and%2520recent%2520advances%2520in%2520drug%2520development%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D2174%26epage%3D2185%26doi%3D10.2174%2F092986711795656234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geary, T.</span></span> <span> </span><span class="NLM_article-title">Ivermectin 20 years on: maturation of a wonder drug</span>. <i>Trends Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">530</span>– <span class="NLM_lpage">532</span>, <span class="refDoi"> DOI: 10.1016/j.pt.2005.08.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fj.pt.2005.08.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=16126457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFeiu7vE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2005&pages=530-532&author=T.+Geary&title=Ivermectin+20+years+on%3A+maturation+of+a+wonder+drug&doi=10.1016%2Fj.pt.2005.08.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Ivermectin 20 years on: maturation of a wonder drug</span></div><div class="casAuthors">Geary, Timothy G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Parasitology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">530-532</span>CODEN:
                <span class="NLM_cas:coden">TPRACT</span>;
        ISSN:<span class="NLM_cas:issn">1471-4922</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Ivermectin has been on the veterinary market for almost a quarter of a century and has been approved for human use for 18 years.  Its use has revolutionized the treatment of nematode and arthropod parasites in animals and has provided hope for the control or even eradication of filariases in humans.  Although much remains to be learned about how the drug works and how resistance to it will develop, it has earned the title of 'wonder drug'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojSYF8c9NaXrVg90H21EOLACvtfcHk0lh2JixTKvRIOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFeiu7vE&md5=1cdddc83be460a7f18b5c6ede8783c4b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.pt.2005.08.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pt.2005.08.014%26sid%3Dliteratum%253Aachs%26aulast%3DGeary%26aufirst%3DT.%26atitle%3DIvermectin%252020%2520years%2520on%253A%2520maturation%2520of%2520a%2520wonder%2520drug%26jtitle%3DTrends%2520Parasitol.%26date%3D2005%26volume%3D21%26spage%3D530%26epage%3D532%26doi%3D10.1016%2Fj.pt.2005.08.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">King, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suamani, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanuku, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Satofan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancuso, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goss, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robinson, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siba, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weil, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazura, J. W.</span></span> <span> </span><span class="NLM_article-title">A trial of a triple-drug treatment for lymphatic filariasis</span>. <i>New Engl. J. Med.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>379</i></span>,  <span class="NLM_fpage">1801</span>– <span class="NLM_lpage">1810</span>, <span class="refDoi"> DOI: 10.1056/nejmoa1706854</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1056%2Fnejmoa1706854" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=30403937" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Gktb3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=379&publication_year=2018&pages=1801-1810&author=C.+L.+Kingauthor=J.+Suamaniauthor=N.+Sanukuauthor=Y.-C.+Chengauthor=S.+Satofanauthor=B.+Mancusoauthor=C.+W.+Gossauthor=L.+J.+Robinsonauthor=P.+M.+Sibaauthor=G.+J.+Weilauthor=J.+W.+Kazura&title=A+trial+of+a+triple-drug+treatment+for+lymphatic+filariasis&doi=10.1056%2Fnejmoa1706854"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">A trial of a triple-drug treatment for lymphatic filariasis</span></div><div class="casAuthors">King, Christopher L.; Suamani, James; Sanuku, Nelly; Cheng, Yao-Chieh; Satofan, Samson; Mancuso, Brooke; Goss, Charles W.; Robinson, Leanne J.; Siba, Peter M.; Weil, Gary J.; Kazura, James W.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">379</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">1801-1810</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">1533-4406</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">BACKGROUND The World Health Organization has targeted lymphatic filariasis for global elimination by 2020 with a strategy of mass drug administration.  This trial tested whether a single dose of a three-drug regimen of ivermectin plus diethylcarbamazine plus albendazole results in a greater sustained clearance of microfilariae than a single dose of a two-drug regimen of diethylcarbamazine plus albendazole and is noninferior to the two-drug regimen administered once a year for 3 years.  METHODS In a randomized, controlled trial involving adults from Papua New Guinea with Wuchereria bancrofti microfilaremia, we assigned 182 participants to receive a single dose of the three-drug regimen (60 participants), a single dose of the two-drug regimen (61 participants), or the two-drug regimen once a year for 3 years (61 participants).  Clearance of microfilariae from the blood was measured at 12, 24, and 36 mo after trial initiation.  RESULTS The three-drug regimen cleared microfilaremia in 55 of 57 participants (96%) at 12 mo, in 52 of 54 participants (96%) at 24 mo, and in 55 of 57 participants (96%) at 36 mo.  A single dose of the two-drug regimen cleared microfilaremia in 18 of 56 participants (32%) at 12 mo, in 31 of 55 participants (56%) at 24 mo, and in 43 of 52 participants (83%) at 36 mo (P = 0.02 for the three-drug regimen vs. a single dose of the two-drug regimen at 36 mo).  The two-drug regimen administered once a year for 3 years cleared microfilaremia in 20 of 59 participants (34%) at 12 mo, in 42 of 56 participants (75%) at 24 mo, and in 51 of 52 participants (98%) at 36 mo (P = 0.004 for noninferiority of the three-drug regimen vs. the two-drug regimen administered once a year for 3 years at 36 mo).  Moderate adverse events were more common in the group that received the three-drug regimen than in the combined two-drug-regimen groups (27% vs. 5%, P<0.001).  There were no serious adverse events.  CONCLUSIONS The three-drug regimen induced clearance of microfilariae from the blood for 3 years in almost all participants who received the treatment and was superior to the two-drug regimen administered once and noninferior to the two-drug regimen administered once a year for 3 years. (Funded by the Bill and Melinda Gates Foundation; ClinicalTrials.gov no., NCT01975441.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoY6AcjxP4Fp7Vg90H21EOLACvtfcHk0ljsVFuszISjbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Gktb3I&md5=214d933b84da2a47562e3358531f0fec</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1056%2Fnejmoa1706854&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252Fnejmoa1706854%26sid%3Dliteratum%253Aachs%26aulast%3DKing%26aufirst%3DC.%2BL.%26aulast%3DSuamani%26aufirst%3DJ.%26aulast%3DSanuku%26aufirst%3DN.%26aulast%3DCheng%26aufirst%3DY.-C.%26aulast%3DSatofan%26aufirst%3DS.%26aulast%3DMancuso%26aufirst%3DB.%26aulast%3DGoss%26aufirst%3DC.%2BW.%26aulast%3DRobinson%26aufirst%3DL.%2BJ.%26aulast%3DSiba%26aufirst%3DP.%2BM.%26aulast%3DWeil%26aufirst%3DG.%2BJ.%26aulast%3DKazura%26aufirst%3DJ.%2BW.%26atitle%3DA%2520trial%2520of%2520a%2520triple-drug%2520treatment%2520for%2520lymphatic%2520filariasis%26jtitle%3DNew%2520Engl.%2520J.%2520Med.%26date%3D2018%26volume%3D379%26spage%3D1801%26epage%3D1810%26doi%3D10.1056%2Fnejmoa1706854" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slatko, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foster, J. M.</span></span> <span> </span><span class="NLM_article-title">The Wolbachia endosymbiont as an anti-filarial nematode target</span>. <i>Symbiosis</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">65</span>, <span class="refDoi"> DOI: 10.1007/s13199-010-0067-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1007%2Fs13199-010-0067-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=20730111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A280%3ADC%252BC2sbos1OrsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=55-65&author=B.+E.+Slatkoauthor=M.+J.+Taylorauthor=J.+M.+Foster&title=The+Wolbachia+endosymbiont+as+an+anti-filarial+nematode+target&doi=10.1007%2Fs13199-010-0067-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The Wolbachia endosymbiont as an anti-filarial nematode target</span></div><div class="casAuthors">Slatko Barton E; Taylor Mark J; Foster Jeremy M</div><div class="citationInfo"><span class="NLM_cas:title">Symbiosis (Philadelphia, Pa.)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-65</span>
        ISSN:<span class="NLM_cas:issn">0334-5114</span>.
    </div><div class="casAbstract">Human disease caused by parasitic filarial nematodes is a major cause of global morbidity.  The parasites are transmitted by arthropod intermediate hosts and are responsible for lymphatic filariasis (elephantiasis) or onchocerciasis (river blindness).  Within these filarial parasites are intracellular alpha-proteobacteria, Wolbachia, that were first observed almost 30 years ago.  The obligate endosymbiont has been recognized as a target for anti-filarial nematode chemotherapy as evidenced by the loss of worm fertility and viability upon antibiotic treatment in an extensive series of human trials.  While current treatments with doxycycline and rifampicin are not practical for widespread use due to the length of required treatments and contraindications, anti-Wolbachia targeting nevertheless appears a promising alternative for filariasis control in situations where current programmatic strategies fail or are unable to be delivered and it provides a superior efficacy for individual therapy.  The mechanisms that underlie the symbiotic relationship between Wolbachia and its nematode hosts remain elusive.  Comparative genomics, bioinfomatic and experimental analyses have identified a number of potential interactions, which may be drug targets.  One candidate is de novo heme biosynthesis, due to its absence in the genome sequence of the host nematode, Brugia malayi, but presence in Wolbachia and its potential roles in worm biology.  We describe this and several additional candidate targets, as well as our approaches for understanding the nature of the host-symbiont relationship.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSIXJeADOTvyHthwrmtH4OBfW6udTcc2ebry7WuKidlJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2sbos1OrsQ%253D%253D&md5=0e8be5a2bb0819139ea34b8693282248</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1007%2Fs13199-010-0067-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13199-010-0067-1%26sid%3Dliteratum%253Aachs%26aulast%3DSlatko%26aufirst%3DB.%2BE.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DFoster%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520Wolbachia%2520endosymbiont%2520as%2520an%2520anti-filarial%2520nematode%2520target%26jtitle%3DSymbiosis%26date%3D2010%26volume%3D51%26spage%3D55%26epage%3D65%26doi%3D10.1007%2Fs13199-010-0067-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Volkmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Büttner, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfo-Debrekyei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adjei, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Büttner, D. W.</span></span> <span> </span><span class="NLM_article-title">Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms</span>. <i>Microbes Infect.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1016/s1286-4579(03)00026-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fs1286-4579%2803%2900026-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=12706439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD3sXivFGitb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2003&pages=261-273&author=A.+Hoeraufauthor=S.+Mandauthor=L.+Volkmannauthor=M.+B%C3%BCttnerauthor=Y.+Marfo-Debrekyeiauthor=M.+Taylorauthor=O.+Adjeiauthor=D.+W.+B%C3%BCttner&title=Doxycycline+in+the+treatment+of+human+onchocerciasis%3A+Kinetics+of+Wolbachia+endobacteria+reduction+and+of+inhibition+of+embryogenesis+in+female+Onchocerca+worms&doi=10.1016%2Fs1286-4579%2803%2900026-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Doxycycline in the treatment of human onchocerciasis: kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms</span></div><div class="casAuthors">Hoerauf, Achim; Mand, Sabine; Volkmann, Lars; Buttner, Marcelle; Marfo-Debrekyei, Yeboah; Taylor, Mark; Adjei, Ohene; Buttner, Dietrich W.</div><div class="citationInfo"><span class="NLM_cas:title">Microbes and Infection</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">261-273</span>CODEN:
                <span class="NLM_cas:coden">MCINFS</span>;
        ISSN:<span class="NLM_cas:issn">1286-4579</span>.
    
            (<span class="NLM_cas:orgname">Editions Scientifiques et Medicales Elsevier</span>)
        </div><div class="casAbstract">Recently, experts have warned that mass treatment with ivermectin alone may not interrupt the transmission of Onchocerca.  Hence, addnl. drugs are needed, such as antibiotics acting on symbiotic endobacteria of the filariae, the causative agents of onchocerciasis.  Based on animal expts., human onchocerciasis was treated with doxycycline, and preliminary observations published in 2001 in The Lancet showed sterility in female worms by depletion and marked redn. in symbiotic Wolbachia endobacteria from the filariae.  Here, a detailed kinetic anal. of the features of the worms, following administration or not of doxycycline to the patients is reported.  Sixty-three onchocerciasis patients in Ghana were treated with 100 mg doxycycline daily for 6 wk and 2 or 6 mo later with ivermectin.  Onchocercomas were extirpated 2, 6, 11 and 18 mo after the onset of treatment and the filariae were examd. by immunohistol. and PCR.  The anal. showed: (i) progressive depletion of Wolbachia from adult worms and microfilariae by doxycycline over a period of 6 mo; (ii) inhibition of embryogenesis by doxycycline after 6 mo with respect to all embryo stages followed by decline in microfilariae after 11 mo; (iii) redn. in spermatozoa in the female genital tract by doxycycline, whereas spermiogenesis was only partly reduced after 11 and 18 mo; (iv) no relevant macro- or microfilaricidal activity; (v) depletion/marked redn. in endobacteria and inhibition of embryogenesis were sustained until 18 mo after doxycycline and 12 mo after co-administration of ivermectin; (vi) no severe adverse side effects were seen.  Due to its long-lasting inhibition of embryogenesis, doxycycline presents an addnl. strategy for the treatment of onchocerciasis and control of Onchocerca microfilariae transmission.  Extension of the existing registration will not require much time or high cost.  Treatment of individual patients can be considered immediately.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX76OYzrrgGLVg90H21EOLACvtfcHk0ljsVFuszISjbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXivFGitb0%253D&md5=72a1546db5deb6cf6a5ebba1945c24f2</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fs1286-4579%2803%2900026-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs1286-4579%252803%252900026-1%26sid%3Dliteratum%253Aachs%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DMand%26aufirst%3DS.%26aulast%3DVolkmann%26aufirst%3DL.%26aulast%3DB%25C3%25BCttner%26aufirst%3DM.%26aulast%3DMarfo-Debrekyei%26aufirst%3DY.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DAdjei%26aufirst%3DO.%26aulast%3DB%25C3%25BCttner%26aufirst%3DD.%2BW.%26atitle%3DDoxycycline%2520in%2520the%2520treatment%2520of%2520human%2520onchocerciasis%253A%2520Kinetics%2520of%2520Wolbachia%2520endobacteria%2520reduction%2520and%2520of%2520inhibition%2520of%2520embryogenesis%2520in%2520female%2520Onchocerca%2520worms%26jtitle%3DMicrobes%2520Infect.%26date%3D2003%26volume%3D5%26spage%3D261%26epage%3D273%26doi%3D10.1016%2Fs1286-4579%2803%2900026-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruppa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfo-Debrekyei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debrah, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfarr, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adjei, O.</span></span> <span> </span><span class="NLM_article-title">Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production</span>. <i>Med. Microbiol. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>192</i></span>,  <span class="NLM_fpage">211</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1007/s00430-002-0174-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1007%2Fs00430-002-0174-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=12684759" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVOiurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=192&publication_year=2003&pages=211-216&author=A.+Hoeraufauthor=S.+Mandauthor=K.+Fischerauthor=T.+Kruppaauthor=Y.+Marfo-Debrekyeiauthor=A.+Y.+Debrahauthor=K.+M.+Pfarrauthor=O.+Adjei&title=Doxycycline+as+a+novel+strategy+against+bancroftian+filariasis-depletion+of+Wolbachia+endosymbionts+from+Wuchereria+bancrofti+and+stop+of+microfilaria+production&doi=10.1007%2Fs00430-002-0174-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Doxycycline as a novel strategy against bancroftian filariasis-depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production</span></div><div class="casAuthors">Hoerauf, Achim; Mand, Sabine; Fischer, Kerstin; Kruppa, Thomas; Marfo-Debrekyei, Yeboah; Debrah, Alexander Yaw; Pfarr, Kenneth M.; Adjei, Ohene; Buettner, Dietrich W.</div><div class="citationInfo"><span class="NLM_cas:title">Medical Microbiology and Immunology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">192</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">211-216</span>CODEN:
                <span class="NLM_cas:coden">MMIYAO</span>;
        ISSN:<span class="NLM_cas:issn">0300-8584</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Chemotherapy of onchocerciasis by doxycycline, which targets symbiotic Wolbachia endobacteria, has been shown to result in a long-term sterility of adult female worms and corresponding absence of microfilariae.  It represents an addnl. chemotherapeutic approach.  The aim of this study was to det. whether a similar regimen would also show efficacy against Wuchereria bancrofti.  Ghanaian individuals (n = 93) with lymphatic filariasis and a min. microfilaremia of 40 microfilariae/mL were included in a treatment study consisting of four arms: (1) doxycycline 200 mg/day for 6 wk; (2) doxycycline as in (1), followed by a single dose of ivermectin after 4 mo; (3) ivermectin only; or (4) no treatment during observation period of 1 yr (ivermectin at the end of the study).  Doxycycline treatment resulted in a 96% loss of Wolbachia, as detd. by real time PCR from microfilariae.  After 12 mo, doxycycline had led to a 99% redn. of microfilaremia when given alone, and to a complete amicrofilaremia together with ivermectin.  In contrast, after ivermectin treatment alone a significant presence of microfilariae remained (9% compared to pretreatment), as known from other studies.  This study shows that doxycycline is also effective in depleting Wolbachia from W. bancrofti.  It is likely that the mechanism of doxycycline is similar to that in other filarial species, i.e., a predominant blockade of embryogenesis, leading to a decline of microfilariae according to their half-life.  This could render doxycycline treatment an addnl. tool for the treatment of microfilaria-assocd. diseases in bancroftian filariasis, such as tropical pulmonary eosinophilia and microfiluria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobgWs6R6DU07Vg90H21EOLACvtfcHk0lhF6ww1LvWLCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVOiurc%253D&md5=26491a1dc911595fadcc5d608c1732ac</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1007%2Fs00430-002-0174-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00430-002-0174-6%26sid%3Dliteratum%253Aachs%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DMand%26aufirst%3DS.%26aulast%3DFischer%26aufirst%3DK.%26aulast%3DKruppa%26aufirst%3DT.%26aulast%3DMarfo-Debrekyei%26aufirst%3DY.%26aulast%3DDebrah%26aufirst%3DA.%2BY.%26aulast%3DPfarr%26aufirst%3DK.%2BM.%26aulast%3DAdjei%26aufirst%3DO.%26atitle%3DDoxycycline%2520as%2520a%2520novel%2520strategy%2520against%2520bancroftian%2520filariasis-depletion%2520of%2520Wolbachia%2520endosymbionts%2520from%2520Wuchereria%2520bancrofti%2520and%2520stop%2520of%2520microfilaria%2520production%26jtitle%3DMed.%2520Microbiol.%2520Immunol.%26date%3D2003%26volume%3D192%26spage%3D211%26epage%3D216%26doi%3D10.1007%2Fs00430-002-0174-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mand, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adjei, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleischer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Büttner, D. W.</span></span> <span> </span><span class="NLM_article-title">Depletion of Wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>357</i></span>,  <span class="NLM_fpage">1415</span>– <span class="NLM_lpage">1416</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(00)04581-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fs0140-6736%2800%2904581-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=11356444" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A280%3ADC%252BD3M3mtlGmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=357&publication_year=2001&pages=1415-1416&author=A.+Hoeraufauthor=S.+Mandauthor=O.+Adjeiauthor=B.+Fleischerauthor=D.+W.+B%C3%BCttner&title=Depletion+of+Wolbachia+endobacteria+in+Onchocerca+volvulus+by+doxycycline+and+microfilaridermia+after+ivermectin+treatment&doi=10.1016%2Fs0140-6736%2800%2904581-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Depletion of wolbachia endobacteria in Onchocerca volvulus by doxycycline and microfilaridermia after ivermectin treatment</span></div><div class="casAuthors">Hoerauf A; Mand S; Adjei O; Fleischer B; Buttner D W</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">357</span>
        (<span class="NLM_cas:issue">9266</span>),
    <span class="NLM_cas:pages">1415-6</span>
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    </div><div class="casAbstract">Ivermectin is the drug used for mass chemotherapy of onchocerciasis within the WHO African Programme for Onchocerciasis Control.  This approach aims to eliminate the disease as a public health problem but using one dose per year may not completely interrupt transmission since it does not suppress microfilaridermia thoroughly enough.  Here we show that additional treatment with doxycycline, previously shown to sterilise adult female worms for a few months by depletion of symbiotic wolbachia endobacteria, significantly enhances ivermectin-induced suppression of microfilaridermia, rendering anti-wolbachia treatment a promising basis for blocking transmission by a drug-based approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ_4Vhuc5mpj5dYoSR9eyvsfW6udTcc2eYPgwF8iDq54bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3mtlGmsQ%253D%253D&md5=80d853b62b101ffcb3144d12dfc0e227</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2800%2904581-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252800%252904581-5%26sid%3Dliteratum%253Aachs%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DMand%26aufirst%3DS.%26aulast%3DAdjei%26aufirst%3DO.%26aulast%3DFleischer%26aufirst%3DB.%26aulast%3DB%25C3%25BCttner%26aufirst%3DD.%2BW.%26atitle%3DDepletion%2520of%2520Wolbachia%2520endobacteria%2520in%2520Onchocerca%2520volvulus%2520by%2520doxycycline%2520and%2520microfilaridermia%2520after%2520ivermectin%2520treatment%26jtitle%3DLancet%26date%3D2001%26volume%3D357%26spage%3D1415%26epage%3D1416%26doi%3D10.1016%2Fs0140-6736%2800%2904581-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goetze, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiernickel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elsner, P.</span></span> <span> </span><span class="NLM_article-title">Phototoxicity of doxycycline: a systematic review on clinical manifestations, frequency, cofactors, and prevention</span>. <i>Skin Pharmacol. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">76</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1159/000458761</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1159%2F000458761" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=28291967" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotVOju74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2017&pages=76-80&author=S.+Goetzeauthor=C.+Hiernickelauthor=P.+Elsner&title=Phototoxicity+of+doxycycline%3A+a+systematic+review+on+clinical+manifestations%2C+frequency%2C+cofactors%2C+and+prevention&doi=10.1159%2F000458761"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Phototoxicity of Doxycycline: A Systematic Review on Clinical Manifestations, Frequency, Cofactors, and Prevention</span></div><div class="casAuthors">Goetze, Steven; Hiernickel, Christian; Elsner, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Skin Pharmacology and Physiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">76-80</span>CODEN:
                <span class="NLM_cas:coden">SPPKE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-5527</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background: One of the most important dermatol. side effects of doxycycline is photosensitivity.  As doxycycline is important for malaria prophylaxis and malaria is mainly spread in countries with high sun radiation, special attention should be paid to this adverse effect.  While there are many publications on the phototoxicity of tetracyclines in general, only a few exist focusing on doxycycline.  The objective of this systematic review was to summarize all available reports on clin. manifestations, influencing factors like UV dose or dose of medication, and the possibilities of prevention by sun protection.  Methods: This review is based on a systematic search in PubMed for articles in English and German and a manual search between 1990 and 2015.  Results: The no. of publications is low.  Clin. symptoms vary from light sunburn-like sensation (burning, erythema) to large-area photodermatitis.  Also, onycholysis is possible.  The triggering UV spectrum seems to consist mainly of UVA1 (340-400 nm), so UV-protective products should be used that cover this range.  Travelers to tropical countries taking doxycycline for malaria prophylaxis need thorough medical counseling to avoid possibly severe phototoxic reactions.  Conclusion: Evidence base must be improved for giving advice on appropriate prevention measures to travelers taking doxycycline and having a risk of significant sun exposure.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsu5U1oK1WZLVg90H21EOLACvtfcHk0lhF6ww1LvWLCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotVOju74%253D&md5=bd16f4b8013da5b5754226f396ac5737</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1159%2F000458761&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000458761%26sid%3Dliteratum%253Aachs%26aulast%3DGoetze%26aufirst%3DS.%26aulast%3DHiernickel%26aufirst%3DC.%26aulast%3DElsner%26aufirst%3DP.%26atitle%3DPhototoxicity%2520of%2520doxycycline%253A%2520a%2520systematic%2520review%2520on%2520clinical%2520manifestations%252C%2520frequency%252C%2520cofactors%252C%2520and%2520prevention%26jtitle%3DSkin%2520Pharmacol.%2520Physiol.%26date%3D2017%26volume%3D30%26spage%3D76%26epage%3D80%26doi%3D10.1159%2F000458761" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardon-Wendel, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demanga-Ngangue, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamgno, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chippaux, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boussinesq, M.</span></span> <span> </span><span class="NLM_article-title">Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">18</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/s0140-6736(96)11094-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fs0140-6736%2896%2911094-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=9217715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADyaK2sXkvFygsLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=1997&pages=18-22&author=J.+Gardonauthor=N.+Gardon-Wendelauthor=N.+Demanga-Ngangueauthor=J.+Kamgnoauthor=J.-P.+Chippauxauthor=M.+Boussinesq&title=Serious+reactions+after+mass+treatment+of+onchocerciasis+with+ivermectin+in+an+area+endemic+for+Loa+loa+infection&doi=10.1016%2Fs0140-6736%2896%2911094-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection</span></div><div class="casAuthors">Gardon, Jacques; Gardon-Wendel, Nathalie; Demanga-Ngangue; Kamgno, Joseph; Chippaux, Jean-Philippe; Boussinesq, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">9070</span>),
    <span class="NLM_cas:pages">18-22</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Lancet</span>)
        </div><div class="casAbstract">In 1995, the World Bank launched an African Program for Onchocerciasis Control to eliminate Onchocerca volvulus disease from 19 African countries by means of community-based ivermectin treatment (CBIT).  Several cases of encephalopathy have been reported after ivermectin in people heavily infected with microfilaria of Loa loa (loiasis).  We assessed the incidence of serious events in an area where onchocerciasis and loiasis are both endemic.  Ivermectin (at 150 μg/kg) was given to 17877 people living in the Lekie area of Cameroon.  50 μL samples of capillary blood were taken during the daytime before treatment from all adults (aged ≥15 yr), and the nos. of L loa and Mansonella perstans microfilaria in them were counted.  Patients were monitored for 7 days after treatment.  Adverse reactions were classified as mild, marked, or serious.  Serious reactions were defined as those assocd. with a functional impairment that required at least a week of full-time assistance to undertake normal activities.  We calcd. the relative risk of developing marked or serious reactions for increasing L loa microfilarial loads.  Risk factors for serious reactions were identified and assessed with a logistic regression model.  20 Patients (0.11%) developed serious reactions without neurol. signs but assocd. with a functional impairment lasting more than a week.  Two other patients were in coma for 2-3 days, assocd. with L loa microfilaria in cerebrospinal fluid.  Occurrence of serious reactions was related to the intensity of pretreatment L loa microfilaremia.  The relative risk of developing marked or serious reactions was significantly higher when the L loa load exceeded 8000 microfilaria/mL; for serious reactions, the risk is very high (odds ratio >1000) for loads above 50 000 microfilaria/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiBNGlpdyehrVg90H21EOLACvtfcHk0ljmrJbzx6mIUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXkvFygsLc%253D&md5=59a4ad8f92ea9b9f295f0885e52caaf3</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2Fs0140-6736%2896%2911094-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0140-6736%252896%252911094-1%26sid%3Dliteratum%253Aachs%26aulast%3DGardon%26aufirst%3DJ.%26aulast%3DGardon-Wendel%26aufirst%3DN.%26aulast%3DDemanga-Ngangue%26aufirst%3DN.%26aulast%3DKamgno%26aufirst%3DJ.%26aulast%3DChippaux%26aufirst%3DJ.-P.%26aulast%3DBoussinesq%26aufirst%3DM.%26atitle%3DSerious%2520reactions%2520after%2520mass%2520treatment%2520of%2520onchocerciasis%2520with%2520ivermectin%2520in%2520an%2520area%2520endemic%2520for%2520Loa%2520loa%2520infection%26jtitle%3DLancet%26date%3D1997%26volume%3D350%26spage%3D18%26epage%3D22%26doi%3D10.1016%2Fs0140-6736%2896%2911094-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Albers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esum, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tendongfor, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klarmann, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfarr, K.</span></span> <span> </span><span class="NLM_article-title">Retarded Onchocerca volvulus L1 to L3 larval development in the Simulium damnosum vector after anti-wolbachial treatment of the human host</span>. <i>Parasites Vectors</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">12</span>, <span class="refDoi"> DOI: 10.1186/1756-3305-5-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1186%2F1756-3305-5-12" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=22236497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtVOksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=12&author=A.+Albersauthor=M.+Esumauthor=N.+Tendongforauthor=P.+Enyongauthor=U.+Klarmannauthor=S.+Wanjiauthor=A.+Hoeraufauthor=K.+Pfarr&title=Retarded+Onchocerca+volvulus+L1+to+L3+larval+development+in+the+Simulium+damnosum+vector+after+anti-wolbachial+treatment+of+the+human+host&doi=10.1186%2F1756-3305-5-12"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Retarded Onchocerca volvulus L1 to L3 larval development in the Simulium damnosum vector after anti-wolbachial treatment of the human host</span></div><div class="casAuthors">Albers, Anna; Esum, Mathias Eyong; Tendongfor, Nicholas; Enyong, Peter; Klarmann, Ute; Wanji, Samuel; Hoerauf, Achim; Pfarr, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Parasites & Vectors</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12</span>CODEN:
                <span class="NLM_cas:coden">PVAEAK</span>;
        ISSN:<span class="NLM_cas:issn">1756-3305</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: The human parasite Onchocerca volvulus harbours Wolbachia endosymbionts essential for worm embryogenesis, larval development and adult survival.  In this study, the development of Wolbachia-depleted microfilariae (first stage larvae) to infective third stage larvae (L3) in the insect vector Simulium damnosum was analyzed.  Methods: Infected volunteers in Cameroon were randomly and blindly allocated into doxycycline (200 mg/day for 6 wk) or placebo treatment groups.  After treatment, blackflies were allowed to take a blood meal on the volunteers, captured and dissected for larval counting and DNA extn. for quant. real-time PCR anal.  Results: PCR results showed a clear redn. in Wolbachia DNA after doxycycline treatment in microfilariae from human skin biopsies with >50% redn. at one month post-treatment, eventually reaching a redn. of >80%.  Larval stages recovered from the insect vector had similar levels of redn. of endosymbiotic bacteria.  Larval recoveries were analyzed longitudinally after treatment to follow the kinetics of larval development.  Beginning at three months post-treatment, significantly fewer L3 were seen in the blackflies that had fed on doxycycline treated volunteers.  Concomitant with this, the proportion of second stage larvae (L2) was significantly increased in this group.  Conclusions: Doxycycline treatment and the resulting decline of Wolbachia endobacteria from the microfilaria resulted in retarded development of larvae in the insect vector.  Thus, anti-wolbachial treatment could have an additive effect for interrupting transmission by reducing the no. of L3 that can be transmitted by blackflies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqoeSq_H3p2bVg90H21EOLACvtfcHk0ljmrJbzx6mIUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtVOksr0%253D&md5=2f0334d4af00957da6b6aeb64c9296bf</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1186%2F1756-3305-5-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-3305-5-12%26sid%3Dliteratum%253Aachs%26aulast%3DAlbers%26aufirst%3DA.%26aulast%3DEsum%26aufirst%3DM.%26aulast%3DTendongfor%26aufirst%3DN.%26aulast%3DEnyong%26aufirst%3DP.%26aulast%3DKlarmann%26aufirst%3DU.%26aulast%3DWanji%26aufirst%3DS.%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DPfarr%26aufirst%3DK.%26atitle%3DRetarded%2520Onchocerca%2520volvulus%2520L1%2520to%2520L3%2520larval%2520development%2520in%2520the%2520Simulium%2520damnosum%2520vector%2520after%2520anti-wolbachial%2520treatment%2520of%2520the%2520human%2520host%26jtitle%3DParasites%2520Vectors%26date%3D2012%26volume%3D5%26spage%3D12%26doi%3D10.1186%2F1756-3305-5-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, W. J.</span></span> <span> </span><span class="NLM_article-title">Antibiotic substances from basidiomycetes: IX. Drosophila subtarata. (batsch ex fr.) quel</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1952</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">555</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1073/pnas.38.7.555</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1073%2Fpnas.38.7.555" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=16589145" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADyaG3sXivFSqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=1952&pages=555-560&author=F.+Kavanaghauthor=A.+Herveyauthor=W.+J.+Robbins&title=Antibiotic+substances+from+basidiomycetes%3A+IX.+Drosophila+subtarata.+%28batsch+ex+fr.%29+quel&doi=10.1073%2Fpnas.38.7.555"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic substances from basidiomycetes. IX. Drosophila subatrata</span></div><div class="casAuthors">Kavanagh, Frederick; Hervey, Annette; Robbins, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">555-60</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">cf. C.A. 46, 5662d; following abstr.  Drosophila subatrata produced an activity of 1000 diln. units/ml. for Staphylococcus aureus when grown in shake culture for two weeks on corn steep medium.  Active substances were isolated thus: culture liquid was acidified to pH 3.4, extd. with 0.1 vol. CHCl3 which was then extd. with 0.5 M NaHCO3 to give an aq. ext. (I) contg. 37% of the solids and 20% of the S. aureus activity.  The CHCl3 extn. was evapd. to 1/10 vol. and extd. with an equal vol. of 0.5 M NaHCO3 to give a soln. (II) contg. 25% of the S. aureus activity and 3% of the solids.  The remaining CHCl3 ext. was further extd. with 0.5 M carbonate buffer pH 10 which removed a small amt. of an active substance, drosophilin A (III), isolated by acidifying the buffer soln., extg. with Et2O, and evapg. to yield yellow crystals of III, yield 100 mg. from 31 l. of culture medium.  III dissolved in C6H6, decolorized with C, filtered, and the C6H6 evapd. yielded crystals, which after recrystn. from hexane or dil. aq. alc. m. 118°.  III was also sol. in Me2CO, EtOH, CHCl3, Et2O, and slightly sol. in H2O, showed no basic properties was weakly acidic, gave a color reaction with alc. FeCl3, had absorption peak at 301 mμ, did not ppt. with AgNO3, reduced alk. MnO4-, reacted with alk. AgNO3 with formation of AgCl, did not react with 2, 4-(NO2)2C6H3NHNH2, did not give reactions for α,β-unsatd. ketones, contained 11.70% OCH3, had a mol. wt. 249, and infrared analysis indicated H attached to unsatd. C, a OH group and a CH3 or CH2 group.  The above CHCl3 concentrate after extn. with pH 10 buffer was extd. with 0.5 M Na2CO3 and then by N KOH, the CHCl3 evapd., the solids remaining dissolved in C6H6, and C6H6 evapd. to yield crystals of drosophilin B (IV) which were identical with pleuromutilin.  The II ext. was acidified, the acids taken up in Et2O, the Et2O soln. shaken repeatedly with 0.25 vol. 0.1 N AgNO3, and the yellow ppt. removed each time and kept under H2O.  The combined Ag ppts. were washed with Et2O and H2O, more Et2O added, the Ag compd. decompd. with HCl and the acids were taken up in Et2O.  The substances in Et2O were subjected to counter-current distribution between CHCl3 and 0.5 M phosphate buffer at pH 6.9; most of the solids and antibacterial activity were in the CHCl3 which was distributed again in a 4 funnel system using pH 7.5 buffer.  The purest substance, 4 mg. of drosophilin C (V), was found in the third funnel.  I was acidified, extd. with CHCl3, the CHCl3 shaken with 0.5 vol. pH 6 buffer, and the CHCl3 extd. repeatedly with AgNO3 with removal of the pptd. Ag compd. before using fresh AgNO3.  Counter-current distributions with pH 7 buffer of the CHCl3 soln. yielded drosophilin D (VI), sol. in org. solvents, and pptd. from aq. alc. by AgNO3 as was V.  VI titrated in 20% EtOH as a monobasic acid with pK 4.2 and equiv. wt. 405 and showed ultraviolet spectra characteristic of polyacetylene substances.  The activities of the 4 compds. were measured against 7 organisms and 60 bacteriophages.  The substances were active mainly against gram-pos. bacteria; III was active against staphylophage 8, IV against streptophage 6 and 7; V and VI were inactive against phage.  III and IV were not inactivated by incubation with blood; V was 7/8 inactivated and VI lost 0.5 its activity.  IV was not toxic to mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrexTWmThQB87Vg90H21EOLACvtfcHk0ljmrJbzx6mIUw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG3sXivFSqtA%253D%253D&md5=9824a5c8bb8d0c1fdb840a43025d7699</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1073%2Fpnas.38.7.555&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.38.7.555%26sid%3Dliteratum%253Aachs%26aulast%3DKavanagh%26aufirst%3DF.%26aulast%3DHervey%26aufirst%3DA.%26aulast%3DRobbins%26aufirst%3DW.%2BJ.%26atitle%3DAntibiotic%2520substances%2520from%2520basidiomycetes%253A%2520IX.%2520Drosophila%2520subtarata.%2520%2528batsch%2520ex%2520fr.%2529%2520quel%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1952%26volume%3D38%26spage%3D555%26epage%3D560%26doi%3D10.1073%2Fpnas.38.7.555" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hervey, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robbins, W. J.</span></span> <span> </span><span class="NLM_article-title">Antibiotic substances from basidiomycetes: viii. pleurotus multilus (fr.) sacc. and pleurotus passeckerianus pilat</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">1951</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">570</span>– <span class="NLM_lpage">574</span>, <span class="refDoi"> DOI: 10.1073/pnas.37.9.570</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1073%2Fpnas.37.9.570" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=16589015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADyaG38XjtlSntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1951&pages=570-574&author=F.+Kavanaghauthor=A.+Herveyauthor=W.+J.+Robbins&title=Antibiotic+substances+from+basidiomycetes%3A+viii.+pleurotus+multilus+%28fr.%29+sacc.+and+pleurotus+passeckerianus+pilat&doi=10.1073%2Fpnas.37.9.570"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic substances from Basidiomyces. VIII. Pleurotus mutilus and Pleurotus passeckerianus</span></div><div class="casAuthors">Kavanagh, Frederick; Hervey, Annette; Robbins, Wm. J.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1951</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">570-4</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">cf. C.A. 44, 8423c.  Pleuromutilin (I), an antibacterial substance formed by both P. mutilis and P. passeckerianus was recovered from the fermentation beer by extn. with CHCl3 at pH 5.3, the CHCl3 evapd. at low temp., and the remaining brown gum dissolved in ether which on evapn. yielded white crystals of I.  I was sol. in alc., acetone, CHCl3, and ether; slightly sol. in H2O; and insol. in hexane.  I contains 69.75% C and 9.03% H, has a mol. wt. of 310, m. 166-9° (cor.) without decompn., and [α]D20 ≤ 0.05° (0.2% in 50% EtOH).  The absorption spectrum showed a weak band at 290 mμ (ε = 21.7) and end absorption below 230 mμ.  I was a stable, neutral compd. and sublimed at about 140°.  Crystals were obtained from the fifth funnel of an 8-funnel counter-current distribution of crude gum between 50% H2O-MeOH and a 3:2 mixt. of Et2O-hexane.  I was active mainly against gram-pos. bacteria, showed partial activity against streptococci phage, and was inactive against several fungi species when tested at 0.5 mg./ml.  The activity of I was not reduced after 4 hrs. in broth contg. 5% blood.  I was bacteriostatic for Staphylococcus aureus at 0.25-2 γ/ml. broth and bactericidal at 4 γ/ml.  The LD50 of I for mice (intraperitoneally) was greater than 60 mg./kg.  A single subcutaneous dose of I at 50 mg./kg. protected 63% of the mice, infected with Streptococcus hemolyticus, for 7 days.  I had no effect on growth of sarcoma 180 or Plasmodium gallinaceum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqRlKsz11Vq7Vg90H21EOLACvtfcHk0li5Ml5iJuCJxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XjtlSntQ%253D%253D&md5=6e77a9a767c3732146a93cc28e2be781</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.37.9.570&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.37.9.570%26sid%3Dliteratum%253Aachs%26aulast%3DKavanagh%26aufirst%3DF.%26aulast%3DHervey%26aufirst%3DA.%26aulast%3DRobbins%26aufirst%3DW.%2BJ.%26atitle%3DAntibiotic%2520substances%2520from%2520basidiomycetes%253A%2520viii.%2520pleurotus%2520multilus%2520%2528fr.%2529%2520sacc.%2520and%2520pleurotus%2520passeckerianus%2520pilat%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D1951%26volume%3D37%26spage%3D570%26epage%3D574%26doi%3D10.1073%2Fpnas.37.9.570" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlünzen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pyetan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fucini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yonath, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of peptide bond formation by pleuromutilins: the structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin</span>. <i>Mol. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1287</span>– <span class="NLM_lpage">1294</span>, <span class="refDoi"> DOI: 10.1111/j.1365-2958.2004.04346.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1111%2Fj.1365-2958.2004.04346.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=15554968" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOlsr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2004&pages=1287-1294&author=F.+Schl%C3%BCnzenauthor=E.+Pyetanauthor=P.+Fuciniauthor=A.+Yonathauthor=J.+M.+Harms&title=Inhibition+of+peptide+bond+formation+by+pleuromutilins%3A+the+structure+of+the+50S+ribosomal+subunit+from+Deinococcus+radiodurans+in+complex+with+tiamulin&doi=10.1111%2Fj.1365-2958.2004.04346.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of peptide bond formation by pleuromutilins: The structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin</span></div><div class="casAuthors">Schluenzen, Frank; Pyetan, Erez; Fucini, Paola; Yonath, Ada; Harms, Joerg M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Microbiology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1287-1294</span>CODEN:
                <span class="NLM_cas:coden">MOMIEE</span>;
        ISSN:<span class="NLM_cas:issn">0950-382X</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">Tiamulin, a prominent member of the pleuromutilin class of antibiotics, is a potent inhibitor of protein synthesis in bacteria.  Up to now the effect of pleuromutilins on the ribosome has not been detd. on a mol. level.  The 3.5 Å structure of the 50S ribosomal subunit from Deinococcus radiodurans in complex with tiamulin provides for the first time a detailed picture of its interactions with the 23S rRNA, thus explaining the mol. mechanism of the antimicrobial activity of the pleuromutilin class of antibiotics.  Our results show that tiamulin is located within the peptidyl transferase center (PTC) of the 50S ribosomal subunit with its tricyclic mutilin core positioned in a tight pocket at the A-tRNA binding site.  Also, the extension, which protrudes from its mutilin core, partially overlaps with the P-tRNA binding site.  Thereby, tiamulin directly inhibits peptide bond formation.  Comparison of the tiamulin binding site with other PTC targeting drugs, like chloramphenicol, clindamycin and streptogramins, may facilitate the design of modified or hybridized drugs that extend the applicability of this class of antibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2D1Idh-v-kLVg90H21EOLACvtfcHk0li5Ml5iJuCJxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOlsr3I&md5=9c1cff85ea16f04813897b2778077237</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1111%2Fj.1365-2958.2004.04346.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1365-2958.2004.04346.x%26sid%3Dliteratum%253Aachs%26aulast%3DSchl%25C3%25BCnzen%26aufirst%3DF.%26aulast%3DPyetan%26aufirst%3DE.%26aulast%3DFucini%26aufirst%3DP.%26aulast%3DYonath%26aufirst%3DA.%26aulast%3DHarms%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520peptide%2520bond%2520formation%2520by%2520pleuromutilins%253A%2520the%2520structure%2520of%2520the%252050S%2520ribosomal%2520subunit%2520from%2520Deinococcus%2520radiodurans%2520in%2520complex%2520with%2520tiamulin%26jtitle%3DMol.%2520Microbiol.%26date%3D2004%26volume%3D54%26spage%3D1287%26epage%3D1294%26doi%3D10.1111%2Fj.1365-2958.2004.04346.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Veve, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, J. L.</span></span> <span> </span><span class="NLM_article-title">Lefamulin: review of a promising novel pleuromutilin antibiotic</span>. <i>Pharmacotherapy</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">935</span>– <span class="NLM_lpage">946</span>, <span class="refDoi"> DOI: 10.1002/phar.2166</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1002%2Fphar.2166" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=30019769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs12is7zE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2018&pages=935-946&author=M.+P.+Veveauthor=J.+L.+Wagner&title=Lefamulin%3A+review+of+a+promising+novel+pleuromutilin+antibiotic&doi=10.1002%2Fphar.2166"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Lefamulin: Review of a Promising Novel Pleuromutilin Antibiotic</span></div><div class="casAuthors">Veve, Michael P.; Wagner, Jamie L.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacotherapy</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">935-946</span>CODEN:
                <span class="NLM_cas:coden">PHPYDQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-9114</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">The emergence and spread of antimicrobial resistance have led to a global public health emergency requiring development of new antimicrobial classes.  Lefamulin (formally BC-3781) is a novel pleuromutilin antibiotic currently undergoing Food and Drug Administration review for community-acquired bacterial pneumonia (CABP) as i.v. (IV) and oral (PO) formulations.  Although pleuromutilin antibiotics were first developed in the 1950s, lefamulin is the first to be used for systemic treatment of bacterial infections in humans.  Lefamulin exhibits a unique mechanism of action through inhibition of protein synthesis by binding to the peptidyl transferase center of the 50S bacterial ribosome, thus preventing the binding of tRNA for peptide transfer.  Lefamulin displays activity against gram-pos. and atypical organisms assocd. with CABP (i.e., Streptococcus pneumoniae,Haemophilus influenzae, Mycoplasma pneumoniae,Legionella pneumophila, and Chlamydophila pneumoniae), with an expanded gram-pos. spectrum including Staphylococcus aureus (i.e., methicillin-resistant, vancomycin-intermediate, and heterogeneous strains) and vancomycin-resistant Enterococcus faecium.  Lefamulin was also shown to retain activity against multidrug-resistant Neisseria gonorrhoeae and Mycoplasma genitalium.  Lefamulin exhibits time-dependent killing, and the pharmacodynamic target best assocd. with antibacterial activity is fAUC0-24/MIC (min. inhibitory concn. [MIC]).  Preclin. and phase II trials indicate that lefamulin concs. in lung tissue are well tolerated at an IV dose of 150 mg twice/day over 1 h or a PO dose of 600 mg twice/day, and preliminary phase III data suggest similar efficacy when compared with moxifloxacin with or without linezolid in CABP.  Documented resistance and cross-resistance with other gram-pos. antibacterials remains low.  Addnl. published in vitro, in vivo, and preclin. trial data suggest further exploration of lefamulin in various infectious disease states (e.g., acute bacterial skin and skin structure infections, and sexually transmitted infections).  This review discusses the pertinent bacterial spectrum of activity, preclin. and ongoing clin. data, and potential roles in therapy for lefamulin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrai5MjdMSCqLVg90H21EOLACvtfcHk0li5Ml5iJuCJxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs12is7zE&md5=1d12eb7df78105bde865e23af4e9c636</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fphar.2166&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fphar.2166%26sid%3Dliteratum%253Aachs%26aulast%3DVeve%26aufirst%3DM.%2BP.%26aulast%3DWagner%26aufirst%3DJ.%2BL.%26atitle%3DLefamulin%253A%2520review%2520of%2520a%2520promising%2520novel%2520pleuromutilin%2520antibiotic%26jtitle%3DPharmacotherapy%26date%3D2018%26volume%3D38%26spage%3D935%26epage%3D946%26doi%3D10.1002%2Fphar.2166" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dornhelm, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogenauer, G.</span></span> <span> </span><span class="NLM_article-title">The effects of tiamulin, a semisynthetic pleuromutilin derivative, on bacterial polypeptide chain initiation</span>. <i>Eur. J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1978</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">465</span>– <span class="NLM_lpage">473</span>, <span class="refDoi"> DOI: 10.1111/j.1432-1033.1978.tb12699.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1111%2Fj.1432-1033.1978.tb12699.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=365525" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADyaE1MXms1Grtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=1978&pages=465-473&author=P.+Dornhelmauthor=G.+Hogenauer&title=The+effects+of+tiamulin%2C+a+semisynthetic+pleuromutilin+derivative%2C+on+bacterial+polypeptide+chain+initiation&doi=10.1111%2Fj.1432-1033.1978.tb12699.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The effects of tiamulin, a semisynthetic pleuromutilin derivative, on bacterial polypeptide chain initiation</span></div><div class="casAuthors">Dornhelm, Peter; Hoegenauer, Gregor</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1978</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">465-73</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">Tiamulin (I)  [55297-95-5], a water-sol. and highly effective semisynthetic deriv. of pleuromutilin led to the formation of physiolog. inactive polypeptide chain initiation complexes which readily decompd. and did not enter the phase of peptide chain elongation.  Once elongation began it continued even in the presence of I as was shown by measuring the formation of N-acetylphenylalanine-poly(phenylalanine).  The formation of abortive initiation complexes was obsd. regardless of whether AcPhe-tRNA of fMet-tRNA was used as an initiator or whether artificial messengers or a natural messenger, like R17 bacteriophage RNA, was used.  When this drug was acting on whole cells, it led to the disappearance of polysomes.  The only structures which could be detected were of the monosome size.  Therefore, polysomes seem to elongate the polypeptide chains in whole cells in the presence of this antibiotic, but since effective reinitiation is blocked, the polysome pool of the cell soon becomes depleted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_mj68-cgi2rVg90H21EOLACvtfcHk0li5Ml5iJuCJxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1MXms1Grtw%253D%253D&md5=82b5285c1ffcb795194b8155ee6de2ae</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1978.tb12699.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1978.tb12699.x%26sid%3Dliteratum%253Aachs%26aulast%3DDornhelm%26aufirst%3DP.%26aulast%3DHogenauer%26aufirst%3DG.%26atitle%3DThe%2520effects%2520of%2520tiamulin%252C%2520a%2520semisynthetic%2520pleuromutilin%2520derivative%252C%2520on%2520bacterial%2520polypeptide%2520chain%2520initiation%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1978%26volume%3D91%26spage%3D465%26epage%3D473%26doi%3D10.1111%2Fj.1432-1033.1978.tb12699.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritsche, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sader, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, J. E.</span></span> <span> </span><span class="NLM_article-title">Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">2583</span>– <span class="NLM_lpage">2586</span>, <span class="refDoi"> DOI: 10.1128/aac.01432-05</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1128%2Faac.01432-05" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=16801451" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD28XmvVWrtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=2583-2586&author=R.+N.+Jonesauthor=T.+R.+Fritscheauthor=H.+S.+Saderauthor=J.+E.+Ross&title=Activity+of+retapamulin+%28SB-275833%29%2C+a+novel+pleuromutilin%2C+against+selected+resistant+gram-positive+cocci&doi=10.1128%2Faac.01432-05"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant Gram-positive cocci</span></div><div class="casAuthors">Jones, Ronald N.; Fritsche, Thomas R.; Sader, Helio S.; Ross, James E.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">2583-2586</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Retapamulin (SB-275833), the first pleuromutilin to be developed for human topical use, was tested against a selected population of staphylococci and β-hemolytic streptococci.  The MIC90 results for retapamulin were 0.12 μg/mL for Staphylococcus aureus and ≤0.03 μg/mL for Streptococcus pyogenes; no cross-resistance was obsd. for organism subsets resistant to oxacillin, erythromycin, or mupirocin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1DMTvarj5ALVg90H21EOLACvtfcHk0lhTPt7DZxACFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmvVWrtL0%253D&md5=48b91d3b2458757e9d898a573d6d4faa</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1128%2Faac.01432-05&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.01432-05%26sid%3Dliteratum%253Aachs%26aulast%3DJones%26aufirst%3DR.%2BN.%26aulast%3DFritsche%26aufirst%3DT.%2BR.%26aulast%3DSader%26aufirst%3DH.%2BS.%26aulast%3DRoss%26aufirst%3DJ.%2BE.%26atitle%3DActivity%2520of%2520retapamulin%2520%2528SB-275833%2529%252C%2520a%2520novel%2520pleuromutilin%252C%2520against%2520selected%2520resistant%2520gram-positive%2520cocci%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D2583%26epage%3D2586%26doi%3D10.1128%2Faac.01432-05" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sader, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paukner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivezic-Schoenfeld, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biedenbach, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmitz, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, R. N.</span></span> <span> </span><span class="NLM_article-title">Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1170</span>– <span class="NLM_lpage">1175</span>, <span class="refDoi"> DOI: 10.1093/jac/dks001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1093%2Fjac%2Fdks001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=22287234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC38Xlt1GnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2012&pages=1170-1175&author=H.+S.+Saderauthor=S.+Pauknerauthor=Z.+Ivezic-Schoenfeldauthor=D.+J.+Biedenbachauthor=F.+J.+Schmitzauthor=R.+N.+Jones&title=Antimicrobial+activity+of+the+novel+pleuromutilin+antibiotic+BC-3781+against+organisms+responsible+for+community-acquired+respiratory+tract+infections+%28CARTIs%29&doi=10.1093%2Fjac%2Fdks001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Antimicrobial activity of the novel pleuromutilin antibiotic BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs)</span></div><div class="casAuthors">Sader, Helio S.; Paukner, Susanne; Ivezic-Schoenfeld, Zrinka; Biedenbach, Douglas J.; Schmitz, Franz J.; Jones, Ronald N.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1170-1175</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">BC-3781 is an investigational semi-synthetic pleuromutilin antibiotic, which recently finished a clin. Phase 2 trial in acute bacterial skin and skin structure infections.  BC-3781 binds to the 50S ribosomal subunit and cross-resistance with other antimicrobial classes is uncommon.  The authors evaluated the activity of BC-3781 against organisms responsible for community-acquired respiratory tract infections (CARTIs).  BC-3781 and comparator agents were susceptibility tested against Streptococcus pneumoniae (157 isolates; 33% penicillin resistant), Haemophilus influenzae (102; 50% β-lactamase producers), Moraxella catarrhalis (50) and Legionella pneumophila (30) by broth microdilution and the agar diln. method.  Mycoplasma pneumoniae (50 strains) was tested by broth microdilution, while Chlamydophila pneumoniae (50 strains) MIC values were detd. using HEp-2 cells.  Against S. pneumoniae (MIC50/90 0.12/0.25 mg/L) BC-3781 was 16- and 8-fold more active than azithromycin (MIC50/90 2/>16 mg/L) and levofloxacin (MIC50/90 1/1 mg/L), resp., and its activity was not adversely affected by resistance to penicillin.  S. pneumoniae showed high resistance rates to azithromycin (50.3%) and clindamycin (31.2%), all being inhibited by BC-3781 at concns. ≤0.5 mg/L.  H. influenzae and M. catarrhalis exhibited low BC-3781 MIC values independent of β-lactamase prodn.  BC-3781 activity against L. pneumophila (MIC50/90 0.06/0.5 mg/L) was similar to that of erythromycin, but lower than that of azithromycin.  BC-3781 also showed potent activity against M. pneumoniae and C. pneumoniae, with MIC50/90 of 0.006/0.006 and 0.02/0.04 mg/L, resp.  Thus, BC-3781 was very active against organisms commonly assocd. with CARTIs and its activity was not neg. influenced by resistance to other antimicrobials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXyavd7lK10bVg90H21EOLACvtfcHk0lhTPt7DZxACFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xlt1GnsLs%253D&md5=1e3c11b2a906ed7f46ff354381e6b135</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdks001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdks001%26sid%3Dliteratum%253Aachs%26aulast%3DSader%26aufirst%3DH.%2BS.%26aulast%3DPaukner%26aufirst%3DS.%26aulast%3DIvezic-Schoenfeld%26aufirst%3DZ.%26aulast%3DBiedenbach%26aufirst%3DD.%2BJ.%26aulast%3DSchmitz%26aufirst%3DF.%2BJ.%26aulast%3DJones%26aufirst%3DR.%2BN.%26atitle%3DAntimicrobial%2520activity%2520of%2520the%2520novel%2520pleuromutilin%2520antibiotic%2520BC-3781%2520against%2520organisms%2520responsible%2520for%2520community-acquired%2520respiratory%2520tract%2520infections%2520%2528CARTIs%2529%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2012%26volume%3D67%26spage%3D1170%26epage%3D1175%26doi%3D10.1093%2Fjac%2Fdks001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aitken, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalziel, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burch, D. G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ripley, P. H.</span></span> <span> </span><span class="NLM_article-title">Comparative in vitro activity of valnemulin against porcine bacterial pathogens</span>. <i>Vet. Rec.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">128</span>, <span class="refDoi"> DOI: 10.1136/vr.144.5.128</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1136%2Fvr.144.5.128" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10070704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A280%3ADyaK1M7mvF2isg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=1999&pages=128&author=I.+A.+Aitkenauthor=J.+H.+Morganauthor=R.+Dalzielauthor=D.+G.+S.+Burchauthor=P.+H.+Ripley&title=Comparative+in+vitro+activity+of+valnemulin+against+porcine+bacterial+pathogens&doi=10.1136%2Fvr.144.5.128"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Comparative in vitro activity of valnemulin against porcine bacterial pathogens</span></div><div class="casAuthors">Aitken I A; Morgan J H; Dalziel R; Burch D G; Ripley P H</div><div class="citationInfo"><span class="NLM_cas:title">The Veterinary record</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">128</span>
        ISSN:<span class="NLM_cas:issn">0042-4900</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTXoNoODdxxBuR_TJajKxJDfW6udTcc2eakYGr-7JVmQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1M7mvF2isg%253D%253D&md5=1a1b725cb2584f3abec176be211fab41</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1136%2Fvr.144.5.128&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fvr.144.5.128%26sid%3Dliteratum%253Aachs%26aulast%3DAitken%26aufirst%3DI.%2BA.%26aulast%3DMorgan%26aufirst%3DJ.%2BH.%26aulast%3DDalziel%26aufirst%3DR.%26aulast%3DBurch%26aufirst%3DD.%2BG.%2BS.%26aulast%3DRipley%26aufirst%3DP.%2BH.%26atitle%3DComparative%2520in%2520vitro%2520activity%2520of%2520valnemulin%2520against%2520porcine%2520bacterial%2520pathogens%26jtitle%3DVet.%2520Rec.%26date%3D1999%26volume%3D144%26spage%3D128%26doi%3D10.1136%2Fvr.144.5.128" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berner, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, H.</span></span> <span> </span><span class="NLM_article-title">Synthese ab-trans-anellierter derivate des tricyclischen diterpens pleuromutilin durch intramolekulare 1,5-hydrid-verschiebung</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">1807</span>– <span class="NLM_lpage">1811</span>, <span class="refDoi"> DOI: 10.1016/0040-4020(80)80078-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2F0040-4020%2880%2980078-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADyaL3MXmsFyrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1980&pages=1807-1811&author=H.+Bernerauthor=G.+Schulzauthor=H.+Schneider&title=Synthese+ab-trans-anellierter+derivate+des+tricyclischen+diterpens+pleuromutilin+durch+intramolekulare+1%2C5-hydrid-verschiebung&doi=10.1016%2F0040-4020%2880%2980078-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of an AB-trans-annulated derivative of the tricyclic diterpene pleuromutilin through an intramolecular 1,5-hydride shift</span></div><div class="casAuthors">Berner, H.; Schulz, G.; Schneider, H.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1807-11</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">Reaction of the diterpene pleuromutilin I with HC(OMe)3 (MeOH, 25°, 48 h) gave the 11-keto-3-methylester II with AB-trans-configuration (almost quant.).  The reaction occurred through a 1,5-hydride shift between C-3 and C-11.  The reverse reaction occurred on treatment of II with Lewis acid (ZnCl2, dioxane, 25°, 4 h).  Mechanistic aspects and structural assignments are discussed, based on chem. and spectral (1H and 13C NMR) study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYELtJ0RC_JbVg90H21EOLACvtfcHk0liPF5xn0wxbyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXmsFyrtw%253D%253D&md5=563f99fecaac59a80a2c1eae76c8ad5d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2F0040-4020%2880%2980078-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0040-4020%252880%252980078-0%26sid%3Dliteratum%253Aachs%26aulast%3DBerner%26aufirst%3DH.%26aulast%3DSchulz%26aufirst%3DG.%26aulast%3DSchneider%26aufirst%3DH.%26atitle%3DSynthese%2520ab-trans-anellierter%2520derivate%2520des%2520tricyclischen%2520diterpens%2520pleuromutilin%2520durch%2520intramolekulare%25201%252C5-hydrid-verschiebung%26jtitle%3DTetrahedron%26date%3D1980%26volume%3D36%26spage%3D1807%26epage%3D1811%26doi%3D10.1016%2F0040-4020%2880%2980078-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Brooks, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colthurst, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinks, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hunt, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearson, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shea, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takle, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodnutt, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pleuromutilins</span></span> <span> </span><span class="NLM_article-title">Pleuromutilins. Part 1 The identification of novel mutilin 14-carbamates</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1221</span>– <span class="NLM_lpage">1231</span>, <span class="refDoi"> DOI: 10.1016/s0968-0896(00)00338-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fs0968-0896%2800%2900338-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=1221-1231&author=G.+Brooksauthor=W.+Burgessauthor=D.+Colthurstauthor=J.+D.+Hinksauthor=E.+Huntauthor=M.+J.+Pearsonauthor=B.+Sheaauthor=A.+K.+Takleauthor=J.+M.+Wilsonauthor=G.+Woodnuttauthor=+Pleuromutilins&title=Pleuromutilins.+Part+1+The+identification+of+novel+mutilin+14-carbamates&doi=10.1016%2Fs0968-0896%2800%2900338-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fs0968-0896%2800%2900338-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0968-0896%252800%252900338-2%26sid%3Dliteratum%253Aachs%26aulast%3DBrooks%26aufirst%3DG.%26aulast%3DBurgess%26aufirst%3DW.%26aulast%3DColthurst%26aufirst%3DD.%26aulast%3DHinks%26aufirst%3DJ.%2BD.%26aulast%3DHunt%26aufirst%3DE.%26aulast%3DPearson%26aufirst%3DM.%2BJ.%26aulast%3DShea%26aufirst%3DB.%26aulast%3DTakle%26aufirst%3DA.%2BK.%26aulast%3DWilson%26aufirst%3DJ.%2BM.%26aulast%3DWoodnutt%26aufirst%3DG.%26aulast%3DPleuromutilins%26atitle%3DPleuromutilins.%2520Part%25201%2520The%2520identification%2520of%2520novel%2520mutilin%252014-carbamates%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2001%26volume%3D9%26spage%3D1221%26epage%3D1231%26doi%3D10.1016%2Fs0968-0896%2800%2900338-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X. L.</span>; <span class="NLM_string-name">Jacobs, R. T.</span>; <span class="NLM_string-name">Hernandez, V.</span>; <span class="NLM_string-name">Xia, Y.</span>; <span class="NLM_string-name">Plattner, J. J.</span>; <span class="NLM_string-name">Cao, K. J.</span></span> <span> </span><span class="NLM_article-title">Boron Containing Small Molecules</span>. WO <span class="NLM_patent">2006089067 A2</span>, Feb 27, <span class="NLM_year">2017</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=X.+L.+Li&author=R.+T.+Jacobs&author=V.+Hernandez&author=Y.+Xia&author=J.+J.+Plattner&author=K.+J.+Cao&title=Boron+Containing+Small+Molecules"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%2BL.%26atitle%3DBoron%2520Containing%2520Small%2520Molecules%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Clare, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span> <span> </span><span class="NLM_article-title">Development and Validation of a High-Throughput Anti-WolbachiaWhole-Cell Screen</span>. <i>J. Biomol. Screening</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">64</span>– <span class="NLM_lpage">69</span>, <span class="refDoi"> DOI: 10.1177/1087057114551518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1177%2F1087057114551518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=25278497" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptlCqsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=64-69&author=R.+H.+Clareauthor=D.+A.+N.+Cookauthor=K.+L.+Johnstonauthor=L.+Fordauthor=S.+A.+Wardauthor=M.+J.+Taylor&title=Development+and+Validation+of+a+High-Throughput+Anti-WolbachiaWhole-Cell+Screen&doi=10.1177%2F1087057114551518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Development and validation of a high-throughput anti-Wolbachia whole-cell screen: a route to macrofilaricidal drugs against onchocerciasis and lymphatic filariasis</span></div><div class="casAuthors">Clare, Rachel H.; Cook, Darren A. N.; Johnston, Kelly L.; Ford, Louise; Ward, Stephen A.; Taylor, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biomolecular Screening</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">64-69, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">JBISF3</span>;
        ISSN:<span class="NLM_cas:issn">1087-0571</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications</span>)
        </div><div class="casAbstract">There is an urgent need to develop new, safe, and affordable macrofilaricidal drugs for onchocerciasis and lymphatic filariasis treatment and control.  The Anti-Wolbachia Consortium (A·WOL) aims to provide a novel treatment with macrofilaricidal activity by targeting the essential bacterial symbiont Wolbachia.  The consortium is currently screening a diverse range of compds. to find new chem. space to drive this drug discovery initiative and address this unmet demand.  To increase the throughput and capacity of the A·WOL cell-based screen, we have developed a 384-well format assay using a high-content imaging system (Operetta) in conjunction with optimized Wolbachia growth dynamics in the C6/36 Aedes albopictus mosquito cell line.  This assay uses texture anal. of cells stained with SYTO 11 as a direct measure of bacterial load.  This validated assay has dramatically increased the capacity and throughput of the A·WOL compd. library screening program 25-fold, enriching the no. of new anti-Wolbachia hits identified for further development as potential macrofilaricides for onchocerciasis and lymphatic filariasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSxBmXB7eU-7Vg90H21EOLACvtfcHk0liPF5xn0wxbyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptlCqsw%253D%253D&md5=d1ede349473598c6e4bd9e9e531fe73e</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1177%2F1087057114551518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1087057114551518%26sid%3Dliteratum%253Aachs%26aulast%3DClare%26aufirst%3DR.%2BH.%26aulast%3DCook%26aufirst%3DD.%2BA.%2BN.%26aulast%3DJohnston%26aufirst%3DK.%2BL.%26aulast%3DFord%26aufirst%3DL.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26atitle%3DDevelopment%2520and%2520Validation%2520of%2520a%2520High-Throughput%2520Anti-WolbachiaWhole-Cell%2520Screen%26jtitle%3DJ.%2520Biomol.%2520Screening%26date%3D2015%26volume%3D20%26spage%3D64%26epage%3D69%26doi%3D10.1177%2F1087057114551518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Serbus, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landmann, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, W. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruybal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lokey, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debec, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, W.</span></span> <span> </span><span class="NLM_article-title">A cell-based screen reveals that the albendazole metabolite, albendazole sulfone, targets Wolbachia</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">e1002922</span>, <span class="refDoi"> DOI: 10.1371/journal.ppat.1002922</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1371%2Fjournal.ppat.1002922" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=23028321" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVaktrjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&pages=e1002922&author=L.+R.+Serbusauthor=F.+Landmannauthor=W.+M.+Brayauthor=P.+M.+Whiteauthor=J.+Ruybalauthor=R.+S.+Lokeyauthor=A.+Debecauthor=W.+Sullivan&title=A+cell-based+screen+reveals+that+the+albendazole+metabolite%2C+albendazole+sulfone%2C+targets+Wolbachia&doi=10.1371%2Fjournal.ppat.1002922"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">A cell-based screen reveals that the albendazole metabolite, albendazole sulfone, targets Wolbachia</span></div><div class="casAuthors">Serbus, Laura R.; Landmann, Frederic; Bray, Walter M.; White, Pamela M.; Ruybal, Jordan; Lokey, R. Scott; Debec, Alain; Sullivan, William</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e1002922</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Wolbachia endosymbionts carried by filarial nematodes give rise to the neglected diseases African river blindness and lymphatic filariasis afflicting millions worldwide.  Here, the authors identify new Wolbachia-disrupting compds. by conducting high-throughput cell-based chem. screens using a Wolbachia-infected, fluorescently labeled Drosophila cell line.  This screen yielded several Wolbachia-disrupting compds. including three that resembled albendazole, a widely used anthelmintic drug that targets nematode microtubules.  Follow-up studies demonstrate that a common albendazole metabolite, albendazole sulfone, reduces intracellular Wolbachia titer both in Drosophila melanogaster and Brugia malayi, the nematode responsible for lymphatic filariasis.  Significantly, albendazole sulfone does not disrupt Drosophila microtubule organization, suggesting that this compd. reduces titer through direct targeting of Wolbachia.  Accordingly, both DNA staining and FtsZ immunofluorescence demonstrates that albendazole sulfone treatment induces Wolbachia elongation, a phenotype indicative of binary fission defects.  This suggests that the efficacy of albendazole in treating filarial nematode-based diseases is attributable to dual targeting of nematode microtubules and their Wolbachia endosymbionts.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzCFI0jrY1z7Vg90H21EOLACvtfcHk0ljgmbTvyL-6Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVaktrjK&md5=a6f0050e35f00284158b4289f6a24d03</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002922%26sid%3Dliteratum%253Aachs%26aulast%3DSerbus%26aufirst%3DL.%2BR.%26aulast%3DLandmann%26aufirst%3DF.%26aulast%3DBray%26aufirst%3DW.%2BM.%26aulast%3DWhite%26aufirst%3DP.%2BM.%26aulast%3DRuybal%26aufirst%3DJ.%26aulast%3DLokey%26aufirst%3DR.%2BS.%26aulast%3DDebec%26aufirst%3DA.%26aulast%3DSullivan%26aufirst%3DW.%26atitle%3DA%2520cell-based%2520screen%2520reveals%2520that%2520the%2520albendazole%2520metabolite%252C%2520albendazole%2520sulfone%252C%2520targets%2520Wolbachia%26jtitle%3DPLoS%2520Pathog.%26date%3D2012%26volume%3D8%26spage%3De1002922%26doi%3D10.1371%2Fjournal.ppat.1002922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wring, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sligar, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowling, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercer, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rewerts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaukel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Owens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacchi, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scandale, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, R.</span></span> <span> </span><span class="NLM_article-title">SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 human African trypanosomiasis</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1151</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0001151</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1371%2Fjournal.pntd.0001151" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=21738803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC3MXotlOgsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2011&pages=e1151&author=R.+T.+Jacobsauthor=B.+Nareauthor=S.+A.+Wringauthor=M.+D.+Orrauthor=D.+Chenauthor=J.+M.+Sligarauthor=M.+X.+Jenksauthor=R.+A.+Noeauthor=T.+S.+Bowlingauthor=L.+T.+Mercerauthor=C.+Rewertsauthor=E.+Gaukelauthor=J.+Owensauthor=R.+Parhamauthor=R.+Randolphauthor=B.+Beaudetauthor=C.+J.+Bacchiauthor=N.+Yarlettauthor=J.+J.+Plattnerauthor=Y.+Freundauthor=C.+Dingauthor=T.+Akamaauthor=Y.-K.+Zhangauthor=R.+Brunauthor=M.+Kaiserauthor=I.+Scandaleauthor=R.+Don&title=SCYX-7158%2C+an+orally-active+benzoxaborole+for+the+treatment+of+stage+2+human+African+trypanosomiasis&doi=10.1371%2Fjournal.pntd.0001151"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">SCYX-7158, an orally-active benzoxaborole for the treatment of stage 2 Human African trypanosomiasis</span></div><div class="casAuthors">Jacobs, Robert T.; Nare, Bakela; Wring, Stephen A.; Orr, Matthew D.; Chen, Daitao; Sligar, Jessica M.; Jenks, Matthew X.; Noe, Robert A.; Bowling, Tana S.; Mercer, Luke T.; Rewerts, Cindy; Gaukel, Eric; Owens, Jennifer; Parham, Robin; Randolph, Ryan; Beaudet, Beth; Bacchi, Cyrus J.; Yarlett, Nigel; Plattner, Jacob J.; Freund, Yvonne; Ding, Charles; Akama, Tsutomu; Zhang, Y.-K.; Brun, Reto; Kaiser, Marcel; Scandale, Ivan; Don, Robert</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e1151</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Human African trypanosomiasis (HAT) is an important public health problem in sub-Saharan Africa, affecting hundreds of thousands of individuals.  An urgent need exists for the discovery and development of new, safe, and effective drugs to treat HAT, as existing therapies suffer from poor safety profiles, difficult treatment regimens, limited effectiveness, and a high cost of goods.  We have discovered and optimized a novel class of small-mol. boron-contg. compds., benzoxaboroles, to identify SCYX-7158 as an effective, safe and orally active treatment for HAT.  Methodol./Principal Findings: A drug discovery project employing integrated biol. screening, medicinal chem. and pharmacokinetic characterization identified SCYX-7158 as an optimized analog, as it is active in vitro against relevant strains of Trypanosoma brucei, including T. b. rhodesiense and T. b. gambiense, is efficacious in both stage 1 and stage 2 murine HAT models and has physicochem. and in vitro absorption, distribution, metab., elimination and toxicol. (ADMET) properties consistent with the compd. being orally available, metabolically stable and CNS permeable.  In a murine stage 2 study, SCYX-7158 is effective orally at doses as low as 12.5 mg/kg (QD × 7 days).  In vivo pharmacokinetic characterization of SCYX-7158 demonstrates that the compd. is highly bioavailable in rodents and non-human primates, has low i.v. plasma clearance and has a 24-h elimination half-life and a vol. of distribution that indicate good tissue distribution.  Most importantly, in rodents brain exposure of SCYX-7158 is high, with Cmax>10 μg/mL and AUC0-24 hr>100 μg*h/mL following a 25 mg/kg oral dose.  Furthermore, SCYX-7158 readily distributes into cerebrospinal fluid to achieve therapeutically relevant concns. in this compartment.  Conclusions/Significance: The biol. and pharmacokinetic properties of SCYX-7158 suggest that this compd. will be efficacious and safe to treat stage 2 HAT.  SCYX-7158 has been selected to enter preclin. studies, with expected progression to phase 1 clin. trials in 2011.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpdyaAga5lprVg90H21EOLACvtfcHk0ljgmbTvyL-6Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXotlOgsLY%253D&md5=a54f2d57149e6714c7f6acf5f5280a7d</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0001151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0001151%26sid%3Dliteratum%253Aachs%26aulast%3DJacobs%26aufirst%3DR.%2BT.%26aulast%3DNare%26aufirst%3DB.%26aulast%3DWring%26aufirst%3DS.%2BA.%26aulast%3DOrr%26aufirst%3DM.%2BD.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DSligar%26aufirst%3DJ.%2BM.%26aulast%3DJenks%26aufirst%3DM.%2BX.%26aulast%3DNoe%26aufirst%3DR.%2BA.%26aulast%3DBowling%26aufirst%3DT.%2BS.%26aulast%3DMercer%26aufirst%3DL.%2BT.%26aulast%3DRewerts%26aufirst%3DC.%26aulast%3DGaukel%26aufirst%3DE.%26aulast%3DOwens%26aufirst%3DJ.%26aulast%3DParham%26aufirst%3DR.%26aulast%3DRandolph%26aufirst%3DR.%26aulast%3DBeaudet%26aufirst%3DB.%26aulast%3DBacchi%26aufirst%3DC.%2BJ.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DAkama%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DScandale%26aufirst%3DI.%26aulast%3DDon%26aufirst%3DR.%26atitle%3DSCYX-7158%252C%2520an%2520orally-active%2520benzoxaborole%2520for%2520the%2520treatment%2520of%2520stage%25202%2520human%2520African%2520trypanosomiasis%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2011%26volume%3D5%26spage%3De1151%26doi%3D10.1371%2Fjournal.pntd.0001151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Berner, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulz, H.</span></span> <span> </span><span class="NLM_article-title">Chemie der pleuromutiline-II</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">915</span>– <span class="NLM_lpage">919</span>, <span class="refDoi"> DOI: 10.1016/s0040-4020(01)97660-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fs0040-4020%2801%2997660-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADyaL3MXltFCrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1981&pages=915-919&author=H.+G.+Bernerauthor=H.+Schulz&title=Chemie+der+pleuromutiline-II&doi=10.1016%2Fs0040-4020%2801%2997660-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Chemistry of pleuromutilins.  II.  Synthesis of 12-devinylpleuromutilins</span></div><div class="casAuthors">Berner, H.; Schulz, G.; Schneider, H.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">915-19</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    </div><div class="casAbstract">The title compd. I was prepd. from the AB-trans annulated pleuromutilin deriv. II (R = CH:CH2) (III) by sequential ozonolysis, decarbonylation, and rearrangement reactions.  The key intermediate in the prepn. of II (R = H) (IV) was assigned the α-configuration on the basis of chem. correlation and spectroscopic anal.  Several related species, including 12-devinyltiamulin, were also prepd. from III and IV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsgSl-Snn5_LVg90H21EOLACvtfcHk0ljgmbTvyL-6Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXltFCrtbc%253D&md5=571e9a76e10b95bc77bc6cb6739ee3c8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fs0040-4020%2801%2997660-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0040-4020%252801%252997660-4%26sid%3Dliteratum%253Aachs%26aulast%3DBerner%26aufirst%3DH.%2BG.%26aulast%3DSchulz%26aufirst%3DH.%26atitle%3DChemie%2520der%2520pleuromutiline-II%26jtitle%3DTetrahedron%26date%3D1981%26volume%3D37%26spage%3D915%26epage%3D919%26doi%3D10.1016%2Fs0040-4020%2801%2997660-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novak, R.</span></span> <span> </span><span class="NLM_article-title">Are pleuromutilin antibiotics finally fit for human use?</span>. <i>Ann. N.Y. Acad. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>1241</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1111/j.1749-6632.2011.06219.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1111%2Fj.1749-6632.2011.06219.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=22191527" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC38XisFGmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1241&publication_year=2011&pages=71-81&author=R.+Novak&title=Are+pleuromutilin+antibiotics+finally+fit+for+human+use%3F&doi=10.1111%2Fj.1749-6632.2011.06219.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Are pleuromutilin antibiotics finally fit for human use?</span></div><div class="casAuthors">Novak, Rodger</div><div class="citationInfo"><span class="NLM_cas:title">Annals of the New York Academy of Sciences</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">1241</span>
        (<span class="NLM_cas:issue">Antimicrobial Therapeutics Reviews</span>),
    <span class="NLM_cas:pages">71-81</span>CODEN:
                <span class="NLM_cas:coden">ANYAA9</span>;
        ISSN:<span class="NLM_cas:issn">0077-8923</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  In 1951, the first ref. to the antibacterial substance pleuromutilin was made in a paper published in the Proceedings of the National Academy of Sciences.  Researchers had identified several species of the mold genus Pleurotus that inhibited the growth of Staphylococcus aureus.  The elucidation of the structure in 1962 led to the initiation of a development program at Sandoz, which was followed by the approval of tiamulin in 1979 for use in veterinary medicine.  Although in 2007 retapamulin became the first pleuromutilin approved for topical use in humans, it was not until 2011, exactly 60 years after the first mention of the class, that a pleuromutilin antibiotic, BC-3781, could be tested successfully in a clin. phase II trial for systemic use in patients.  This review will discuss key aspects of this antibacterial class and provide some insight into the question of why it took half a century to develop a systemic pleuromutilin for human use.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo-f4Y5rdMUT7Vg90H21EOLACvtfcHk0lg8h1v18k1L6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XisFGmtbs%253D&md5=7fbae3ecd8b88799cc25f857a58cceaf</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1111%2Fj.1749-6632.2011.06219.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1749-6632.2011.06219.x%26sid%3Dliteratum%253Aachs%26aulast%3DNovak%26aufirst%3DR.%26atitle%3DAre%2520pleuromutilin%2520antibiotics%2520finally%2520fit%2520for%2520human%2520use%253F%26jtitle%3DAnn.%2520N.Y.%2520Acad.%2520Sci.%26date%3D2011%26volume%3D1241%26spage%3D71%26epage%3D81%26doi%3D10.1111%2Fj.1749-6632.2011.06219.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Novak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shlaes, D. M.</span></span> <span> </span><span class="NLM_article-title">The pleuromutilin antibiotics: a new class for human use</span>. <i>Curr. Opin. Investig. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">182</span>– <span class="NLM_lpage">191</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2010&pages=182-191&author=R.+Novakauthor=D.+M.+Shlaes&title=The+pleuromutilin+antibiotics%3A+a+new+class+for+human+use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNovak%26aufirst%3DR.%26aulast%3DShlaes%26aufirst%3DD.%2BM.%26atitle%3DThe%2520pleuromutilin%2520antibiotics%253A%2520a%2520new%2520class%2520for%2520human%2520use%26jtitle%3DCurr.%2520Opin.%2520Investig.%2520Drugs%26date%3D2010%26volume%3D11%26spage%3D182%26epage%3D191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prince, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivezic-Schoenfeld, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tack, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Novak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obermayr, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talbot, G. H.</span></span> <span> </span><span class="NLM_article-title">Phase II clinical study of BC-3781, a pleuromutilin antibiotic, in treatment of patients with acute bacterial skin and skin structure infections</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">2087</span>– <span class="NLM_lpage">2094</span>, <span class="refDoi"> DOI: 10.1128/aac.02106-12</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1128%2Faac.02106-12" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2013&pages=2087-2094&author=W.+T.+Princeauthor=Z.+Ivezic-Schoenfeldauthor=C.+Lellauthor=K.+J.+Tackauthor=R.+Novakauthor=F.+Obermayrauthor=G.+H.+Talbot&title=Phase+II+clinical+study+of+BC-3781%2C+a+pleuromutilin+antibiotic%2C+in+treatment+of+patients+with+acute+bacterial+skin+and+skin+structure+infections&doi=10.1128%2Faac.02106-12"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1128%2Faac.02106-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.02106-12%26sid%3Dliteratum%253Aachs%26aulast%3DPrince%26aufirst%3DW.%2BT.%26aulast%3DIvezic-Schoenfeld%26aufirst%3DZ.%26aulast%3DLell%26aufirst%3DC.%26aulast%3DTack%26aufirst%3DK.%2BJ.%26aulast%3DNovak%26aufirst%3DR.%26aulast%3DObermayr%26aufirst%3DF.%26aulast%3DTalbot%26aufirst%3DG.%2BH.%26atitle%3DPhase%2520II%2520clinical%2520study%2520of%2520BC-3781%252C%2520a%2520pleuromutilin%2520antibiotic%252C%2520in%2520treatment%2520of%2520patients%2520with%2520acute%2520bacterial%2520skin%2520and%2520skin%2520structure%2520infections%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2013%26volume%3D57%26spage%3D2087%26epage%3D2094%26doi%3D10.1128%2Faac.02106-12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeitlinger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwameis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burian, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matzneller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wicha, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strickmann, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prince, W.</span></span> <span> </span><span class="NLM_article-title">Simultaneous assessment of the pharmacokinetics of a pleuromutilin, lefamulin, in plasma, soft tissues and pulmonary epithelial lining fluid</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1022</span>– <span class="NLM_lpage">1026</span>, <span class="refDoi"> DOI: 10.1093/jac/dkv442</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1093%2Fjac%2Fdkv442" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=26747098" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFyltrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2016&pages=1022-1026&author=M.+Zeitlingerauthor=R.+Schwameisauthor=A.+Burianauthor=B.+Burianauthor=P.+Matznellerauthor=M.+M%C3%BCllerauthor=W.+W.+Wichaauthor=D.+B.+Strickmannauthor=W.+Prince&title=Simultaneous+assessment+of+the+pharmacokinetics+of+a+pleuromutilin%2C+lefamulin%2C+in+plasma%2C+soft+tissues+and+pulmonary+epithelial+lining+fluid&doi=10.1093%2Fjac%2Fdkv442"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Simultaneous assessment of the pharmacokinetics of a pleuromutilin, lefamulin, in plasma, soft tissues and pulmonary epithelial lining fluid</span></div><div class="casAuthors">Zeitlinger, M.; Schwameis, R.; Burian, A.; Burian, B.; Matzneller, P.; Mueller, M.; Wicha, W. W.; Strickmann, D. B.; Prince, W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1022-1026</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Background: Lefamulin is a pleuromutilin antibiotic under evaluation for the treatment of bacterial infections, including respiratory tract infections.  Currently, there are no high-quality pharmacokinetic data on drug tissue concns. of lefamulin available.  Methods: A single dose of i.v. lefamulin (150 mg) was given to 12 healthy men.  The registered EudraCT no. for this study was 2010-021938-54.  Lefamulin concns. were simultaneously measured in plasma, skeletal muscle tissue, s.c. adipose tissue and epithelial lining fluid (ELF) over 24 h, and corresponding pharmacokinetic parameters were calcd.  Microdialysis was used to measure unbound lefamulin concns. in skeletal muscle tissue and s.c. adipose tissue, which were similar to unbound lefamulin concns. in plasma.  Bronchoalveolar lavage was performed 1, 2, 4 and 8 h post-dose to det. lefamulin concns. in ELF.  Results: Unbound lefamulin levels showed a 5.7-fold higher exposure in ELF compared with that in plasma, demonstrating good penetration to the target site.  Conclusions: Lefamulin may be an addn. to the therapeutic armamentarium for the treatment of infections.  Simultaneous measurements of unbound drug concn. can guide target attainment for future therapeutic trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsVcGJen007rVg90H21EOLACvtfcHk0lg8h1v18k1L6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFyltrzO&md5=f0cc6808f773dd46ddc9d21f0a6a34bb</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1093%2Fjac%2Fdkv442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252Fdkv442%26sid%3Dliteratum%253Aachs%26aulast%3DZeitlinger%26aufirst%3DM.%26aulast%3DSchwameis%26aufirst%3DR.%26aulast%3DBurian%26aufirst%3DA.%26aulast%3DBurian%26aufirst%3DB.%26aulast%3DMatzneller%26aufirst%3DP.%26aulast%3DM%25C3%25BCller%26aufirst%3DM.%26aulast%3DWicha%26aufirst%3DW.%2BW.%26aulast%3DStrickmann%26aufirst%3DD.%2BB.%26aulast%3DPrince%26aufirst%3DW.%26atitle%3DSimultaneous%2520assessment%2520of%2520the%2520pharmacokinetics%2520of%2520a%2520pleuromutilin%252C%2520lefamulin%252C%2520in%2520plasma%252C%2520soft%2520tissues%2520and%2520pulmonary%2520epithelial%2520lining%2520fluid%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D2016%26volume%3D71%26spage%3D1022%26epage%3D1026%26doi%3D10.1093%2Fjac%2Fdkv442" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Horie, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borchardt, R. T.</span></span> <span> </span><span class="NLM_article-title">Lingua::EN::Titlecase</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">772</span>, <span class="refDoi"> DOI: 10.1023/a:1016140429238</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1023%2Fa%3A1016140429238" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2002&pages=765-772&author=F.+Tangauthor=K.+Horieauthor=R.+T.+Borchardt&title=Lingua%3A%3AEN%3A%3ATitlecase&doi=10.1023%2Fa%3A1016140429238"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1023%2Fa%3A1016140429238&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252Fa%253A1016140429238%26sid%3Dliteratum%253Aachs%26aulast%3DTang%26aufirst%3DF.%26aulast%3DHorie%26aufirst%3DK.%26aulast%3DBorchardt%26aufirst%3DR.%2BT.%26atitle%3DLingua%253A%253AEN%253A%253ATitlecase%26jtitle%3DPharm.%2520Res.%26date%3D2002%26volume%3D19%26spage%3D765%26epage%3D772%26doi%3D10.1023%2Fa%3A1016140429238" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halliday, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimaraes, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrer, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metuge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patrick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnaud, K.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwenti, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsbrook, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steven, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enyong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J. D.</span></span> <span> </span><span class="NLM_article-title">A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis</span>. <i>Parasites Vectors</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">472</span>, <span class="refDoi"> DOI: 10.1186/preaccept-4686600213964315</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1186%2Fpreaccept-4686600213964315" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=25338621" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslGmsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=472&author=A.+Hallidayauthor=A.+F.+Guimaraesauthor=H.+E.+Tyrerauthor=H.+Metugeauthor=C.+Patrickauthor=K.-O.+Arnaudauthor=T.+Kwentiauthor=G.+Forsbrookauthor=A.+Stevenauthor=D.+Cookauthor=P.+Enyongauthor=S.+Wanjiauthor=M.+J.+Taylorauthor=J.+D.+Turner&title=A+murine+macrofilaricide+pre-clinical+screening+model+for+onchocerciasis+and+lymphatic+filariasis&doi=10.1186%2Fpreaccept-4686600213964315"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis</span></div><div class="casAuthors">Halliday, Alice; Guimaraes, Ana F.; Tyrer, Hayley E.; Metuge, Haelly Mejane; Patrick, Chounna Ndongmo Winston; Arnaud, Kengne-Ouafo Jonas; Kwenti, Tayong Dizzle Bita; Forsbrook, George; Steven, Andrew; Cook, Darren; Enyong, Peter; Wanji, Samuel; Taylor, Mark J.; Turner, Joseph D.</div><div class="citationInfo"><span class="NLM_cas:title">Parasites & Vectors</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">472/1-472/31, 31 pp.</span>CODEN:
                <span class="NLM_cas:coden">PVAEAK</span>;
        ISSN:<span class="NLM_cas:issn">1756-3305</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: New drugs effective against adult filariae macrofilaricides would accelerate the elimination of lymphatic filariasis and onchocerciasis.  Anti-Onchocerca drug development is hampered by the lack of a facile model.  We postulated that SCID mice could be developed as a fmacrofilaricide screening model.  Methods: The filaricides: albendazole ABZ, diethylcarbamazine DEC, flubendazole FBZ, ivermectin IVM and the anti-Wolbachia macrofilaricide, minocycline MIN were tested in Brugia malayi Bm-parasitized BALB/c SCID mice vs vehicle control VC.  Responses were compared to BALB/c wild type WT.  Onchocerca ochengi male worms or onchocercomata were surgically implanted into BALB/c SCID, CB.17 SCID, BALB/c WT mice or Meriones gerbils.  Survival was evaluated at 7-15 days.  BALB/c SCID were tested to evaluate the responsiveness of pre-clin. macrofilaricides FBZ and rifapentine RIFAP against male Onchocerca.  Results: WT and SCID responded with >95% efficacy following ABZ or DEC treatments against Bm larvae P < 0.0001.  IVM was partially filaricidal against Bm larvae in WT and SCID WT; 39.8%, P = 0.0356 and SCID; 56.7%, P = 0.026.  SCID responded similarly to WT following IVM treatment of microfilaremias WT; 79%, P = 0.0194.  SCID; 76%, P = 0.0473.  FBZ induced a total macrofilaricidal response against adult Bm in WT and SCID WT; P = 0.0067, SCID; P = 0.0071.  MIN induced a >90% redn. in Bm Wolbachia burdens P < 0.0001 and a blockade of microfilarial release P = 0.0215 in SCID.  Male Onchocerca survival was significantly higher in SCID vs WT mice, but not gerbils, after +15 days 60% vs 22% vs 39% P = 0.0475.  Onchocercoma implants had engrafted into host tissues, with evidence of neovascularisation, after +7 days and yielded viable macro/microfilariae ex vivo.  FBZ induced a macrofilaricidal effect in Onchocerca male implanted SCID at +5 wk FBZ; 1.67% vs VC; 43.81%, P = 0.0089.  Wolbachia loads within male Onchocerca were reduced by 99% in implanted SCID receiving RIFAP for +2 wk.  Conclusions: We have developed a 'pan-filarial' small animal research model that is sufficiently robust, with adequate capacity and throughput, to screen existing and future pre-clin. candidate macrofilaricides.  Pilot data suggests a murine onchocercoma xenograft model is achievable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3XSy0WTfXYbVg90H21EOLACvtfcHk0lh-6PkBIJXOKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslGmsr4%253D&md5=002f530a288c6d90cd60f22597634c1e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1186%2Fpreaccept-4686600213964315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fpreaccept-4686600213964315%26sid%3Dliteratum%253Aachs%26aulast%3DHalliday%26aufirst%3DA.%26aulast%3DGuimaraes%26aufirst%3DA.%2BF.%26aulast%3DTyrer%26aufirst%3DH.%2BE.%26aulast%3DMetuge%26aufirst%3DH.%26aulast%3DPatrick%26aufirst%3DC.%26aulast%3DArnaud%26aufirst%3DK.-O.%26aulast%3DKwenti%26aufirst%3DT.%26aulast%3DForsbrook%26aufirst%3DG.%26aulast%3DSteven%26aufirst%3DA.%26aulast%3DCook%26aufirst%3DD.%26aulast%3DEnyong%26aufirst%3DP.%26aulast%3DWanji%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DTurner%26aufirst%3DJ.%2BD.%26atitle%3DA%2520murine%2520macrofilaricide%2520pre-clinical%2520screening%2520model%2520for%2520onchocerciasis%2520and%2520lymphatic%2520filariasis%26jtitle%3DParasites%2520Vectors%26date%3D2014%26volume%3D7%26spage%3D472%26doi%3D10.1186%2Fpreaccept-4686600213964315" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Specht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfarr, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arriens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klarmann-Schulz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koschel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sternberg, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span> <span> </span><span class="NLM_article-title">Combinations of registered drugs reduce treatment times required to deplete Wolbachia in the Litomosoides sigmodontis mouse model</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">e0006116</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0006116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1371%2Fjournal.pntd.0006116" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2018&pages=e0006116&author=S.+Spechtauthor=K.+M.+Pfarrauthor=S.+Arriensauthor=M.+P.+H%C3%BCbnerauthor=U.+Klarmann-Schulzauthor=M.+Koschelauthor=S.+Sternbergauthor=C.+Martinauthor=L.+Fordauthor=M.+J.+Taylorauthor=A.+Hoerauf&title=Combinations+of+registered+drugs+reduce+treatment+times+required+to+deplete+Wolbachia+in+the+Litomosoides+sigmodontis+mouse+model&doi=10.1371%2Fjournal.pntd.0006116"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0006116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0006116%26sid%3Dliteratum%253Aachs%26aulast%3DSpecht%26aufirst%3DS.%26aulast%3DPfarr%26aufirst%3DK.%2BM.%26aulast%3DArriens%26aufirst%3DS.%26aulast%3DH%25C3%25BCbner%26aufirst%3DM.%2BP.%26aulast%3DKlarmann-Schulz%26aufirst%3DU.%26aulast%3DKoschel%26aufirst%3DM.%26aulast%3DSternberg%26aufirst%3DS.%26aulast%3DMartin%26aufirst%3DC.%26aulast%3DFord%26aufirst%3DL.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DHoerauf%26aufirst%3DA.%26atitle%3DCombinations%2520of%2520registered%2520drugs%2520reduce%2520treatment%2520times%2520required%2520to%2520deplete%2520Wolbachia%2520in%2520the%2520Litomosoides%2520sigmodontis%2520mouse%2520model%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2018%26volume%3D12%26spage%3De0006116%26doi%3D10.1371%2Fjournal.pntd.0006116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Volkmann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span> <span> </span><span class="NLM_article-title">Antibiotic therapy in murine filariasis (Litomosoides sigmodontis): comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability</span>. <i>Trop. Med. Int. Health</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">392</span>– <span class="NLM_lpage">401</span>, <span class="refDoi"> DOI: 10.1046/j.1365-3156.2003.01040.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1046%2Fj.1365-3156.2003.01040.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=12753632" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD3sXksVagsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2003&pages=392-401&author=L.+Volkmannauthor=K.+Fischerauthor=M.+Taylorauthor=A.+Hoerauf&title=Antibiotic+therapy+in+murine+filariasis+%28Litomosoides+sigmodontis%29%3A+comparative+effects+of+doxycycline+and+rifampicin+on+Wolbachia+and+filarial+viability&doi=10.1046%2Fj.1365-3156.2003.01040.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotic therapy in murine filariasis (Litomosoides sigmodontis): Comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability</span></div><div class="casAuthors">Volkmann, Lars; Fischer, Kerstin; Taylor, Mark; Hoerauf, Achim</div><div class="citationInfo"><span class="NLM_cas:title">Tropical Medicine & International Health</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">392-401</span>CODEN:
                <span class="NLM_cas:coden">TMIHFL</span>;
        ISSN:<span class="NLM_cas:issn">1360-2276</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">The symbiosis of filarial nematodes and rickettsial Wolbachia endobacteria has been exploited as a target for antibiotic therapy of filariasis.  Depletion of Wolbachia after tetracycline treatment results in filarial sterility because of interruption of embryogenesis and inhibits larval development and adult worm viability.  The aim of this study was to investigate if antibiotic intervention of BALB/c mice infected with the rodent filaria Litomosoides sigmodontis with rifampicin or the combination of rifampicin and doxycycline can be used to shorten the treatment period.  Both regimens, when given over a period of 14 days initiated with infection, were sufficient to deplete Wolbachia as evidenced by immunohistol. and semiquant. PCR.  Worm development and filarial load were significantly reduced in expts. followed up until 63 days p.i.  The therapy inhibited embryogenesis and led to filarial sterility.  In contrast, treatment with doxycycline alone for 21 days led only to a modest redn. of Wolbachia, filarial growth retardation, worm viability and fertility.  In conclusion, the combination of antirickettsial drugs could be used as a suitable tool to explore the min. duration of therapy required for the depletion of Wolbachia in parasitized hosts subsequent to the onset of patency in human and animal filariasis and the prevention of adverse reactions in human infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlfCS_Sos3PrVg90H21EOLACvtfcHk0lh-6PkBIJXOKQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXksVagsbg%253D&md5=c7f510a315609608385a898e59ad8deb</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1046%2Fj.1365-3156.2003.01040.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1365-3156.2003.01040.x%26sid%3Dliteratum%253Aachs%26aulast%3DVolkmann%26aufirst%3DL.%26aulast%3DFischer%26aufirst%3DK.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DHoerauf%26aufirst%3DA.%26atitle%3DAntibiotic%2520therapy%2520in%2520murine%2520filariasis%2520%2528Litomosoides%2520sigmodontis%2529%253A%2520comparative%2520effects%2520of%2520doxycycline%2520and%2520rifampicin%2520on%2520Wolbachia%2520and%2520filarial%2520viability%26jtitle%3DTrop.%2520Med.%2520Int.%2520Health%26date%3D2003%26volume%3D8%26spage%3D392%26epage%3D401%26doi%3D10.1046%2Fj.1365-3156.2003.01040.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissen-Pähle, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmetz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henkle-Dührsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blaxter, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Büttner, D. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallin, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Qaoud, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucius, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleischer, B.</span></span> <span> </span><span class="NLM_article-title">Tetracycline therapy targets intracellular bacteria in the filarial nematode Litomosoides sigmodontis and results in filarial infertility</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>103</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">18</span>, <span class="refDoi"> DOI: 10.1172/jci4768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1172%2Fjci4768" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=1999&pages=11-18&author=A.+Hoeraufauthor=K.+Nissen-P%C3%A4hleauthor=C.+Schmetzauthor=K.+Henkle-D%C3%BChrsenauthor=M.+L.+Blaxterauthor=D.+W.+B%C3%BCttnerauthor=M.+Y.+Gallinauthor=K.+M.+Al-Qaoudauthor=R.+Luciusauthor=B.+Fleischer&title=Tetracycline+therapy+targets+intracellular+bacteria+in+the+filarial+nematode+Litomosoides+sigmodontis+and+results+in+filarial+infertility&doi=10.1172%2Fjci4768"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1172%2Fjci4768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252Fjci4768%26sid%3Dliteratum%253Aachs%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DNissen-P%25C3%25A4hle%26aufirst%3DK.%26aulast%3DSchmetz%26aufirst%3DC.%26aulast%3DHenkle-D%25C3%25BChrsen%26aufirst%3DK.%26aulast%3DBlaxter%26aufirst%3DM.%2BL.%26aulast%3DB%25C3%25BCttner%26aufirst%3DD.%2BW.%26aulast%3DGallin%26aufirst%3DM.%2BY.%26aulast%3DAl-Qaoud%26aufirst%3DK.%2BM.%26aulast%3DLucius%26aufirst%3DR.%26aulast%3DFleischer%26aufirst%3DB.%26atitle%3DTetracycline%2520therapy%2520targets%2520intracellular%2520bacteria%2520in%2520the%2520filarial%2520nematode%2520Litomosoides%2520sigmodontis%2520and%2520results%2520in%2520filarial%2520infertility%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1999%26volume%3D103%26spage%3D11%26epage%3D18%26doi%3D10.1172%2Fjci4768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ajendra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Specht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neumann, A.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gondorf, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gentil, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, M. P.</span></span> <span> </span><span class="NLM_article-title">ST2 deficiency does not impair type 2 immune responses during chronic filarial infection but leads to an increased microfilaremia due to an impaired splenic microfilarial clearance</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">e93072</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0093072</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1371%2Fjournal.pone.0093072" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=24663956" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVWgu7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=e93072&author=J.+Ajendraauthor=S.+Spechtauthor=A.-L.+Neumannauthor=F.+Gondorfauthor=D.+Schmidtauthor=K.+Gentilauthor=W.+H.+Hoffmannauthor=M.+J.+Taylorauthor=A.+Hoeraufauthor=M.+P.+H%C3%BCbner&title=ST2+deficiency+does+not+impair+type+2+immune+responses+during+chronic+filarial+infection+but+leads+to+an+increased+microfilaremia+due+to+an+impaired+splenic+microfilarial+clearance&doi=10.1371%2Fjournal.pone.0093072"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">ST2 deficiency does not impair type 2 immune responses during chronic filarial infection but leads to an increased microfilaremia due to an impaired splenic microfilarial clearance</span></div><div class="casAuthors">Ajendra, Jesuthas; Specht, Sabine; Neumann, Anna-Lena; Gondorf, Fabian; Schmidt, David; Gentil, Katrin; Hoffmann, Wolfgang H.; Taylor, Mark J.; Hoerauf, Achim; Huebner, Marc P.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e93072/1-e93072/13, 13 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Background: Interactions of the Th2 cytokine IL-33 with its receptors ST2 lead to amplified Type 2 immune responses.  As Type 2 immune responses are known to mediate protection against helminth infections we hypothesized that the lack of ST2 would lead to an increased susceptibility to filarial infections.  Methodol./Principal Finding: ST2 deficient and immunocompetent BALB/c mice were infected with the filarial nematode Litomosoides sigmodontis.  At different time points after infection mice were analyzed for worm burden and their immune responses were examd. within the thoracic cavity, the site of infection, and systemically using spleen cells and plasma.  Absence of ST2 led to significantly increased levels of peripheral blood microfilariae, the filarial progeny, whereas L. sigmodontis adult worm burden was not affected.  Development of local and systemic Type 2 immune responses were not impaired in ST2 deficient mice after the onset of microfilaremia, but L. sigmodontis infected ST2-ko mice had significantly reduced total nos. of cells within the thoracic cavity and spleen compared to infected immunocompetent controls.  Pronounced microfilaremia in ST2-ko mice did not result from an increased microfilariae release by adult female worms, but an impaired splenic clearance of microfilariae.  Conclusions/Significance: Our findings suggest that the absence of ST2 does not impair the establishment of adult L. sigmodontis worms, but is important for the splenic clearance of microfilariae from peripheral blood.  Thus, ST2 interactions may be important for therapies that intend to block the transmission of filarial disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCbPEcyfdJq7Vg90H21EOLACvtfcHk0ljxIrxokTHgfA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVWgu7fP&md5=4e2b67df481b83a657a6d3b9f1489af0</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0093072&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0093072%26sid%3Dliteratum%253Aachs%26aulast%3DAjendra%26aufirst%3DJ.%26aulast%3DSpecht%26aufirst%3DS.%26aulast%3DNeumann%26aufirst%3DA.-L.%26aulast%3DGondorf%26aufirst%3DF.%26aulast%3DSchmidt%26aufirst%3DD.%26aulast%3DGentil%26aufirst%3DK.%26aulast%3DHoffmann%26aufirst%3DW.%2BH.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DH%25C3%25BCbner%26aufirst%3DM.%2BP.%26atitle%3DST2%2520deficiency%2520does%2520not%2520impair%2520type%25202%2520immune%2520responses%2520during%2520chronic%2520filarial%2520infection%2520but%2520leads%2520to%2520an%2520increased%2520microfilaremia%2520due%2520to%2520an%2520impaired%2520splenic%2520microfilarial%2520clearance%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26spage%3De93072%26doi%3D10.1371%2Fjournal.pone.0093072" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morris, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitre, E.</span></span> <span> </span><span class="NLM_article-title">A comprehensive, model-based review of vaccine and repeat infection trials for filariasis</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">421</span>, <span class="refDoi"> DOI: 10.1128/cmr.00002-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1128%2Fcmr.00002-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=23824365" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A280%3ADC%252BC3sjotVamtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2013&pages=381-421&author=C.+P.+Morrisauthor=H.+Evansauthor=S.+E.+Larsenauthor=E.+Mitre&title=A+comprehensive%2C+model-based+review+of+vaccine+and+repeat+infection+trials+for+filariasis&doi=10.1128%2Fcmr.00002-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">A comprehensive, model-based review of vaccine and repeat infection trials for filariasis</span></div><div class="casAuthors">Morris C Paul; Evans Holly; Larsen Sasha E; Mitre Edward</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">381-421</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">SUMMARY Filarial worms cause highly morbid diseases such as elephantiasis and river blindness.  Since the 1940s, researchers have conducted vaccine trials in 27 different animal models of filariasis.  Although no vaccine trial in a permissive model of filariasis has provided sterilizing immunity, great strides have been made toward developing vaccines that could block transmission, decrease pathological sequelae, or decrease susceptibility to infection.  In this review, we have organized, to the best of our ability, all published filaria vaccine trials and reviewed them in the context of the animal models used.  Additionally, we provide information on the life cycle, disease phenotype, concomitant immunity, and natural immunity during primary and secondary infections for 24 different filaria models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRNFVB97lPF5q69lAbTj9rGfW6udTcc2ea399IsrAJrN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3sjotVamtQ%253D%253D&md5=d3ba508e642aec25807c2a1128de1854</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1128%2Fcmr.00002-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Fcmr.00002-13%26sid%3Dliteratum%253Aachs%26aulast%3DMorris%26aufirst%3DC.%2BP.%26aulast%3DEvans%26aufirst%3DH.%26aulast%3DLarsen%26aufirst%3DS.%2BE.%26aulast%3DMitre%26aufirst%3DE.%26atitle%3DA%2520comprehensive%252C%2520model-based%2520review%2520of%2520vaccine%2520and%2520repeat%2520infection%2520trials%2520for%2520filariasis%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D2013%26volume%3D26%26spage%3D381%26epage%3D421%26doi%3D10.1128%2Fcmr.00002-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Layland, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajendra, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritter, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiszniewsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubner, M. P.</span></span> <span> </span><span class="NLM_article-title">Development of patent Litomosoides sigmodontis infections in semi-susceptible C57BL/6 mice in the absence of adaptive immune responses</span>. <i>Parasites Vectors</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">396</span>, <span class="refDoi"> DOI: 10.1186/s13071-015-1011-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1186%2Fs13071-015-1011-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=26209319" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A280%3ADC%252BC28%252FmvFKisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2015&pages=396&author=L.+E.+Laylandauthor=J.+Ajendraauthor=M.+Ritterauthor=A.+Wiszniewskyauthor=A.+Hoeraufauthor=M.+P.+Hubner&title=Development+of+patent+Litomosoides+sigmodontis+infections+in+semi-susceptible+C57BL%2F6+mice+in+the+absence+of+adaptive+immune+responses&doi=10.1186%2Fs13071-015-1011-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Development of patent Litomosoides sigmodontis infections in semi-susceptible C57BL/6 mice in the absence of adaptive immune responses</span></div><div class="casAuthors">Layland Laura E; Ajendra Jesuthas; Ritter Manuel; Wiszniewsky Anna; Hoerauf Achim; Hubner Marc P</div><div class="citationInfo"><span class="NLM_cas:title">Parasites & vectors</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">396</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  One of the most advantageous research aspects of the murine model of filariasis, Litomosoides sigmodontis, is the availability of mouse strains with varying susceptibility to the nematode infection.  In C57BL/6 mice, L. sigmodontis worms are largely eliminated in this strain by day 40 post-infection and never produce their offspring, microfilariae (Mf).  This provides a unique opportunity to decipher potential immune pathways that are required by filariae to achieve a successful infection.  In this study we tracked worm development and patency, the production of microfilariae and thus the transmission life-stage, in Rag2IL-2Rγ(-/-) mice which are deficient in T, B and NK cell populations.  FINDINGS:  Although worm burden was comparable between wildtype (WT) and Rag2IL-2Rγ(-/-) mice on d30, by day 72 post-infection, parasites in Rag2IL-2Rγ(-/-) mice were still in abundance, freely motile and all mice presented high quantities of Mf both at the site of infection, the thoracic cavity (TC), and in peripheral blood.  Levels of cytokine (IL-4, IL-6, TNFα) and chemokine (MIP-2, RANTES, Eotaxin) parameters were generally low in the TC of infected Rag2IL-2Rγ(-/-)mice at both time-points.  The frequency of neutrophils however was higher in Rag2IL-2Rγ(-/-)mice whereas eosinophils and macrophage populations, including alternatively activated macrophages, were elevated in WT controls.  CONCLUSION:  Our data highlight that adaptive immune responses prevent the development of patent L. sigmodontis infections in semi-susceptible C57BL/6 mice and suggest that induction of such responses may offer a strategy to prevent transmission of human filariasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJvMC16URAclHFYivNCdPRfW6udTcc2ea399IsrAJrN7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252FmvFKisA%253D%253D&md5=0e4b52446072a84c5023100cc003a5e5</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1186%2Fs13071-015-1011-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs13071-015-1011-2%26sid%3Dliteratum%253Aachs%26aulast%3DLayland%26aufirst%3DL.%2BE.%26aulast%3DAjendra%26aufirst%3DJ.%26aulast%3DRitter%26aufirst%3DM.%26aulast%3DWiszniewsky%26aufirst%3DA.%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DHubner%26aufirst%3DM.%2BP.%26atitle%3DDevelopment%2520of%2520patent%2520Litomosoides%2520sigmodontis%2520infections%2520in%2520semi-susceptible%2520C57BL%252F6%2520mice%2520in%2520the%2520absence%2520of%2520adaptive%2520immune%2520responses%26jtitle%3DParasites%2520Vectors%26date%3D2015%26volume%3D8%26spage%3D396%26doi%3D10.1186%2Fs13071-015-1011-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hong, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benayoud, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nixon, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clare, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shiotani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webborn, P. J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kavanagh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aljayyoussi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steven, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Archer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Struever, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frohberger, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ehrens, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hübner, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubbard, A. T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tate, E. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Serwa, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leung, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berry, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gusovsky, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemingway, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, P. M.</span></span> <span> </span><span class="NLM_article-title">AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">1414</span>– <span class="NLM_lpage">1419</span>, <span class="refDoi"> DOI: 10.1073/pnas.1816585116</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1073%2Fpnas.1816585116" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=30617067" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsF2nurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2019&pages=1414-1419&author=W.+D.+Hongauthor=F.+Benayoudauthor=G.+L.+Nixonauthor=L.+Fordauthor=K.+L.+Johnstonauthor=R.+H.+Clareauthor=A.+Cassidyauthor=D.+A.+N.+Cookauthor=A.+Siuauthor=M.+Shiotaniauthor=P.+J.+H.+Webbornauthor=S.+Kavanaghauthor=G.+Aljayyoussiauthor=E.+Murphyauthor=A.+Stevenauthor=J.+Archerauthor=D.+Strueverauthor=S.+J.+Frohbergerauthor=A.+Ehrensauthor=M.+P.+H%C3%BCbnerauthor=A.+Hoeraufauthor=A.+P.+Robertsauthor=A.+T.+M.+Hubbardauthor=E.+W.+Tateauthor=R.+A.+Serwaauthor=S.+C.+Leungauthor=L.+Qieauthor=N.+G.+Berryauthor=F.+Gusovskyauthor=J.+Hemingwayauthor=J.+D.+Turnerauthor=M.+J.+Taylorauthor=S.+A.+Wardauthor=P.+M.+O%E2%80%99Neill&title=AWZ1066S%2C+a+highly+specific+anti-Wolbachia+drug+candidate+for+a+short-course+treatment+of+filariasis&doi=10.1073%2Fpnas.1816585116"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">AWZ1066S, a highly specific anti-Wolbachia drug candidate for a short-course treatment of filariasis</span></div><div class="casAuthors">Hong, W. David; Benayoud, Farid; Nixon, Gemma L.; Ford, Louise; Johnston, Kelly L.; Clare, Rachel H.; Cassidy, Andrew; Cook, Darren A. N.; Siu, Amy; Shiotani, Motohiro; Webborn, Peter J. H.; Kavanagh, Stefan; Aljayyoussi, Ghaith; Murphy, Emma; Steven, Andrew; Archer, John; Struever, Dominique; Frohberger, Stefan J.; Ehrens, Alexandra; Hubner, Marc P.; Hoerauf, Achim; Roberts, Adam P.; Hubbard, Alasdair T. M.; Tate, Edward W.; Serwa, Remigiusz A.; Leung, Suet C.; Qie, Li; Berry, Neil G.; Gusovsky, Fabian; Hemingway, Janet; Turner, Joseph D.; Taylor, Mark J.; Ward, Stephen A.; O'Neill, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1414-1419</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Onchocerciasis and lymphatic filariasis are two neglected tropical diseases that together affect ∼ 157 million people and inflict severe disability.  Both diseases are caused by parasitic filarial nematodes with elimination efforts constrained by the lack of a safe drug that can kill the adult filaria (macrofilaricide).  Previous proof-of-concept human trials have demonstrated that depleting > 90% of the essential nematode endosymbiont bacterium, Wolbachia, using antibiotics, can lead to permanent sterilization of adult female parasites and a safe macrofilaricidal outcome.  AWZ1066S is a highly specific anti-Wolbachia candidate selected through a lead optimization program focused on balancing efficacy, safety and drug metab./pharmacokinetic (DMPK) features of a thienopyrimidine/quinazoline scaffold derived from phenotypic screening.  AWZ1066S shows superior efficacy to existing anti-Wolbachia therapies in validated preclin. models of infection and has DMPK characteristics that are compatible with a short therapeutic regimen of 7 days or less.  This candidate mol. is well-positioned for onward development and has the potential to make a significant impact on communities affected by filariasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCa13fiW76BbVg90H21EOLACvtfcHk0lh4kVzVlmkHOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsF2nurY%253D&md5=55b391a0e3ca8ad730191fb9aa47cf8f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1816585116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1816585116%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DW.%2BD.%26aulast%3DBenayoud%26aufirst%3DF.%26aulast%3DNixon%26aufirst%3DG.%2BL.%26aulast%3DFord%26aufirst%3DL.%26aulast%3DJohnston%26aufirst%3DK.%2BL.%26aulast%3DClare%26aufirst%3DR.%2BH.%26aulast%3DCassidy%26aufirst%3DA.%26aulast%3DCook%26aufirst%3DD.%2BA.%2BN.%26aulast%3DSiu%26aufirst%3DA.%26aulast%3DShiotani%26aufirst%3DM.%26aulast%3DWebborn%26aufirst%3DP.%2BJ.%2BH.%26aulast%3DKavanagh%26aufirst%3DS.%26aulast%3DAljayyoussi%26aufirst%3DG.%26aulast%3DMurphy%26aufirst%3DE.%26aulast%3DSteven%26aufirst%3DA.%26aulast%3DArcher%26aufirst%3DJ.%26aulast%3DStruever%26aufirst%3DD.%26aulast%3DFrohberger%26aufirst%3DS.%2BJ.%26aulast%3DEhrens%26aufirst%3DA.%26aulast%3DH%25C3%25BCbner%26aufirst%3DM.%2BP.%26aulast%3DHoerauf%26aufirst%3DA.%26aulast%3DRoberts%26aufirst%3DA.%2BP.%26aulast%3DHubbard%26aufirst%3DA.%2BT.%2BM.%26aulast%3DTate%26aufirst%3DE.%2BW.%26aulast%3DSerwa%26aufirst%3DR.%2BA.%26aulast%3DLeung%26aufirst%3DS.%2BC.%26aulast%3DQie%26aufirst%3DL.%26aulast%3DBerry%26aufirst%3DN.%2BG.%26aulast%3DGusovsky%26aufirst%3DF.%26aulast%3DHemingway%26aufirst%3DJ.%26aulast%3DTurner%26aufirst%3DJ.%2BD.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DP.%2BM.%26atitle%3DAWZ1066S%252C%2520a%2520highly%2520specific%2520anti-Wolbachia%2520drug%2520candidate%2520for%2520a%2520short-course%2520treatment%2520of%2520filariasis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2019%26volume%3D116%26spage%3D1414%26epage%3D1419%26doi%3D10.1073%2Fpnas.1816585116" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easom, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, H.</span></span> <span> </span><span class="NLM_article-title">Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1299</span>– <span class="NLM_lpage">1307</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2011.12.096</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fj.bmcl.2011.12.096" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=22243961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCnsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=1299-1307&author=Y.-K.+Zhangauthor=J.+J.+Plattnerauthor=Y.+R.+Freundauthor=E.+E.+Easomauthor=Y.+Zhouauthor=L.+Yeauthor=H.+Zhouauthor=D.+Watersonauthor=F.-J.+Gamoauthor=L.+M.+Sanzauthor=M.+Geauthor=Z.+Liauthor=L.+Liauthor=H.+Wangauthor=H.+Cui&title=Benzoxaborole+antimalarial+agents.+Part+2%3A+Discovery+of+fluoro-substituted+7-%282-carboxyethyl%29-1%2C3-dihydro-1-hydroxy-2%2C1-benzoxaboroles&doi=10.1016%2Fj.bmcl.2011.12.096"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxaborole antimalarial agents. Part 2: Discovery of fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span></div><div class="casAuthors">Zhang, Yong-Kang; Plattner, Jacob J.; Freund, Yvonne R.; Easom, Eric E.; Zhou, Yasheen; Ye, Long; Zhou, Huchen; Waterson, David; Gamo, Francisco-Javier; Sanz, Laura M.; Ge, Min; Li, Zhiya; Li, Lingchao; Wang, Hailong; Cui, Han</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1299-1307</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">New boron-contg. benzoxaborole compds. were designed and synthesized for a continuing structure-activity relation (SAR) study to assess the antimalarial activity changes derived from side-chain structural variation, substituent modification on the benzene ring and removal of boron from five-membered oxaborole ring.  This SAR study demonstrated that boron is required for the antimalarial activity, and discovered that three of the newly prepd. fluoro-substituted 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles have excellent potencies (IC50 0.026-0.209 μM) against Plasmodium falciparum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqR7ILmo50S7Vg90H21EOLACvtfcHk0lh4kVzVlmkHOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCnsbg%253D&md5=1b1dfbd62c694f926255c6edb7016b0f</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2011.12.096&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2011.12.096%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DFreund%26aufirst%3DY.%2BR.%26aulast%3DEasom%26aufirst%3DE.%2BE.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DL.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DGamo%26aufirst%3DF.-J.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGe%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DCui%26aufirst%3DH.%26atitle%3DBenzoxaborole%2520antimalarial%2520agents.%2520Part%25202%253A%2520Discovery%2520of%2520fluoro-substituted%25207-%25282-carboxyethyl%2529-1%252C3-dihydro-1-hydroxy-2%252C1-benzoxaboroles%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D1299%26epage%3D1307%26doi%3D10.1016%2Fj.bmcl.2011.12.096" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easom, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Retz, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.-H.</span></span> <span> </span><span class="NLM_article-title">Benzoxaborole antimalarial agents. Part 3: design and syntheses of (carboxy-13C-3,3-2H2)-labeled and (3-14C)-labeled 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1002/jlcr.2926</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1002%2Fjlcr.2926" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC38XmtFeksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=201-205&author=Y.-K.+Zhangauthor=J.+J.+Plattnerauthor=E.+E.+Easomauthor=L.+Liuauthor=D.+M.+Retzauthor=M.+Geauthor=H.-H.+Zhou&title=Benzoxaborole+antimalarial+agents.+Part+3%3A+design+and+syntheses+of+%28carboxy-13C-3%2C3-2H2%29-labeled+and+%283-14C%29-labeled+7-%282-carboxyethyl%29-1%2C3-dihydro-1-hydroxy-2%2C1-benzoxaboroles&doi=10.1002%2Fjlcr.2926"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Benzoxaborole antimalarial agents. Part 3: design and syntheses of (carboxy-13C-3,3-2H2)-labeled and (3-14C)-labeled 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaboroles</span></div><div class="casAuthors">Zhang, Yong-Kang; Plattner, Jacob J.; Easom, Eric E.; Liu, Liang; Retz, Daniel M.; Ge, Min; Zhou, Hui-Hong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">201-205</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Two new isotopically labeled compds., (carboxy-13C-3,3-2H2)-7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (2) and (3-14C)-7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (3), were designed and synthesized to support the preclin. development studies of a potential new antimalarial agent, 7-(2-carboxyethyl)-1,3-dihydro-1-hydroxy-2,1-benzoxaborole (1).  Copyright © 2012 John Wiley and Sons, Ltd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4FVwqW_iAjrVg90H21EOLACvtfcHk0ljSTJEtpNjbLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XmtFeksL0%253D&md5=65431e32fb81b0c68fd53e1e67f9325a</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.2926&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.2926%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.-K.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DEasom%26aufirst%3DE.%2BE.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DRetz%26aufirst%3DD.%2BM.%26aulast%3DGe%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DH.-H.%26atitle%3DBenzoxaborole%2520antimalarial%2520agents.%2520Part%25203%253A%2520design%2520and%2520syntheses%2520of%2520%2528carboxy-13C-3%252C3-2H2%2529-labeled%2520and%2520%25283-14C%2529-labeled%25207-%25282-carboxyethyl%2529-1%252C3-dihydro-1-hydroxy-2%252C1-benzoxaboroles%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2012%26volume%3D55%26spage%3D201%26epage%3D205%26doi%3D10.1002%2Fjlcr.2926" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nare, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wring, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bacchi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaudet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bowling, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Freund, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaukel, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jarnagin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenks, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mejia, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orr, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parham, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Randolph, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rattendi, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rewerts, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sligar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarlett, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Don, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, R.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system african trypanosomiasis</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">4379</span>– <span class="NLM_lpage">4388</span>, <span class="refDoi"> DOI: 10.1128/aac.00498-10</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1128%2Faac.00498-10" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=4379-4388&author=B.+Nareauthor=S.+Wringauthor=C.+Bacchiauthor=B.+Beaudetauthor=T.+Bowlingauthor=R.+Brunauthor=D.+Chenauthor=C.+Dingauthor=Y.+Freundauthor=E.+Gaukelauthor=A.+Hussainauthor=K.+Jarnaginauthor=M.+Jenksauthor=M.+Kaiserauthor=L.+Mercerauthor=E.+Mejiaauthor=A.+Noeauthor=M.+Orrauthor=R.+Parhamauthor=J.+Plattnerauthor=R.+Randolphauthor=D.+Rattendiauthor=C.+Rewertsauthor=J.+Sligarauthor=N.+Yarlettauthor=R.+Donauthor=R.+Jacobs&title=Discovery+of+novel+orally+bioavailable+oxaborole+6-carboxamides+that+demonstrate+cure+in+a+murine+model+of+late-stage+central+nervous+system+african+trypanosomiasis&doi=10.1128%2Faac.00498-10"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1128%2Faac.00498-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.00498-10%26sid%3Dliteratum%253Aachs%26aulast%3DNare%26aufirst%3DB.%26aulast%3DWring%26aufirst%3DS.%26aulast%3DBacchi%26aufirst%3DC.%26aulast%3DBeaudet%26aufirst%3DB.%26aulast%3DBowling%26aufirst%3DT.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DDing%26aufirst%3DC.%26aulast%3DFreund%26aufirst%3DY.%26aulast%3DGaukel%26aufirst%3DE.%26aulast%3DHussain%26aufirst%3DA.%26aulast%3DJarnagin%26aufirst%3DK.%26aulast%3DJenks%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DM.%26aulast%3DMercer%26aufirst%3DL.%26aulast%3DMejia%26aufirst%3DE.%26aulast%3DNoe%26aufirst%3DA.%26aulast%3DOrr%26aufirst%3DM.%26aulast%3DParham%26aufirst%3DR.%26aulast%3DPlattner%26aufirst%3DJ.%26aulast%3DRandolph%26aufirst%3DR.%26aulast%3DRattendi%26aufirst%3DD.%26aulast%3DRewerts%26aufirst%3DC.%26aulast%3DSligar%26aufirst%3DJ.%26aulast%3DYarlett%26aufirst%3DN.%26aulast%3DDon%26aufirst%3DR.%26aulast%3DJacobs%26aufirst%3DR.%26atitle%3DDiscovery%2520of%2520novel%2520orally%2520bioavailable%2520oxaborole%25206-carboxamides%2520that%2520demonstrate%2520cure%2520in%2520a%2520murine%2520model%2520of%2520late-stage%2520central%2520nervous%2520system%2520african%2520trypanosomiasis%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D4379%26epage%3D4388%26doi%3D10.1128%2Faac.00498-10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Palencia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, C. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easom, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meewan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sexton, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franzblau, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woolhiser, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gruppo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenaerts, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parish, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waters, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ioerger, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sacchettini, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cusack, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel oral protein synthesis inhibitors of mycobacterium tuberculosis that target leucyl-trna synthetase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">6271</span>– <span class="NLM_lpage">6280</span>, <span class="refDoi"> DOI: 10.1128/aac.01339-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1128%2Faac.01339-16" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2016&pages=6271-6280&author=A.+Palenciaauthor=X.+Liauthor=W.+Buauthor=W.+Choiauthor=C.+Z.+Dingauthor=E.+E.+Easomauthor=L.+Fengauthor=V.+Hernandezauthor=P.+Houstonauthor=L.+Liuauthor=M.+Meewanauthor=M.+Mohanauthor=F.+L.+Rockauthor=H.+Sextonauthor=S.+Zhangauthor=Y.+Zhouauthor=B.+Wanauthor=Y.+Wangauthor=S.+G.+Franzblauauthor=L.+Woolhiserauthor=V.+Gruppoauthor=A.+J.+Lenaertsauthor=T.+O%E2%80%99Malleyauthor=T.+Parishauthor=C.+B.+Cooperauthor=M.+G.+Watersauthor=Z.+Maauthor=T.+R.+Ioergerauthor=J.+C.+Sacchettiniauthor=J.+Rullasauthor=I.+Angulo-Barturenauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=A.+Mendozaauthor=D.+Barrosauthor=S.+Cusackauthor=J.+J.+Plattnerauthor=M.+R.+K.+Alley&title=Discovery+of+novel+oral+protein+synthesis+inhibitors+of+mycobacterium+tuberculosis+that+target+leucyl-trna+synthetase&doi=10.1128%2Faac.01339-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1128%2Faac.01339-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252Faac.01339-16%26sid%3Dliteratum%253Aachs%26aulast%3DPalencia%26aufirst%3DA.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBu%26aufirst%3DW.%26aulast%3DChoi%26aufirst%3DW.%26aulast%3DDing%26aufirst%3DC.%2BZ.%26aulast%3DEasom%26aufirst%3DE.%2BE.%26aulast%3DFeng%26aufirst%3DL.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DHouston%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DMeewan%26aufirst%3DM.%26aulast%3DMohan%26aufirst%3DM.%26aulast%3DRock%26aufirst%3DF.%2BL.%26aulast%3DSexton%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DWan%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DFranzblau%26aufirst%3DS.%2BG.%26aulast%3DWoolhiser%26aufirst%3DL.%26aulast%3DGruppo%26aufirst%3DV.%26aulast%3DLenaerts%26aufirst%3DA.%2BJ.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DT.%26aulast%3DParish%26aufirst%3DT.%26aulast%3DCooper%26aufirst%3DC.%2BB.%26aulast%3DWaters%26aufirst%3DM.%2BG.%26aulast%3DMa%26aufirst%3DZ.%26aulast%3DIoerger%26aufirst%3DT.%2BR.%26aulast%3DSacchettini%26aufirst%3DJ.%2BC.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DMendoza%26aufirst%3DA.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DCusack%26aufirst%3DS.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26atitle%3DDiscovery%2520of%2520novel%2520oral%2520protein%2520synthesis%2520inhibitors%2520of%2520mycobacterium%2520tuberculosis%2520that%2520target%2520leucyl-trna%2520synthetase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2016%26volume%3D60%26spage%3D6271%26epage%3D6280%26doi%3D10.1128%2Faac.01339-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hernandez, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rock, F. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mak, Y. S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easom, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plattner, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Herrán, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza-Losana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alemparte, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rullas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crouch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ortega, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barros, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alley, M. R. K.</span></span> <span> </span><span class="NLM_article-title">Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[<i>c</i>][1,2]oxaborol-1(3H)-ol (GSK656)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8011</span>– <span class="NLM_lpage">8026</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00631</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00631" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFGms7jJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8011-8026&author=X.+Liauthor=V.+Hernandezauthor=F.+L.+Rockauthor=W.+Choiauthor=Y.+S.+L.+Makauthor=M.+Mohanauthor=W.+Maoauthor=Y.+Zhouauthor=E.+E.+Easomauthor=J.+J.+Plattnerauthor=W.+Zouauthor=E.+P%C3%A9rez-Herr%C3%A1nauthor=I.+Giordanoauthor=A.+Mendoza-Losanaauthor=C.+Alemparteauthor=J.+Rullasauthor=I.+Angulo-Barturenauthor=S.+Crouchauthor=F.+Ortegaauthor=D.+Barrosauthor=M.+R.+K.+Alley&title=Discovery+of+a+Potent+and+Specific+M.+tuberculosis+Leucyl-tRNA+Synthetase+Inhibitor%3A+%28S%29-3-%28Aminomethyl%29-4-chloro-7-%282-hydroxyethoxy%29benzo%5Bc%5D%5B1%2C2%5Doxaborol-1%283H%29-ol+%28GSK656%29&doi=10.1021%2Facs.jmedchem.7b00631"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of a potent and specific M. tuberculosis leucyl-tRNA synthetase inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)</span></div><div class="casAuthors">Li, Xianfeng; Hernandez, Vincent; Rock, Fernando L.; Choi, Wai; Mak, Yvonne S. L.; Mohan, Manisha; Mao, Weimin; Zhou, Yasheen; Easom, Eric E.; Plattner, Jacob J.; Zou, Wuxin; Perez-Herran, Esther; Giordano, Ilaria; Mendoza-Losana, Alfonso; Alemparte, Carlos; Rullas, Joaquin; Angulo-Barturen, Inigo; Crouch, Sabrinia; Ortega, Fatima; Barros, David; Alley, M. R. K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8011-8026</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Cyclic boronate monoesters I (X = Cl, Br; R1, R2 = alkoxy, aryloxy, 2-hydroxyethyl; R1R2 = OCH2O, OCH2CH2O) were prepd. by cyclization of substituted 2-boronobenzaldehydes with nitromethane with subsequent nitro-group redn. and examd. in vitro for their inhibition of M. tuberculosis leucyl-tRNA synthetase (Mtb LeuRS) and in vivo in a mouse model of acute TB infection.  There is an urgent need to develop new and safer antitubercular agents that possess a novel mode of action.  We synthesized and evaluated a novel series of 3-aminomethyl 4-halogen benzoxaboroles as Mycobacterium tuberculosis (Mtb) leucyl-tRNA synthetase (LeuRS) inhibitors.  A no. of Mtb LeuRS inhibitors were identified that demonstrated good antitubercular activity with high selectivity over human mitochondrial and cytoplasmic LeuRS.  Further evaluation of these Mtb LeuRS inhibitors by in vivo pharmacokinetics (PK) and murine tuberculosis (TB) efficacy models led to the discovery of GSK3036656 (abbreviated as GSK656).  This mol. shows potent inhibition of Mtb LeuRS (IC50 = 0.20 μM) and in vitro antitubercular activity (Mtb H37Rv MIC = 0.08 μM).  Addnl., it is highly selective for the Mtb LeuRS enzyme with IC50 of >300 μM and 132 μM for human mitochondrial LeuRS and human cytoplasmic LeuRS, resp.  In addn., it exhibits remarkable PK profiles and efficacy against Mtb in mouse TB infection models with superior tolerability over initial leads.  This compd. has been progressed to clin. development for the treatment of tuberculosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr2t6WBCJKOrVg90H21EOLACvtfcHk0lh5kkEZcXCfLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFGms7jJ&md5=c5626f1a1028f79e175a07cb6c01ec44</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00631&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00631%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DHernandez%26aufirst%3DV.%26aulast%3DRock%26aufirst%3DF.%2BL.%26aulast%3DChoi%26aufirst%3DW.%26aulast%3DMak%26aufirst%3DY.%2BS.%2BL.%26aulast%3DMohan%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DW.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DEasom%26aufirst%3DE.%2BE.%26aulast%3DPlattner%26aufirst%3DJ.%2BJ.%26aulast%3DZou%26aufirst%3DW.%26aulast%3DP%25C3%25A9rez-Herr%25C3%25A1n%26aufirst%3DE.%26aulast%3DGiordano%26aufirst%3DI.%26aulast%3DMendoza-Losana%26aufirst%3DA.%26aulast%3DAlemparte%26aufirst%3DC.%26aulast%3DRullas%26aufirst%3DJ.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DCrouch%26aufirst%3DS.%26aulast%3DOrtega%26aufirst%3DF.%26aulast%3DBarros%26aufirst%3DD.%26aulast%3DAlley%26aufirst%3DM.%2BR.%2BK.%26atitle%3DDiscovery%2520of%2520a%2520Potent%2520and%2520Specific%2520M.%2520tuberculosis%2520Leucyl-tRNA%2520Synthetase%2520Inhibitor%253A%2520%2528S%2529-3-%2528Aminomethyl%2529-4-chloro-7-%25282-hydroxyethoxy%2529benzo%255Bc%255D%255B1%252C2%255Doxaborol-1%25283H%2529-ol%2520%2528GSK656%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8011%26epage%3D8026%26doi%3D10.1021%2Facs.jmedchem.7b00631" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Klarmann-Schulz, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Specht, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debrah, A. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Batsa, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ayisi-Boateng, N. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Osei-Mensah, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mubarik, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Konadu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricchiuto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fimmers, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arriens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubben, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoerauf, A.</span></span> <span> </span><span class="NLM_article-title">Comparison of doxycycline, minocycline, doxycycline plus albendazole and albendazole alone in their efficacy against onchocerciasis in a randomized, open-label, pilot trial</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0005156</span>, <span class="refDoi"> DOI: 10.1371/journal.pntd.0005156</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1371%2Fjournal.pntd.0005156" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=28056021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1CltbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&pages=e0005156&author=U.+Klarmann-Schulzauthor=S.+Spechtauthor=A.+Y.+Debrahauthor=L.+Batsaauthor=N.+K.+Ayisi-Boatengauthor=J.+Osei-Mensahauthor=Y.+Mubarikauthor=P.+Konaduauthor=A.+Ricchiutoauthor=R.+Fimmersauthor=S.+Arriensauthor=B.+Dubbenauthor=L.+Fordauthor=M.+Taylorauthor=A.+Hoerauf&title=Comparison+of+doxycycline%2C+minocycline%2C+doxycycline+plus+albendazole+and+albendazole+alone+in+their+efficacy+against+onchocerciasis+in+a+randomized%2C+open-label%2C+pilot+trial&doi=10.1371%2Fjournal.pntd.0005156"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of doxycycline, minocycline, doxycycline plus albendazole and albendazole alone in their efficacy against onchocerciasis in a randomized, open-label, pilot trial</span></div><div class="casAuthors">Klarmann-Schulz, Ute; Specht, Sabine; Debrah, Alexander Yaw; Batsa, Linda; Ayisi-Boateng, Nana Kwame; Osei-Mensah, Jubin; Mubarik, Yusif; Konadu, Peter; Ricchiuto, Arcangelo; Fimmers, Rolf; Arriens, Sandra; Dubben, Bettina; Ford, Louise; Taylor, Mark; Hoerauf, Achim</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Neglected Tropical Diseases</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e0005156/1-e0005156/22</span>CODEN:
                <span class="NLM_cas:coden">PNTDAM</span>;
        ISSN:<span class="NLM_cas:issn">1935-2735</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">The search for new macrofilaricidal drugs against onchocerciasis that can be administered in shorter regimens than required for doxycycline (DOX, 200mg/d given for 4-6 wk), identified minocycline (MIN) with superior efficacy to DOX.  Further redn. in the treatment regimen may be achieved with co-administration with std. anti-filarial drugs.  Therefore a randomized, open-label, pilot trial was carried out in an area in Ghana endemic for onchocerciasis, comprising 5 different regimens: the std. regimen DOX 200mg/d for 4 wk (DOX 4w, N = 33), the exptl. regimens MIN 200mg/d for 3 wk (MIN 3w; N = 30), DOX 200mg/d for 3 wk plus albendazole (ALB) 800mg/d for 3 days (DOX 3w + ALB 3d, N = 32), DOX 200mg/d for 3 wk (DOX 3w, N = 31) and ALB 800mg for 3 days (ALB 3d, N = 30).  Out of 158 randomized participants, 116 (74.4%) were present for the follow-up at 6 mo of whom 99 participants (63.5%) followed the treatment per protocol and underwent surgery.  Histol. anal. of the adult worms in the extirpated nodules revealed absence of Wolbachia in 98.8% (DOX 4w), 81.4% (DOX 3w + ALB 3d), 72.7% (MIN 3w), 64.1% (DOX 3w) and 35.2% (ALB 3d) of the female worms.  All 4 treatment regimens showed superiority to ALB 3d (p < 0.001, p < 0.001, p = 0.002, p = 0.008, resp.), which was confirmed by real-time PCR.  Addnl., DOX 4w showed superiority to all other treatment arms.  Furthermore DOX 4w and DOX 3w + ALB 3d showed a higher amt. of female worms with degenerated embryogenesis compared to ALB 3d (p = 0.028, p = 0.042, resp.).  These results confirm earlier studies that DOX 4w is sufficient for Wolbachia depletion and the desired parasitol. effects.  The data further suggest that there is an additive effect of ALB (3 days) on top of that of DOX alone, and that MIN shows a trend for stronger potency than DOX.  These latter two results are preliminary and need confirmation in a fully randomized controlled phase 2 trial.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlwgxbbUwQlLVg90H21EOLACvtfcHk0lh5kkEZcXCfLA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1CltbjE&md5=7289403e651ec6f4be3aa5068d5fd7f9</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0005156&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0005156%26sid%3Dliteratum%253Aachs%26aulast%3DKlarmann-Schulz%26aufirst%3DU.%26aulast%3DSpecht%26aufirst%3DS.%26aulast%3DDebrah%26aufirst%3DA.%2BY.%26aulast%3DBatsa%26aufirst%3DL.%26aulast%3DAyisi-Boateng%26aufirst%3DN.%2BK.%26aulast%3DOsei-Mensah%26aufirst%3DJ.%26aulast%3DMubarik%26aufirst%3DY.%26aulast%3DKonadu%26aufirst%3DP.%26aulast%3DRicchiuto%26aufirst%3DA.%26aulast%3DFimmers%26aufirst%3DR.%26aulast%3DArriens%26aufirst%3DS.%26aulast%3DDubben%26aufirst%3DB.%26aulast%3DFord%26aufirst%3DL.%26aulast%3DTaylor%26aufirst%3DM.%26aulast%3DHoerauf%26aufirst%3DA.%26atitle%3DComparison%2520of%2520doxycycline%252C%2520minocycline%252C%2520doxycycline%2520plus%2520albendazole%2520and%2520albendazole%2520alone%2520in%2520their%2520efficacy%2520against%2520onchocerciasis%2520in%2520a%2520randomized%252C%2520open-label%252C%2520pilot%2520trial%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2017%26volume%3D11%26spage%3De0005156%26doi%3D10.1371%2Fjournal.pntd.0005156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span> <span> </span><span class="NLM_article-title">In vitro and in vivo metabolite profiling of valnemulin using ultraperformance liquid chromatography-quadrupole/time-of-flight hybrid mass spectrometry</span>. <i>J. Agric. Food Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">9201</span>– <span class="NLM_lpage">9210</span>, <span class="refDoi"> DOI: 10.1021/jf5012402</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jf5012402" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2014&pages=9201-9210&author=S.+Yangauthor=W.+Shiauthor=D.+Huauthor=S.+Zhangauthor=H.+Zhangauthor=Z.+Wangauthor=L.+Chengauthor=F.+Sunauthor=J.+Shenauthor=X.+Cao&title=In+vitro+and+in+vivo+metabolite+profiling+of+valnemulin+using+ultraperformance+liquid+chromatography-quadrupole%2Ftime-of-flight+hybrid+mass+spectrometry&doi=10.1021%2Fjf5012402"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjf5012402&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjf5012402%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.%26aulast%3DShi%26aufirst%3DW.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DCheng%26aufirst%3DL.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DShen%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DX.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520metabolite%2520profiling%2520of%2520valnemulin%2520using%2520ultraperformance%2520liquid%2520chromatography-quadrupole%252Ftime-of-flight%2520hybrid%2520mass%2520spectrometry%26jtitle%3DJ.%2520Agric.%2520Food%2520Chem.%26date%3D2014%26volume%3D62%26spage%3D9201%26epage%3D9210%26doi%3D10.1021%2Fjf5012402" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lykkeberg, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornett, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halling-Sørensen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, S. H.</span></span> <span> </span><span class="NLM_article-title">Isolation and structural elucidation of tiamulin metabolites formed in liver microsomes of pigs</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">223</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2006.03.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fj.jpba.2006.03.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=16725295" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD28Xosl2msLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2006&pages=223-231&author=A.+K.+Lykkebergauthor=C.+Cornettauthor=B.+Halling-S%C3%B8rensenauthor=S.+H.+Hansen&title=Isolation+and+structural+elucidation+of+tiamulin+metabolites+formed+in+liver+microsomes+of+pigs&doi=10.1016%2Fj.jpba.2006.03.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and structural elucidation of tiamulin metabolites formed in liver microsomes of pigs</span></div><div class="casAuthors">Lykkeberg, Anne Kruse; Cornett, Claus; Halling-Sorensen, Bent; Hansen, Steen Honore</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">223-231</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Although the antimicrobial tiamulin is extensively metabolized in pigs, the metab. is not well investigated.  In this work the NADPH dependent metab. of tiamulin in liver microsomes from pigs has been studied.  The tiamulin metabolites formed in the incubations were analyzed using LC-MS, and three major metabolites were isolated using solid phase extn. and preparative HPLC.  The final structure elucidations were performed by tandem mass spectrometry and 1H and 13C NMR.  The structures of the metabolites were found to be 2β-hydroxy-tiamulin, 8α-hydroxy-tiamulin and N-deethyl-tiamulin.  In addn., the LC-MS chromatograms revealed two other minor metabolites.  From their chromatog. and from MS2 anal. the structures were estd. to be 2β-hydroxy-N-deethyl-tiamulin and 8α-hydroxy-N-deethyl-tiamulin, but the structures were not confirmed by NMR.  In these studies approx. 20% of tiamulin was deethylated, 10% was hydroxylated in the 2β-position and 7% was hydroxylated in the 8α-position.  About 40% of tiamulin was metabolized during the incubation conditions used.  The protein pptn. in the incubations was performed using perchloric acid, and the preparative purifn. was performed under alk. conditions.  Therefore, the stability of the metabolites under these conditions was studied.  The metabolites were found to be stable in the acid soln., but under alk. conditions, particularly at room temp., the stability of esp. 8α-hydroxy-tiamulin was considerably reduced (40% loss after 1 wk).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2qHszJYcLlrVg90H21EOLACvtfcHk0liGnxIS43I8tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xosl2msLk%253D&md5=891a4fd581e29fa7350ec30ab2baad20</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2006.03.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2006.03.023%26sid%3Dliteratum%253Aachs%26aulast%3DLykkeberg%26aufirst%3DA.%2BK.%26aulast%3DCornett%26aufirst%3DC.%26aulast%3DHalling-S%25C3%25B8rensen%26aufirst%3DB.%26aulast%3DHansen%26aufirst%3DS.%2BH.%26atitle%3DIsolation%2520and%2520structural%2520elucidation%2520of%2520tiamulin%2520metabolites%2520formed%2520in%2520liver%2520microsomes%2520of%2520pigs%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2006%26volume%3D42%26spage%3D223%26epage%3D231%26doi%3D10.1016%2Fj.jpba.2006.03.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bakowski, M. A.</span>; <span class="NLM_string-name">Shiroodi, R. K.</span>; <span class="NLM_string-name">Liu, R.</span>; <span class="NLM_string-name">Olejniczak, J.</span>; <span class="NLM_string-name">Yang, B.</span>; <span class="NLM_string-name">Gagaring, K.</span>; <span class="NLM_string-name">Guo, H.</span>; <span class="NLM_string-name">White, P. M.</span>; <span class="NLM_string-name">Chappell, L.</span>; <span class="NLM_string-name">Debec, A.</span>; <span class="NLM_string-name">Landmann, F.</span>; <span class="NLM_string-name">Dubben, B.</span>; <span class="NLM_string-name">Lenz, F.</span>; <span class="NLM_string-name">Struever, D.</span>; <span class="NLM_string-name">Ehrens, A.</span>; <span class="NLM_string-name">Frohberger, S.</span>; <span class="NLM_string-name">Sjoberg, H.</span>; <span class="NLM_string-name">Pionnier, N.</span>; <span class="NLM_string-name">Murphy, E.</span>; <span class="NLM_string-name">Archer, J.</span>; <span class="NLM_string-name">Steven, A.</span>; <span class="NLM_string-name">Chunda, V. C.</span>; <span class="NLM_string-name">Fombad, F. F.</span>; <span class="NLM_string-name">Chounna, P. W.</span>; <span class="NLM_string-name">Njouendou, A. J.</span>; <span class="NLM_string-name">Metuge, H. M.</span>; <span class="NLM_string-name">Ndzeshang, B. L.</span>; <span class="NLM_string-name">Gandjui, N. V.</span>; <span class="NLM_string-name">Akumtoh, D. N.</span>; <span class="NLM_string-name">Kwenti, T. D.</span>; <span class="NLM_string-name">Woods, A. K.</span>; <span class="NLM_string-name">Joseph, S. B.</span>; <span class="NLM_string-name">Hull, M. V.</span>; <span class="NLM_string-name">Xiong, W.</span>; <span class="NLM_string-name">Kuhen, K. L.</span>; <span class="NLM_string-name">Taylor, M.</span>; <span class="NLM_string-name">Wanji, S.</span>; <span class="NLM_string-name">Turner, J. D.</span>; <span class="NLM_string-name">Hübner, M. P.</span>; <span class="NLM_string-name">Hoerauf, A.</span>; <span class="NLM_string-name">Roland, J.</span>; <span class="NLM_string-name">Tremblay, M. S.</span>; <span class="NLM_string-name">Schultz, P. G.</span>; <span class="NLM_string-name">Sullivan, W.</span>; <span class="NLM_string-name">Chu, X.</span>; <span class="NLM_string-name">Petrassi, H. M.</span>; <span class="NLM_string-name">McNamara, C. W.</span></span> <span> </span><span class="NLM_article-title">A single-dose oral therapy for the treatment of lymphatic filariasis and river blindness</span>.  <i>Sci. Transl. Med.</i>, accepted.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Bakowski%2C+M.+A.%3B+Shiroodi%2C+R.+K.%3B+Liu%2C+R.%3B+Olejniczak%2C+J.%3B+Yang%2C+B.%3B+Gagaring%2C+K.%3B+Guo%2C+H.%3B+White%2C+P.+M.%3B+Chappell%2C+L.%3B+Debec%2C+A.%3B+Landmann%2C+F.%3B+Dubben%2C+B.%3B+Lenz%2C+F.%3B+Struever%2C+D.%3B+Ehrens%2C+A.%3B+Frohberger%2C+S.%3B+Sjoberg%2C+H.%3B+Pionnier%2C+N.%3B+Murphy%2C+E.%3B+Archer%2C+J.%3B+Steven%2C+A.%3B+Chunda%2C+V.+C.%3B+Fombad%2C+F.+F.%3B+Chounna%2C+P.+W.%3B+Njouendou%2C+A.+J.%3B+Metuge%2C+H.+M.%3B+Ndzeshang%2C+B.+L.%3B+Gandjui%2C+N.+V.%3B+Akumtoh%2C+D.+N.%3B+Kwenti%2C+T.+D.%3B+Woods%2C+A.+K.%3B+Joseph%2C+S.+B.%3B+Hull%2C+M.+V.%3B+Xiong%2C+W.%3B+Kuhen%2C+K.+L.%3B+Taylor%2C+M.%3B+Wanji%2C+S.%3B+Turner%2C+J.+D.%3B+H%C3%BCbner%2C+M.+P.%3B+Hoerauf%2C+A.%3B+Roland%2C+J.%3B+Tremblay%2C+M.+S.%3B+Schultz%2C+P.+G.%3B+Sullivan%2C+W.%3B+Chu%2C+X.%3B+Petrassi%2C+H.+M.%3B+McNamara%2C+C.+W.+A+single-dose+oral+therapy+for+the+treatment+of+lymphatic+filariasis+and+river+blindness.+Sci.+Transl.+Med.%2C+accepted."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBakowski%26aufirst%3DM.%2BA.%26atitle%3DA%2520single-dose%2520oral%2520therapy%2520for%2520the%2520treatment%2520of%2520lymphatic%2520filariasis%2520and%2520river%2520blindness%26jtitle%3DSci.%2520Transl.%2520Med." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jayoussi, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrer, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimaraes, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myhill, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clare, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steven, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span> <span> </span><span class="NLM_article-title">Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">23458</span>, <span class="refDoi"> DOI: 10.1038/srep23458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1038%2Fsrep23458" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=26996237" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1Chsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=23458&author=R.+Sharmaauthor=G.+A.+Jayoussiauthor=H.+E.+Tyrerauthor=J.+Gambleauthor=L.+Haywardauthor=A.+F.+Guimaraesauthor=J.+Daviesauthor=D.+Waterhouseauthor=D.+A.+Cookauthor=L.+J.+Myhillauthor=R.+H.+Clareauthor=A.+Cassidyauthor=A.+Stevenauthor=K.+L.+Johnstonauthor=L.+Fordauthor=J.+D.+Turnerauthor=S.+A.+Wardauthor=M.+J.+Taylor&title=Minocycline+as+a+re-purposed+anti-Wolbachia+macrofilaricide%3A+superiority+compared+with+doxycycline+regimens+in+a+murine+infection+model+of+human+lymphatic+filariasis&doi=10.1038%2Fsrep23458"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">Minocycline as a re-purposed anti-Wolbachia macrofilaricide: superiority compared with doxycycline regimens in a murine infection model of human lymphatic filariasis</span></div><div class="casAuthors">Sharma, Raman; Jayoussi, Ghaith Al; Tyrer, Hayley E.; Gamble, Joanne; Hayward, Laura; Guimaraes, Ana F.; Davies, Jill; Waterhouse, David; Cook, Darren A. N.; Myhill, Laura J.; Clare, Rachel H.; Cassidy, Andrew; Steven, Andrew; Johnston, Kelly L.; Ford, Louise; Turner, Joseph D.; Ward, Stephen A.; Taylor, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">23458</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Lymphatic filariasis and onchocerciasis are parasitic helminth diseases, which cause severe morbidities such as elephantiasis, skin disease and blindness, presenting a major public health burden in endemic communities.  The anti-Wolbachia consortium (A·WOL: http://www.a-wol.com/) has identified a no. of registered antibiotics that target the endosymbiotic bacterium, Wolbachia, delivering macrofilaricidal activity.  Here we use pharmacokinetics/pharmacodynamics (PK/PD) anal. to rationally develop an anti-Wolbachia chemotherapy by linking drug exposure to pharmacol. effect.  We compare the pharmacokinetics and anti-Wolbachia efficacy in a murine Brugia malayi model of minocycline vs. doxycycline.  Doxycycline exhibits superior PK in comparison to minocycline resulting in a 3-fold greater exposure in SCID mice.  Monte-Carlo simulations confirmed that a bi-daily 25-40 mg/Kg regimen is bioequivalent to a clin. effective 100-200 mg/day dose for these tetracyclines.  Pharmacodynamic studies showed that minocycline depletes Wolbachia more effectively than doxycycline (99.51% vs. 90.35%) after 28 day 25 mg/Kg bid regimens with a more potent block in microfilarial prodn.  PK/PD anal. predicts that minocycline would be expected to be 1.7 fold more effective than doxycycline in man despite lower exposure in our infection models.  Our findings warrant onward clin. investigations to examine the clin. efficacy of minocycline treatment regimens against lymphatic filariasis and onchocerciasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5k1pdDtponbVg90H21EOLACvtfcHk0liGnxIS43I8tQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1Chsbg%253D&md5=37b9ba73b50edf26c88c5e557c01d802</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1038%2Fsrep23458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep23458%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DJayoussi%26aufirst%3DG.%2BA.%26aulast%3DTyrer%26aufirst%3DH.%2BE.%26aulast%3DGamble%26aufirst%3DJ.%26aulast%3DHayward%26aufirst%3DL.%26aulast%3DGuimaraes%26aufirst%3DA.%2BF.%26aulast%3DDavies%26aufirst%3DJ.%26aulast%3DWaterhouse%26aufirst%3DD.%26aulast%3DCook%26aufirst%3DD.%2BA.%26aulast%3DMyhill%26aufirst%3DL.%2BJ.%26aulast%3DClare%26aufirst%3DR.%2BH.%26aulast%3DCassidy%26aufirst%3DA.%26aulast%3DSteven%26aufirst%3DA.%26aulast%3DJohnston%26aufirst%3DK.%2BL.%26aulast%3DFord%26aufirst%3DL.%26aulast%3DTurner%26aufirst%3DJ.%2BD.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26atitle%3DMinocycline%2520as%2520a%2520re-purposed%2520anti-Wolbachia%2520macrofilaricide%253A%2520superiority%2520compared%2520with%2520doxycycline%2520regimens%2520in%2520a%2520murine%2520infection%2520model%2520of%2520human%2520lymphatic%2520filariasis%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26spage%3D23458%26doi%3D10.1038%2Fsrep23458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al Jayoussi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrer, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Priestley, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clare, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steven, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hemingway, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span> <span> </span><span class="NLM_article-title">Albendazole and antibiotics synergize to deliver short-course anti-Wolbachiacurative treatments in preclinical models of filariasis</span>. <i>Proc. Natl. Acad. Sci. U.S.A.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">E9712</span>– <span class="NLM_lpage">E9721</span>, <span class="refDoi"> DOI: 10.1073/pnas.1710845114</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1073%2Fpnas.1710845114" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2017&pages=E9712-E9721&author=J.+D.+Turnerauthor=R.+Sharmaauthor=G.+Al+Jayoussiauthor=H.+E.+Tyrerauthor=J.+Gambleauthor=L.+Haywardauthor=R.+S.+Priestleyauthor=E.+A.+Murphyauthor=J.+Daviesauthor=D.+Waterhouseauthor=D.+A.+N.+Cookauthor=R.+H.+Clareauthor=A.+Cassidyauthor=A.+Stevenauthor=K.+L.+Johnstonauthor=J.+McCallauthor=L.+Fordauthor=J.+Hemingwayauthor=S.+A.+Wardauthor=M.+J.+Taylor&title=Albendazole+and+antibiotics+synergize+to+deliver+short-course+anti-Wolbachiacurative+treatments+in+preclinical+models+of+filariasis&doi=10.1073%2Fpnas.1710845114"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1710845114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1710845114%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DJ.%2BD.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DAl%2BJayoussi%26aufirst%3DG.%26aulast%3DTyrer%26aufirst%3DH.%2BE.%26aulast%3DGamble%26aufirst%3DJ.%26aulast%3DHayward%26aufirst%3DL.%26aulast%3DPriestley%26aufirst%3DR.%2BS.%26aulast%3DMurphy%26aufirst%3DE.%2BA.%26aulast%3DDavies%26aufirst%3DJ.%26aulast%3DWaterhouse%26aufirst%3DD.%26aulast%3DCook%26aufirst%3DD.%2BA.%2BN.%26aulast%3DClare%26aufirst%3DR.%2BH.%26aulast%3DCassidy%26aufirst%3DA.%26aulast%3DSteven%26aufirst%3DA.%26aulast%3DJohnston%26aufirst%3DK.%2BL.%26aulast%3DMcCall%26aufirst%3DJ.%26aulast%3DFord%26aufirst%3DL.%26aulast%3DHemingway%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DS.%2BA.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26atitle%3DAlbendazole%2520and%2520antibiotics%2520synergize%2520to%2520deliver%2520short-course%2520anti-Wolbachiacurative%2520treatments%2520in%2520preclinical%2520models%2520of%2520filariasis%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2017%26volume%3D114%26spage%3DE9712%26epage%3DE9721%26doi%3D10.1073%2Fpnas.1710845114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aljayyoussi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyrer, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ford, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sjoberg, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pionnier, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamble, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Metuge, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, D. A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steven, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guimaraes, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clare, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnston, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myhill, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayward, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wanji, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turner, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, S. A.</span></span> <span> </span><span class="NLM_article-title">Short-course, high-dose rifampicin achieves wolbachia depletion predictive of curative outcomes in preclinical models of lymphatic filariasis and onchocerciasis</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">210</span>, <span class="refDoi"> DOI: 10.1038/s41598-017-00322-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1038%2Fs41598-017-00322-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=28303006" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A280%3ADC%252BC1czntFGisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&pages=210&author=G.+Aljayyoussiauthor=H.+E.+Tyrerauthor=L.+Fordauthor=H.+Sjobergauthor=N.+Pionnierauthor=D.+Waterhouseauthor=J.+Daviesauthor=J.+Gambleauthor=H.+Metugeauthor=D.+A.+N.+Cookauthor=A.+Stevenauthor=R.+Sharmaauthor=A.+F.+Guimaraesauthor=R.+H.+Clareauthor=A.+Cassidyauthor=K.+L.+Johnstonauthor=L.+Myhillauthor=L.+Haywardauthor=S.+Wanjiauthor=J.+D.+Turnerauthor=M.+J.+Taylorauthor=S.+A.+Ward&title=Short-course%2C+high-dose+rifampicin+achieves+wolbachia+depletion+predictive+of+curative+outcomes+in+preclinical+models+of+lymphatic+filariasis+and+onchocerciasis&doi=10.1038%2Fs41598-017-00322-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Short-Course, High-Dose Rifampicin Achieves Wolbachia Depletion Predictive of Curative Outcomes in Preclinical Models of Lymphatic Filariasis and Onchocerciasis</span></div><div class="casAuthors">Aljayyoussi Ghaith; Tyrer Hayley E; Ford Louise; Sjoberg Hanna; Pionnier Nicolas; Waterhouse David; Davies Jill; Gamble Joanne; Cook Darren A N; Steven Andrew; Sharma Raman; Guimaraes Ana F; Clare Rachel H; Cassidy Andrew; Johnston Kelly L; Myhill Laura; Hayward Laura; Turner Joseph D; Taylor Mark J; Ward Stephen A; Metuge Haelly; Wanji Samuel; Metuge Haelly; Wanji Samuel</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">210</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Lymphatic filariasis (LF) and onchocerciasis are priority neglected tropical diseases targeted for elimination.  The only safe drug treatment with substantial curative activity against the filarial nematodes responsible for LF (Brugia malayi, Wuchereria bancrofti) or onchocerciasis (Onchocerca volvulus) is doxycycline.  The target of doxycycline is the essential endosymbiont, Wolbachia.  Four to six weeks doxycycline therapy achieves >90% depletion of Wolbachia in worm tissues leading to blockade of embryogenesis, adult sterility and premature death 18-24 months post-treatment.  Long treatment length and contraindications in children and pregnancy are obstacles to implementing doxycycline as a public health strategy.  Here we determine, via preclinical infection models of Brugia malayi or Onchocerca ochengi that elevated exposures of orally-administered rifampicin can lead to Wolbachia depletions from filariae more rapidly than those achieved by doxycycline.  Dose escalation of rifampicin achieves >90% Wolbachia depletion in time periods of 7 days in B. malayi and 14 days in O. ochengi.  Using pharmacokinetic-pharmacodynamic modelling and mouse-human bridging analysis, we conclude that clinically relevant dose elevations of rifampicin, which have recently been determined as safe in humans, could be administered as short courses to filariasis target populations with potential to reduce anti-Wolbachia curative therapy times to between one and two weeks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSEk6Y8PgO0_pHZzFRCXxVKfW6udTcc2ebcM3JkYC5eErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1czntFGisA%253D%253D&md5=f5d52bcb266b99691966a8f6ce86fc2a</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1038%2Fs41598-017-00322-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-017-00322-5%26sid%3Dliteratum%253Aachs%26aulast%3DAljayyoussi%26aufirst%3DG.%26aulast%3DTyrer%26aufirst%3DH.%2BE.%26aulast%3DFord%26aufirst%3DL.%26aulast%3DSjoberg%26aufirst%3DH.%26aulast%3DPionnier%26aufirst%3DN.%26aulast%3DWaterhouse%26aufirst%3DD.%26aulast%3DDavies%26aufirst%3DJ.%26aulast%3DGamble%26aufirst%3DJ.%26aulast%3DMetuge%26aufirst%3DH.%26aulast%3DCook%26aufirst%3DD.%2BA.%2BN.%26aulast%3DSteven%26aufirst%3DA.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DGuimaraes%26aufirst%3DA.%2BF.%26aulast%3DClare%26aufirst%3DR.%2BH.%26aulast%3DCassidy%26aufirst%3DA.%26aulast%3DJohnston%26aufirst%3DK.%2BL.%26aulast%3DMyhill%26aufirst%3DL.%26aulast%3DHayward%26aufirst%3DL.%26aulast%3DWanji%26aufirst%3DS.%26aulast%3DTurner%26aufirst%3DJ.%2BD.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26aulast%3DWard%26aufirst%3DS.%2BA.%26atitle%3DShort-course%252C%2520high-dose%2520rifampicin%2520achieves%2520wolbachia%2520depletion%2520predictive%2520of%2520curative%2520outcomes%2520in%2520preclinical%2520models%2520of%2520lymphatic%2520filariasis%2520and%2520onchocerciasis%26jtitle%3DSci.%2520Rep.%26date%3D2017%26volume%3D7%26spage%3D210%26doi%3D10.1038%2Fs41598-017-00322-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McGarry, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerton, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, M. J.</span></span> <span> </span><span class="NLM_article-title">Population dynamics of Wolbachia bacterial endosymbionts in Brugia malayi</span>. <i>Mol. Biochem. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/s0166-6851(04)00028-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=10.1016%2Fs0166-6851%2804%2900028-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=15287587" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtFalurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2004&pages=57-67&author=H.+McGarryauthor=G.+L.+Egertonauthor=M.+J.+Taylor&title=Population+dynamics+of+Wolbachia+bacterial+endosymbionts+in+Brugia+malayi&doi=10.1016%2Fs0166-6851%2804%2900028-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Population dynamics of Wolbachia bacterial endosymbionts in Brugia malayi</span></div><div class="casAuthors">McGarry, Helen F.; Egerton, Gillian L.; Taylor, Mark J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Biochemical Parasitology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">57-67</span>CODEN:
                <span class="NLM_cas:coden">MBIPDP</span>;
        ISSN:<span class="NLM_cas:issn">0166-6851</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The human filarial nematode Brugia malayi contains an endosymbiotic bacterium, Wolbachia.  We used real-time quant. polymerase chain reaction (QPCR) and microscopy to investigate the population dynamics of the bacterium-nematode assocn.  Two Wolbachia (wsp and ftsZ) and one nematode (gst) genes were amplified from all life-cycle stages of B. malayi and results expressed as gene copies per worm and as Wolbachia/nematode ratios.  Since the genes were single copy and there was one genome per Wolbachia, the gene copy nos. were equiv. to the nos. of bacteria.  These were similar in microfilariae and the mosquito-borne larval stages (L2 and L3), with the lowest ratios of Wolbachia/nematode DNA.  However, within 7 days of infection of the mammalian host, bacteria had increased 600-fold and the bacteria/worm ratio was the highest of all life-cycle stages.  The rapid multiplication continued throughout L4 development, so that the major period of bacterial population growth occurred within 4 wk of infection of the definitive host.  Microscopy confirmed that there were few bacteria in mosquito-derived L3 but many, in large groups, in L4 collected 9 and 21 days after infection.  In adult male worms up to 15 mo of age, the bacterial populations were maintained, while in females, bacteria nos. increased as the worms matured and as the ovary and embryonic larval stages became infected.  These results support the hypothesis that the bacteria are essential for larval development in the mammalian host and for the long-term survival of adult worms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEXDmoBxaKO7Vg90H21EOLACvtfcHk0ljGnm8ysvZumQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtFalurs%253D&md5=d128f8033d8067a3ccb89d421f0d3ab7</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1016%2Fs0166-6851%2804%2900028-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fs0166-6851%252804%252900028-3%26sid%3Dliteratum%253Aachs%26aulast%3DMcGarry%26aufirst%3DH.%26aulast%3DEgerton%26aufirst%3DG.%2BL.%26aulast%3DTaylor%26aufirst%3DM.%2BJ.%26atitle%3DPopulation%2520dynamics%2520of%2520Wolbachia%2520bacterial%2520endosymbionts%2520in%2520Brugia%2520malayi%26jtitle%3DMol.%2520Biochem.%2520Parasitol.%26date%3D2004%26volume%3D135%26spage%3D57%26epage%3D67%26doi%3D10.1016%2Fs0166-6851%2804%2900028-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i103"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01854">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_55445"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01854">10.1021/acs.jmedchem.8b01854</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings (SMILES) and biochemical and in vitro ADME data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01854/suppl_file/jm8b01854_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01854/suppl_file/jm8b01854_si_001.csv">jm8b01854_si_001.csv (9.55 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01854&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01854%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-5%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01854" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                992KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991b4c8a793be6","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
